1 - 2020-CAP Surveys Catalog

Laboratory medicine is changing at a rapid pace.
Our comprehensive range of programs

is constantly evolving to keep you in step with these changes, so you will have more
time for what matters most—accuracy in the laboratory.
• Choose from more than 650

programs—see pages 4-6 for our
full listing of new programs.
• Offer your staff up to 100 CE credits 2020 Surveys and Anatomic Pathology
with CAP Surveys. Education Programs
• Educate staff on testing trends and
best practices with our Participant
Summary Reports’ extensive
discussions.
• Purchase your programs and manage
your account online—you can review,
2020 Surveys and Anatomic Pathology Education Programs

modify, and submit your prepopulated
quote.
From routine to esoteric, our programs help you deliver performance you can measure and
accuracy you can trust.
325 Waukegan Road

Northfield, IL 60093-2750
800-323-4040
847-832-7000 (Country code: 001) PERFORMANCE YOU CAN MEASURE. ACCURACY YOU CAN TRUST.
© 2019 College of American Pathologists. All rights reserved. 27780.0719

cap.org
Together, we move forward to achieve better You can offer your staff more than 100
patient care. CE credits.
Laboratory medicine is forever changing—more rapidly than ever before. Our comprehensive
range of laboratory quality solutions constantly evolves to keep in step with these changes,
enabling you more time for what matters most—accuracy in the laboratory.
Year over year the CAP innovates, drawing on the collective knowledge of thousands of
experts in laboratory medicine to help laboratories navigate the changes they face. Much of
this innovation comes from integrated solutions that include accreditation and proficiency
testing (PT). Leveraging this knowledge helps you stay ahead of new technologies, changing
testing requirements, and emerging diseases that contribute to the rapid evolution of
clinical laboratory medicine.
CAP PT programs give you confidence in your results by allowing you to compare your
performance against the largest peer groups. And our accreditation peer inspection model
allows participants to develop meaningful connections and share best practices.
The CAP strives to improve every aspect of PT and accreditation, including:
• Expanding our broad range of PT with new testing programs—39 new Surveys in 2019
and 2020 for microbiology, anatomic pathology, molecular pathology, and many other
disciplines
• Annually updating our 21 discipline-specific accreditation checklists—simplifying the

compliance process and providing a roadmap for running a high-quality laboratory
And we are never done moving forward. The CAP continues to innovate and improve our
laboratory quality solutions, providing better ways to serve you. After all, achieving the
highest quality service and best patient care possible is the primary goal for all of us.
Enhance your learning with continuing education (CE) content that is tightly
integrated with proficiency testing challenges.
• For many of our Surveys, each member of a participating laboratory has

complimentary enrollment to online CE activities.
• Meet certification and licensure requirements with CE across multiple disciplines.
• Advance skills with education activities developed by more than 600 experts in
pathology and laboratory medicine.
• Access CE activities for up to 12 months.
To learn more and see how to access CE, visit cap.org and search Surveys CE.
Table of Contents
1 New Developments ...................................... 3–6 15 Microbiology ......................................... 171–206
Microbiology ............................................... 172
2 Continuing Education ................................ 7–20
Bacteriology ................................................ 173
Continuing Education Programs ..................... 8
Competency Assessment Program ............... 15 Mycobacteriology ....................................... 188
QMEd™ Online Educational Courses ............. 18 Mycology..................................................... 189
Parasitology ................................................ 192
3 Quality Management Tools ...................... 21–38
Virology ....................................................... 195
Q-PROBESTM .................................................. 24
Q-TRACKS® .................................................... 29 Multidiscipline Microbiology ....................... 201
Infectious Disease Serology ........................ 205
4 Quality Cross Check ................................. 39–50
16 Immunology and Flow Cytometry ........ 207–218
5 Point-of-Care Programs .......................... 51–54
Immunology ................................................ 208
6 General Chemistry and Therapeutic Flow Cytometry ........................................... 215
Drug Monitoring ....................................... 55–80
General Chemistry and Therapeutic 17 Transfusion Medicine, Viral Markers,
Drug Monitoring ........................................ 56 and Parentage Testing ......................... 219–234
Urine Chemistry ............................................ 68 Transfusion Medicine .................................. 220
Special Chemistry ......................................... 71 Viral Markers .............................................. 230
Parentage Testing ....................................... 233
7 Endocrinology .......................................... 81–90
8 Blood Gas, Critical Care, 18 Histocompatibility ............................... 235–240

and Oximetry ............................................ 91–94
19 Genetics and Molecular Pathology ...... 241–262
9 Toxicology ............................................... 95–110 Cytogenetics ............................................... 242
Biochemical and Molecular Genetics .......... 245
10 Accuracy-Based Programs ................... 111–116
Next-Generation Sequencing ..................... 254
Accuracy-Based Programs ......................... 112
Validated Materials .................................... 116 Molecular Oncology—Solid Tumors ............ 258
Molecular Oncology—Hematologic ............. 262
11 Instrumentation Verification Tools ....... 117–134
Calibration Verification/Linearity ................ 118 20 Anatomic Pathology .............................. 263–292
Instrumentation Quality Surgical Pathology ...................................... 264
Management Programs ........................... 132 General Immunohistochemistry .................. 278
12 Hematology and Predictive Markers ..................................... 281
Clinical Microscopy .............................. 135–154 Specialty Anatomic Pathology .................... 283
Hematology................................................. 136 Cytopathology ............................................. 285
Clinical Microscopy ..................................... 146
21 Forensic Sciences ................................ 293–296
13 Reproductive Medicine ........................ 155–158
Andrology and Embryology .......................... 156 22 Analyte/Procedure Index ..................... 297–344
14 Coagulation .......................................... 159–170 23 Program Code Page Index .................... 345–348

Insight at a glance.
In just seconds, the CAP’s Performance Analytics Dashboard provides valuable

insights into your laboratory’s performance, letting you proactively focus energy
on areas that need immediate attention while filtering out distractions. Updated
daily, this complimentary proficiency testing and CAP accreditation performance
monitoring tool reduces the stress of managing today’s laboratory by giving you
fast access to a single laboratory’s or an expansive network’s performance.
To view a demo, search Performance Analytics Dashboard at cap.org.

1 New Developments
1
New Developments
Immunohistochemistry (IHC) testing
is changing at a rapid pace—so is our
proficiency testing.
• Evaluate your laboratory’s preanalytic processing
steps for tissue and slide preparation of melanoma
(HQMEL) and gliomas (HQNEU).
• Assess analytic and interpretive steps of IHC testing
for the biomarkers c-Myc and Bcl-2 (MYBC).
• Test both pre- and postanalytic steps for IHC of
dermatopathology markers (DPIHC).
New Developments
1
New Developments
New Developments
Quality Management Tools

Subsection Name Program Code Page
Technical Competency Assessment of
Q-PROBES™ QP201 25
Peripheral Blood Smears
Red Blood Cell Utilization: Single and
Q-PROBES QP202 26
Double Unit Transfusions
Q-PROBES Inpatient Test Utilization and Volume Benchmarking QP203 27
Turnaround Time for Image–Guided Breast
Q-PROBES QP204 28
Needle Biopsy Specimens
Quality Cross Check

General Chemistry and Therapeutic
Quality Cross Check—Cardiac Markers CRTQ 42
Drug Monitoring
General Chemistry and Therapeutic Drug Monitoring

Quality Cross Check—Cardiac Markers CRTQ 62
Drug Monitoring
Microbiology
Bacteriology Routine Microbiology Combination RMC 176
Bacteriology Mycoplasma genitalium, Molecular MGEN 185
Virology HSV, VZV—Molecular ID5 198
Multidiscipline Microbiology Infectious Disease, Pneumonia Panel IDPN 203
4 College of American Pathologists 2020 Surveys & Anatomic Pathology Education Programs
New Developments
1
Immunology and Flow Cytometry
New Developments
Flow Cytometry Flow Cytometry—Post-Immunotherapy Analysis FL6 216
Transfusion Medicine, Viral Markers, and Parentage Testing

AABT, AABT1,
Transfusion Medicine Antibody Titer—Automated 224
AABT2, AABT3
Histocompatibility
Section Name Program Code Page
AABT, AABT1,
Histocompatibility Antibody Titer—Automated 238
AABT2, AABT3
Anatomic Pathology
Surgical Pathology CAP/NSH HistoQIP Central Nervous System IHC HQNEU 272
Surgical Pathology CAP/NSH HistoQIP In Situ Hybridization (Kappa/Lambda) HQISH 272
Surgical Pathology CAP/NSH HistoQIP Melanoma IHC HQMEL 273
General Immunohistochemistry Dermatopathology Immunohistochemistry DPIHC 278
General Immunohistochemistry c-Myc/Bcl-2 Immunohistochemistry Tissue Microarray MYBC 279
CAP/ACMG HER2 Gene Amplification by FISH,
Predictive Markers CYHI 282
Interpretation Only
800-323-4040 | 847-832-7000 Option 1 | cap.org 5

2019 New Programs
1
2019 New Programs
New Developments
Name Program Code Page
Quality Cross Check

Quality Cross Check—Transfusion Medicine JATQ 42

Plasma Cardiac Markers International PCARI 65
Fecal Calprotectin FCAL 75
Endocrinology
MMA and Active B12 MMA 82
Toxicology
Novel Opioids and Benzodiazepines NOB 105
Blood Cannabinoids THCB 106
Antifungal Drugs Monitoring AFD 106
Accuracy-Based Programs
Accuracy-Based Glucose, Insulin, and C-Peptide ABGIC 115
Instrumentation Validation Tools

C-Peptide/Insulin Calibration Verification/Linearity LN46 131
Reproductive Medicine
Postvasectomy Sperm Count—Automated PV1 156
Microbiology
Carbapenem-resistant Organisms CRO 180
Molecular Vaginal Panel MVP 185
Gastrointestinal Panel, 5 Challenge GIP5 204

Viral Markers—Series 6, Additional Material VM6X 231
Genetics and Molecular Pathology

CAP/ACMG Cardiomyopathy Sequencing Panel CMSP 246
CAP/ACMG Inherited Cancer Sequencing Panel ICSP 247
Anatomic Pathology
HQIP Whole Slide Image Quality Improvement Program HQWSI 274
CD30 Immunohistochemistry Tissue Microarray CD30 279
p16 Immunohistochemistry Tissue Microarray P16 279
2 Continuing Education
2
Continuing Education
Simplify your record keeping with
Competency Assessment Program.
Be ready for your next inspection:
• Use checklists and courses to document specific
actions and dates.
• Meet deadlines with automated scheduled reminders.
• Upload supporting documentation for complete,
organized records.
• Offer staff 80+ CE credits from included Competency
Assessment courses.
Continuing Education Programs....................................................................................................................... 8
Competency Assessment Program................................................................................................................. 15
QMEd™ Online Educational Courses .............................................................................................................. 18
Continuing Education Programs

2
Your laboratory demonstrates its commitment to quality by choosing
CAP Surveys programs. You’ll find the same level of quality in the CAP
Continuing Education Programs.
CME (Continuing Medical Education for Physicians)

Accreditation
The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
CME Category 1
The CAP designates these enduring materials educational activities for a maximum of the stated number of AMA PRA Category
1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to CME participants of enduring* materials courses:

An AMA requirement mandates that all physicians wishing to claim CME credits must pass a scored assessment. All CAP
enduring materials CME courses require participants to pass a scored assessment prior to claiming credit.
*Enduring courses are those courses that endure over time, such as print or online courses.
CE (Continuing Education for Nonphysicians)

The CAP designates these educational activities for a maximum of the stated number of credits of continuing education.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Certification Maintenance Program (CMP)
accepts these activities to meet its continuing education requirements. The states of California and Florida also approve these
activities for continuing education credit.
Cytotechnologists may apply the credits from the PAP Education (PAPCE/PAPJE/PAPKE/PAPLE/PAPME), NGC, FNAG, FNA,
and TICP programs toward the required educational activities for the American Society of Cytopathology (ASC) Continuing
Education Credit Program (CECC) and the International Academy of Cytology (IAC).
This activity is eligible for continuing medical education (CME) credit or continuing education (CE) credit.
Surveys Continuing Education Activities

When your laboratory participates in CAP Surveys, every member of your team can enroll in education activities and earn
continuing education (CE) credit at no additional charge. Simply follow these steps: 2
1. Establish a free Web account.
2. Complete a reading provided in the Participant Summary or Final Critique.
3. Answer online learning assessment questions.
4. Claim CE certificate.
Each member of your staff can access the Surveys education activities for a maximum of 12 months.
Surveys Educational Activities

Catalog
Program Name Program Code Discipline
Page(s)
C1, C3/C3X, C4, C7,
General Chemistry and Therapeutic Drugs Chemistry 56-58
CZ/CZX/CZ2X, Z
Quality Cross Check—Whole Blood Glucose WBGQ Chemistry 41
Y, YY, DY, BGS, BU, EPO, 84-86,
Endocrinology Chemistry
ING, RAP 88-89
Blood Gas AQ, AQ2, AQ3, AQ4 Chemistry 92
Coagulation—Limited CGB, CGL, CGDF Coagulation 160
Cytogenetics CY, CYBK Cytogenetics 242
Hematology—Basic HE, HEP Hematology and Clinical Microscopy 136
Blood Cell Identification, Photographs BCP, BCP2 Hematology and Clinical Microscopy 139
FH1-FH4, FH6, FH9-10,
Hematology Automated Differential Series Hematology and Clinical Microscopy 136
FH13
Virtual Peripheral Blood Smear VPBS Hematology and Clinical Microscopy 143
Bone Marrow Cell Differential BMD Hematology and Clinical Microscopy 139
CAP/NSH HistoQIP HQIP Histology 271
IG, IGX, ANA, ASO, CRP, HCG,
74,76,
IM, RF, RFX, RUB, RUBX, IL, M,
Immunology Immunology 208-210,
OLI, G, LPE, SPE, UBJP, RDS,
212-214
CCP, S2, S4, S5, AHT
Bacteriology D Microbiology 173
Mycology and Aerobic Actinomycetes F Microbiology 189
D1, D2, D3, D5, D6, D8, MC3,
Limited Bacteriology Microbiology 175-178
MC4, RMC
Sperm Count, Motility, Morphology, and
SMCD, SM1CD, SM2CD Reproductive Medicine 156
Viability
Semen Analysis SC, SC1, PV, SM, SV, ASA Reproductive Medicine 156
96, 99, 104-
DFC, DMPM, SCDD, FTC, UDC,
Toxicology Toxicology 105, 107-
NOB, T
108
J, J1, JE1, JAT, JATE1, EXM,
Transfusion Medicine Transfusion Medicine 220-222
EXM2
800-323-4040 | 847-832-7000 Option 1 | cap.org 9

Surveys Self-Reported Training Opportunities

When your laboratory participates in CAP Surveys, every member of your team can receive self-reported training opportunities.
2
Self-Reported Training Opportunities*
Catalog
Program Name Program Code Source
Page(s)
QP201 - Technical Competency Assessment of
QP201 Data Analysis and Critique 25
Peripheral Blood Smears
QP202 - Red Blood Cell Utilization: Single and
Double Unit Transfusions
QP203 - Inpatient Test Utilization and Volume
Benchmarking
QP204 - Turnaround Time for Image-Guided
Breast Needle Biopsy Specimens
Hematology and Clinical Microscopy
Blood Cell Identification, Photographs BCP, BCP2 Participant Summary 139
Bone Marrow Cell Differential BMD Participant Summary 139
Extended Virtual Peripheral Blood Smear EHE1 Participant Summary 144
FH1–FH13,
Hematology Automated Differential Series Participant Summary 136
FH1P–FH13P
Hematology—Basic HE, HEP Participant Summary 136
Hemoglobinopathy HG Participant Summary 140
Virtual Body Fluid VBF Participant Summary 148
Virtual Peripheral Blood Smear VPBS Participant Summary 143
Clinical Microscopy CMP, CMMP, CMP1 Participant Summary 146-147
Microbiology
Blood Parasite BP Participant Summary/Final Critique 193
Expanded Bacteriology DEX Participant Summary/Final Critique 174
Mycobacteriology E Participant Summary/Final Critique 188
Yeast F1 Participant Summary/Final Critique 189
Parasitology P Participant Summary/Final Critique 192
Ticks, Mites, and Other Arthropods TMO Participant Summary 194
Worm Identification WID Participant Summary 194
*Notes:
• CAP Self-Reported Training Opportunities do not offer CE credit, but can be used toward fulfilling requirements for certification maintenance
by agencies such as the American Society for Clinical Pathology (ASCP). Please verify with your certifying agency to determine your education
requirements.
• These opportunities are subject to change. Refer to the Participant Summary/Final Critique for availability.
Continuing Certification (CC)

Continuing Certification (CC), formerly known as Maintenance of Certification (MOC), is the board certification program
that involves continuous professional development and ensures that an American Board of Pathology (ABP) board-certified 2
pathologist is committed to lifelong learning and competency in a specialty and/or subspecialty.
There are six competency categories defined by the American Board of Medical Specialties (ABMS) and endorsed by the ABP
to fulfill specific CC requirements. They are listed below with their descriptions.
All CAP education activities providing CME credits meet the CC Part II: Lifelong Learning requirements. Some programs will
meet the requirements for Self-Assessment Module (SAM) and/or CC Part IV at the laboratory or the individual levels. Programs
that meet Part IV are identified within the description of the program. Visit the CAP website for the current list of programs that
meet the requirements for CC Part II and Part IV.
Interpersonal and Communication Skills
Demonstrate interpersonal and communication skills that result in effective information exchange and teaming with patients,
patients’ families, and professional associates.
Medical Knowledge
Demonstrate knowledge of established and evolving biomedical, clinical, and cognate sciences and the application of this
knowledge to pathology.
Practice-Based Learning and Improvement
Demonstrate ability to investigate and evaluate diagnostic and laboratory practices in your own laboratory, appraise and
assimilate scientific evidence, and improve laboratory practices and patient care.
Patient Care
Demonstrate a satisfactory level of diagnostic competence and provide appropriate and effective consultation in the context
of pathology services.
Professionalism
Demonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to
diverse patient population.
Systems-Based Practice
Demonstrate understanding of and contribution to local, regional, and national health care systems, and support health care
in systems-based practice definition.
Self Assessment Module: This activity fulfills the SAM credit requirements for CC and is therefore eligible for SAM
credit. Participants who successfully complete an online assessment may apply their earned credit(s) to the ABP’s
SAM requirements.
Note to CME/CE participants: The AMA mandates that all education providers (such as the CAP) require participants pass
assessment questions in an enduring* program in order to earn and claim CME credits. All participants in any activity granting
CME/CE will be required to complete and pass assessment questions before claiming their credits.
For CME/SAM activities ONLY: Participants have a total of three opportunities to take and pass the post-test, with feedback
provided after each question. The AMA requires that participants pass the post-test in an enduring program to claim credit;
therefore, if they do not pass, they cannot claim credit.
*Enduring programs are those courses that endure over time such as print or online courses.
800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Education Programs
2 Maximum AMA PRA Maximum
Catalog
Program Name Program Code CME Category 1 Credits™ CE Credits Format
Page
Annually Annually
Autopsy Pathology AUP/AUP1 12.5**** NA Online 283

Clinical Pathology Improvement
CPIP/CPIP1 15**** NA Online 14
Program*
Digital Slide Program—
DPATH/DPATH1 15**** NA Online (DigitalScope®) 267
Dermatopathology*
Digital Slide Program in FNA* FNA/FNA1 10 10 Online (DigitalScope) 290
Fine-Needle Aspiration
FNAG/FNAG1 10 10 Glass Slides 291
Glass Slides
Forensic Pathology FR/FR1 12.5**** 12.5 Online 294
Hematopathology Online
HPATH/HPATH1 12.5**** 12 Online (DigitalScope) 145
Education
Glass Slides
Nongynecologic
NGC/NGC1 25 25 With Online Cases 289
Cytopathology Education**
(DigitalScope)
Neuropathology Program NP/NP1 10**** NA Online (DigitalScope) 284
PAPCE/APAPCE
PAPJE/APAPJE
Gynecologic Cytopathology PAPKE/APAPKE
8 8 Glass Slides 286
PAP Education Program*** PAPLE/APAPLE
PAPME/APAPME
Series 1 or 2
PAPCPT/APAPCPT
Glass Slide Cytopathology PAP PAPJPT/APAPJPT
PT Program (with Glass Slide PAPKPT/APAPKPT 8 8 Glass Slides 285
PAP Education)*** PAPLPT/APAPLPT
PAPMPT/APAPMPT
Performance Improvement
PIP/PIP1 40 NA Glass Slides 265
Program in Surgical Pathology
Continued on the next page
*Program is available for purchase online. Go to cap.org and choose the Learning tab.
**NGC provides up to 20 CME/CE credits for the glass slides and 5 CME/CE credits for the online slide portion of the program.
***PAP provides up to 8 CME/CE credits for glass slides.
****SAM credits are included in CME totals for the appropriate programs.
Third Page Filler

Education Programs continued
Maximum AMA PRA Maximum
Catalog
2
Program Name Program Code CME Category 1 Credits™ CE Credits Format
Page
Annually Annually
Online Performance
Improvement Program in PIPW/PIPW1 40 NA Online (DigitalScope) 264
Surgical Pathology*
Nongynecologic Cytopathology
Intraoperative Touch Imprint/ TICP/TICP1 10**** 10 Online (DigitalScope) 288
Crush Preparation Program*
Variant Interpretation Only
VIP/VIP1 3 3 Online 252
Program
Virtual Biopsy Program* VBP/VBP1 25**** NA Online (DigitalScope) 266
*Program is available for purchase online. Go to cap.org and choose the Learning tab.
****SAM credits are included in CME totals for the appropriate programs.
System Requirements
DigitalScope is a Web-based whole slide image (WSI) retrieval and viewing system. DigitalScope is supported with Microsoft
Internet Explorer 11.0 (limited support for IE 9 and 10) or later, Firefox 4.0 or later, Safari 3, and the latest Google Chrome
version.
For the most up-to-date information on system requirements, go to cap.org and select CONTACT & SUPPORT. The download
speed and the appearance of the activity will vary depending on the type and speed of your Internet connection, computer’s
power, and browser. 1/3
Simplify ordering with our online store.

Order PT, quality management programs,
learning opportunities, publications, and more.
From the online store, you can:
• Review your 2020 prepopulated quote (based
on your 2019 order)
• Add new programs based on your test menu
• Manage your shipping and billing information
To get started, visit cap.org and select SHOP
at the top of the home page.
27686_OnlineStoreThird_filler.indd 1 5/22/19 4:13 PM

800-323-4040 | 847-832-7000 Option 1 | cap.org 13
Clinical Pathology Improvement Programs (CPIP/CPIP1)

CPIP supports pathologists who principally practice clinical pathology as well as those who primarily practice anatomic
2 pathology but cover clinical pathology. A diverse portfolio of real-life case scenarios, including images and clinical background,
helps pathologists to stay abreast of issues and advances in the lab.
Designed for pathologists, by pathologists. Each case is developed and peer-reviewed ensuring what you learn is practical and
easily applied to your work. Thought provoking questions with feedback and a multiple-choice post-test allow you to assess
and confirm your diagnostic skills. Participants who earn a passing score on the post-test may apply their earned credits to the
ABP’s CC requirements.
Program Information
Clinical Pathology Improvement Program
• CPIP - One online clinical
CPIP/CPIP1 laboratory case per month
Program Name Program Code Cases/Year • CPIP1 - Reporting option
CPIP/CPIP1 with CME/SAM credit for
Online cases in 12 (One per month. each additional pathologist
clinical pathology
z
See below.) (within the same institution);
must order in conjunction
Additional Information with CPIP
Consider the CPIP program if you are a: • Earn a maximum of 15 CME/
• Medical director seeking to continuously improve the clinical pathology SAM credits (AMA PRA
knowledge and collective skills of your pathology team. Category 1 Credits™) per year
• Pathologist with clinical and/or laboratory management responsibilities. • This activity meets the
• Pathologist seeking CME/SAM or CC credits in clinical pathology. ABP CC Part IV Practice
• Subspecialty clinical pathologist who needs to keep current. Performance Assessment
requirements
To learn more visit www.cap.org and search CPIP.
• Twelve cases per year; your
Case Schedule CAP shipping contact will be
Discipline Month 2020
(subject to change) notified via email when the
Lab Management How to retire a test January activity is available
Toxicology Non-cancer pain management February
Molecular approach to
Hematology March
myeloid neoplasms
Chemistry Growth hormone testing April
Blood bank education
Transfusion Medicine May
for clinical staff
Hematology Neutrophilia June
Microbiology Automation in clinical microbiology July
Transfusion Medicine Utilization of platelets and plasma August
Hematology Flow/lymphocytosis September
Cell-free and/or circulating tumor
Molecular Pathology October
cell DNA testing for solid tumors
Chemistry Adrenal function testing November
Lab Management Physician wellness December
Competency Assessment Program

2
About one of every four laboratories is cited for a deficiency related to its
competency assessment records. You can avoid becoming a part of this statistic.
The CAP’s Competency Assessment Program helps keep you in compliance by managing your personnel’s competency
assessment performance and records. Use the CAP’s Competency Assessment Program to track compliance to all six of the
elements of competency assessment as defined by CLIA. Customizable to fit your specific laboratory’s procedures, Competency
Assessment Program offers benefits that simplify your documentation process.
• Be organized. Stay on top of your documentation and records with easy-to-use management reports, employee progress
tracking, and individual employee transcripts so your laboratory is inspection-ready at all times.
• Obtain real-time results. Generate management reports with just a few clicks.
• Strengthen your learning. The program comes ready with multiple relevant, applicable courses already loaded, and new courses
are added every six months.
• Customize training to your needs. If the wide selection of ready-made training courses (Pro Courses) doesn’t meet your
needs, customize them. You can match courses to your laboratory’s exact standard procedures.
• Save time. Tools like ChecklistBuilder, CourseBuilder, and Competency Profiles allow your administrators easy, convenient
methods to document all six areas of competency as defined by CLIA and the CAP Laboratory Accreditation Program.
• Access anywhere. The Competency Assessment Program is cloud based, so it’s available 24/7 from any PC, laptop, or
tablet—wherever you have an Internet connection. Courses are available for users throughout the subscription period.
• Stay focused. Use instrument-specific checklists for assessing competency and training.
• Remain in compliance. Many of the ready-made educational courses provide your staff the opportunity to earn CE credits.
Add Safety & Compliance Courses Especially Developed for the Laboratory
As an add-on option, Competency Assessment Program offers a package of seven non-credit, complementary safety and
compliance courses—appropriate for annual laboratory-specific compliance training and for clinical laboratory science
students prior to clinical rotations. These courses include:
• OSHA Bloodborne Pathogens
• OSHA Hazard Communication and Chemical Hygiene
• OSHA Electrical Safety
• OSHA Fire Safety
• OSHA Formaldehyde
• Tuberculosis Awareness for Health Care Workers
• Medical Error Prevention: Patient Safety
The CAP updates these courses as necessary to reflect changes in regulations or best practices.
With the Competency Assessment Program, you can keep your laboratory organized and inspection-ready every day
of the year. Choose the Competency Assessment Program subscription that fits your lab. Please refer to the ordering
information and course descriptions on the following pages. For more information, visit cap.org and choose Laboratory
Professionals Learning Programs via the Learning tab.
Competency Assessment Program with Optional

Number of Users Competency Assessment Program
Safety & Compliance Courses**
1 CA0001 CA0001 + XCA0001
2 to 50 CA0050 CA0050 + XCA0050
51 to 250* CA0250 CA0250 + XCA0250
*For subscriptions for more than 250 users, please contact the CAP for more information.
**Safety & Compliance Course subscriptions require a standard Competency Assessment Program subscription.
800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Assessment Course Schedule

2 Discipline January 2020 Release July 2020 Release
Blood Banking/Transfusion
Direct antiglobulin test ABO typing discrepancies
Medicine—Generalist
Blood Banking/Transfusion
Direct antiglobulin test ABO typing discrepancies
Medicine—Specialist
Chemistry Clinical toxicology Electrolytes, acid base, and anion gap
Hematology and Coagulation Erythrocyte morphology White blood cell inclusions
Histology Immunohistochemistry—part 2 Histology specimen handling
Monitoring the testing process in Human chorionic gonadotropin and fetal
Immunology
immunology fibronectin
Microbiology—Generalist Genital tract pathogens The microbiology of wounds
Microbiology—Specialist Genital tract pathogens The microbiology of wounds
Phlebotomy/Specimen Processing Professionalism and ethics Venipuncture
Provider-performed microscopy and
Point-of-Care Testing Urine dipstick
limited waived testing
Quality Programs/Management Document control New instrument method validation
Safety Hazardous chemicals Laboratory waste and spill management
Microscopic urinalysis part 2—crystals
Urinalysis/Body fluids Serous and synovial fluids
and casts
Pro Course Schedule

Discipline January 2020 Release July 2020 Release
Blood components—storage, handling,
Blood Banking/Transfusion Medicine Quality control in the blood bank laboratory
and selection
Chemistry Cardiac biomarkers Therapeutic drug monitoring
Hematology and Coagulation Erythrocyte inclusions White blood cells
Histology Quality management in histology Immunohistochemistry—part 1
Immunology Hepatitis testing Rapid serology kit tests
Microbiology Blood cultures Microbiology of the gastrointestinal tract
General specimen handling and
Phlebotomy/Specimen Processing Common pitfalls in specimen processing
transportation requirements
Point-of-Care Testing Whole blood glucose testing Blood gas testing
Investigating occurrences (occurrence
Development and implementation of a
Quality Programs/Management reports, root cause analysis, corrective
quality management program
action)
Safety Bloodborne pathogens General laboratory safety
Urinalysis/Body Fluids Physical and chemical urinalysis Microscopic urinalysis—part 1
Half Page Filler
Safety & Compliance Courses

OSHA Bloodborne Pathogens. Addresses the OSHA Bloodborne Pathogens standard as it applies to clinical and medical 2
laboratories. Covers major bloodborne pathogens, including hepatitis B and HIV. Focuses on proper handling of sharps,
personal protective equipment (PPE), engineering controls such as microbiological safety cabinets, and proper work practices
like handwashing.
OSHA Hazard Communication and Chemical Hygiene. Describes the OSHA Chemical Hygiene Standard and helps satisfy OSHA
requirements for annual training. Explains Haz-Com, the National Fire Protection Agency diamond, the Safety Data Sheet, and
common-sense laboratory safety rules applied to clinical laboratory practice.
OSHA Electrical Safety. Addresses electrical safety and electrical hazards commonly found in the clinical laboratory. Covers
prevention and safety measures, fighting electrical fires, and treatment of electrical injuries.
OSHA Fire Safety. Teaches the basics of fire safety in the clinical laboratory, including classes of fire and key acronyms, such as
PASS and RACE. Addresses fire prevention, drills, and firefighting techniques.
OSHA Formaldehyde. Covers essentials for any laboratory that uses formaldehyde or formalin. Shares facts about
formaldehyde, safety risks, proper handling procedure, monitoring, spill clean-up, and personal protective equipment.
Tuberculosis Awareness for Health Care Workers. Provides background information about spread of tuberculosis, purified
protein derivative (PPD) testing procedures, CDC guidelines, and methods of control.
Medical Error Prevention: Patient Safety. Includes potential causes of medical errors in the clinical laboratory, important
legislation and definitions, and steps laboratory professionals can take to reduce the impact of medical errors in their
workplace. Serves as an ideal part of an effective medical error reduction program. Appropriate for both experienced and newer
laboratory personnel.
Note: The Safety & Compliance courses are not available for purchase separately. The courses listed above do not offer CE credit.
1/2
Half Page Filler

Enhance the culture of patient safety in your laboratory.
Connect the patient safety culture in your laboratory to the overall
mission and goals of your health care enterprise.
• Prevent errors in communication, handoffs, and transitions
• Use technology to improve laboratory patient safety
• Learn how cognitive bias can contribute to patient safety errors
• Build high-reliability teams
• Engage the patient navigator to address safety issues through
continuity and coordination of care
• Develop and implement a patient safety curriculum for the laboratory
• Understand how accreditation milestones advance patient
safety initiatives
Add Patient Safety In Anatomic & Clinical Pathology
Laboratories (PUB316) to your order.
Or, view sample pages and purchase online: Item number: PUB316
• printed books at estore.cap.org Softcover; 128 pages; 2017
• ebooks at ebooks.cap.org
800-323-4040 | 847-832-7000 Option 1 | cap.org 17

800-323-4040 | 847-832-7000 Option 1 | cap.org 33
QMEd™ Online Educational Courses

2
Tailored education and quality tools developed with pathologist input
Quality Management Educational Resources (QMEd) courses will help you:

• Build a quality management system (QMS) – one piece at a time – that sustains your
continuous improvement and Lean efforts.
• Improve your processes and eliminate waste
• Self-assess your current QMS against international quality standards
• Interpret ISO 15189 requirements
• Improve your document control system
• Perform internal audits using tracer audit and process audit methods
• Implement and refine occurrence management with root cause analysis
• Measure, analyze, and set goals with senior management
Program information
• Courses are delivered online via a highly interactive user interface that allows you to learn at your own pace.
• Courses are licensed for one year, allow sharing of logins, and include continuing education (CE) credit.
About the Courses

Quality Culture
Order ISOEDCL
Designed for laboratory medical directors, administrative directors, quality managers, and other leaders who can affect the
culture of their laboratory through their decisions and actions. The course provides an adaptable program for proactively
shaping culture. It includes video commentary by CAP member pathologists. Includes a unique Culture Assessment Tool that
helps laboratory leadership get a picture of where your organization needs to improve and where it is strong. This tool helps
make culture change a reality.
4 CE credits available
Root Cause Analysis
Order ISOEDRC
Learn real-world methodology to conduct a root cause analysis, along with the tools necessary to implement it. Learn from
actual examples of complete root cause analysis based on projects in laboratories like yours. You will even perform key steps
based on a participant case study. Includes the RCA Performance and Feedback Toolkit, a set of tools an organization can use
to guide and assess root cause analysis projects. The course is designed for laboratory quality managers and implementation
team members.
Mistake Proofing
Order ISOEDMP
Increase your ability to design new processes, modify existing processes, minimize mistakes, and manage your risks. This
course provides a methodology focused on five main categories of mistake-proofing tactics and shows examples of these
tactics from the domain of laboratory medicine. It includes video commentary by CAP member pathologists with experience
using Lean and other process improvement techniques.
Internal Auditing
Order ISOEDIA
Increase your capabilities for internal auditing with a proven methodology for process audits, tracer audits, and laser audits. 2
Learn how to prepare for interviews, communicate findings to your quality management team, and use audits to drive process
improvements. The course provides detailed, real-world examples you can use to build your own audit plans, plus multimedia
presentations of key concepts.
Management Review
Order ISOEDMR
This course interprets the ISO 15189 requirements for management review. The CAP’s ISO 15189 assessors discuss how
to structure the review meeting, communicate results of quality assessments, and prompt strategic decisions from
management—all in the context of the overall health of your organization.
Quality Manual Development

Order ISOEDQM
This course provides guidance on how to go beyond a quality plan to develop a manual that organizes and communicates your
laboratory’s quality management system. You will see an example of an effectively structured and written manual so you can
organize and create your own. Plus, the CAP’s ISO 15189 assessors show you approaches to link your quality policy to quality
objectives and metrics.
Document Control
Order ISOEDDC
This “how-to” course on document control systems details how to control documents in a way that meets ISO 15189
requirements, how to accomplish document control even with minimal resources (such as spreadsheets), and how document
control contributes to cost containment. Audio recordings of the CAP’s ISO 15189 assessors provide examples and commentary
on common pitfalls and issues.
QMS Implementation Roadmap

Order ISOEDRM
Outlines the practical steps necessary to build, implement, and maintain a quality management system that meets the
ISO 15189 standard. Video recordings of the CAP’s ISO 15189 assessors provide perspective on best practices and pitfalls.
Designed for laboratory quality managers, plus your implementation team members.
15189 Walkthrough
Order ISOEDWT
Designed for laboratory quality managers (along with your medical and administrative decision makers) considering
implementation of an ISO 15189 program. Summarizes each section of the standard, while clarifying its intent and key
requirements. See video recordings of the CAP’s ISO 15189 assessors who offer context and examples of how technical
problems relate to more fundamental deficiencies in the quality management system.
Make sure your laboratory team is ready to meet the challenges ahead. Add QMEd courses to your order form.
Use code ISOEDAL to add the entire series for a 25% discount.
For more information, visit cap.org and search QMEd.
800-323-4040 | 847-832-7000 Option 1 | cap.org 19

How current is your laboratory
quality management plan?
Created specifically for the needs of the anatomic pathology Quality Management In
laboratory, this comprehensive manual can help you develop, Anatomic Pathology
implement, and maintain a comprehensive quality program. Learn Item number: PUB125
valuable tips for designing your own laboratory quality plan that Softcover; 228 pages; 135+ figures
documents regulatory compliance. Text includes cross-references and tables; 2017
to the CAP’s Laboratory Accreditation Program checklists, Joint
Commission standards, and CLIA ’88.
ADD IT TO YOUR ORDER OR
PURCHASE ONLINE.
Printed books at estore.cap.org
Ebooks at ebooks.cap.org
Filler #38
3 Quality Management Tools
3
Engage in quality measures with the
latest Q-PROBES™ programs.

• Assess technologist’s competency of peripheral blood
smears using online whole slide images (QP201).
• Audit your transfusion practices for appropriate use of
blood products by assessing single versus double RBC
unit transfusions (QP202).
• Benchmark your core laboratory test volume to support
your test utilization initiatives (QP203).
• Benchmark your turnaround time for image-guided
breast needle biopsy specimens (QP204).

Q-PROBES™......................................................................................................................................... 24
Q-TRACKS® .......................................................................................................................................... 29
Clinical Pathology Monitors.............................................................................................................. 31
Anatomic Pathology Monitor ............................................................................................................ 37
New Programs
Technical Competency Assessment of Peripheral Blood Smears (QP201)............................................ 25
Red Blood Cell Utilization: Single and Double Unit Transfusions (QP202) ............................................ 26
Inpatient Test Utilization and Volume Benchmarking (QP203) ............................................................. 27
Turnaround Time for Image–Guided Breast Needle Biopsy Specimens (QP204)................................... 28
Discontinued Programs
Technical Staffing Ratios (QP191)
Opioid Drug Testing Stewardship (QP192)
Expression Rates in Invasive Breast Carcinoma (QP193)
The Impact of Pathologist Review of Peripheral Blood Smears (QP194)

3 Use the CAP’s Quality Management Tools (QMT) to improve the Total Testing Process by
identifying quality improvement opportunities of selected key processes in the clinical and
anatomic pathology laboratories, examining preanalytical, analytical, and postanalytical phases:

• Establish realistic goals by comparing performance against similar institutions with
comparable demographics
• Monitor progress through unique and robust quality indicators on a periodical basis
• Make effective quality management decisions based on practical and in-depth
individual reports provided to participants
• Improve efficiencies to allow time for more patient-centric activities
• Easily integrate quality management into your daily work processes with predesigned
monitoring tools developed by laboratory professionals and scientists
Q-PROBES™ A One-Time Opportunity to Perform In-Depth Quality Assessment
Q-TRACKS® A Program for Continuous Quality Monitoring
Q-PROBES and Q-TRACKS activities meet the American Board of Pathology Continuing
Certification (CC), formerly known as Maintenance of Certification (MOC), requirements.
Purchase Q-PROBES or Q-TRACKS combination packages and save.

Module/Package Program Code
Four Q-PROBES studies (includes all four studies) PRO
CP/AP Q-TRACKS Monitors (combined CP/AP module includes all 11 QT monitors) QTP
Clinical Pathology Monitors (includes all 10 CP monitors) QTC
Q-PROBES and Q-TRACKS

offer a comprehensive collection of tools to
complement your quality management program needs.* 3

Clinical Pathology
Turnaround Time
Patient Safety
Microbiology
Postanalytic
Hematology
Satisfaction
Transfusion
Preanalytic
Chemistry/
Pathology
Anatomic
Customer
Medicine
Select Q-PROBES and Q-TRACKS studies
Analytic
to support your quality improvement
initiatives.
Q-PROBES
Technical Competency Assessment of Peripheral Blood
z z z z
Smears (QP201)
Red Blood Cell Utilization: Single and Double Unit
z z z z z z z
Transfusions (QP202)
Inpatient Test Utilization and Volume
z z z z z z
Benchmarking (QP203)
Turnaround Time for Image–Guided Breast Needle
z z z z z
Biopsy Specimens (QP204)
Q-TRACKS
Patient Identification Accuracy (QT1) z z z z
Blood Culture Contamination (QT2) z z z z z z
Laboratory Specimen Acceptability (QT3) z z z z
In-Date Blood Product Wastage (QT4) z z z
Gynecologic Cytology Outcomes:
z z z z z z
Biopsy Correlation Performance (QT5)
Satisfaction with Outpatient Specimen Collection (QT7) z z z z
Stat Test Turnaround Time Outliers (QT8) z z z z z
Critical Values Reporting (QT10) z z z z z
Troponin Turnaround Times (QT15) z z z z z z z z
Corrected Results (QT16) z z z z z z z
Outpatient Order Entry Errors (QT17) z z z z
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes
benchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requires accredited
hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor, assess, and
correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).
800-323-4040 | 847-832-7000 Option 1 | cap.org 23

Q-PROBES
Q-PROBES
A One-Time Opportunity to Perform In-Depth Quality Assessment
3
Implement quality monitoring—Use Q-PROBES short-term comprehensive quality studies1 to
learn how to start monitoring and measuring key processes that you may not have followed in
the past or that are not commonly monitored in most laboratories. Q-PROBES studies analyze
hot topics and industry trends to keep the laboratory current.
Gain experience in data collection and analysis—Participants will collect data during
predetermined dates. Based on submitted data, the CAP provides personalized reports with the
individual participant’s performance compared against other participants.
Strengthen your quality assessment expertise—The CAP’s pathologist experts provide

in-depth discussion and identify best practices for laboratories to strive for. In addition,
consolidated results of the studies are carefully reviewed and analyzed to be published in
the form of scientific articles. Such articles give participants an extra layer of information
to be utilized for further analysis.
Q-PROBESTM 2015: QP151 - Blood Bank Safety Practices
Participants in the Q-PROBES program receive: Quality Management Report: Individual Report of Results
• User guide
Your All Institutions Percentiles
Performance Indicator Result 10th 50th 90th Performance Distribution
(left edge (right edge
◆ of box)
(vertical line)
of box)
ABO mislabeled specimen rate (per 1000 ◆
• Templates and instructions for data collection

3.68 0.00 4.04 18.19
specimens) (n=30)
0 5 10 15 20
Performance note: The bar graph ranges from the 10th to 90th percentile. The thick vertical line represents the median value.
Lower percentiles (shaded area and lower) represent better relative performance.
• Individual report, how to interpret the results

guide, overall aggregated data
Your All Institutions Percentiles
Additional Information
Result 10th 50th 90th
ABO typing result discrepancy rate (per 1000 2.17 0.00 0.00 1.82
specimens) (n=29)
• Data Analysis and Critique that includes data Estimated annual rate of ABO typing result
discrepancies (per 1000 specimens) (n=30)
0.23 0.00 0.00 0.41
distributions and initial analysis of laboratory

Mislabeled ABO specimen rejection rate (%) (n=15) 100.0 88.9 100.0 100.0
practices and commentaries from pathologist

experts on improvement opportunities
• Notification of the scientific articles that are published with the results of the studies
For your institution's use
Reviewed by: Date:
Q-PROBES activities meet the American Board of Pathology Continuing Certification (CC), Comments/Actions:
formerly known as Maintenance of Certification (MOC), requirements.

Data summarized in this Individual Report of Results includes data returned by 03/27/2015.
Kit ID Number: CAP Number:
5HSRUW Date: 03/27/2015 /DE1DPH
1
Q-PROBES studies are available only one time annually and may not be repeated in the future.
Q-PROBES
Technical Competency Assessment of Peripheral

Blood Smears QP201
Introduction
3
The widespread use of automated white blood cell (WBC) differential counts and computer generated whole slide imaging
has decreased the time that the technical staff dedicates to morphological assessment of blood cells. However,

technologists must maintain their morphological skills and laboratories are required to provide education and assess
competency in this area on a regular basis.
Participation in this Q-PROBES study helps laboratories meet CLIA personnel requirements (Subpart M, 42 CFR §493.1);
CAP Laboratory Accreditation Program Checklist statements GEN.55500, Competency Assessment of Testing Personnel;
and The Joint Commission Standards HR. 01.05.03, 01.06.01, and 01.07.01 for training and education, competency, and
evaluation of hospital personnel.
Objectives
This study will help assess the effectiveness of educational and practical experience policies and procedures dedicated to
the laboratory’s efforts in maintaining technologist skills in the performance of accurate WBC differential counts and other
peripheral blood smear morphological assessment. The evaluation provided will assist in the construction of individual
educational programs for the technical staff and will highlight areas of improvement to focus on.
Data Collection
Information will be collected from each site regarding their institution’s minimum qualification and experience
requirements of their technologists, their ongoing educational programs in peripheral blood smear evaluation, as well as
relevant procedures and policies.
A series of online, whole slide images of Wright-Giemsa stained peripheral blood smears using DigitalScope® technology
will be available to each participating institution to assess technologists’ performance on WBC differential counts and
morphology assessment. Participants will also provide information about their competency assessment programs,
continuing education, and professional background. Each program ordered provides input forms for use by up to 10
technologists. Laboratories that need forms for more than 10 individuals should order additional programs (available in
multiples of 10).
Performance Indicators
• Individual technologist score (%) based on a standardized competency assessment method to determine a technologist’s
ability to identify various WBC types, red blood cell morphology, and platelet morphology in normal and abnormal cases
• Overall laboratory score based on the facility’s individual technologist performance(s)
A summary of responses to the general questions will be provided to participants.
This is a one-time study conducted in the first quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org 25

Q-PROBES
Red Blood Cell Utilization: Single and Double Unit Transfusions QP202
Introduction
The use of lower thresholds for transfusing red blood cells (RBC) has effectively reduced the number of RBC transfusions
3 performed. When healthcare providers order a blood transfusion, they request the number of RBC units that should be
transfused. Most orders are for either 1 (single) unit or 2 (double) units of RBC in non-emergent scenarios. This includes
inpatient transfusions provided to acute and chronically ill patients, post-operative patients, and patients in intensive care
unit settings. However, the need to transfuse 2 RBC units during a transfusion episode has been questioned because a single
unit transfusion may sufficiently increase oxygen carrying capacity for most patients.
Enrollment in this study will assist laboratories in meeting the CAP Laboratory Accreditation Program Transfusion Checklist
statement TRM.40875, Transfusion Service Medical Director Responsibility, regarding monitoring and auditing transfusion
practices, and establishing criteria for transfusion. Use of this study assists laboratories in meeting and applying The Joint
Commission Standards QSA.05.01.01 and 05.02.01 requirements for policies and procedures for blood transfusion services.
Objectives
This Q-PROBES study will allow participants to assess how frequently single RBC units are ordered and subsequently
transfused to hospitalized patients requiring non-emergent transfusions compared to all transfusion events with either
single or double RBC units ordered. Additionally, this study will allow participants to evaluate conformance of RBC
transfusion practice with their own institutional guidelines.
Data Collection
Participants will identify up to 50 transfusion events from patients treated and received either 1 or 2 RBC unit(s). This study
will be limited to hospital inpatients. Preoperative and intraoperative orders for surgical patients and emergency orders
for RBC transfusion will be excluded. Orders for 3 or more RBC units will be excluded as these are often unstable patients
requiring urgent transfusion.
For each of the eligible transfusion episodes, participants will record the pre-transfusion and post-transfusion hemoglobin
levels and the type of ordering service.
• Percentage of single RBC transfusion events out of all transfusion events administering single or double RBC units during
the study period
• Percentage of RBC transfusions in compliance with institutional guidelines during the study period
Additional Measure
• Average pre-RBC transfusion hemoglobin value
This is a one-time study conducted in the second quarter.
Q-PROBES
Inpatient Test Utilization and Volume Benchmarking QP203

Introduction
It is well established that test ordering practices vary widely between healthcare providers even when adjusted for similar
patient populations and conditions. Similarly, ordering practices vary between healthcare facilities which depend, in part, 3
on certain operational practices and policies. This may involve test menu configuration, ordering protocols, or restriction

policies such as use of laboratory formularies. Another method to evaluate potential gaps in utilization practices is to
evaluate adjusted volume of specific tests between facilities. This information can be useful to laboratories for prompting
evaluation of potential factors associated with differences in the quantity of specific tests performed when compared
to peers.
Objectives
The purpose of this study is to provide participants with comparative benchmarks involving annual volumes of various
inpatient tests and number of inpatient days. The amount of testing performed per inpatient day will be used to adjust for
ordering practice variability between facilities.
In addition, associations between standardized test volumes and ordering practices in use by participants, such as test
menu design, reflex testing, decision support, standing orders, and order restriction policies, will be evaluated.
Data Collection
Participants will report the 2019 annual volume for specific inpatient tests including both common high volume tests as
well as less commonly ordered low volume tests. Annual inpatient days will also be collected.
Other information such as whether the test is included on a panel will be collected in addition to information about general
laboratory stewardship policies and procedures.
For each inpatient test:
• Annual inpatient test volume standardized by inpatient days
• Index score of standardized inpatient test volume
This is a one-time study conducted in the third quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org 27

Q-PROBES
Turnaround Time for Image–Guided Breast Needle

Biopsy Specimens QP204
3 Introduction
Needle biopsies are performed increasingly for the primary diagnosis of breast disease, particularly in patients with
mammographic or ultrasound abnormalities suspicious for malignancy. In a typical workflow the radiologist incorporates
the pathologic findings into the radiology report with correlation, requiring a rapid turnaround time for the pathology
report in order to expedite patient care. As the goal of these procedures is to expedite surgical intervention in those
patients requiring it, often with the assistance of a nurse navigator, many institutions track the turnaround times for biopsy
submission, pathologist and radiologist verification of their respective reports, and time to surgery. Notably, there are no
established pathology benchmarks for breast needle biopsy turnaround time.
Objectives
The aims of this study are to:
• Determine the average turnaround time for image-guided breast needle biopsy specimens, defined as the time from
specimen accessioning in the laboratory to verification and release of the final report by the pathologist
• Identify key elements of processing and reporting that influence the turnaround time, including the American Society
of Clinical Oncology/College of American Pathologists guideline for at least six hours of formalin fixation, the relative
complexity of establishing benign, atypical/borderline, and malignant diagnoses, and the frequent need for additional
studies, including additional deeper sections, immunohistochemistry, and intradepartmental consultation
Data Collection
Participants will submit data from up to 50 image-guided breast needle biopsy specimens received during the study period,
including the time of biopsy (when available), the time the specimen was accessioned in the laboratory, the duration of
formalin fixation, and all non-routine studies obtained on the case, as outlined in the objectives above. The final pathologic
diagnosis will also be recorded in order to stratify turnaround times with regard to benign, atypical/borderline, and
malignant diagnoses, if sufficient data is provided.
Performance Indicator
• Time from specimen accessioning in the laboratory to final pathologist report
This is a one-time study conducted in the fourth quarter.
Q-TRACKS
Q-TRACKS
A Program for Continuous Quality Monitoring
Identify and monitor opportunities for quality improvement over time 3
Use established Q-TRACKS programs to identify opportunities to quantitate your quality improvement measures.

Evaluate quality improvements
Measure the effectiveness and impact of implemented changes in key processes. The individual reports include performance
of quality indicators over time, benchmarking information, trends, and suggested areas for improvement.
Step 1:
Establish realistic benchmarks by comparing
your laboratory to others like yours.
Step 2:
Q-TRACKS: QT3 - Laboratory Specimen Acceptability
External Comparison Report: January-March Identify improvement opportunities.
(most like you)
Q-TRACKS: QT3 - Laboratory Specimen Acceptability

Trend Analysis Report: January-March
Step 3:
Monitor improvement over time to
ensure accurate results, patient
safety, and quality patient care.
800-323-4040 | 847-832-7000 Option 1 | cap.org 29

Q-TRACKS
Half Page Filler
Participants in Q-TRACKS programs receive:

• User Guide
• Templates and instructions for data collection
• Quarterly reports that include fingerprint clusters, customer-defined groups, and all institution comparisons
3 • Peer directory
Q-TRACKS activities meet the American Board of Pathology Continuing Certification (CC), formerly known as Maintenance
of Certification (MOC), requirements.
1/2
Half Page Filler
Laboratory Administration for Pathologists, Second Edition (PUB312)

Laboratory Administration for Pathologists is designed to provide 2nd
pathologists with an overview of the fundamentals of management Edition
and leadership, addressing the specific role and responsibility of the
pathologist in directing the laboratory.
• Provides information for both clinical and anatomic pathology practice
• Includes an overview of patient safety not available in the first edition
• Covers financial management of the laboratory and the pathology practice
• Geared for trainees and those entering practice while appropriate
for all pathologists
Add it to your order.
Or, view sample pages and purchase online:
• printed books at estore.cap.org Item number: PUB312
• ebooks at ebooks.cap.org Hardcover; 296 pages; 2019
Q-TRACKS
Q-TRACKS Clinical Pathology Monitors
Patient Identification Accuracy QT1 3

In order to report accurate laboratory results and meet The Joint Commission National Patient Safety Goal #1: “Identify

patients correctly,” institutions must properly identify patients. Since most laboratories perform testing away from the
patient, patient identification, labeling of specimens, and coordination with test requisitions must be performed accurately
and completely. By continuously monitoring for wristband errors, participants can promptly identify and correct problems
that may interfere with patient care services. Use this monitor to help meet CAP Laboratory Accreditation Program General
Checklist statements GEN.20316, GEN 40490, and GEN.40825.
Objectives
Assess the incidence of wristband errors within individual institutions, compare performance between participating
institutions, and identify improvement opportunities.
Data Collection
On six predetermined days per month, participants will monitor patient wristband identification for all phlebotomies
performed at their institution. Phlebotomists will tally the total number of wristbands checked, the number of errors found,
and the types of wristband errors. This monitor includes all routinely wristbanded patients. Include emergency department
patients only if the emergency department routinely applies wristbands to these patients.
Performance Indicator Performance Breakdown
• Wristband error rate (%) • Breakdown of wristband error types (%)
Blood Culture Contamination QT2

Despite advances in blood culture practices and technology, false-positive blood culture results due to contaminants continue
to be a critical problem. Blood culture contamination rate, the primary indicator of preanalytic performance in microbiology, is
associated with increased length of hospital stay, additional expense, and the administration of unnecessary antibiotics.
The CAP and other accrediting organizations require you to monitor and evaluate key indicators of quality for improvement
opportunities. Use this monitor to help meet CAP Laboratory Accreditation Checklist statement note MIC.22630:“It is
recommended that blood culture statistics, including number of contaminated cultures, be maintained and reviewed regularly
by the laboratory director. The laboratory should establish a threshold for an acceptable rate of contamination. Tracking the
contamination rate and providing feedback to phlebotomists or other persons drawing cultures has been shown to reduce
contamination rates.” This will also help laboratories meet The Joint Commission Standard QSA 04.07.01 EP3.
Objective
Determine the rate of blood culture contamination using standardized criteria for classifying contaminants.
Data Collection
On a monthly basis, participants will tabulate the total number of blood cultures processed and the total number of
contaminated blood cultures. Blood cultures from neonatal patients are tabulated separately. For the purposes of this study,
participants will consider a blood culture to be contaminated if they find one or more of the following organisms in only one
of a series of blood culture specimens: Coagulase-negative Staphylococcus; Micrococcus; Alpha-hemolytic viridans group
streptococci; Propionibacterium acnes; Corynebacterium sp. (diptheroids); or Bacillus sp. Participants have the option to
monitor institution-specific subgroups, for example, a specific department or patient population.
• Neonatal contamination rate (%) • Other contamination rate (%) • Overall contamination rate (%)
Look for your input forms approximately three weeks prior to the quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org 31

Q-TRACKS
Laboratory Specimen Acceptability QT3

A substantial amount of rework, diagnostic and therapeutic delay, and patient inconvenience can result from specimen
rejection. Patient redraws may result from unlabeled, mislabeled, and incompletely labeled specimens; clotted and/or
3 hemolyzed specimens; or insufficient specimen quantity. By continuously monitoring specimen acceptability, collection,
and transport, laboratories can promptly identify and correct problems. Enrollment in this Q-TRACK may assist the
laboratory in monitoring compliance with CAP Laboratory Accreditation Program General Checklist statement GEN.40825:
“There is a system to positively identify all patient specimens, specimen types, and aliquots at all times.”
Objective
Identify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology/coagulation
sections of the clinical laboratory for testing.
Data Collection
This monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the
clinical laboratory. On a weekly basis, participants will record the total number of specimens received, the number of
rejected specimens, and the primary reason each specimen was rejected.
Performance Indicator Performance Breakdown

• Specimen rejection rate (%) • Breakdown of reasons for rejection (%)
In-Date Blood Product Wastage QT4

Blood for transfusion is a precious resource. At a minimum, wastage of blood that is not out-of-date represents a financial
loss to the healthcare system. More ominously, systemic wastage of blood may reflect an environment of care that is out of
control and may pose risks to patient safety.
Enrollment in this program assists laboratories in meeting regulatory requirements as follows:
• CAP Laboratory Accreditation Program Checklist statements: TRM.40875 that requires the transfusion service medical
director to monitor and audit transfusion practices to ensure the appropriate use of blood; TRM.30800, Disposition
Records; and TRM.32275, Component Records, regarding recording the use of each blood or component product from
receipt to final disposition.
• The Joint Commission Standards QSA.05.02.01, adequate blood and blood components; QSA.05.03.03, requirements for
policies and procedures for returning unused blood products to blood transfusion services; and QSA.05.22.01, records of
blood product disposition.
• AABB Standards for Blood Banks and Transfusion Services assessment 8.2 that requires transfusing facilities to have a
peer-review program that monitors transfusion practices for blood components.
Objective
Compare the rates of blood product wastage (ie, units discarded in-date) in participating hospitals and track rates of
improvement over time.
Data Collection
On a monthly basis, participants will use blood bank records to obtain information on the total number of units transfused
for each type of blood component. Participants will track the number and type of blood units that are wasted in-date and
the circumstances of wastage. This monitor includes the following types of blood components: whole blood (allogeneic), red
blood cells (allogeneic), frozen plasma, platelet concentrates, single donor platelets, and cryoprecipitate.
Performance Indicators Performance Breakdown

• Overall blood wastage rate (%) • Breakdown of circumstances of wastage (%)
• Wastage rates by blood component type (%)
Q-TRACKS
Satisfaction with Outpatient Specimen Collection QT7

Specimen collection is one of the few areas of laboratory medicine that involves direct outpatient contact. As a result,
patient satisfaction with this service is a vital indicator of quality laboratory performance. The CAP’s Laboratory
Accreditation Program requires measurement of patient satisfaction with laboratory services (Checklist statement
GEN.20335). Use this monitor to help meet this requirement.
3
Objective

Assess patient satisfaction with outpatient phlebotomy services by measuring patients’ assessments of laboratory service
hours, waiting time, comfort level, professionalism and courtesy, and privacy.
Data Collection
On a monthly basis, participants will provide copies of a standardized questionnaire in English and Spanish to a minimum
of 25 outpatients (maximum of 99 outpatients) using predetermined data collection criteria. This monitor includes any
outpatient undergoing venipuncture. This monitor excludes patients seen in the emergency department, ambulatory surgery
area, urgent care facility, chest pain center, 23-hour short-stay facility, employee health department, outpatient health
screening fair/promotion, dialysis center, nursing home, or extended care facility.
• Satisfaction scores and satisfaction rates (% of patients rating 4 or 5) for the following categories:
o Overall experience o Professionalism and courtesy
o Waiting time o Patient privacy
o Patient comfort o Laboratory hours of operation
Stat Test Turnaround Time Outliers QT8

The stat test turnaround time (TAT) outlier rate, expressed as a percentage of tests missing target reporting times, is
a measure of outcomes that evaluates how well the laboratory meets patient and clinician needs. This monitor helps
meet CAP Laboratory Accreditation Program Checklist statement GEN.20316: “The QM program includes monitoring key
indicators of quality in the preanalytic, analytic, and postanalytic phases.”
Objective
Monitor the frequency that stat test TAT intervals exceed institutional stat test TAT expectations.
Data Collection
Before beginning data collection, participants will establish a specimen receipt-to-report deadline for emergency
department (ED) stat potassium tests. On six predetermined days per month, participants will monitor the TAT of up to
10 randomly selected ED stat potassium tests on each of three, eight-hour shifts (up to 180 tests per month) and track the
number of ED stat potassium results reported later than the established reporting deadline. This monitor includes stat
potassium tests ordered as part of a panel and excludes stat potassium levels that are requested on body fluids other than
blood, as part of timed or protocol studies, or after the specimen arrives in the laboratory.
Performance Indicator Performance Breakdowns

• Stat test TAT outlier rate (%) • Breakdown of outliers by shift (%)
• Breakdown of outliers by day of week (%)
800-323-4040 | 847-832-7000 Option 1 | cap.org 33

Q-TRACKS
Third Page Filler
Critical Values Reporting QT10

Laboratories commonly refer to critical values as results requiring immediate notification to the physician or caregiver
for necessary patient evaluation or treatment. Regulations from agencies and accreditors such as the CMS, The Joint
3 Commission (National Patient Safety Goal NPSG.02.03.01), and the CAP Laboratory Accreditation Program (Checklist
statement GEN.20316, COM.30000, COM.30100) mandate that laboratories develop and implement an alert system for
critical values. Use this monitor to document compliance with your laboratory’s alert plan.
Objective
Evaluate the documentation of successful critical values reporting in the general laboratory for inpatients and outpatients.
Data Collection
On a monthly basis, participants will evaluate 120 inpatient and 120 outpatient critical values. Data collection will include
general chemistry, hematology, and coagulation analytes on the critical values list. Retrospectively, participants will record
the total number of critical values monitored and the number with documentation of successful notification. In addition,
participants will provide the number of critical values that were not communicated within three hours, the number of failed
notifications due to laboratory oversight, and the number of successful notifications to licensed caregivers. This monitor will
exclude critical values for cardiac markers, drugs of abuse, therapeutic drug levels, urinalysis, blood gases, point-of-care
tests, and tests performed at reference laboratories.
• Total critical values reporting rate (%)
• Inpatient critical values reporting rate (%)
1/3 • Outpatient critical values reporting rate (%)

• Failed notification (<3 hours) rate (%)
Third Page Fillers
Build a culture of quality in your laboratory.

The QMEd online course Quality Culture gives you the tools to:
• Assess your current culture
• Prioritize your needs
• Use proven change levers that make a lasting difference
The course will help you build a culture characterized by:
• Innovation • Process Orientation
• Speaking Up • Teamwork and
• Going Above and Involvement
Beyond • Risk Awareness
• Transparency
Includes a unique quality-culture assessment tool that helps
make culture change a reality.
See p. 18. Add ISOEDCL to your order.
20 College of American Pathologists 2020 Surveys Pickup Filler Pages

Q-TRACKS
Troponin Turnaround Times QT15

Patients presenting to the emergency department (ED) with chest pain must be evaluated quickly. Rapid serum troponin
measurement is an important part of ED practice that can provide decisive information for patient management. Reducing
delays in troponin testing has been reported to result in shorter length of stay in the ED and more rapid initiation of
anti-ischemic treatment. EDs and chest pain centers should, therefore, have effective procedures for ensuring optimal
3
turnaround time (TAT) for troponin testing and a process for ongoing monitoring to ensure that performance

meets expectations.
QT15 was enhanced for 2019 with additional time intervals to help pinpoint process time challenges. Laboratories may use
this monitor to help meet CAP Laboratory Accreditation Program Checklist statement GEN.20316 QM Indicators of Quality.
The American College of Cardiology and the American Heart Association recommend troponin as the preferred diagnostic
biomarker in their Acute Coronary Syndromes guideline.
Objectives
This study will assist participating laboratories to determine and monitor:
• The median TATs for processes from order time through result availability, with up to five time intervals within the
total testing process
• The percent compliance for troponin results with their institution’s established deadline
Data Collection
Six days per month, collect data from nine patients presenting to the ED with chest pain and tested for troponin level.
Data includes time of troponin test order, specimen collection, laboratory receipt, and result availability. Participants
are not required to provide data from each TAT component. Participants will select TAT metrics that they wish to monitor,
with the option to monitor all metrics.
Participants will also complete a questionnaire about clinical and laboratory practices related to troponin testing.
Median TATs for the following time intervals:
• Test order to specimen collection
• Specimen collection to laboratory receipt
• Laboratory receipt to result availability
• Specimen collection to result availability
• Test order to result availability
Compliance (%) with insitutional threshold for the following time intervals:
• Specimen collection to result availability
• Test order to result availability
800-323-4040 | 847-832-7000 Option 1 | cap.org 35

Q-TRACKS
Corrected Results QT16

The CAP developed this Q-TRACKS monitor in recognition of the importance of timely detection and correction of erroneous
laboratory results. Accuracy in laboratory results is critical to the effectiveness of a physician’s plan of care for a patient.
3 An erroneous result can delay or alter patient treatment; therefore, detection of erroneous results should be a priority in
every laboratory and should be monitored as a key quality indicator. Help measure your compliance with CLIA 493.1299,
Postanalytic Systems Quality Assessment, and help meet CAP Laboratory Accreditation Program Checklist statement
GEN.20316 with this monitor.

Objective
Monitor the number of corrected test results within individual institutions and compare performance with that of all
institutions and those institutions similar to yours.
Data Collection
On a monthly basis, participants will monitor the number of corrected test results and the total number of billable tests for
that month. Include test results for all patients in all care settings with the following exclusions: anatomic pathology tests,
narrative physician-interpreted tests (eg, bone marrow biopsies and peripheral smear reports), and point-of-care tests.
Performance Indicator
• Test result correction rate (per 10,000 billable tests)
Outpatient Order Entry Errors QT17

Order accuracy bears an obvious relationship to the quality of laboratory testing. When the laboratory fails to complete
a requested test, it delays the diagnostic evaluation, consumes resources, causes patient inconvenience, and may prolong
therapy. When the laboratory completes a test that was not requested, the cost of care increases, patients may be
subjected to unnecessary phlebotomy, and laboratory efficiency declines. Use this monitor to help meet CAP Laboratory
Accreditation Program Checklist statement GEN.20316 for test order accuracy and meet The Joint Commission Standard
DC.01.02.01: The laboratory performs testing based on written laboratory test orders.
Objective
Measure the incidence of incorrectly interpreted and entered outpatient physician test orders into the laboratory
information system, compare performance across institutions, and track performance over time.
Data Collection
On six preselected weekdays per month, participants will compare eight outpatient requisitions or order sheets to the
orders entered into the laboratory’s information system to determine if any order entry errors occurred.
This monitor includes test order review from ambulatory outpatients seen in offices and clinics operated by your laboratory
services, private physician offices, nursing homes, extended care facilities, and free-standing phlebotomy areas. Also
included are send-out tests, chemistry, hematology, microbiology, immunology, toxicology, and urinalysis tests on
outpatients. Order entry error categories include requesting physician errors, incorrect and extra test orders, missing test
orders and diagnosis codes, test priority errors, and copy or fax result errors.
This monitor excludes tests performed in transfusion medicine or anatomic pathology and also excludes tests from the
following patient care settings: inpatient, emergency department, ambulatory surgery, urgent care, chest pain center,
23-hour short-stay facility, employee health department, outpatient screening fair/promotion, and dialysis center.
Performance Indicators Performance Breakdown

• Overall outpatient order entry error rate (%) • Breakdown of error types (%)
• Order entry error rates by type (%)
Q-TRACKS
Q-TRACKS Anatomic Pathology Monitor
Gynecologic Cytology Outcomes: Biopsy Correlation Performance QT5 3

The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results is a significant part of the

cytopathology laboratory’s quality assurance program. By monitoring this correlation, the laboratory can identify and
address potential problems requiring improvement, thereby ensuring better patient results. This Q-TRACKS study helps
laboratories meet CAP Laboratory Accreditation Program Cytopathology Checklist statements CYP.07543 and CYP.07600
on cytologic/histologic correlation, and The Joint Commission Standard QSA.08.06.03: The cytology laboratory has
a process to correlate cytologic interpretations with the corresponding histologic finding.
Objective
Quantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.
Data Collection
On a monthly basis, participants will record the number of true-positive, false-positive, and false-negative cytology-biopsy
correlations. The false-negative correlations will be classified into four error categories: screening errors, interpretive errors,
screening and interpretive errors, and adequacy determination errors. Participants will also record the biopsy diagnoses for
Pap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or atypical glandular cells (AGC). This
monitor includes cervical biopsy specimens submitted to the laboratory that have a corresponding satisfactory or
satisfactory but limited Pap test within three months of the biopsy.
• Predictive value of positive cytology (%)
• Sensitivity (%)
• Screening/interpretation sensitivity (%)
• Sampling sensitivity (%)
• Percent positive for ASC-US interpretations
• Percent positive for ASC-H interpretations
• Percent positive for AGC interpretations
800-323-4040 | 847-832-7000 Option 1 | cap.org 37

Unbind your competency
assessment efforts.
Traditionally, documenting competency assessment meant Improve your laboratory’s

shelves of three-ring binders. No more. With the Competency readiness for inspection.
Assessment Program from the College of American
Add the appropriate
Pathologists, all your documentation is right on your computer,
instantly available at any time.
Competency Assessment
Program subscription to your
2020 Competency Assessment Program subscription includes: order form.
• Updated assessment and training courses in
11 laboratory disciplines
• Customizable courses and checklists
• Online tools including assignments by team and shift,
progress dashboards, and automated reminders
CAP NEW Full PageFiller #7

4 Quality Cross Check
Simplify biannual instrument 4

comparability studies with Quality
Quality Cross Check

Cross Check.
Quality Cross Check.
• Receive custom reports with peer group evaluations
and instrument comparability statistics.
• Monitor transfusion medicine performance and assess
assess comparability
comparability across multiple
across multiple
automated
automated
and manual
and
manual methods
methods with thewith
Quality
the Cross
new Quality
Check—Transfusion
Cross Check—
Transfusion
Medicine program
Medicine
(JATQ).
program (JATQ).
New Programs
Quality Cross Check—Cardiac Markers (CRTQ)..................................................................................42
Quality Cross Check
Perform instrument comparability and stay in compliance
Quality Cross Check is a convenient solution to monitor instrument performance and assess
comparability across multiple instruments in your laboratory and to identify potential issues
before they affect patient results.
4
How It Works
Quality Cross Check
• Receive three challenges in each of two mailings a year.

• Report up to three instruments for each challenge (and report up to 30 instruments
for Quality Cross Check—Whole Blood Glucose).
• Receive a custom report package that includes peer group comparison and
instrument comparability statistics for each reported analyte.
Stay in Compliance
In August 2015, the Centers for Medicare & Medicaid Services (CMS) reiterated that
laboratories are not permitted to test proficiency testing samples on multiple instruments
unless that is how the laboratory tests patient specimens.
The CMS interpretation was expanded beyond regulated analytes to include analytes not listed
in Subpart I of the Clinical Laboratory Improvement Amendments regulations, including waived
methods.
Quality Cross Check complements your existing CAP Surveys to monitor multiple instrument
performance and is compliant with the CMS directive.
Monitoring Performance of Glucose Meters

Beginning in 2017, PT for waived whole blood glucose on glucose meters was no longer
required for laboratories accredited by the CAP. Laboratories are required to perform
alternative performance assessment.
In response to this change, the CAP introduced the Quality Cross Check—Whole Blood Glucose
program (WBGQ). Participants in this program will enjoy the benefits of Quality Cross Check
and have the ability to report up to 30 instruments for each challenge.
Quality Cross Check
Program Information
Quality Cross Check—Chemistry and Therapeutic
• Three 5.0-mL liquid serum
Drug Monitoring CZQ specimens in duplicate
Analyte Program Code Challenges per Shipment
4
• Report up to three
CZQ instruments
Quality Cross Check

See Survey CZ analytes on • Conventional and
z 3
pages 56-58 International System of Units
This program does not meet regulatory requirements for proficiency testing; see Survey CZ (SI) reporting offered
on pages 56-58. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
Program Information
Quality Cross Check—BNP BNPQ
• Three 1.5-mL liquid
Analyte Program Code Challenges per Shipment specimens
BNPQ • Report up to three
BNP z 3 instruments
NT-proBNP z 3 • Conventional and
This program does not meet regulatory requirements for proficiency testing; see Survey BNP or International System of
BNP5 on page 61. For additional information about the Quality Cross Check program, see page 40. Units (SI) reporting offered
• Two shipments per year
Program Information
Quality Cross Check—Whole
• Three 2.0-mL whole blood
Blood Glucose WBGQ specimens
Analyte Program Code Challenges per Shipment • Report up to 30 instruments
WBGQ • Two shipments per year
Glucose z 3
The CAP Accreditation Program requires all accredited laboratories performing waived whole
blood glucose testing using glucose meters to perform alternative performance assessment. This
program can be used to meet alternative performance assessment requirements.
800-323-4040 | 847-832-7000 Option 1 | cap.org 41

Quality Cross Check
Program Information
Quality Cross Check—Body Fluid Chemistry FLDQ
• Three 3.0-mL simulated
Analyte Program Code Challenges per Shipment liquid body fluid specimens
FLDQ in duplicate
Albumin z 3 • Report up to three
Amylase z 3 instruments
4 CA19-9 z 1 • Two shipments per year

Carcinoembryonic antigen (CEA) z 1
Quality Cross Check
Cholesterol z 3
Creatinine z 3
Glucose z 3
Lactate z 3
Lactate dehydrogenase (LD) z 3
pH z 3
Protein, total z 3
Triglycerides z 3
Urea nitrogen z 1
This program does not meet regulatory requirements for proficiency testing; see Survey FLD
on page 72. For additional information about the Quality Cross Check program, see page 40.
Program Information
Quality Cross Check—Hemoglobin A1c GHQ
• Three 0.8-mL previously
Analyte Program Code Challenges per Shipment frozen liquid specimens in
GHQ triplicate
Hemoglobin A1c z 3 • Report up to three
This program does not meet regulatory requirements for proficiency testing; see Survey GH5 instruments
on page 63. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
Program Information
Quality Cross Check—Cardiac Markers CRTQ
CRTQ • Report up to three
CK-MB, immunochemical z 3 instruments
Myoglobin z 3 • Two shipments per year
Troponin I z 3
This program does not meet regulatory requirements for proficiency testing; see Survey CRT
Quality Cross Check
Third Page Filler
Endocrinology
Program Information
Quality Cross Check—Parathyroid Hormone PTHQ
• Three 5.0-mL lyophilized
Analyte Program Code Challenges per Shipment serum specimens in
PTHQ duplicate 4
Parathyroid hormone (PTH) z 3 • Report up to three
Quality Cross Check

This program does not meet regulatory requirements for proficiency testing; see Survey ING instruments
on page 86. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
1/3
Third Page Fillers

World-class recognition deserves to be displayed.
Let your peers, patients, and the public know you’ve earned
the CAP accreditation certification mark.
Proudly display the mark. It distinguishes you as one of more than 8,000 laboratories
worldwide that have attained CAP accreditation, the most respected and
recognized laboratory accreditation in the world.
800-323-4040 | 847-832-7000 Option 1 | cap.org 43

800-323-4040 | 847-832-7000 Option 1 | cap.org 9
Quality Cross Check
Blood Gas, Critical Care, and Oximetry
Program Information
Quality Cross Check—Blood Oximetry
SOQ specimens in triplicate
4 Analyte Program Code Challenges per Shipment • Report up to three
SOQ instruments
Quality Cross Check
Carboxyhemoglobin z 3 • Conventional and

Hematocrit, estimated z 3 International System of Units
(SI) reporting offered
Hemoglobin, total z 3
Methemoglobin z 3
Oxyhemoglobin z 3
This program does not meet regulatory requirements for proficency testing; see Survey SO
Program Information
Quality Cross Check—Blood Gas
• AQQ, AQ2Q - Three 2.5-mL
AQQ, AQ2Q, AQ3Q, AQ4Q specimens in triplicate and
Analyte Program Code Challenges per Shipment three 2.5-mL specimens for
hematocrit testing in
AQQ AQ2Q AQ3Q AQ4Q
triplicate; appropriate for all
Calcium, ionized z z z z 3 methods except i-STAT®
Chloride z z z z 3 • AQ3Q, AQ4Q - Three
Hematocrit z z z z 3 1.7-mL specimens in
Hemoglobin, estimated z z z z 3 triplicate for i-STAT methods
only
Lactate z z z z 3
Magnesium, ionized z z 3
instruments
pCO2 z z z z 3
• Conventional and
pH z z z z 3 International System of Units
pO2 z z z z 3 (SI) reporting offered
Potassium z z z z 3 • Two shipments per year
Sodium z z z z 3
tCO2 z z z z 3
Creatinine z z 3
Glucose z z 3
Urea nitrogen (BUN) z z 3
It is not appropriate to report hemoglobin or hematocrit by co-oximetry in this program.
These programs do not meet regulatory requirements for proficiency testing; see Surveys AQ
and AQ2-AQ4 on page 92. For additional information about the Quality Cross Check program,
see page 40.
Quality Cross Check
Program Information
Quality Cross Check—Hematology Series
FH3Q, FH4Q, FH6Q, FH9Q specimens with pierceable
Challenges per caps 4
Analyte/Procedure Program Code
Shipment
Quality Cross Check

FH3Q FH4Q FH6Q FH9Q instruments
Hematocrit z z z z 3 • For method compatibility,
Hemoglobin z z z z 3 see instrument matrix on
page 138
Immature granulocyte parameter z 3
Immature platelet function (IPF)% z 3 • Two shipments per year
Large unstained cells (LUC) z 3

MCV, MCH, MCHC z z z z 3
MPV z z z z 3
Nucleated red blood cell count
z z 3
(nRBC)
Platelet count z z z z 3
RDW z z z z 3
Red blood cell count z z z z 3
WBC differential z z z z 3
White blood cell count z z z z 3
These programs do not meet regulatory requirements for proficiency testing; see the FH Series
Program Information
Quality Cross Check—Reticulocyte
• RTQ - Three 1.0-mL stabilized
RTQ, RT3Q, RT4Q red blood cell specimens
Challenges per • RT3Q - Three 3.0-mL
Instrument/Method Program Code
Shipment
stabilized red blood cell
RTQ RT3Q RT4Q specimens
Abbott Cell-Dyn 4000, Sapphire, • RT4Q - Three 2.0-mL
Siemens ADVIA 120/2120, and stabilized red blood cell
z 3
all other automated and manual specimens
methods
• Includes percentage and
Coulter GenS, HmX, LH500, LH700, absolute result reporting
z 3
MAXM, STKS, Unicel DxH series
Sysmex XE-2100, XE-2100C, instruments
XE-2100D, XE-2100L, XE-5000, z 3
XN-series, XT-2000i, XT-4000i • Two shipments per year
These programs do not meet regulatory requirements for proficiency testing; see the RT Series on
page 141. For additional information about the Quality Cross Check program, see page 40.
800-323-4040 | 847-832-7000 Option 1 | cap.org 45

Quality Cross Check
Third Page Filler
Program Information
Quality Cross Check—Urinalysis CMQ
• Three 10.0-mL liquid urine
Analyte Program Code Challenges per Shipment specimens for use with all
CMQ instruments
Bilirubin z 3 • Report up to three
Blood or hemoglobin z 3 instruments
4 Glucose z 3 • Two shipments per year

hCG urine, qualitative z 3
Quality Cross Check
Ketones z 3
Leukocyte esterase z 3
Nitrite z 3
Osmolality z 3
pH z 3
Protein, qualitative z 3
Reducing substances z 3
Specific gravity z 3
Urobilinogen z 3
This program does not meet regulatory requirements for proficiency testing; see Surveys CMP
and CMP1 on page 146. For additional information about the Quality Cross Check program,
1/3 see page 40.

Third Page Fillers
Program Information
Quality Cross Check—Occult Blood OCBQ
• Three 2.0-mL simulated fecal
OCBQ • Report up to three
Occult blood z 3 instruments
This program does not meet regulatory requirements for proficiency testing; see Survey OCB • Two shipments per year
We are here to help. Fast Focus on Compliance—the inspector’s quick guide.

A resource for laboratories and inspectors alike, our Fast Focus on Compliance mini-training vignettes help
you prepare for future laboratory inspections by gaining a clear understanding of the requirements and
receiving insight into areas that need improvement:
• What Did You REALLY Mean...How to Write a “Good” Deficiency
• Identifying Systemic Issues—Critical Role of the Inspection Team Leader
• Inspecting Method Validation/Verification Studies
• Inspecting Personnel Records
• 12 Inspector Tools to Make Your Inspection Go More Smoothly
• Proficiency Testing Referral and Communications
Access these concentrated topics online by searching Fast Focus on Compliance at cap.org

Quality Cross Check
Half Page Filler
Coagulation
Program Information
Quality Cross Check—Coagulation CGLQ
Challenges per plasma specimens in
Analyte Program Code
Shipment
triplicate, two 1.0-mL plasma 4
CGLQ specimens, and one 2.0-mL
Quality Cross Check

Activated partial thromboplastin time z 3 serum specimen
Fibrinogen z 3 • Report up to three
instruments
International normalized ratio (INR) z 3
Prothrombin time z 3 • Two shipments per year
D-dimer z 2
Fibrin(ogen) degradation products,
z 1
plasma
Fibrin(ogen) degradation products, serum z 1
This program does not meet regulatory requirements for proficiency testing; see Survey CGL
1/2
Half Page Filler
So You’re Going to Collect a Blood Specimen (PUB225)

Up to 70% of laboratory errors occur prior to sample analysis
and testing. Ensure everyone on your team is equipped to
procure a quality blood specimen with this modern update
to the classic reference guide.
• Step-by-step instructions for venipuncture, skin puncture,
and infant heelstick
• Best practices for collection, transporting, processing,
and storage
• Procedures for blood smears, blood cultures, and
neonatal screening
• Special considerations for the difficult venipuncture
• Four ways to inspire confidence in your patient
Buy multiple copies and save. Call 800-323-4040 option 1
(Country Code 001).
Item number: PUB225
Or, view sample pages and purchase online: Spiral bound; 84 pages;
• printed books at estore.cap.org 30+ images and tables; 2017
800-323-4040 | 847-832-7000 Option 1 | cap.org 47

F32 Half
Quality Cross Check Third Page Filler
Program Information
Quality Cross Check—
• CTQ - Three 3.0-mL
Activated Clotting Time Series lyophilized whole blood
CTQ, CT1Q, CT2Q, CT3Q, CT5Q specimens in triplicate with
corresponding diluents
Challenges per
Instrument/Cartridge Program Code
Shipment • CT1Q - Three 1.7-mL
lyophilized whole blood
4 CTQ CT1Q CT2Q CT3Q CT5Q
specimens in triplicate with
ITC Hemochron CA510/FTCA510
®
z 3
ITC Hemochron FTK-ACT 3
Quality Cross Check
z
• CT2Q - Three 0.5-mL
ITC Hemochron Jr. Signature/ACT+ z 3 lyophilized whole blood/
ITC Hemochron Jr. Signature/ACT-LR z 3 diluent ampules in triplicate
ITC Hemochron P214/P215 z 3 • CT3Q - Three 0.5-mL
i-STAT Celite and Kaolin ACT
®
z 3 lyophilized whole blood/
Medtronic HemoTec diluent ampules in triplicate
z 3
ACT/ACTII/ACT Plus HR-ACT • CT5Q - Three 1.7-mL
Medtronic HemoTec lyophilized whole blood
z 3 specimens in triplicate with
ACT/ACTII/ACT Plus LR-ACT
Medtronic HemoTec
z 3 • Report up to three
ACT/ACTII/ACT Plus R-ACT
Medtronic Hepcon HMS, HMS Plus z 3
instruments 1/3
These programs do not meet regulatory requirements for proficiency testing; see Surveys CT-CT3 • Two shipments per year
Third Page Fillers

and CT5 on page 164. For additional information about the Quality Cross Check program,
see page 40.
Ensure your laboratory’s information is up-to-date.

The CAP’s online Organizational Profile tool ensures your laboratory’s
information is current to alleviate any issues with your proficiency
testing and accreditation procedures. No more mailing forms
or experiencing delays in processing—information is recorded
in real time.
Log into e-LAB Solutions Suite to review and update
your laboratory’s information.
48 College of American Pathologists 2020 Surveys & Anatomic

800-323-4040 Pathology Education
| 847-832-7000 Option 1 |Programs
cap.org 1
F1 Third Black Dot New
Quality Cross Check
Third Page Filler
Transfusion Medicine
Program Information
Quality Cross Check—Transfusion
• Three 7.0-mL 13-17% whole
Medicine JATQ blood specimens 4
Procedure Program Code Challenges per Shipment • May be used with automated
Quality Cross Check

JATQ and manual procedures
ABO grouping z 3
Antibody detection z 3
Rh typing z 3
This program does not meet regulatory requirements for proficiency testing; see Survey JAT
1/3
Third Page Fillers

Make critical transfusion decisions with confidence.
Transfusion Medicine in the Hot Seat is a valuable educational
resource for pathology trainees and pathologists practicing
transfusion medicine. The text presents a total of 26 realistic
transfusion scenarios divided into three sections:
• Antibodies • Blood Components • Complications

The short-case format makes the information easily accessible
and can serve as the basis for a transfusion medicine curriculum in
clinical pathology.
• ebooks at ebooks.cap.org Softcover; 123 pages
800-323-4040 | 847-832-7000 Option 1 | cap.org 49

800-323-4040 | 847-832-7000 Option 1 | cap.org 17


5 Point-of-Care Programs
Keep your point-of-care (POC)

instruments and staff operating at
peak performance. 5
• Improve waived test results with POC Competency
Point-of-Care Programs
Challenges that evaluate instrument and method
performance, troubleshoot issues, assess staff
competency, and provide training information.
• Gain insights with the Point-of-Care Testing Toolkit,
an ebook resource for all members of the team.
POC Competency Challenges are designed to improve waived test results. These programs
evaluate instrument and method performance, troubleshoot, assess staff competency, and provide
information to train staff. Expected results will be provided. These programs are not proficiency
testing programs and participants will not return results to the CAP.
POC Competency Challenges may have limited availability and stability.
5 POC Competency Challenges Program Information

• POC1 - One positive 10.0-mL
POC1, POC2, POC3, POC4 liquid urine specimen
Challenges per • POC2 - One abnormal

Program Name Program Code
Shipment
2.0-mL whole blood
POC1 POC2 POC3 POC4 specimen
hCG Competency z 10 • POC3 - One abnormal
Glucose Competency z 10 10.0-mL liquid urine
specimen
Urine Dipstick Competency z 10
Strep Screen Competency z 10 • POC4 - One 1.0-mL positive
liquid specimen
• Each program provides
material to test up to 10 staff
• Shipments available upon
request
POC Competency Challenges Program Information

• POC6 - One abnormal 0.3-mL
POC6, POC7, POC8, POC9 lyophilized plasma specimen
Challenges per (five vials) and five
Shipment corresponding diluents
POC6 POC7 POC8 POC9 • POC7 - One abnormal 2.5-mL
PT/INR, CoaguChek XS Plus and whole blood specimen
z 10 compatible with the
XS Pro Competency
HemoCue® B, HemoCue 201,
Waived Chemistry, Glucose, and
z 10 and Stanbio HemoPoint® H2
Hemoglobin Competency
instruments
Influenza A/B Antigen Detection
z 10 • POC8 - One 1.5-mL positive
Competency
liquid specimen for influenza
Fecal Occult Blood Competency z 10 A; one 1.5-mL positive liquid
specimen for influenza B
• POC9 - One positive 2.0-mL
fecal specimen
request
Half Page Filler Point-of-Care Programs
Program Information
POC Competency Challenges
• POC10 - One abnormal
POC10, POC11, POC12 2.5-mL aqueous blood gas
Challenges per specimen (10 vials) and one
Shipment 2.5-mL hematocrit/
POC10 POC11 POC12 hemoglobin specimen (10
vials)
Blood Gases Competency z 10
• POC11 - One abnormal
Blood Gases, i-STAT ®
z 10 2.5-mL aqueous specimen
Competency
Plasma Cardiac Markers
(10 vials) for blood gas and
hematocrit/hemoglobin
5
z 10
Competency testing
• POC12 - One 1.5-mL
plasma specimen (two
vials); compatible with
plasma-based tests, such
as Alere Triage® and i-STAT
instruments
1/2 • Shipments available upon
request
Half Page Filler
Guide your point-of-care testing with confidence.

Point-of-Care Testing (POCT) Toolkit
POCT implementation requires a systematic approach that involves all stakeholders. This toolkit
serves as a resource for any member of the POCT team who wants to learn about POCT or who has
responsibility to guide or direct POCT. Pathologists may also use the toolkit to guide other members of
their POCT teams, including POCT coordinators and medical technologists who are involved in POCT.
The toolkit covers:
• POCT advantages and disadvantages
• Current and projected technology
• Pathologist, laboratory director, and
POCT coordinator roles in POCT
• Selection of appropriate test methods
• Validation and verification protocols
• Quality control and data management
• Patient safety
• POCT training and competency
Purchase the ebook at ebooks.cap.org.
24 College of American Pathologists 2020 Surveys Option

800-323-4040 | 847-832-7000 Pickup1Filler Pages
| cap.org 53
F24 Half
Third Page Filler

Program Information
POC Competency Challenges
• POC14 - Five abnormal
POC14, POC15, POC16 1.7-mL lyophilized whole
Challenges per blood specimens with five
Shipment corresponding diluents
POC14 POC15 POC16 and one calcium chloride
diluent vial; compatible with
Medtronic ACT/ACT, i-STAT
z 5 Medtronic HemoTect ACT/
Competency
ACTII/ACT Plus, Medtronic
Hemochron Jr IL GEM PCL Hepcon HMS/HMS Plus, and
5 ACT-LR Competency
z 5
i-STAT Celine and Kaolin ACT
Hemochron Jr Signature IL GEM • POC15 - Five abnormal
z 5
PCL ACT Competency 0.5-mL lyophilized whole

blood/diluent ampules;
compatible with IL GEM
PCL Plus ACT-LR and ITC
Hemochron Jr./Signature
ACT-LR
• POC16 - Five abnormal
0.5-mL lyophilized whole
blood/diluent ampules;
compatible with IL GEM PCL
Plus ACT and ITC Hemochron
Jr./Signature ACT+
• Each program provides 1/3
material to test up to five
staff
request

on your 2019 order)

6 General Chemistry and Therapeutic
Drug Monitoring
Monitor performance of cardiac marker

testing across multiple instruments with
Quality Cross Check—Cardiac Markers
(CRTQ).
• Test multiple instruments at one time—Quality Cross
6
Check is not PT and not subject to CMS restrictions.

• Simplify biannual instrument comparability studies—
receive customized reports that include peer group
evaluations and instrument comparability statistics.

General Chemistry and Therapeutic Drug Monitoring........................................................................... 56
Urine Chemistry ................................................................................................................................... 68
Special Chemistry ................................................................................................................................ 71
New Programs
Quality Cross Check—Cardiac Markers (CRTQ) ................................................................................... 62
Sweat Analysis Series (SW3)

Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
General Chemistry and Therapeutic Drugs
• C1, C3, C4, CZ, Z - Five
C1, C3/C3X, C4, CZ/CZX/CZ2X, Z 5.0-mL liquid serum
Challenges per specimens
Shipment
• C3X, CZX - Five 5.0-mL
CZ/CZX/ liquid serum specimens in
C1 C3/C3X C4 CZ2X Z duplicate
Alanine aminotransferase • CZ2X - Five 5.0-mL liquid
6 (ALT/SGPT)
z z z 5
serum specimens in
Albumin z z z 5 triplicate
Alkaline phosphatase z z z 5 • Conventional and

Amylase z z z 5 International System of Units
Aspartate aminotransferase
z z z 5
(AST/SGOT) • Three shipments per year
Bilirubin, direct z z z z 5 • For second instrument
Bilirubin, total* z z z z 5 reporting options, see the
Quality Cross Check program,
Calcium z z z z 5
CZQ, on page 58
Chloride z z z z 5
Cholesterol, total z z z z 5
Cortisol z z z 5
Creatine kinase (CK) z z z 5
Creatinine z z z z 5
Glucose z z z z 5
HDL cholesterol z z z z 5
Human chorionic gonadotropin (hCG),
z z z z 5
quantitative
Iron z z z 5
Lactate dehydrogenase (LD) z z z 5
LDL cholesterol, measured z z z z 5
Lipoprotein (a) z z z 5
Magnesium z z z 5
Pancreatic amylase z z z 5
Potassium z z z z 5
Protein, total z z z 5
Sodium z z z z 5
Triiodothyronine (T3), free z z z 5
Triiodothyronine (T3), total z z z 5
T3, uptake and related tests z z z 5
*General Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditation
requirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 65.
Program Information
• C1, C3, C4, CZ, Z - Five
C1, C3/C3X, C4, CZ/CZX/CZ2X, Z continued 5.0-mL liquid serum
Shipment
Thyroxine (T4), free z z z 5 • CZ2X - Five 5.0-mL liquid
Thyroxine (T4), total z z z 5 serum specimens in
Thyroid-stimulating triplicate
z z z 5
hormone (TSH) • Conventional and
Triglycerides z z z z 5 International System of Units 6
Urea nitrogen (BUN) z z z z 5
• Three shipments per year

Uric acid z z z z 5
Acid phosphatase z z 5 • For second instrument
reporting options, see the
Ammonia z z 5
Quality Cross Check program,
Apolipoprotein A1 z z 5 CZQ, on page 58
Apolipoprotein B z z 5
Calcium, ionized z z 5
Carbon dioxide (CO2) z z z z 5
Ferritin z z 5
Gamma glutamyl transferase (GGT) z z z 5
Iron binding capacity,
z z 5
total (measured)
Iron binding capacity,
z z 5
unsaturated (measured)
Lactate z z 5
Lipase z z 5
Osmolality z z 5
Phosphorus (inorganic) z z z 5
Prealbumin z z 5
Transferrin z z 5
Lithium z z z z 5
Acetaminophen z z 5
Amikacin z z 5
Caffeine z z 5
Carbamazepine z z 5
Carbamazepine, free z z 5
Digoxin z z 5
Digoxin, free z z 5
Disopyramide z z 5
800-323-4040 | 847-832-7000 Option 1 | cap.org 57

Program Information
• C1, C3, C4, CZ, Z - Five
C1, C3/C3X, C4, CZ/CZX/CZ2X, Z continued 5.0-mL liquid serum
Shipment
Ethosuximide z z 5 • CZ2X - Five 5.0-mL liquid
Gentamicin z z 5 serum specimens in
Lidocaine z z 5 triplicate
Methotrexate z z 5 • Conventional and
6 N-acetylprocainamide (NAPA) z z 5
International System of Units
Phenobarbital z z 5
Phenytoin z z 5
• For second instrument
Phenytoin, free z z 5
reporting options, see the
Primidone z z 5 Quality Cross Check program,
Procainamide z z 5 CZQ, below
Quinidine z z 5
Salicylate z z 5
Theophylline z z 5
Tobramycin z z 5
Valproic acid z z 5
Valproic acid, free z z 5
Vancomycin z z 5
Program Information
Quality Cross Check—Chemistry and Therapeutic
Drug Monitoring CZQ specimens in duplicate
Analyte Program Code Challenges per Shipment • Report up to three
CZQ instruments
See Survey CZ analytes on • Conventional and
z 3
pages 56-58 International System of Units
This program does not meet regulatory requirements for proficiency testing; see Survey CZ on (SI) reporting offered
pages 56-58. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
The Quality Cross Check Program:
• Provides a solution for monitoring performance across multiple instruments and
is in compliance with the CMS directive regarding proficiency testing on multiple
instruments.
• Simplifies instrument comparability efforts by providing custom reports with both
peer group comparison and instrument comparability statistics.
Program Information
Harmonized Thyroid ABTH
• Three 1.0-mL frozen human
Analyte Program Code Challenges per Shipment serum specimens
ABTH • Two shipments per year
Triiodothyronine (T3), free z 3
Triiodothyronine (T3), total z 3
Thyroxine (T4), free z 3
Thyroxine (T4), total z 3
Thyroid-stimulating hormone (TSH) z 3
• Analytes will be evaluated using harmonization. 6
• Specimens are collected by a modified application of Clinical Laboratory
and Standards Institute Guideline CLSI C37-A, Preparation and Validation of

Commutable Frozen Human Serum Pools as Secondary Reference Materials for
Cholesterol Measurement Procedures; Approved Guideline.
Program Information
CAP/AACC Immunosuppressive Drugs CS
CS • For laboratories monitoring
Cyclosporine z 3 cyclosporine, sirolimus, and
Sirolimus (rapamycin) z 3 tacrolimus in transplant
patients
Tacrolimus z 3
AACC
Program Information
Antifungal Drugs Monitoring AFD
• Three 2.0-mL serum
Procedure Program Code Challenges per Shipment specimens
AFD • For laboratories performing
Fluconazole z 3 quantitative analysis of anti-
Itraconazole z 3 fungal agents
Posaconazole z 3 • Two shipments per year
Voriconazole z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 59

Program Information
Everolimus EV
EV • Two shipments per year
Everolimus z 3
Program Information
Mycophenolic Acid MPA
MPA • Two shipments per year
6 Mycophenolic acid z 3
Program Information
Therapeutic Drug Monitoring—Extended ZE
ZE • Two shipments per year
Clozapine z 3
Gabapentin z 3
Lacosamide z 3
Lamotrigine z 3
Levetiracetam z 3
Oxcarbazepine metabolite z 3
Pregabalin z 3
Rufinamide z 3
Teriflunomide z 3
Topiramate z 3
Zonisamide z 3
Program Information
Therapeutic Drug Monitoring—Special ZT
ZT • Two shipments per year
Amitriptyline z 3
Desipramine z 3
Imipramine z 3
Nortriptyline z 3
Tricyclics, total (qualitative/
z 3
quantitative)
Program Information
Accuracy-Based Lipids ABL
• Three 1.0-mL human serum
ABL • Two shipments per year
Apolipoprotein A1* z 3
Apolipoprotein B* z 3
Cholesterol* z 3
HDL cholesterol* z 3
Non-HDL cholesterol z 3
LDL cholesterol z 3
Lipoprotein (a) z 3 6
Triglycerides* z 3

*This analyte will be evaluated against the reference method.
Program Information
B-Type Natriuretic Peptides BNP, BNP5
• BNP - Two 1.0-mL liquid
Analyte Challenges per Shipment plasma specimens
Program Code • Conventional and
BNP BNP5 International System of
BNP 2 5 Units (SI) reporting offered;
two shipments per year
NT-proBNP 2 5
• BNP5 - Five 1.0-mL liquid
Additional Information plasma specimens
• The College of American Pathologists Accreditation Program requires all accredited
laboratories performing non-waived testing for BNP and NT-proBNP to complete
International System of
15 PT challenges per year.
Units (SI) reporting offered;
• For i-STAT®, use Plasma Cardiac Markers programs PCARM or PCARMX. three shipments per year
• For second instrument reporting options, see the Quality Cross Check program,
BNPQ, below.
Program Information
BNP z 3 instruments
BNP5 above. For additional information about the Quality Cross Check program, see page 40. Units (SI) reporting offered
The Quality Cross Check Program: • Two shipments per year
instruments.
800-323-4040 | 847-832-7000 Option 1 | cap.org 61

Program Information
Cardiac Markers CRT, CRTI, TNT, TNT5
• CRT - Five 2.0-mL liquid
Challenges per serum specimens
Shipment
• CRTI - Ten 2.0-mL liquid
CRT CRTI TNT TNT5
serum specimens
CK-MB, immunochemical z z 5
• TNT - Two 2.0-mL liquid
CK isoenzymes (CK-BB, CK-MB, serum specimens
z 5
CK-MM), electrophoretic
• TNT5 - Five 2.0-mL liquid
LD1, LD2, LD3, LD4, LD5, serum specimens
z 5
electrophoretic
LD1/LD2 ratio calculation
z 5
6 and interpretation
Myoglobin z z 2
Troponin I z z 5
Troponin T, two challenges z 2
Troponin T, five challenges z 5
The College of American Pathologists Accreditation Program requires all accredited
laboratories performing non-waived testing for Troponin I and Troponin T to complete
Program Information
Quality Cross Check—Cardiac Markers CRTQ
CRTQ • Report up to three
CK-MB, immunochemical z 3 instruments
Myoglobin z 3 • Two shipments per year
Troponin I z 3
This program does not meet regulatory requirements for proficiency testing; see Survey CRT
above. For additional information about the Quality Cross Check program, see page 40.

instruments.
Program Information
Hemoglobin A1c GH2, GH5
• GH2 - Three 0.8-mL liquid
Analyte Challenges per Shipment human whole blood
Program Code specimens; two shipments
GH2 GH5 per year
Hemoglobin A1c 3 5 • GH5 - Five 0.8-mL liquid

human whole blood
Additional Information specimens; three shipments
• These Surveys will be evaluated against the National Glycohemoglobin per year
Standardization Program (NGSP) reference method.
laboratories performing non-waived testing for Hemoglobin A1c to complete 15 PT
challenges per year.
6

GHQ, below.
Program Information
Quality Cross Check—Hemoglobin A1c GHQ
• Three 0.8-mL previously
Analyte Program Code Challenges per Shipment frozen liquid specimens in
GHQ triplicate
Hemoglobin A1c z 3 • Report up to three
This program does not meet regulatory requirements for proficiency testing; see Survey GH5, instruments
above. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
instruments.
Program Information
Hemoglobin A1c GH5I
• Five 0.5-mL lyophilized
Analyte Program Code Challenges per Shipment specimens with a 3.0-mL
GH5I dropper-tipped vial of diluent
Hemoglobin A1c z 5 • Designed for international
laboratories that have
experienced significant
• This program meets the CAP’s Accreditation Program requirements for shipping and receiving
proficiency testing. issues and require longer
• This Survey will not be evaluated against the National Glycohemoglobin specimen stability
Standardization Program (NGSP) reference method. See Survey GH5 to be
evaluated against the NGSP reference method.
800-323-4040 | 847-832-7000 Option 1 | cap.org 63

Program Information
Glycated Serum Albumin GSA
GSA • Two shipments per year
Glycated serum albumin z 3
Program Information
High-Sensitivity C-Reactive Protein HSCRP
HSCRP • Two shipments per year
6 High-sensitivity C-reactive protein z 3
Program Information
Homocysteine HMS
HMS • Two shipments per year
Homocysteine z 3
Program Information
Ketones KET
• Two 2.0-mL serum
KET • For semi-quantitative
Beta-hydroxybutyrate z 2 methods using the
Total ketones z 2 nitroprusside reaction for
total ketones testing
Program Information
Chemistry—Limited, Waived LCW
LCW • For use with waived methods
Cholesterol z 3 such as the Cholestech LDX®
Glucose z 3 and Roche ACCU-CHEK®
Instant Plus
HDL cholesterol z 3
• The glucose specimens
LDL cholesterol z 3
are not appropriate for
Triglycerides z 3 use on other whole blood
glucose meters
Program Information
Neonatal Bilirubin NB, NB2
• NB - Five 1.0-mL human
Analyte Challenges per Shipment serum specimens; three
Program Code shipments per year
NB NB2 • NB2 - Two 1.0-mL human
Bilirubin, direct 2 2 serum specimens; must
order in conjunction with
Bilirubin, total 5 2
a five-challenge total
One human-based serum specimen will offer the value assigned using the reference bilirubin proficiency testing
method procedure (Clin Chem. 1985;31:1779-1789). program to meet regulatory
requirements; two shipments
per year
• Conventional and 6

Units (SI) reporting offered
Plasma Cardiac Markers PCARM, PCARMX, PCARI Program Information

• PCARM - Five 1.5-mL liquid
Analyte Program Code Challenges per Shipment EDTA plasma specimens for
PCARM PCARMX PCARI point-of-care instruments
such as Quidel Triage Cardiac
BNP z z z 5
(CardiacHS, D-dimer, BNP,
CK-MB z z z 5 and SOB) and i-STAT
D-dimer z z 2 • PCARMX - All Survey PCARM
Myoglobin z z 2 specimens in duplicate
Troponin I z z z 5 • PCARI - Five 0.29-mL liquid
The College of American Pathologists Accreditation Program requires all accredited laboratories plasma specimens for use
performing non-waived testing for BNP and Troponin I to complete 15 PT challenges per year. with Quidel Triage Cardio 2,
Cardio 3, and Troponin I
panels
800-323-4040 | 847-832-7000 Option 1 | cap.org 65

Whole Blood Chemistry Compatibility Matrix

Compatible
Whole Blood Analyzer/Method Analyte Page
Survey Programs
Hemocue® Glucose HCC 66
Roche Reflotron ®
Cholesterol 56-57
C1, C4
Glucose 56-57
Cholestech LDX ®
Total cholesterol 64
HDL cholesterol 64
LCW
Triglycerides 64
Glucose 64
6 Whole blood cholesterol meters Cholesterol C1, C4, LCW 56-57, 64
HCC2, 66,
Whole blood glucose meters Glucose
WBGQ 67
Nova StatSensor®/
Creatinine WBCR 66
StatSensor Xpress™
Program Information
Waived Combination HCC, HCC2
• HCC - Two 1.0-mL whole
Analyte Program Code Challenges per Shipment blood specimens; two
HCC HCC2 shipments per year
Hematocrit z 2 • HCC2 - Total of four
Hemoglobin z z 2 shipments per year
Urinalysis/urine hCG z 2 • Hematocrit, hemoglobin, and
urinalysis/urine hCG testing -
Whole blood glucose z z 2 (HCC)/3 (HCC2)
Two 3.0-mL whole blood
specimens and two 10.0-mL
urine specimens; two
shipments per year: A and C
• Whole blood glucose
testing - Three 2.5-mL
whole blood specimens; two
shipments per year: B and D
• To verify instrument
compatibility, refer to
the instrument matrix
on this page
Whole Blood Creatinine WBCR Program Information

• Five 4.0-mL whole blood
WBCR
• For use with the Nova
Creatinine z 5 StatSensor/StatSensor
Xpress
Program Information
Quality Cross Check—Whole
Blood Glucose WBGQ specimens
Analyte Program Code Challenges per Shipment • Report up to 30 instruments
WBGQ • Two shipments per year
Glucose z 3
The CAP Accreditation Program requires all accredited laboratories performing waived whole
blood glucose testing using glucose meters to perform alternative performance assessment. This
program can be used to meet alternative performance assessment requirements.

is in compliance with the CMS directive regarding proficiency testing on multiple 6
instruments.

Improve the reliability of your patient results with CAP Survey

Validated Materials
Use the same material that is sent in the Surveys program to:
• Identify and troubleshoot instrument/method problems
• Correlate results with other laboratories or instruments
• Document correction of problems identified in Surveys
• Utilize material with confirmed results as an alternative external quality control
• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily
available results.
Chemistry/TDM, Validated Material Program Information

Validated Material Program Code Corresponding Survey Pages • Five 5.0-mL liquid serum
Chemistry/TDM CZVM CZ 56-58 specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org 67

Urine Chemistry
Urine Chemistry
Program Information
Urine Chemistry—General U
• Six 15.0-mL urine specimens
• One mailing per year will
U include an additional
Amylase z 3 educational specimen for
Calcium z 3 uric acid testing for a total
of seven challenges per year
Chloride z 3
6 Creatinine z 3
Glucose z 3 Units (SI) reporting offered
Magnesium z 3 • Two shipments per year

Nitrogen, total z 3
Osmolality z 3
Phosphorus z 3
Potassium z 3
Protein, total z 3
Sodium z 3
Urea nitrogen z 3
Uric acid z 3
Urine albumin, quantitative z 3
Urine albumin:creatinine ratio z 3
Program Information
Accuracy-Based Urine ABU
• Three 5.0-mL human urine
ABU • Two shipments per year
Calcium z 3
Creatinine z 3
Protein, total z 3
Urine albumin: creatinine ratio z 3
Target values for albumin are obtained by LC-MS/MS after trypsin digestion, performed by the
Renal Testing Laboratory, Mayo Clinic, Rochester, MN, using calibration materials prepared from
human serum albumin (>99% pure).
Other analytes will be compared by peer group for harmonization purposes.
Urine Chemistry
Program Information
Kidney Stone Risk Assessment KSA
KSA • Two shipments per year
Citrate z 3
Cystine z 3
Oxalate z 3
Sulfate z 3
Urine Chemistry—Special N, NX Program Information 6

• N - Six 10.0-mL lyophilized
urine specimens and three

N, NX 10.0-mL liquid urine
3-methoxytyramines z 3 specimens
5-hydroxyindoleacetic acid z 3 • NX - All lyophilized Survey N
17-hydroxycorticosteroids z 3 specimens in duplicate and
17-ketosteroids z 3 three 10.0-mL liquid urine
specimens
Aldosterone z 3
Coproporphyrins z 3
Cortisol, urinary free z 3
Dopamine z 3
Epinephrine z 3
Homovanillic acid z 3
Metanephrine z 3
Norepinephrine z 3
Normetanephrine z 3
Uroporphyrin z 3
Vanillylmandelic acid z 3
Program Information
Myoglobin, Urine MYG
• Two 1.0-mL urine specimens
MYG
Myoglobin, urine, qualitative and
z 2
quantitative
800-323-4040 | 847-832-7000 Option 1 | cap.org 69

Urine Chemistry
Third Page Filler
Program Information
Porphobilinogen, Urine UPBG
• Three 5.0-mL urine
UPBG • For use with qualitative and
Porphobilinogen z 3 quantitative methods

Validated Materials
6 • Correlate results with other laboratories or instruments

available results.
Urine Chemistry—General, Validated Material Program Information

Validated Material Program Code Corresponding Survey Page • Six 15.0-mL urine specimens
Urine Chemistry UVM U 68 • One mailing per year will 1/3
include an additional
Third Page Fillers

specimen for uric acid
testing
Urinalysis Benchtop Reference Guide (UABRG)

• Thirty-four different cell identifications, including
common and rare cells
• Detailed descriptions for each cell morphology
• Eight tabbed sections for easy reference
• A durable and water-resistant format to withstand
years of benchtop use—5” x 6½”
• printed books at estore.cap.org
Item number: UABRG
Spiral bound; 38 pages;
34 images; 2014
800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Special Chemistry
Third Page Filler
Special Chemistry
Program Information
1,5-Anhydroglucitol AG
AG • Two shipments per year
1,5-anhydroglucitol z 3
Aldolase ADL Program Information 6

• Two 3.0-mL liquid serum

ADL • Two shipments per year
Aldolase z 2
Program Information
Angiotensin Converting Enzyme ACE
• Two 2.0-mL lyophilized
ACE
Challenges per Shipment serum specimens 1/3
Angiotensin converting enzyme,
Third Page Drug

z 2
quantitative
Fillers
Monitoring
in real time.
800-323-4040 | 847-832-7000 Option 1 | cap.org 71

800-323-4040 | 847-832-7000 Option 1 | cap.org 1
Special Chemistry
Half Page Filler
Program Information
Body Fluid Chemistry FLD
FLD • Conventional and
Albumin z 3 International System of
Amylase z 3 Units (SI) reporting offered
CA19-9 z 1 • Two shipments per year
CEA z 1
Cholesterol z 3
Creatinine z 3
6 Glucose z 3
Lactate z 3

pH z 3
Protein, total z 3
Triglycerides z 3
Urea nitrogen z 1
For second instrument reporting options, see the Quality Cross Check program, FLDQ,
on page 73. 1/2
Half Page Filler

Body Fluids Benchtop Reference Guide (BFBRG)
• Thirty-six color images, including common and rare cells,
crystals, and other cell inclusions
• Detailed descriptions of each cell including facts,
cell morphology and inclusions
• Nine tabbed sections for easy reference
o Erythroid Series
o Lymphoid Series
o Myeloid Series
o Mononuclear Phagocytic Series
o Lining Cells
o Miscellaneous Cells
o Crystals
o Microorganisms
o Miscellaneous Findings
Or, view sample pages and purchase online: Item number: BFBRG
• printed books at estore.cap.org Spiral bound; 42 pages;
• ebooks at ebooks.cap.org 36 images; 2013
800-323-4040 | 847-832-7000 Option 1 | cap.org 27

Special Chemistry
Program Information
Quality Cross Check—Body Fluid Chemistry FLDQ
FLDQ in duplicate
Albumin z 3 • Report up to three
Amylase z 3 instruments
CA19-9 z 1 • Two shipments per year
Carcinoembryonic antigen (CEA) z 1
Cholesterol z 3
Creatinine z 3
Glucose z 3 6
Lactate z 3

pH z 3
Protein, total z 3
Triglycerides z 3
Urea nitrogen z 1
This program does not meet regulatory requirements for proficiency testing; see Survey FLD on
page 72. For additional information about the Quality Cross Check program, see page 40.

instruments.
Program Information
Body Fluid Chemistry 2 FLD2
• Three 3.0-mL liquid body
Analyte Program Code Challenges per Shipment fluid specimens
FLD2 • Conventional and
Alkaline phosphatase z 3 International System of
Bilirubin z 3 Units (SI) reporting offered
Calcium z 3 • Two shipments per year
Chloride z 3
Lipase z 3
Potassium z 3
Sodium z 3
Uric acid z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 73

Special Chemistry
Program Information
Cadmium CD
Analyte Program Code Challenges per Shipment specimens and three
CD 13.0-mL urine specimens
Beta-2-microglobulin, urine z 3 • Conventional and
Cadmium, urine z 3 International System of Units
Cadmium, whole blood z 3
• Six shipments per year
Creatinine, urine z 3
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for
proficiency testing (OSHA standard-29 CFR 1910.1027AppF).
6
Program Information
Cerebrospinal Fluid Chemistry and
• M - Three 5.0-mL simulated

Oligoclonal Bands M, OLI liquid spinal fluid specimens
Analyte Program Code Challenges per Shipment • OLI - Three 1.0-mL simulated
M OLI liquid spinal fluid specimens
Albumin, quantitative z z 3 and three paired serum
specimens; one educational
Electrophoresis (albumin pattern interpretation
z z 3
and gamma globulin) dry challenge and three
Glucose z z 3 educational activities to
IgG, quantitative z z 3 calculate CSF IgG index and
synthesis rate each mailing
Lactate z z 3
Lactate dehydrogenase (LD) z z 3
Protein, total z z 3
Oligoclonal bands z 3
Program Information
Cystatin C CYS
CYS • Two shipments per year
Cystatin C z 2
Special Chemistry
Program Information
Fecal Calprotectin FCAL
• Three 1.0-g simulated fecal
FCAL • Two shipments per year
Fecal calprotectin z 3
Program Information
Fecal Fat FCFS
• Two 10.0-g simulated fecal
Analyte Program Code Challenges per Shipment fat specimens
FCFS • For microscopic detection
Fecal fat, qualitative z 2 of neutral fats (triglycerides) 6
and/or split fats (total free

fatty acids)
Program Information
Fructosamine FT
FT • Two shipments per year
Fructosamine z 2
Program Information
Glucose-6-Phosphate Dehydrogenase G6PDS
Analyte Program Code Challenges per Shipment hemolysate specimens
G6PDS • Two shipments per year
G6PD, qualitative and quantitative z 2
Program Information
Lipoprotein-Associated Phospholipase A2 PLA
• Two 1.0-mL liquid specimens
PLA
Lipoprotein-associated
z 2
phospholipase (Lp-PLA2) activity
800-323-4040 | 847-832-7000 Option 1 | cap.org 75

Special Chemistry
Program Information
Lipoprotein and Protein Electrophoresis
• LPE - Two 1.0-mL liquid
LPE, SPE, UBJP serum specimens
Analyte Program Code Challenges per Shipment • SPE - Two 1.0-mL lyophilized
LPE SPE UBJP serum specimens; two
Lipoprotein electrophoresis z 2 educational protein
electrophoresis dry
IgA, quantitation z 2 challenges per year
IgG, quantitation z 2 • UBJP - Two 10.0-mL urine
IgM, quantitation z 2 specimens
M-protein (Paraprotein) identification z 2 • Two shipments per year
6 Protein, total z 2
Protein electrophoresis z 2
Protein electrophoresis pattern

z 2
interpretation
Urine Bence Jones protein z 2
Program Information
Lamellar Body Count LBC
Procedure Program Code Challenges per Shipment liquid amniotic fluid
LBC specimens
Lamellar body count z 3 • For use with LBC methods
performed on all hematology
analyzers
Program Information
Plasma Hemoglobin PHG
PHG
Plasma hemoglobin z 2
Special Chemistry
Program Information
Procalcitonin PCT
PCT • Two shipments per year
Procalcitonin z 3
Program Information
Pseudocholinesterase C7
• One 2.0-mL lyophilized
Analyte Program Code Challenges per Shipment serum specimen
C7 • Three shipments per year
Pseudocholinesterase z 1 6

Program Information
Salivary Cortisol SALC
• Three 1.0-mL synthetic oral
SALC • Two shipments per year
Salivary cortisol z 3
Program Information
Accuracy-Based Testosterone, Estradiol ABS
ABS • Two shipments per year
Albumin z 3
Cortisol z 3
Estradiol z 3
Follicle-stimulating hormone (FSH) z 3
Luteinizing hormone (LH) z 3
Sex hormone-binding globulin
z 3
(SHBG)
Testosterone z 3
The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.
800-323-4040 | 847-832-7000 Option 1 | cap.org 77

Special Chemistry
Program Information
Total Bile Acids TBLA
TBLA • Two shipments per year
Total bile acids z 3
Program Information
Trace Metals R
R • Conventional and
6 Aluminum z 3 International System of
Chromium z 3 Units (SI) reporting offered
Copper z 3 • Two shipments per year

Manganese z 3
Selenium z 3
Zinc z 3
Program Information
Trace Metals, Urine TMU
• Two 25.0-mL urine
TMU • Conventional and
Aluminum z 2 International System of Units
Arsenic z 2 (SI) reporting offered
Chromium z 2 • For laboratories that monitor
trace metals at normal and
Cobalt z 2
toxic levels
Copper z 2
Lead z 2
Manganese z 2
Mercury z 2
Selenium z 2
Thallium z 2
Zinc z 2
Special Chemistry
Program Information
Trace Metals, Whole Blood TMWB
TMWB • Conventional and
Arsenic, total z 3 (SI) reporting offered
Cobalt z 3
toxic levels
Copper z 3
Manganese z 3
Mercury z 3 6
Selenium z 3

Thallium z 3
Zinc z 3
Program Information
Sweat Analysis Series SW1, SW2, SW4
• SW1, SW2, SW4 - Three
Analyte Program Code Challenges per Shipment 5.0-mL simulated liquid
SW1, SW2, SW4 human sweat specimens
Chloride z 3 • Two shipments per year
Conductivity z 3
For method compatibility, see chart below.
Sweat Analysis Series Compatibility Matrix

Method/Procedure Program Code Materials Included
SW1 SW2 SW4
Precut 2-cm diameter
Orion direct electrode z
Whatman filter papers
Wescor Macroduct™ and 22-gauge blunt-tipped
z
Nanoduct ® Systems needles
No additional
All other methodologies z
materials provided
800-323-4040 | 847-832-7000 Option 1 | cap.org 79

Special Chemistry
Third Page Filler

Program Information
Viscosity V
V • Two shipments per year
Viscosity z 2
Program Information
Soluble Transferrin Receptor STFR
• Three 2.5-mL liquid human
STFR • Two shipments per year
6 Soluble transferrin receptor (sTfR) z 3

Validated Materials
1/3
Each laboratory receives a Survey Participant Summary, which includes
readily available results.
Cerebrospinal Fluid, Validated Material Program Information

Validated Material Program Code Corresponding Survey Page • Three 5.0-mL simulated
Cerebrospinal Fluid MVM M 74 liquid spinal fluid specimens
Help pathologists stay current with rapidly

changing issues in clinical pathology.
The Clinical Pathology Improvement Program
(CPIP) provides peer-reviewed, interactive, case-
based learning activities that cover a diverse
portfolio of real-life clinical scenarios. Every
month, you receive a new online module with
images and clinical details that unfold as you
solve the case in real time. Earn CME/SAM credits
upon successful completion of the posttest.
Add CPIP/CPIP1 to your Surveys order.
7 Endocrinology
Be confident in the accuracy of your

C-peptide and insulin testing.
• Test your results against reference method targets
with the Accuracy-Based Glucose, Insulin, and
C-Peptide (ABGIC) program.
• Identify instrument issues before they impact patient 7
results with the C-Peptide/Insulin Calibration
Endocrinology
Verification/Linearity (LN46) program.
New Analyte Additions

Accuracy-Based Vitamin D (ABVD).....................................................................................................85
Endocrinology
Endocrinology
Program Information
Ligand—General K, KK, K2
• K - Five 5.0-mL liquid serum
Challenges per specimens; three shipments
Shipment
per year
K, KK K2
• KK - Five 5.0-mL liquid
Alpha-fetoprotein (AFP) z 5 serum specimens in
CEA z z 3 duplicate; three shipments
per year
Cortisol z 5
Ferritin z z 3 • K2 - Three 5.0-mL liquid
serum specimens; two
Folate, serum 3
7 hCG, quantitative
z
z
z
5
shipments per year
Immunoglobulin E (IgE) z 5
Endocrinology
Prostate-specific antigen (PSA) z z 2 (K,KK)/3 (K2)

Prostate-specific antigen,
z 2
complexed (cPSA)
Prostate-specific antigen, free z 2
Prostatic acid phosphatase (PAP) z 3
T3 uptake and related tests z 5
Vitamin B12 z z 3
Program Information
MMA and Active B12 MMA
Challenges per serum specimens
Shipment
MMA
Active vitamin B12 z 3
Methylmalonic acid z 3
Endocrinology
Program Information
B-Type Natriuretic Peptides BNP, BNP5
• BNP - Two 1.0-mL liquid
Analyte Challenges per Shipment plasma specimens
Program Code • Conventional and
BNP BNP5 International System of
BNP 2 5 Units (SI) reporting offered;
NT-proBNP 2 5
• BNP5 - Five 1.0-mL liquid
Additional Information plasma specimens
laboratories performing non-waived testing for BNP and NT-proBNP to complete
Units (SI) reporting offered;
• For i-STAT®, use Plasma Cardiac Markers programs PCARM or PCARMX. three shipments per year
BNPQ, below. 7
Endocrinology
Program Information
BNP z 3 instruments
BNP5 above. For additional information about the Quality Cross Check program, see page 40. Units (SI) reporting offered
The Quality Cross Check Program: • Two shipments per year
instruments.
800-323-4040 | 847-832-7000 Option 1 | cap.org 83

Endocrinology
Program Information
Ligand—Special Y, YY, DY
• Y - Three 5.0-mL liquid serum
Analyte Program Code Challenges per Shipment specimens in duplicate
Y, YY DY • YY - Three 5.0-mL liquid
11-deoxycortisol z 3 serum specimens in
17-hydroxyprogesterone z 3 triplicate
Androstenedione z 3 • DY - Must order in
conjunction with Survey Y or
DHEA sulfate z 3
YY
Estradiol z 3
Estriol, unconjugated (uE3) z 3 International System of
Follicle-stimulating hormone (FSH) z 3 Units (SI) reporting offered
Growth hormone (GH) z 3 • Two shipments per year
7 IGF-1 (somatomedin C) z 3
Progesterone 3
Endocrinology
z
Prolactin z 3
Testosterone z 3
Testosterone, bioavailable (measured) z 3
Testosterone, free (measured) z 3
Sex hormone-binding globulin (SHBG) z 3
Program Information
Antimüllerian Hormone AMH
AMH • Two shipments per year
Antimüllerian hormone z 3
Program Information
25-OH Vitamin D, Total VITD
VITD • Conventional and
25-OH vitamin D, total z 3 International System of Units
Endocrinology
Program Information
Bone and Growth BGS
BGS • Conventional and
IGF-1 (somatomedin C) z 3 International System of
Osteocalcin z 3 Units (SI) reporting offered
Program Information
Accuracy-Based Vitamin D ABVD
• Three 1.0-mL liquid human 7
serum specimens
ABVD • Serum is from multi-donor
Endocrinology
25-OH vitamin D (D2 and D3) z 3 endogenous pools
Calcium z 3 • Conventional and
• The Centers for Disease Control and Prevention (CDC) will establish reference
targets using isotope-dilution LC-MS/MS method. • Two shipments per year
• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C37-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials
for Cholesterol Measurement Procedures; Approved Guideline.
Program Information
Bone and Mineral Metabolism, Urine BU
Analyte Program Code Challenges per Shipment human urine specimens
BU • Conventional and
C-telopeptide (CTx) z 2 International System of
Creatinine z 2 Units (SI) reporting offered
Deoxypyridinoline (DPD) z 2 • Two shipments per year
N-telopeptide (NTx) z 2
Pyridinoline (PYD) z 2
800-323-4040 | 847-832-7000 Option 1 | cap.org 85

Endocrinology
Program Information
Bone Markers and Vitamins
• BMV1 through BMV4 -
BMV1, BMV2, BMV3, BMV4, BMV5, BMV6 Three 5.0-mL liquid serum
Challenges per specimens for each program
Shipment
• BMV5 and BMV6 - Three
BMV1 BMV2 BMV3 BMV4 BMV5 BMV6 1.0-mL liquid serum
1,25 dihydroxy specimens for each program
z 3
vitamin D • Two shipments per year
Bone-specific
alkaline z 3
phosphatase
Vitamin A z 3
Vitamin E (alpha
7 tocopherol, gamma
tocopherol)
z 3
C-telopeptide z 3
Endocrinology
N-telopeptide z 3
Program Information
Insulin, Gastrin, C-Peptide, and PTH ING
ING • Conventional and
C-peptide z 3 International System of
Gastrin z 3 Units (SI) reporting offered
Insulin z 3 • Two shipments per year
Parathyroid hormone (PTH) z 3
Program Information
Accuracy-Based Glucose, Insulin,
and C-Peptide ABGIC specimens
Analyte Program Code Challenges per Shipment • Two shipments per year
ABGIC
C-peptide z 3
Glucose z 3
Insulin z 3
• Target values are based upon the isotope-dilution gas chromatography-mass
spectrometry reference measurement procedure for glucose performed by the CDC
Reference Laboratory, Division of Laboratory Sciences, Centers for Disease Control
and Prevention (Atlanta, GA).
• Target values for C-peptide are established by isotope-dilution mass spectrometry,
performed at the University of Missouri, Diabetes Diagnostic Laboratory.
Endocrinology
Program Information
Quality Cross Check—Parathyroid Hormone PTHQ
Analyte Program Code Challenges per Shipment serum specimens in
PTHQ duplicate
Parathyroid hormone (PTH) z 3 • Report up to three
This program does not meet regulatory requirements for proficiency testing; see Survey ING on instruments
page 86. For additional information about the Quality Cross Check program, see page 40. • Two shipments per year
instruments.
7
Program Information
Second Trimester Maternal Screening FP, FPX
Endocrinology
• FP - Five 1.0-mL liquid serum
Analyte Program Code Challenges per Shipment specimens; two 1.0-mL
FP, FPX simulated amniotic fluid
Alpha-fetoprotein (AFP), amniotic fluid z 2 specimens
Alpha-fetoprotein (AFP), serum z 5 • FPX - All Survey FP serum

specimens in duplicate; two
Dimeric inhibin A (DIA) z 5
1.0-mL simulated amniotic
Estriol, unconjugated (uE3) z 5 fluid specimens
Human chorionic gonadotropin (hCG), • Three shipments per year
z 5
quantitative
The CAP designed these Surveys for laboratories using AFP and hCG for prenatal screening
purposes only. For all other applications, see Survey K or KK on page 82.
Program Information
First Trimester
• FP1T - Five 1.0-mL serum
Maternal Screening FP1T, FP1B specimens
Analyte Program Code Challenges per Shipment • FP1B - Five 1.0-mL serum
FP1T FP1B specimens
Total hCG z 5 • Three shipments per year
Free beta hCG z 5
PAPP-A z z 5
The CAP designed these Surveys for laboratories using hCG for prenatal screening purposes only.
For all other applications, see Survey K or KK on page 82.
800-323-4040 | 847-832-7000 Option 1 | cap.org 87

Endocrinology
Program Information
Noninvasive Prenatal Testing NIPT
• Three maternal plasma
Analyte Program Code Challenges per Shipment samples
NIPT • Two shipments per year
Cell-free DNA screening for fetal
z 3
aneuploidy
Noninvasive prenatal testing is an exercise and is not considered proficiency testing. This exercise
may be used to meet the requirements for alternative assessment.
Program Information
Erythropoietin EPO
EPO • Two shipments per year
7 Erythropoietin z 2
Endocrinology
Program Information
Fetal Fibronectin FF
FF
Fetal fibronectin z 2
Program Information
RBC Folate FOL
• Two 2.0-mL lyophilized whole
Analyte Program Code Challenges per Shipment blood specimens
FOL • Conventional and
RBC folate z 2 International System of Units
Endocrinology
Program Information
Renin and Aldosterone RAP
Analyte Program Code Challenges per Shipment plasma specimens
RAP • Conventional and
Aldosterone z 3 International System of
Renin z 3 Units (SI) reporting offered
Program Information
Tumor Markers TM, TMX
• TM - Three 2.0-mL liquid 7
TM, TMX
Endocrinology
• TMX - All Survey TM
Adrenocorticotropic hormone (ACTH) z 3 specimens in duplicate
Beta-2 microglobulin z 3 • Two shipments per year
CA 15-3 z 3
CA 19-9 z 3
CA 27.29 z 3
CA 72-4 z 3
CA 125 z 3
Calcitonin z 3
Thyroglobulin z 3
Program Information
Human Epididymis Protein 4 HUEP
HUEP • Two shipments per year
Human epididymis protein 4 z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 89

Endocrinology
Third Page Filler

Validated Materials
available results.
Endocrinology, Validated Materials Program Information

7 Validated Material Program Code Corresponding Survey Page • KVM - Five 5.0-mL liquid
serum specimens; three
Ligand—General KVM K 82
shipments per year
Ligand—Special YVM Y 84
Endocrinology
• YVM - Three 5.0-mL liquid

serum specimens in
duplicate; two shipments
per year
1/3
Third Page Fillers
We are here to help. Fast Focus on Compliance—the inspector’s quick guide.

A resource for laboratories and inspectors alike, our Fast Focus on Compliance mini-training vignettes help
you prepare for future laboratory inspections by gaining a clear understanding of the requirements and
receiving insight into areas that need improvement:
• What Did You REALLY Mean...How to Write a “Good” Deficiency
• Identifying Systemic Issues—Critical Role of the Inspection Team Leader
• Inspecting Method Validation/Verification Studies
• Inspecting Personnel Records
• 12 Inspector Tools to Make Your Inspection Go More Smoothly
• Proficiency Testing Referral and Communications
Access these concentrated topics online by searching Fast Focus on Compliance at cap.org

8 Blood Gas, Critical Care, and Oximetry
Our programs closely mimic patient

testing to ensure accuracy.
• Test specimen levels that reflect clinical
decision points.
• Keep current with the latest laboratory best
practices with educational content supplied
in our participant summary reports.
• Gain confidence in your results by comparing
performance against the largest peer groups.
8


Program Information
Critical Care Blood Gas AQ, AQ2, AQ3, AQ4
• AQ, AQ2 - Five 2.5-mL
Challenges per aqueous specimens in
Shipment
duplicate and five 2.5-mL
AQ AQ2 AQ3 AQ4 specimens for hematocrit
Calcium, ionized z z z z 2 testing in duplicate;
appropriate for all methods
Chloride z z z z 5
except i-STAT®
Hematocrit z z z z 5
• AQ3, AQ4 - Five 2.5-mL
Hemoglobin, estimated z z z z 5 specimens in duplicate for
Lactate z z z z 2 i-STAT methods only
Magnesium, ionized z z 2 • Conventional and
pCO2 5 International System of Units
8
z z z z
pH z z z z 5
pO2 z z z z 5
Potassium z z z z 5
Sodium z z z z 5
tCO2 z z z z 5
Creatinine z z 5
Glucose z z 5
For second instrument reporting options, see the Quality Cross Check programs, AQQ, AQ2Q, AQ3Q,
and AQ4Q, on page 93.
It is not appropriate to report hemoglobin and hematocrit results by co-oximetry in this Survey.
Order Survey
Yes
AQ3 or AQ4
Do you use
an i-STAT
instrument?
Order Survey
No
AQ or AQ2
Program Information
Quality Cross Check—Blood Gas
• AQQ, AQ2Q - Three 2.5-mL
AQQ, AQ2Q, AQ3Q, AQ4Q specimens in triplicate and
Analyte Program Code Challenges per Shipment three 2.5-mL specimens for
hematocrit testing in
AQQ AQ2Q AQ3Q AQ4Q
triplicate; appropriate for all
Calcium, ionized z z z z 3 methods except i-STAT®
Chloride z z z z 3 • AQ3Q, AQ4Q - Three
Hematocrit z z z z 3 1.7-mL specimens in
Hemoglobin, estimated z z z z 3 triplicate for i-STAT methods
only
Lactate z z z z 3
Magnesium, ionized z z 3
instruments
pCO2 z z z z 3
pH z z z z 3 International System of Units
pO2 z z z z 3 (SI) reporting offered
Potassium z z z z 3 • Two shipments per year 8
Sodium z z z z 3

tCO2 z z z z 3
Creatinine z z 3
Glucose z z 3
It is not appropriate to report hemoglobin or hematocrit by co-oximetry in this program.
These programs do not meet regulatory requirements for proficiency testing; see Surveys AQ
and AQ2-AQ4 on page 92. For additional information about the Quality Cross Check program,
see page 40.

instruments.
800-323-4040 | 847-832-7000 Option 1 | cap.org 93

Program Information
Blood Oximetry SO
• Five 1.8-mL stabilized
Analyte Program Code Challenges per Shipment human hemoglobin solution
SO specimens
Methemoglobin z 5
Oxyhemoglobin z 5
• This Survey is not compatible with Oxicom-2000, -2100, or -3000 whole
blood oximeters.
SOQ, below.
8
Program Information
Quality Cross Check—Blood Oximetry

SOQ specimens in triplicate
Analyte Program Code Challenges per Shipment • Report up to three
SOQ instruments
Methemoglobin z 3
Oxyhemoglobin z 3
This program does not meet regulatory requirements for proficency testing; see Survey SO above.
For additional information about the Quality Cross Check program, see page 40.

instruments.
9 Toxicology
Toxicology testing is changing at a rapid

pace—so is our proficiency testing.
Introducing new programs for forensic toxicology and
toxicology laboratories that perform:
• Qualitative and/or quantitative analysis of synthetic
opioids and benzodiazepines in whole blood (NOB)
• Qualitative and/or quantitative analysis of
cannabinoids in whole blood (THCB)
Toxicology
New Analyte/Drug Additions
Toxicology (T) ....................................................................................................................................... 96
Urine Toxicology (UT)............................................................................................................................ 96
CAP/AACC Urine Drug Testing, Screening (UDS) ................................................................................... 98
CAP/AACC Urine Drug Testing, Screening, Limited (UDS6) ................................................................... 98
CAP/AACC Forensic Urine Drug Testing, Confirmatory (UDC)................................................................ 99
Oral Fluid for Drugs of Abuse (OFD).................................................................................................... 100
Forensic Toxicology, Criminalistics (FTC) ........................................................................................... 104
Drug Monitoring for Pain Management (DMPM) ................................................................................. 107
Drug-Facilitated Crime (DFC) ............................................................................................................. 108
Toxicology
Toxicology
Use this flowchart as a guide for ordering appropriate toxicology Surveys for your laboratory’s testing menu.
Mixed and Other Matrices

Urine Toxicology Programs
Toxicology Programs
(see catalog listing for program details)
(see catalog listing for
program details)
Qualitative reporting
Screening and/or
ONLY Screening and/or
confirmatory drug
Immunoassay and confirmatory Screening and/or
analysis WITHOUT
nonconfirmatory drug analysis WITH confirmatory drug
quantitation
techniques quantitation analysis with quantitation
(no quantitation)
(no quantitation)
UDS and/or UDS6 DFC, SCDD, or UT DMPM or UDC T, FTC, OFD, NOB, THCB
9
Toxicology
Program Information
Toxicology T
• A total of five specimens
Analyte Program Code Challenges per Shipment consisting of 20.0-mL liquid
T serum and 50.0-mL liquid
See drug listing on next page z 5 urine specimens
• For laboratories performing
qualitative and quantitative
drug analysis on serum and
qualitative analysis on urine
specimens
Program Information
Urine Toxicology UT
• Five 50.0-mL liquid urine
UT • For laboratories performing
See drug listing on next page z 5 qualitative drug analysis
with qualitative confirmatory
testing
Toxicology
T and UT Programs Drug Listing

Challenges will include a mix of drugs from the list below.
6-acetylmorphine (6-AM) Delta-9-THC (serum only) Mephedrone O-desmethyltramadol

7-aminoclonazepam Delta-9-THC-COOH Meprobamate Olanzapine
7-aminoflunitrazepam Demoxepam Methadone Opiate group
Acetaminophen Desipramine Methadone Oxazepam
Alpha-hydroxyalprazolam Desmethylclomipramine metabolite (EDDP) Oxycodone
Alprazolam Desmethylcyclobenzaprine* Methamphetamine Oxymorphone
Amitriptyline Desmethylsertraline Methylenedioxy- Paroxetine
amphetamine (MDA)
Amphetamine Dextromethorphan Pentobarbital
Methylenedioxy-
Amphetamine group Diazepam Phencyclidine
methamphetamine
Aripiprazole Dihydrocodeine (MDMA) Phenethylamine
Atenolol Diltiazem Methylenedioxy- Pheniramine
Atropine Diphenhydramine pyrovalerone (MDPV) Phenobarbital
Barbiturate group Doxepin Methylphenidate Phentermine
Benzodiazepine Doxylamine Metoprolol Phenylephrine 9
group Duloxetine Mirtazapine Phenytoin
Benzoylecgonine Morphine
Toxicology
Ecgonine ethyl ester Pregabalin
Brompheniramine Ecgonine methyl ester N-desmethyltramadol Propoxyphene
Buprenorphine Ephedrine Naproxen Propranolol
Bupropion Fentanyl Nicotine Pseudoephedrine
Butalbital Flunitrazepam Norbuprenorphine Quetiapine
Cannabinoids Fluoxetine Norchlordiazepoxide Quinidine
Carbamazepine Gabapentin Norclomipramine Quinine
Carbamazepine-10, Hydrocodone Norcodeine Ranitidine
11-epoxide
Hydromorphone Norcyclobenzaprine* Salicylates
Carisoprodol
Hydroxybupropion Nordiazepam Sertraline
Chlordiazepoxide
Hydroxyzine Nordoxepin Strychnine
Chlorpheniramine
Ibuprofen Norfentanyl Temazepam
Citalopram
Imipramine Norfluoxetine Topiramate
Clomipramine
Ketamine Norketamine Tramadol
Clonazepam
Lamotrigine Normeperidine Trazodone
Clozapine
Levetiracetam Noroxycodone Tricyclic group
Cocaethylene
Lidocaine Norpropoxyphene Trimipramine
Cocaine
Lorazepam Norsertraline Valproic acid
Codeine
Lysergic acid diethylamide Nortrimipramine Venlafaxine
Cotinine (LSD) Nortriptyline Verapamil
Cyclobenzaprine Meperidine Norverapamil Zolpidem
*Same compound
800-323-4040 | 847-832-7000 Option 1 | cap.org 97

Toxicology
Program Information
CAP/AACC Urine Drug Testing, Screening
• UDS - Five 10.0-mL liquid
UDS, UDS6 urine specimens; three
Analyte Program Code shipments per year
Challenges per Shipment • UDS6 - Three 10.0-mL liquid
UDS6
UDS shipments per year
Limited
Acetaminophen 5 3 • For laboratories performing
drugs of abuse testing on
Amphetamine 5 3
urine specimens using
Amphetamine/methamphetamine group 5 3 immunoassay or other
Barbiturate group 5 3 screening techniques only
Benzodiazepine group 5 3 • Participants will have access
Benzoylecgonine/cocaine metabolites 5 3 to the AACC quarterly
newsletter, Clinical &
Buprenorphine and metabolites 5 3
Forensic Toxicology News
Delta-9-THC-COOH 5 3
Ethanol 5 3
AACC
Fentanyl 5 3
9 Lysergic acid diethylamide (LSD) 5 3
Meprobamate/Carisoprodol 5 3
Toxicology
Methadone 5 3
Methadone metabolite (EDDP) 5 3
Methamphetamine 5 3
Methaqualone 5 3
Methylenedioxymethamphetamine (MDMA) 5 3
Opiate group 5 3
Oxycodone 5 3
Phencyclidine 5 3
Propoxyphene 5 3
Tramadol 5 3
Tricyclic group 5 3
Program Information
Urine Drug Adulterant/Integrity DAI
Shipment
DAI
Creatinine z 3
Glutaraldehyde z 3
Nitrite z 3
Oxidants z 3
pH z 3
Toxicology
Program Information
CAP/AACC Forensic Urine Drug Testing,
• Ten 50.0-mL liquid urine
Confirmatory UDC specimens
Analyte Program Code Challenges per Shipment • For laboratories that
UDC perform both screening
6-acetylmorphine (6-AM) z 10 and confirmatory testing,
including quantitation, for
Alpha-hydroxyalprazolam z 10 drugs of abuse in urine
Amphetamine z 10 specimens; laboratories are
Benzoylecgonine z 10 asked to report creatinine,
pH, and specific gravity for
Buprenorphine z 10
each specimen to ensure
Butalbital z 10 specimen adulteration has
Codeine z 10 not occurred
Delta-9-THC-COOH z 10 • Participants will have access
Fentanyl z 10 to the AACC quarterly
newsletter, Clinical &
Hydromorphone z 10 Forensic Toxicology News
Lorazepam z 10
• Four shipments per year
Methadone z 10 9
Methadone metabolite (EDDP)
Methamphetamine
z 10
10
AACC
Toxicology
z
Methaqualone z 10
Methylenedioxyamphetamine (MDA) z 10
Methylenedioxyethylamphetamine
z 10
(MDEA)
Methylenedioxymethamphetamine
z 10
(MDMA)
Morphine z 10
Norbuprenorphine z 10
Nordiazepam z 10
Norfentanyl z 10
Norpropoxyphene z 10
Oxazepam z 10
Oxycodone z 10
Oxymorphone z 10
Phencyclidine z 10
Phenobarbital z 10
Propoxyphene z 10
Secobarbital z 10
Temazepam z 10
Adulterant/Integrity Indicator
Creatinine z 10
pH z 10
800-323-4040 | 847-832-7000 Option 1 | cap.org 99

Toxicology
Program Information
Oral Fluid for Drugs of Abuse OFD
• Five 2.0-mL oral fluid
OFD • For laboratories performing
Amphetamine Group z 5 drug screening, confirmation,
Amphetamine z 5 and quantitation
Methamphetamine z 5 • Four shipments per year
Methylenedioxyamphetamine (MDA) z 5
Methylenedioxyethylamphetamine (MDEA) z 5
Methylenedioxymethamphetamine (MDMA) z 5
Benzodiazepine Group z 5
Alprazolam z 5
Diazepam z 5
Nordiazepam z 5
Oxazepam z 5
Temazepam z 5
9 Buprenorphine z 5
Buprenorphine and norbuprenorphine z 5
Cocaine and/or metabolite z 5
Toxicology
Benzoylecgonine z 5
Cocaine z 5
Cannabinoids z 5
Delta-9-THC z 5
Delta-9-THC-COOH z 5
Fentanyl and/or metabolite z 5
Fentanyl z 5
Norfentanyl z 5
Methadone z 5
Opiate Group z 5
6-acetylmorphine (6-AM) z 5
Codeine z 5
Hydrocodone z 5
Hydromorphone z 5
Morphine z 5
Oxycodone z 5
Oxymorphone z 5
Phencyclidine (PCP) z 5
Toxicology
Program Information
Vitreous Fluid, Postmortem VF
• Three 5.0-mL synthetic
Analyte Program Code Challenges per Shipment vitreous fluid specimens
VF • For forensic and other
Acetone z 3 toxicology laboratories
Chloride z 3 that perform quantitative
analysis of vitreous fluid
Creatinine z 3
Ethanol z 3
Glucose z 3 (SI) reporting offered
Potassium z 3 • Two shipments per year
Sodium z 3
Vitreous urea nitrogen z 3
Program Information
Serum Drug Screening SDS
SDS • For laboratories that perform 9
Acetaminophen, quantitative z 3 serum drug screening using
Toxicology
Acetone, semiquantitative and qualitative z 3 immunoassay or other
screening techniques
Barbiturate group, qualitative z 3
Benzodiazepine group, qualitative z 3
Salicylate, quantitative z 3
Total tricyclic antidepressants, qualitative z 3
Program Information
CAP/AACC Alcohol/Volatiles AL1,* AL2
• AL1 - Five 5.0-mL liquid
Analyte Program Code Challenges per Shipment whole blood specimens;
AL1* AL2 conventional reporting
Whole Blood Serum
Acetone, quantitative z z 5
• AL2 - Five 2.0-mL liquid
Ethanol, quantitative z z 5 serum specimens;
Ethylene glycol, qualitative and conventional and
z z 5 International System of Units
quantitative
Isopropanol, quantitative z z 5
Methanol, quantitative z z 5 • Three shipments per year
*The American Society of Crime Laboratory Directors/Laboratory Accreditation Board Proficiency

Review Committee (ASCLD/LAB PRC) has approved Survey AL1.
AACC
800-323-4040 | 847-832-7000 Option 1 | cap.org 101

Toxicology
Program Information
Ethanol Biomarkers ETB
Analyte Program Code Challenges per Shipment urine specimens
ETB • Two shipments per year
Ethyl glucuronide (EtG), qualitative
z 3
and quantitative
Ethyl sulfate (EtS), quantitative z 3
Program Information
CAP/AACC Blood Lead BL
• Five 6.0-mL liquid nonhuman
Analyte Program Code Challenges per Shipment whole blood specimens
BL • Conventional and
Lead z 5 International System of Units
This Survey meets the Occupational Safety and Health Administration (OSHA) requirements for (SI) reporting offered
proficiency testing [OSHA lead standards-29 CFR 1910.1025(j)(2)(iii)]. • Three shipments per year
AACC
9
Toxicology
Program Information
Cadmium CD
Analyte Program Code Challenges per Shipment specimens and three
CD 13.0-mL urine specimens
Beta-2-microglobulin, urine z 3 • Conventional and
Cadmium, urine z 3 International System of Units
Cadmium, whole blood z 3
• Six shipments per year
Creatinine, urine z 3
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for
proficiency testing (OSHA standard-29 CFR 1910.1027AppF).
Program Information
Nicotine and Tobacco Alkaloids NTA
NTA • Designed for laboratories
Anabasine z 3 that qualitatively and/or
Cotinine z 3 quantitatively test for
anabasine, cotinine, and/or
Nicotine z 3
nicotine in urine
Toxicology
Program Information
Trace Metals, Urine TMU
TMU • Conventional and
Arsenic z 2 (SI) reporting offered
Cobalt z 2
toxic levels
Copper z 2
Lead z 2
Manganese z 2
Mercury z 2
Selenium z 2
Thallium z 2
Zinc z 2
Program Information
9
Trace Metals, Whole Blood TMWB
Toxicology
TMWB • Conventional and
Arsenic, total z 3 (SI) reporting offered
Cobalt z 3
toxic levels
Copper z 3
Manganese z 3
Mercury z 3
Selenium z 3
Thallium z 3
Zinc z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 103

Toxicology
Program Information
Forensic Toxicology, Criminalistics FTC
Analyte Program Code Challenges per Shipment specimens and one 20.0-mL
FTC synthetic urine specimen
See drug listing below z 4 • For crime and hospital
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board Proficiency laboratories that have
Review Committee (ASCLD/LAB PRC) has approved Survey FTC. forensic toxicology divisions
performing qualitative
and quantitative analysis
of drugs in whole blood
specimens along with a urine
qualitative challenge
FTC Program Drug Listing

9 6-acetylmorphine (6-AM) Ecgonine methyl ester Norpropoxyphene

7-aminoclonazepam Ephedrine Norsertraline
7-aminoflunitrazepam Fentanyl* Nortriptyline
Toxicology
Acetaminophen Fluoxetine O-desmethyltramadol

Alpha-hydroxyalprazolam Flurazepam* Oxazepam
Alprazolam Gamma-hydroxybutyrate (GHB) Oxycodone
Amitriptyline Hydrocodone Oxymorphone
Amphetamine Hydromorphone Paroxetine
Benzoylecgonine Imipramine Pentobarbital
Brompheniramine Ketamine Phencyclidine
Butalbital Lorazepam Phenethylamine
Carisoprodol Lysergic acid diethylamide (LSD) Phenobarbital
Chlorpheniramine Meperidine* Phentermine
Clonazepam Meprobamate Phenytoin
Cocaethylene Methadone Propoxyphene
Cocaine Methadone metabolite (EDDP) Pseudoephedrine
Codeine Methamphetamine Salicylate
Cyclobenzaprine* Methylenedioxyamphetamine (MDA) Secobarbital
Delta-9-THC Methylenedioxymethamphetamine Sertraline
Delta-9-THC-COOH (MDMA) Temazepam
Desipramine Morphine* Tramadol
Desmethylcyclobenzaprine N-desmethyltramadol Trazodone
Dextromethorphan Nordiazepam Zolpidem
Diazepam Nordoxepin
Diphenhydramine Norfentanyl
Norfluoxetine *and/or metabolite(s)
Doxepin
Ecgonine ethyl ester Norketamine
Toxicology
Program Information
Synthetic Cannabinoid/Designer Drugs SCDD
SCDD • For laboratories that perform
Synthetic cannabinoid/designer drugs z 3 screening and confirmatory
testing for the compounds
found in this program
Synthetic cannabinoids and designer drug stimulants are widespread and constantly
changing in respect to the available chemical moieties. In order to stay contemporary, • Two shipments per year
the CAP has decided to modify the compounds in this program in accordance with the
appearance and prevalence of new compounds.
SCDD Program Drug Listing

Challenges will include a mix of drugs.
For the most current list of drugs, please go to cap.org. Under the Laboratory Improvement tab, click
on Catalog and Ordering Information. The list is located under the PT Order Supplements header.
Toxicology
Program Information
Novel Opioids and Benzodiazepines NOB
NOB • For forensic and toxicology
laboratories that
Novel opioids and benzodiazepines z 3
perform qualitative and/
or quantitative analysis
of synthetic opioids and
benzodiazepines
NOB Program Drug Listing

Challenges will include a mix of drugs.
For the most current list of drugs, please go to cap.org. Under the Laboratory Improvement tab, click
on Catalog and Ordering Information. The list is located under the PT Order Supplements header.
800-323-4040 | 847-832-7000 Option 1 | cap.org 105

Toxicology
Half Page Filler
Program Information
Blood Cannabinoids THCB
THCB • For toxicology laboratories
that perform qualitative
Delta-9-THC 3
and/or quantitative analysis
Delta-9-THC-COOH 3 of cannabinoids in blood
11-hydroxy-THC 3 • Two shipments per year
Program Information
Antifungal Drugs Monitoring AFD
AFD • For laboratories performing
Fluconazole 3 quantitative analysis of anti-
Itraconazole 3 fungal agents
Posaconazole 3 • Two shipments per year
9 Voriconazole 3
Toxicology
1/2
Half Page Filler

o Urinary Cells
o Urinary Casts
o Urinary Crystals
At Acid pH
■
At Neutral or Acid pH
■
At Neutral or Alkaline pH
■
o Organisms
o Miscellaneous/Exogenous
Add it to your order. Item number: UABRG
34 images; 2014

Toxicology
Program Information
Drug Monitoring for Pain Management DMPM
DMPM • For laboratories offering
See drug listing below z 3 qualitative, confirmatory,
and/or quantitative urine
drug analysis for pain
management
• Includes clinical cases and
questions along with
detailed descriptions of how
to interpret test results
DMPM Program Drug Listing 9

Toxicology
Amphetamine group Fentanyl Nordiazepam
6-acetylmorphine (6-AM) Fentanyl and/or metabolites Norhydrocodone
7-aminoclonazepam Gabapentin Norfentanyl
Alpha-hydroxyalprazolam Hydrocodone Normeperidine
Alprazolam Hydromorphone Noroxycodone
Amphetamine I-Amphetamine Noroxymorphone
Barbiturate group I-Methamphetamine Norpropoxyphene
Benzodiazepine group Lorazepam O-desmethyltramadol
Benzoylecgonine Lorazepam glucuronide Opiate group
Buprenorphine Meperidine Oxazepam
Buprenorphine and/or metabolites Meperidine and/or metabolites Oxycodone
Butalbital Meprobamate Oxymorphone
Cannabinoids Methadone Phenobarbital
Carisoprodol Methadone metabolite (EDDP) Pregabalin
Carisoprodol and/or metabolites Methamphetamine Propoxyphene
Clonazepam Methylenedioxyamphetamine (MDA) Propoxyphene and/or metabolites
Cocaine Methylenedioxymethamphetamine Tapentadol
Cocaine and/or metabolites (MDMA) Tapentadol-O-sulfate
Codeine Morphine Temazepam
Delta-9-THC-COOH N-desmethyltramadol Tramadol
Diazepam Norbuprenorphine Tramadol and/or metabolites
800-323-4040 | 847-832-7000 Option 1 | cap.org 107

Toxicology
Program Information
Drug-Facilitated Crime DFC
DFC • For laboratories performing
See drug listing below z 3 qualitative urine drug
analysis with confirmation
testing
• Designed for laboratories
performing testing for
drugs associated with drug-
facilitated crimes, which
target drugs at much lower
concentrations than in other
toxicology Surveys
DFC Program Drug Listing

9 4-hydroxytriazolam Fluoxetine
Norvenlafaxine
7-aminoclonazepam Gabapentin
O-desmethyltramadol
Toxicology
7-aminoflunitazepam Gamma hydroxybutyrate (GHB)

Oxazepam
Alpha-hydroxyalprazolam Hydrocodone
Oxycodone
Amitriptyline Hydromorphone
Oxymorphone
Amobarbital Hydroxyzine
Paroxetine
Amphetamine Imipramine
Pentobarbital
Benzoylecgonine Ketamine
Phencyclidine (PCP)
Bromazepam Lorazepam
Phenobarbital
Brompheniramine Meperidine
Phenytoin
Butalbital Meprobamate
Propoxyphene
Carisoprodol Methadone
Quetiapine
Chlorpheniramine Methadone metabolite (EDDP)
Scopolamine
Citalopram/escitalopram Methamphetamine
Secobarbital
Clobazam Methylenedioxyamphetamine (MDA)
Sertraline
Clonidine Methylenedioxymethamphetamine
Tapentadol
Codeine (MDMA)
Temazepam
Cyclobenzaprine Midazolam
Tetrahydrozoline
Delta-9-THC-COOH Morphine
Topiramate
Desipramine Norbuprenorphine
Tramadol
Dextromethorphan Nordoxepin
Trazodone metabolite (m-CPP)
Diphenhydramine Norfluoxetine
Valproic Acid
Doxepin Norketamine
Zaleplon
Doxylamine Normeperidine
Ziprasidone
Estazolam Norpropoxyphene
Zolpidem
Fentanyl Norsertraline
Zopiclone/Eszopiclone
Nortriptyline
Toxicology
Half Page Filler

Validated Materials
available results.
Toxicology, Validated Material Program Information

Validated Material Program Code Corresponding Survey Page • Five 10.0-mL liquid urine
Urine Drug Testing, Screening UDSM UDS 98 specimens
9
1/2
Toxicology
Half Page Filler
Clinical Toxicology Testing: A Guide for Laboratory Professionals,
Second Edition (PUB227)
This book is a practical guide, written for pathologists, to directing hospital toxicology laboratory
operations. This new edition features expanded sections on testing in the clinical setting,
methodologies, and more user-friendly information on specific analytes. It provides the reader with
a comprehensive view of what is needed—and expected—when offering a clinical toxicology service.
Contents include:
• Toxicology testing in the clinical setting, including new chapters on
2nd
pediatric testing and chronic opioid therapy
Edition
• Toxicokinetics and methodologies, with new and expanded information
on laboratory-developed tests, screening assays, targeted tests, and
oral fluids and alternative matrices
• Specific analytes, including novel psychoactive substances and the use
of medical cannabis
• Appendices on such useful topics as urine and serum screens,
therapeutic drug monitoring, and proficiency testing
• ebooks at ebooks.cap.org Softcover; 2019
800-323-4040 | 847-832-7000 Option 1 | cap.org 109

800-323-4040 | 847-832-7000 Option 1 | cap.org 5
Are you ready for your CAP inspection?
More control. Zero risk. Give your

laboratory its best opportunity to be
prepared and be successful.
The CAP Accreditation Readiness Assessment (CARA®) is an “ The Readiness Assessment

on-site evaluation and education program for laboratories [CARA] helped our lab
just beginning their pursuit of CAP accreditation.
immediately spot potential
CARA focuses on: problems before our inspection.
• Facilitating an in-depth understanding of CAP requirements Our CAP inspection went
as they apply to your laboratory like clockwork.”
• Helping you manage the time and resources necessary – Laboratory Director
for compliance with CAP accreditation requirements and
preparation for your initial inspection
• Delivering on-site education when you’re ready for it Email us at
Leverage the expertise of the world’s most respected readiness-assessment@cap.org
pathology organization. to accelerate your quality journey.

10 Accuracy-Based Programs
Gain more value from your accreditation
program.
CAP accreditation is more than “something to check
off your list.” It is an opportunity to help keep your
laboratory operating at peak performance.
• The CAP offers educational material and support,
including highly-trained medical technologists who
are available to answer questions.
• The peer inspection model helps participants develop
meaningful connections, learn from each other, and
share best practices.
10
Accuracy-Based Programs................................................................................................................. 112
Validated Materials............................................................................................................................ 116

Accuracy-Based Vitamin D (ABVD) .................................................................................................... 112
Program Information
Accuracy-Based Lipids ABL
ABL • Two shipments per year
Apolipoprotein A1* z 3
Apolipoprotein B* z 3
Cholesterol* z 3
HDL cholesterol* z 3
Non-HDL cholesterol z 3
LDL cholesterol z 3
Lipoprotein (a) z 3
Triglycerides* z 3
*This analyte will be evaluated against the reference method.
Program Information
Accuracy-Based Vitamin D ABVD
10 • Three 1.0-mL liquid human
ABVD • Serum is from multi-donor

25-OH vitamin D (D2 and D3) z 3 endogenous pools
Calcium z 3 • Conventional and
• The Centers for Disease Control and Prevention (CDC) will establish reference
targets using isotope-dilution LC-MS/MS method. • Two shipments per year
• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C37-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials
for Cholesterol Measurement Procedures; Approved Guideline.
Program Information
Accuracy-Based Testosterone, Estradiol ABS
ABS • Two shipments per year
Albumin z 3
Cortisol z 3
Estradiol z 3
Follicle-stimulating hormone (FSH) z 3
Sex hormone-binding globulin
z 3
(SHBG)
Testosterone z 3
The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.
Program Information
Accuracy-Based Urine ABU
• Three 5.0-mL human urine 10
specimens
ABU • Two shipments per year
Calcium z 3
Creatinine z 3
Protein, total z 3
Urine albumin: creatinine ratio z 3
Target values for albumin are obtained by LC-MS/MS after trypsin digestion, performed by the
Renal Testing Laboratory, Mayo Clinic, Rochester, MN, using calibration materials prepared from
human serum albumin (>99% pure).
Other analytes will be compared by peer group for harmonization purposes.
800-323-4040 | 847-832-7000 Option 1 | cap.org 113

Program Information
Creatinine Accuracy
• Six 1.0-mL human serum
Calibration Verification/Linearity LN24 specimens
Analyte Program Code • Two shipments per year
LN24 LN24 Target Range
Creatinine z 0.6–4.0 mg/dL
Estimated glomerular filtration rate
z
(eGFR)
View your expedited linearity evaluations within two business days by logging into
e-LAB Solutions Suite.
The College of American Pathologists (CAP) and the National Kidney Disease Education
Program (NKDEP) have an initiative to harmonize clinically reported creatinine values.
This initiative is analogous to what the federal health agencies and the clinical
laboratory community did to improve the accuracy of cholesterol and glycohemoglobin
testing.
Program Information
Harmonized Thyroid ABTH
• Three 1.0-mL frozen human
10 Analyte Program Code
ABTH
Challenges per Shipment serum specimens

• Analytes will be evaluated using harmonization.
• Specimens are collected by a modified application of Clinical Laboratory
and Standards Institute Guideline CLSI C37-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials for
Cholesterol Measurement Procedures; Approved Guideline.
Program Information
Hemoglobin A1c Accuracy
• Six 0.8-mL liquid human
Calibration Verification/Linearity LN15 whole blood specimens
Hemoglobin A1c z 5%–12%
CAP-assigned target values derived from Hemoglobin A1c measurements assayed by
National Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
Quarter Page Filler
Program Information
Hemoglobin A1c GH2, GH5
• GH2 - Three 0.8-mL liquid
Analyte Challenges per Shipment human whole blood
Program Code specimens; two shipments
GH2 GH5 per year
Hemoglobin A1c 3 5 • GH5 - Five 0.8-mL liquid

human whole blood
Additional Information specimens; three shipments
• These Surveys will be evaluated against the National Glycohemoglobin per year
Standardization Program (NGSP) reference method.
laboratories performing non-waived testing for Hemoglobin A1c to complete 15 PT
challenges per year.
GHQ, on page 63.
Program Information
Accuracy-Based Glucose, Insulin,
and C-Peptide ABGIC specimens
1/4
ABGIC
10
C-peptide z 3
Glucose z 3
Quarter Page Filler
Insulin z 3
• Target values are based upon the isotope-dilution gas chromatography-mass
spectrometry reference measurement procedure for glucose performed by the CDC
Reference Laboratory, Division of Laboratory Sciences, Centers for Disease Control
and Prevention (Atlanta, GA).
• Target values for C-peptide are established by isotope-dilution mass spectrometry,
performed at the University of Missouri, Diabetes Diagnostic Laboratory.
The CAP is your trusted calibration verification and linearity partner, providing
you with the most comprehensive menu of programs.
• Large peer groups—Maximize confidence in instrument calibration by using peer group data for a broader
view beyond your laboratory.
• Customized report package—Let our team of biostatisticians perform the statistical analysis of your
results so you do not have to.
• Expedited results—View your linearity evaluation for most CVL programs within two business days
of data submission.
See the Instrumentation Verification Tools section of this catalog to determine programs that best fit
your laboratory’s CVL needs.
800-323-4040 | 847-832-7000 Option 1 | cap.org 115

Validated Materials
Validated Materials
Improve the reliability of your patient results with CAP Survey Validated Materials
Each laboratory receives a Survey Participant Summary, which includes readily available results.
Chemistry, Validated Materials

Validated Material Validated Material Code Corresponding Survey Page
Chemistry and Therapeutic Drugs CZVM CZ 56-58
Cerebrospinal Fluid MVM M 74
Urine Chemistry—General UVM U 68
10 Coagulation—Limited, Validated Material


Coagulation—Limited CGM CGL 160
Endocrinology, Validated Materials

Ligand—General KVM K 82
Ligand—Special YVM Y 84
Toxicology, Validated Material

Urine Drug Testing, Screening UDSM UDS 98
11 Instrumentation Verification Tools
Access your expedited linearity results.

• Expedited linearity evaluations are complimentary
and available for most Calibration Verification/
Linearity programs.
• You can view your linearity evaluations within two
business days by logging into e-LAB Solutions Suite.
11
Instrumentation Verification Tools

Calibration Verification/Linearity ....................................................................................................... 118
Instrumentation Quality Management Programs................................................................................ 132
Calibration Verification/Linearity
The CAP CVL program

The CAP is your trusted calibration verification and linearity partner. Our CVL program will help you meet both
CLIA regulations and CAP Laboratory Accreditation Program requirements for calibration and analytical
measurement range verification under 42 CFR493.1255(bX3). Do not let instrument problems impact your
patient results; use the calibration verification and linearity studies to ensure your instrument and method
are performing to their optimal levels.
With your enrollment in the CAP CVL program you will receive:
• Testing Kit
o Kit instructions—Contain important information to help you complete testing and accurately report your
results
o Result form
o Specimens—The majority of CAP CVL programs offer human-based materials to closely mimic your patient
results
• Customized Report Package
o Executive Summary—A quick overview of both your calibration verification and linearity results for all
reported analytes
o Calibration Verification Evaluation
o Linearity Evaluation
11 ■ Rapid result turnaround is complimentary for most CVL programs. View your linearity evaluations within two
business days of submission by logging into e-LAB Solutions Suite.
o Linearity Troubleshooting Report
o Participant Summary—A summary of laboratory performance that includes peer group statistics and
enhanced diagnostic information for early insight into potential problems
• Additional Tools
o Calibration Verification/Linearity Program User’s Guide—Get assistance in interpreting your evaluations and
reports as well as helpful troubleshooting information with suggested actions. Also available online by logging
into e-LAB Solutions Suite
o Calibration Verification Troubleshooting Guide—The guide provides suggested actions if you receive a
calibration verification result of Different, or if your evaluation result is Verified over a range that does not
include all of your reported results
o Calibration Verification/Linearity Surveys Investigation Checklist for Problematic Results—Interpretative
checklists are included to help with troubleshooting and documentation
Your Total Calibration Verification/Linearity (CVL) Solution

CVL Program Page No. Corresponding Proficiency Testing Survey Page No.
LN2 - Chemistry, Lipid, Enzyme CVL 120 C1, C3/C3X, C4,
LN2BV - Chemistry, Lipid, Enzyme all Beckman 56-58
120 CZ/CZX/CZ2X
(except AU), Vitros CVL
LN3 - Therapeutic Drug Monitoring CVL 121 CZ/CZX/CZ2X/Z 56-58
LN5 - Ligand CVL 121-122
LN5S - Ligand all Siemens ADVIA (Centaur, CP, K/KK 82
121-122
and XP) CVL
LN6 - Urine Chemistry CVL 122 U 68
LN7 - Immunology CVL 123 IG/IGX 208
LN8 - Reproductive Endocrinology CVL 123 Y/YY 84
LN9 - Hematology CVL 123 FH series, HE series 136
LN11 - Serum Ethanol CVL 124 AL2 101
LN12 - C-Reactive Protein CVL 124
CRP 208
LN12E - C-Reactive Protein, Extended CVL 124
LN13, LN13C - Blood Gas/Critical Care CVL 124-125 AQ, AQ2, AQ3, AQ4 92
LN15 - Hemoglobin A1c Accuracy CVL 125 GH2, GH5 63
LN16 - Homocysteine CVL 125 HMS 64
LN17 - Whole Blood Glucose CVL 125
LN18, LN19 - Reticulocyte CVL 126 RT, RT2, RT3, RT4 141
LN20 - Urine Albumin CVL 126 U 68
LN21 - High-Sensitivity C-Reactive Protein CVL 126 HSCRP 64 11
LN22 - Flow Cytometry CVL 126 FL 215

LN23 - Prostate-Specific Antigen CVL 127 K/KK 82
LN24 - Creatinine Accuracy CVL 127 C1, C3/C3X, C4, CZ/CZX/CZ2X 56-58
LN25, LN27 - Troponin I and T CVL 127 CRT, CRTI, TNT 62
LN30 - B-Type Natriuretic Peptides CVL 128 BNP 61
LN31 - Immunosuppressive Drugs CVL 128 CS 59
LN32 - Ammonia CVL 128 C1, C3/C3X, CZ/CZX/CZ2X 56-58
LN33 - Serum Myoglobin CVL 128 CRT, CRTI 62
LN34 - Tumor Markers CVL 129 TM/TMX 89
LN35 - Thrombophilia CVL 129 CGS2 162
LN36 - Heparin CVL 129 CGS4 162
LN37 - von Willebrand Factor Antigen CVL 129 CGS3 162
LN38 - CMV Viral Load CVL 130 VLS, VLS2 199
LN39 - HIV Viral Load CVL 130 HIVG, HV2 199
LN40 - Vitamin D CVL 130 VITD 84
LN41 - Procalcitonin CVL 130 PCT 77
LN42 - D-Dimer CVL 131 CGL, CGDF 160
LN43 - Lamellar Body Count CVL 131 LBC 151
LN44 - Fibrinogen CVL 131 CGL 160
LN45 - HCV Viral Load CVL 130 HCV2 198
LN46 - C-Peptide/Insulin CVL 131 ING 86
All CVL Surveys provide individual evaluation reports by analytes,an executive summary,and graphical plots for linearity and calibration verification.
800-323-4040 | 847-832-7000 Option 1 | cap.org 119

Program Information
Chemistry, Lipid, Enzyme Calibration
• Seven 5.0-mL liquid serum
Verification/Linearity LN2, LN2BV specimens for basic
Program chemistry, six 3.0-mL liquid
Analyte LN2 LN2BV Units
Code serum specimens for direct
LN2, (All All Beckman and total bilirubin, seven
Vitros
LN2BV Instruments) (except AU) 2.0-mL liquid serum
Albumin z 1.5–9.0 g/dL specimens for lipids, and
seven 5.0-mL liquid serum
Calcium z 4.0–18.0 mg/dL
specimens for enzymes
Chloride z 60–180 mmol/L
• LN2 – Appropriate for most
CO2 z 7–42 mmol/L major instruments
Creatinine z 0.8–34.0 mg/dL • LN2BV – Appropriate for
Glucose z 20–750 mg/dL Beckman (except AU) and
Iron z 10–950 µg/dL Vitros instruments only
Magnesium z 0.3–9.0 mg/dL • Two shipments per year
Osmolality z 200–600 mOsm/kg H2O
Phosphorus z 0.5–22.0 mg/dL
Potassium z 1.5–13.0 mmol/L
Protein z 1.5–12.0 g/dL
Sodium z 65–195 mmol/L
Urea nitrogen/Urea z 5–170 mg/dL
11 Uric acid z 1–25 mg/dL

Alkaline phosphatase z 25–1,800 25–1,000 25–1,100 U/L
ALT (SGPT) 10–900 10–650 30–700 U/L
z
Amylase z 30–1,800 30–900 30–800 U/L
AST (SGOT) z 10–900 10–500 10–700 U/L
Creatine kinase z 25–2,000 25–1,200 25–700 U/L
CK-2 (MB) Mass z 1–250 1–300 1–200 ng/mL
Gamma glutamyl
z 10–1,400 10–900 10–1,100 U/L
transferase
Lactate
z 50–1,800 50–700 185–3,000 U/L
dehydrogenase
Lipase z 20–1,400 20–190 150–2,500 U/L
Bilirubin, direct z 0.1–10.0 mg/dL
Bilirubin, total z 0.2–25.0 mg/dL
Cholesterol z 35–625 mg/dL
HDL z 7–120 mg/dL
Triglycerides z 20–700 mg/dL
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher
values than the ranges listed.
Program Information
Therapeutic Drug Monitoring
• Six 4.0-mL liquid serum
• A seventh 4.0-mL liquid
LN3 LN3 Target Ranges serum specimen for
Acetaminophen z 20–450 µg/mL acetaminophen and
Amikacin z 2–45 µg/mL vancomycin
Carbamazepine z 2–18 µg/mL • Two shipments per year

Digoxin z 0.5–4.4 ng/mL
Gentamicin z 1–11 µg/mL
Lidocaine z 1–10 µg/mL
Lithium z 0.3–4.0 mmol/L
N-acetylprocainamide (NAPA) z 2–25 µg/mL
Phenobarbital z 8–70 µg/mL
Phenytoin z 5–35 µg/mL
Primidone z 1–22 µg/mL
Procainamide z 2–18 µg/mL
Quinidine z 0.4–7.0 µg/mL
Salicylate z 7–90 mg/dL
Theophylline z 5–35 µg/mL
Tobramycin z 1–12 µg/mL
Valproic acid z 15–140 µg/mL 11
Vancomycin z 7–90 µg/mL

Program Information
Ligand Calibration Verification/Linearity LN5, LN5S
• LN5 - Eight 4.0-mL
Analyte Program Code Target Ranges
liquid serum specimens;
LN5, LN5S* LN5 Target Ranges LN5S Target Ranges appropriate for most major
AFP z 1.0–900.0 ng/mL instruments except Siemens
CEA z 0.5–750.0 ng/mL 0.6–90.0 ng/mL ADVIA Centaur, XP, and CP
users
Cortisol z 1–65 µg/dL
• LN5S - Thirteen 4.0-mL
Ferritin z 2–1,100 ng/mL
Folate z 1.3–20 ng/mL appropriate for Siemens
Human chorionic ADVIA Centaur, XP, and CP
z 5–14,000 mIU/mL
gonadotropin (hCG) users
Triidothyronine (T3), total z 0.5–7.0 ng/mL • Two shipments per year
Thyroxine (T4), total z 1–80 µg/dL
800-323-4040 | 847-832-7000 Option 1 | cap.org 121

Program Information
Ligand Calibration Verification/Linearity
• LN5 - Eight 4.0-mL
LN5, LN5S continued liquid serum specimens;
Analyte Program Code Target Ranges appropriate for most major
LN5, LN5S* LN5 Target Ranges LN5S Target Ranges instruments except Siemens
Thyroid-stimulating ADVIA Centaur, XP, and CP
z 0.01–100 µIU/mL users
hormone (TSH)
Vitamin B12 z 100–2,200 pg/mL • LN5S - Thirteen 4.0-mL
*The LN5S CVL will allow Siemens ADVIA Centaur users to report other major instruments for
analytes other than CEA, if needed. appropriate for Siemens
ADVIA Centaur, XP, and CP
e-LAB Solutions Suite. users
Program Information
Urine Chemistry Calibration Verification/Linearity LN6
• Eighteen 4.0-mL liquid
Analyte Program Code simulated urine specimens
LN6 LN6 Target Ranges • Two shipments per year
Amylase z 40–1,500 U/L
Calcium z 5–30 mg/dL
11 Creatinine
Glucose
z
z
20–460 mg/dL
25–640 mg/dL
Osmolality z 30–1,800 mOsm/kg H20
Phosphorus z 15–200 mg/dL

Potassium z 7–225 mmol/L
Protein, total z 10–235 mg/dL
Urea nitrogen/Urea z 20–2,000 mg/dL
Uric acid z 6–150 mg/dL
Program Information
Immunology Calibration Verification/Linearity
LN7 specimens
LN7 LN7 Target Ranges
Alpha-1 antitrypsin z 25–616 mg/dL
Complement C3 z 21–420 mg/dL
Complement C4 z 5–100 mg/dL
IgA z 32–650 mg/dL
IgG z 150–3,000 mg/dL
IgM z 25–450 mg/dL
Transferrin z 38–950 mg/dL
Program Information
Reproductive Endocrinology
Estradiol z 25–4,500 pg/mL
Follicle-stimulating hormone (FSH) z 3–190 mIU/mL
11
Human chorionic gonadotropin (hCG) z 5–8,000 mIU/mL

Luteinizing hormone (LH) z 2–190 mIU/mL
Progesterone z 1–50 ng/mL
Prolactin z 3–315 ng/mL
Testosterone z 20–1,500 ng/dL
Program Information
Hematology Calibration Verification/Linearity
• Twenty 3.0-mL liquid
LN9 specimens
Hemoglobin z 1.0–22.5 g/dL
Platelet count z 10–4,200 x 109/L
RBC count z 0.3–7.5 x 1012/L
WBC count z 0.5–350.0 x 109/L
800-323-4040 | 847-832-7000 Option 1 | cap.org 123

Program Information
Serum Ethanol Calibration Verification/Linearity
LN11 specimens
Serum ethanol z 15–550 mg/dL
Program Information
C-Reactive Protein; C-Reactive Protein, Extended
• LN12 - Five 1.0-mL
Calibration Verification/Linearity LN12, LN12E liquid serum specimens;
Program Program appropriate for Beckman
Analyte
Code Code Immage, Siemens Dimension,
LN12 LN12E and Vitros instruments
LN12 LN12E
Target Range Target Range • LN12E - Six 1.0-mL
C-reactive protein z 5–110 mg/L z 6–320 mg/L liquid serum specimens;
View your expedited linearity evaluations within two business days by logging into appropriate for Abbott
e-LAB Solutions Suite. Architect, Beckman (except
Not appropriate for reporting high-sensitivity C-reactive protein (hsCRP). For reporting hsCRP, use Immage), Roche, and
LN21 on page 126. Siemens (except Dimension)
instruments
• Select program based on
11 appropriate target range for
assay used
Program Information
Blood Gas/Critical Care
• LN13, LN13C - Ten 2.5-
Calibration Verification/Linearity LN13, LN13C mL ampules of aqueous
Program Program specimens
Analyte
Code Code
LN13 LN13C
LN13 LN13C
Target Ranges Target Ranges
pCO2 z 12–91 mm Hg z 12–91 mm Hg
pH z 6.83–7.82 z 6.83–7.82
pO2 z 18–490 mm Hg z 18–490 mm Hg
Calcium, ionized z 0.15–3.3 mmol/L
Glucose z 10–465 mg/dL
Lactate z 0.2–18 mmol/L
Program Information
Blood Gas/Critical Care Calibration
• LN13, LN13C - Ten 2.5-
Verification/Linearity LN13, LN13C continued mL ampules of aqueous
Program Program specimens
Analyte
Code Code
LN13 LN13C
LN13 LN13C
Target Ranges Target Ranges
Potassium z 0.5–10.7 mmol/L
Program Information
Hemoglobin A1c Accuracy
• Six 0.8-mL liquid human
Calibration Verification/Linearity LN15 whole blood specimens
Hemoglobin A1c z 5%–12%
CAP-assigned target values derived from Hemoglobin A1c measurements assayed by
National Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
Homocysteine Calibration Verification/Linearity LN16 Program Information 11


specimens
LN16 LN16 Target Range • Two shipments per year
Homocysteine z 5–65 µmol/L
Program Information
Whole Blood Glucose
• Five 2.0-mL liquid whole
Calibration Verification/Linearity LN17 blood specimens
Analyte Program Code • Report up to 10 different
LN17 LN17 Target Range ancillary testing sites or
Whole blood glucose z 50–400 mg/dL instruments
View your expedited linearity evaluations within two business days by logging into • Two shipments per year
800-323-4040 | 847-832-7000 Option 1 | cap.org 125

Program Information
Reticulocyte Calibration Verification/Linearity
• LN18 - Five 2.5-mL liquid
LN18, LN19 whole blood specimens with
Instrument/Method Program Code Program Code pierceable caps
LN18 Target LN19 Target • LN19 - Five 3.0-mL liquid
LN18 LN19
Range Range whole blood cell specimens
Coulter Gen•S™, with pierceable caps
LH 500, LH 700 series, z 0.3%–27.0% • Two shipments per year
and UniCel DxH
All other instruments z 0.3%–24.0%
Program Information
Urine Albumin Calibration Verification/Linearity LN20
• Six 5.0-mL urine specimens
Urine albumin z 10–350 mg/L
Urine creatinine z 20–500 mg/dL
Program Information
11 High-Sensitivity C-Reactive Protein
Analyte Program Code • For high-sensitivity methods

LN21 LN21 Target Range only
High-sensitivity C-reactive protein z 0.5–18.0 mg/L • Two shipments per year
Program Information
Flow Cytometry Calibration Verification/Linearity LN22
• Seven 1.0-mL liquid whole
Analyte Program Code blood specimens
CD3+ z 50%–70% positive
CD3+ T lymphocytes absolute z 350–4,000 cells/µL
CD3+/CD4+ z 1%–40% positive
CD3+/CD4+ T lymphocytes absolute z 6–2,000 cells/µL
CD3+/CD8+ z 25%–40% positive
CD3+/CD8+ T lymphocytes absolute z 250–1,600 cells/µL
Program Information
Prostate-Specific Antigen
• Twelve 1.0-mL liquid serum
Prostate-specific antigen z 0.1–90.0 ng/mL
Program Information
Creatinine Accuracy
• Six 1.0-mL human serum
Creatinine z 0.6–4.0 mg/dL
Estimated glomerular filtration rate
z
(eGFR)
The College of American Pathologists (CAP) and the National Kidney Disease Education
Program (NKDEP) have an initiative to harmonize clinically reported creatinine values.
This initiative is analogous to what the federal health agencies and the clinical
laboratory community did to improve the accuracy of cholesterol and glycohemoglobin 11
testing.

Program Information
Troponin Calibration Verification/Linearity
• LN25 - Seven 2.0-mL liquid
LN25, LN27 serum specimens
Analyte Program Code Program Code • LN27 - Six 2.0-mL liquid
LN25 LN25 Target Range LN27 LN27 Target Range serum specimens
Troponin I z 0.05–60.00 ng/mL • Two shipments per year
Troponin T z 0.1–27.00 ng/mL
For LN27, view your expedited linearity evaluations within two business days by logging into
800-323-4040 | 847-832-7000 Option 1 | cap.org 127

Program Information
B-Type Natriuretic Peptides
• Seven 1.0-mL liquid plasma
BNP z 30–6,500 pg/mL
NT-proBNP z 50–50,000 pg/mL
Program Information
Immunosuppressive Drugs
• Seven 2.0-mL liquid whole
Calibration Verification/Linearity LN31 blood hemolysate specimens
Cyclosporine z 60–1,200 ng/mL
Tacrolimus z 1.5–30.0 ng/mL
Program Information
11 Ammonia Calibration Verification/Linearity LN32
• Seven 2.0-mL aqueous
Analyte Program Code specimens
LN32 LN32 Target Range • Two shipments per year

Ammonia z 13–900 µmol/L
Program Information
Serum Myoglobin Calibration Verification/Linearity
LN33 specimens
Myoglobin z 25–900 ng/mL
Program Information
Tumor Markers Calibration Verification/Linearity LN34
Analyte Program Code specimens
CA 125 z 1–1,000 U/mL
CA 15-3 z 2–190 U/mL
CA 19-9 z 10–900 U/mL
Program Information
Coagulation Calibration Verification/Linearity
• LN35, LN37 - Six 1.0-mL
LN35, LN36, LN37 frozen plasma specimens
Analyte Program Code per mailing
LN35 LN36 LN37 Target Ranges • LN36 - Twelve 1.0-mL
Antithrombin activity z 10%–130% frozen plasma specimens
per mailing, which include six
Protein C activity z 10%–100% for low molecular weight
Heparin, low molecular weight z 0.1–2.0 U/mL heparin and six for
Heparin, unfractionated z 0.1–1.3 U/mL unfractionated heparin
von Willebrand factor antigen z 5%–140% • Two shipments per year;
ships on dry ice
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements HEM.38009,
38010, and 38011. 11
800-323-4040 | 847-832-7000 Option 1 | cap.org 129

Program Information
Viral Load Calibration Verification/Linearity
• LN38 - Six 1.5-mL frozen
LN38, LN39, LN45 plasma specimens
Analyte Program Code • Two shipments per year;
LN38* LN39 LN45 Target Ranges ships on dry ice
CMV viral load z 316–1.0M IU/mL

HIV viral load z 50–5.0M IU/mL
HCV viral load z 50–280M IU/mL
*The biohazard warning applies to Survey LN38. • LN39 - Six 2.5-mL plasma
View your expedited linearity evaluations within two business days by logging into specimens
e-LAB Solutions Suite. • LN45 - Seven 2.5-mL frozen
DNA specimens
• Two shipments per year;
ships on dry ice (dry ice does
not apply to LN39)
Program Information
Vitamin D Calibration Verification/Linearity
• Six 1.0-mL serum specimens
LN40
11 LN40 LN40 Target Range

25-OH vitamin D, total z 4–140 ng/mL
Program Information
Procalcitonin Calibration
• Six 1.0-mL frozen serum
Verification/Linearity LN41 specimens
LN41 LN41 Target Range ships on dry ice
Procalcitonin z 0.3–190 ng/mL
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values
than the ranges listed.
Program Information
D-Dimer Calibration
• Six 1.0-mL plasma
D-dimer z 220–5,500 ng/mL FEU
Program Information
Lamellar Body Count Calibration
• Six 2.0-mL simulated liquid
Verification/Linearity LN43 amniotic fluid specimens
Analyte Program Code • For use with lamellar body
LN43 LN43 Target Range count methods performed on
Lamellar body count z 5–200 particles x 109/L hematology analyzers
View your expedited linearity evaluations within two business days by logging into • Two shipments per year
Program Information
Fibrinogen Calibration
• Six 1.0-mL frozen plasma
11
LN44 LN44 Target Range ships on dry ice

Fibrinogen z 80–900 mg/dL
Program Information
C-Peptide/Insulin Calibration
• Seven 2.0-mL frozen serum
C-Peptide z 0.1–35.0 ng/mL

Insulin z 0.8–800 µIU/mL
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values
than the ranges listed.
800-323-4040 | 847-832-7000 Option 1 | cap.org 131

Instrumentation Quality Management Programs
Program Information
Instrumentation I
• Designed to assess
Challenges Program Code instruments not routinely
I challenged during the
A Shipment B Shipment C Shipment proficiency testing process
Adjustable micropipette • Includes appropriate

z z materials to assess
calibration verification/linearity
important functional
Analytical balance check z z
parameters, including
Gravimetric pipette calibration z z accuracy and linearity
Microtiter plate linearity z z • Three shipments per year
Refractometer calibration z z
Spectrophotometer (stray light check) z z
Absorbance check – UV wavelength z
Fluorescent intensity check –
z
fluorescent microscopes
Ocular micrometer calibration z
Osmometer study z
Peak absorbance measurement z
11 pH meter check z
Photometric calibration – visible
z
wavelength
WARNING: The Instrumentation (I) Survey specimens may contain corrosive or toxic substances,
environmental hazards, or irritants.
Program Information
Interfering Substance IFS
• Eighteen 10.0-mL liquid
Analyte Program Code serum specimens
IFS • Designed for verifiying
Bilirubin Hemoglobin Lipid manufacturing interference
Interferent Interferent Interferent specifications and
Alanine aminotransferase (ALT/SGPT) z z z investigating discrepant
results caused by interfering
Albumin z z z
substances
Alkaline phosphatase z z z
• Submit results any time prior
Amylase z z z to the material's expiration
Aspartate aminotransferase (AST/SGOT) z z z date
Calcium z z z • One shipment per year
Chloride z z z
CK2 (MB) mass z z z
Creatine kinase (CK) z z z
Creatinine z z z
Gamma glutamyl transferase (GGT) z z z
Glucose z z z
Iron z z z
Lactate dehydrogenase (LD) z z z
Lipase z z z
Magnesium z z z 11
Osmolality z z z

Phosphorus z z z
Potassium z z z
Protein, total z z z
Sodium z z z
Urea nitrogen (BUN) z z z
Uric acid z z z
The material expires December 1, 2020.
800-323-4040 | 847-832-7000 Option 1 | cap.org 133

Half Page Filler
Program Information
Serum Carryover SCO
• One 10.0-mL liquid serum
Analyte Program Code specimen (low level) and
SCO one 5.0-mL liquid serum
Creatinine z specimen (high level)
hCG z • Designed to screen for

instrument sample probe
Lactate dehydrogenase (LD) z
carryover
Phenytoin z
• One shipment per year
Program Information
Urine Toxicology Carryover UTCO
Analyte Program Code specimens (low and high
UTCO levels)
Benzoylecgonine z • Designed to screen for
Delta-9-THC-COOH z instrument sample probe
carryover
Opiates z
• One shipment per year
Amphetamine z
1/2
11
Page Filler
HalfTools
Instrumentation Verification
Color Atlas of Hematology, Second Edition (PUB222) 2nd

The second edition of Color Atlas of Hematology goes far beyond Edition
other reference texts, delivering keen insight into peripheral blood
pathology.
Explore 480 highly visual pages for the latest details on a range
of issues including molecular and cytogenetics, flow cytometry,
pediatric hematology, and leukemia. Link to 18 engaging videos
prepared by the authors. View 100+ peripheral blood smears
online with DigitalScope® technology, just like they were under the
microscope—only better.
• ebooks at ebooks.cap.org Hardcover; 480 pages; 2019
12 Hematology and Clinical Microscopy
Benefit from the support of 600 experts
in laboratory medicine.
These experts spend countless hours monitoring
testing trends to:
• Determine specimen specifications to challenge
participants.
• Keep our offerings contemporary with new analytes
and programs.
• Provide peer-reviewed continuing medical education,
continuing education, and self-assessment modules.
12

Hematology........................................................................................................................................ 136
Clinical Microscopy............................................................................................................................ 146
Hematology Automated Differential (FH14, FH14P)
Hematology
Hematology
Program Information
Hematology—Basic HE, HEP
• HE and HEP - Five 3.0-mL
Analyte/Procedure Program Code Challenges per Shipment whole blood specimens
HE HEP • HEP - Ten images, each
Blood cell identification z 10 available as photographs and
Hematocrit z z 5 online images
Hemoglobin z z 5 • Three shipments per year
MCV, MCH, and MCHC z z 5
MPV z z 5
Platelet count z z 5
RDW z z 5
Red blood cell count z z 5
White blood cell count z z 5
Program Information
Hematology Automated Differential Series
• FH1-FH10 and FH1P-FH10P
FH1–FH13, FH1P–FH13P - Five 2.5-mL whole blood
Challenges per specimens with pierceable
Shipment caps
12 FH1-
FH10
FH1P-
FH10P
FH13 FH13P • FH13 and FH13P - Five
2.0-mL whole blood
Blood cell identification z z 10 specimens with pierceable
Hematocrit z z z z 5 caps
Hemoglobin z z z z 5 • FHP series - Ten images,

each available as
Immature granulocyte parameter
z z 5 (FH9 only) photographs and online
(IG)
images
Immature platelet fraction (IPF) z z 5 (FH9 only)
• For method compatibility,
Large unstained cell (LUC) z z 5 (FH4 only) see instrument matrix on
MCV, MCH, and MCHC z z z z 5 page 138
MPV z z z z 5 • Three shipments per year
Nucleated red blood cell count 5 (FH3, FH9,
z z z z
(nRBC) and FH13)
RDW z z z z 5
For second instrument reporting options, see the Quality Cross Check programs, FH3Q, FH4Q,
FH6Q, and FH9Q, on page 137.
Hematology
Program Information
Centrifugal Hematology FH15
Analyte/Procedure Program Code Challenges per Shipment specimens
FH15 • For use with QBC
Hematocrit z 5 instruments; not intended for
Hemoglobin z 5 spun hematocrit methods
Platelet count z 5 • Three shipments per year
WBC count z 5
WBC differential (2-part) z 5
Program Information
Quality Cross Check—Hematology Series
FH3Q, FH4Q, FH6Q, FH9Q specimens with pierceable
Challenges per caps
Shipment
FH3Q FH4Q FH6Q FH9Q instruments
Hematocrit z z z z 3 • For method compatibility,
Hemoglobin z z z z 3 see instrument matrix on
page 138
Immature granulocyte parameter z 3
Immature platelet function (IPF)% z 3 • Two shipments per year
Large unstained cells (LUC) z 3

MCV, MCH, MCHC z z z z 3
MPV z z z z 3
12
Nucleated red blood cell count
z z 3
(nRBC)

RDW z z z z 3
These programs do not meet regulatory requirements for proficiency testing; see the FH Series

instruments.
800-323-4040 | 847-832-7000 Option 1 | cap.org 137

Hematology
Hematology Automated Differential Series, Instrument Matrix

Instrument FH and FHQ Series
FH3/ FH4/ FH9/
FH1 FH2 FH6 FH6Q FH10 FH13 FH15
FH3Q FH4Q FH9Q
Abbott Cell-Dyn® 1200, 1400, 1600, 1700,
z
Emerald™
Horiba ABX 9000+, 9018+, 9020+ z
Sysmex K-series, KCP-1, KX-21/21N,
z
pocH-100i, XP-series
CDS/Medonic M-series z
Coulter AcT™, MD 2/8/10/16, ONYX™, S880,
®
z
S-plus V, ST, STKR, T-series
Drew Scientific DC-18, Drew3,
z
Excell 10/16/18, I-1800,
Horiba ABX Micros z
Mindray BC - 2800, 3000/3200 series z
Siemens ADVIA 360
®
z
Abbott Cell-Dyn 3000, 3500, 3700, 4000,
z
Ruby™, Sapphire™
Biosystems SA (HA3/HA5) z
Cell-DYN Emerald 22/AL z
Coulter DxH 500 series z
Drew Scientific Excell 22, 2280 z
Orphee Mythic 18, Orphee Mythic 22 AL,
12 Orphee Mythic 22 OT
z
Siemens ADVIA 560 z

Siemens ADVIA 120, 120 w/SP1, 2120 z

Coulter Gen-S™, HmX, LH500, MAXM™,
z z
MAXM A/L, STKS, VCS™
Sysmex XE-2100, XE-2100C, XE-2100D,
XE-2100DC, XE-2100L, XE-5000, XE-Alpha,
XE-HST, XN-series, XN-L series, XS-500i,
z
XS-800i, XS-1000i, XS-1000iAL, XS-1000iC,
XT-1800i, XT-2000i, XT-4000i, XE-2100D/L
(Blood Center)
Coulter AcT 5 diff (AL, CP, OV) z
DIRUI BF series z
Horiba ABX Pentra 60, 80, 120 z
Coulter LH750, LH755, LH780, LH785,
z z
Unicel DxH series (except DxH500)
QBC z
Hematology
Program Information
Blood Cell Identification, Photographs BCP, BCP2
• BCP - Ten images, each
Procedure Program Code Challenges per Shipment available as photographs and
BCP BCP2 online images
Blood cell identification z z 5 • BCP2 - Six images, each
Educational challenge(s) z z 5 (BCP)/1 (BCP2) available as photographs and
online images
Program Information
Blood Parasite BP
• Five Giemsa-stained blood
Procedure Program Code Challenges per Shipment film sets, photographs,
BP and/or online images
Thin/thick blood film sets* z 5 • A variety of blood parasites,
*This Survey will include corresponding thick films when available. including Plasmodium,
Babesia, Trypanosoma, and
filarial worms
Bone Marrow Cell Differential BMD Program Information

• One online bone marrow
12
Procedure Program Code Challenges per Shipment aspirate whole slide image

BMD that includes five annotated
Bone marrow differential z 1 cells for identification
Bone marrow cell identification z 5 • Powered by DigitalScope®

technology
• Two online activities per year;
• Examine an online, whole slide image that includes a manual 500 bone marrow your CAP shipping contact
differential count and annotated cells for identification. will be notified via email
• Recognize and integrate problem-solving skills through the use of interpretive when the activity is available
questions found throughout the discussion.
• Evaluate cell morphology and identify specific cells in bone marrow.
• See system requirements on page 13.
800-323-4040 | 847-832-7000 Option 1 | cap.org 139

Hematology
Program Information
Erythrocyte Sedimentation Rate
• ESR, ESR1 - Three 6.0-mL
ESR, ESR1, ESR2, ESR3 whole blood specimens
Procedure Program Code Challenges per Shipment • ESR2 - Three 3.0-mL
simulated whole blood
ESR ESR1 ESR2 ESR3
specimens
All methods except the ALCOR, Alifax ,
®
z 3 • ESR3 - Three 3.5-mL whole
Sedimat 15®, and Sedimat 15 Plus
blood specimens
Sedimat 15, Sedimat 15 Plus z 3
Alifax z 3
ALCOR iSED z 3
Program Information
Fetal Red Cell Detection HBF
• Two 1.2-mL liquid whole
Procedure Program Code Challenges per Shipment blood specimens
HBF • Not designed for F cell
Kleihauer-Betke and flow cytometry z 2 quantitation
Rosette fetal screen z 2 • Two online, whole slide
images per year with optional
Acid elution whole slide image z 1
grids for cell counting
• Powered by DigitalScope®
technology
12
Program Information
Hemoglobinopathy HG
• Four 0.5-mL stabilized red
Procedure Program Code Challenges per Shipment blood cell specimens
HG • Two “dry lab” educational
Hemoglobin identification and challenges (case histories,
z 4
quantification electrophoresis patterns,
“Dry lab” educational challenges z 2 and clinical interpretation
questions)
Hemoglobin A2 quantitation z 4
Hemoglobin F quantitation z 1
Sickling test, qualitative z 4
Program Information
Rapid Total White Blood Cell Count RWBC
RWBC • For use with the HemoCue
Rapid total white blood cell count z 5 WBC instrument
Hematology
Program Information
Reticulocyte Series RT, RT2, RT3, RT4
• RT, RT2 - Three 1.0-mL
Instrument/Method Program Code Challenges per Shipment stabilized red blood cell
RT RT2 RT3 RT4 specimens
Abbott Cell-Dyn 4000, Sapphire, • RT3 - Three 3.0-mL stabilized
Siemens ADVIA 120/2120, and all other z 3 red blood cell specimens
automated and manual methods • RT4 - Three 2.0-mL stabilized
Abbott Cell-Dyn 3200, 3500, 3700, red blood cell specimens
z 3
Ruby
Coulter GenS, HmX, LH500,
LH700 series, MAXM, STKS, z 3
Unicel DxH series
Sysmex XE-2100, XE-2100C, XE-2100D,
XE-2100DC, XE-2100L, XE-5000, z 3
XN-series, XT-2000i, XT-4000i
Pierceable caps z z 3
Program Information
Quality Cross Check—Reticulocyte
• RTQ - Three 1.0-mL stabilized
RTQ, RT3Q, RT4Q red blood cell specimens
Instrument/Method Program Code Challenges per Shipment • RT3Q - Three 3.0-mL
RTQ RT3Q RT4Q stabilized red blood cell
Abbott Cell-Dyn 4000, Sapphire, specimens
Siemens ADVIA 120/2120, and all other z 3 • RT4Q - Three 2.0-mL
automated and manual methods stabilized red blood cell 12
Coulter GenS, HmX, LH500, LH700, specimens
z 3
MAXM, STKS, Unicel DxH series • Includes percentage and

Sysmex XE-2100, XE-2100C, absolute result reporting
XE-2100D, XE-2100L, XE-5000, z 3 • Report up to three
XN-series, XT-2000i, XT-4000i instruments
These programs do not meet regulatory requirements for proficiency testing; see the RT Series • Two shipments per year

instruments.
800-323-4040 | 847-832-7000 Option 1 | cap.org 141

Hematology
Third Page Filler
Reticulocyte, Matrix
Program Reticulocyte Absolute Immature Reticulocyte Reticulocyte
count, reticulocyte Reticulocyte Hemoglobin Hemoglobin
percent count Fraction (IRF) Concentration (RET-He)
(CHr)
RT/RTQ z z z z
RT2 z z
RT3/RT3Q z z z
RT4/RT4Q z z z z
Program Information
Sickle Cell Screening SCS
• Three 1.0-mL stabilized
Procedure Program Code Challenges per Shipment human erythrocyte
SCS specimens
Sickling test, qualitative z 3 • Two shipments per year
Program Information
Transfusion-Related Cell Count TRC
• Five 1.2-mL suspensions of
Procedure Program Code Challenges per Shipment platelet-rich plasma 1/3
TRC • Two 1.0-mL vials leukocyte-
Platelet count (platelet-rich reduced platelet material
Third Page Fillers

z 5
plasma) • Two 1.0-mL vials leukocyte-
12 WBC count z 4 reduced red blood cells
Dry challenge z 2 • Three shipments per year
WBC counts must be performed using a Nageotte chamber, fluorescence microscopy, or by
flow cytometry.
Bone Marrow Benchtop Reference Guide (BMBRG)

Bone Marrow Benchtop Reference Guide is an illustrated guide to common
and rare cells. With more than 60 different identifications and a detailed
description for each cell morphology, it’s an affordable, convenient way
to identify various cell types quickly and confidently. Its rugged construction
is well suited for heavy use at the workbench.
Item number: BMBRG

Spiral bound; 2018
800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Hematology
Program Information
Waived Combination HCC, HCC2
• HCC - Two 1.0-mL whole
Analyte Program Code Challenges per Shipment blood specimens; two
HCC HCC2 shipments per year
Hematocrit z 2 • HCC2 - Total of four
Hemoglobin z z 2 shipments per year
Urinalysis/Urine hCG z 2 • Hematocrit, hemoglobin, and

urinalysis/urine hCG testing -
Whole blood glucose z z 2 (HCC)/3 (HCC2)
Two 3.0-mL whole blood
specimens and two 10.0-mL
shipments per year: A and C
• Whole blood glucose
testing - Three 2.5-mL
whole blood specimens; two
shipments per year: B and D
• To verify instrument
compatibility, refer to
the instrument matrix
on page 66
Program Information
Virtual Peripheral Blood Smear VPBS
• Three online, peripheral
Procedure Program Code Challenges per Shipment blood whole slide images
that include 15 annotated
WBC differential
VPBS
z 3 cells for identification 12
Platelet estimate z 3 • Powered by DigitalScope

technology
RBC morphology z 3
Blood cell identification z 15
your CAP shipping contact
Additional Information will be notified via email
• Examine online, whole slide images that include a manual 100 WBC differential when the activity is available
count and annotated cells for identification.
• Evaluate and identify red blood cell (RBC) morphology and identify specific white
blood cells (WBC) in peripheral blood.
• Recognize and integrate problem-solving skills through the use of interpretive
questions found throughout the discussion.
800-323-4040 | 847-832-7000 Option 1 | cap.org 143

Hematology
Half Page Filler
Program Information
Expanded Virtual Peripheral Blood Smear EHE1
• Two online, peripheral blood
Procedure Program Code Challenges per Shipment whole slide images that
EHE1 include 10 annotated cells
WBC differential z 2 for identification
Platelet estimate z 2 • Powered by DigitalScope

technology
RBC morphology z 2
WBC morphology z 2
Blood cell identification z 10 will be notified via email
Additional Information when the activity is available
• More challenging and/or complex testing.
• Examine online, whole slide images that include a manual 100 WBC/differential
count and annotated cells for identification.
• Comprehensive case studies.
• Ability to recognize and integrate problem-solving skills through the use of
interpretive questions found throughout discussion.
• Evaluate and identifiy red blood cell (RBC) morphology and identify specific white
blood cells (WBC) in peripheral blood.
1/2
Half Page Filler
12
Hematology Benchtop Reference Guide (HBRG)
• More than 50 different cell identifications, including

• Six tabbed sections for easy reference
o Erythrocytes
o Erythrocyte Inclusions
o Granulocytic (Myeloid) and Monocytic Cells
o Lymphocytic Cells
o Platelets and Megakaryocytic Cells
o Microorganisms and Artifacts
Item number: HBRG
• ebooks at ebooks.cap.org 50+ images; 2012

Hematology
Program Information
Hematopathology Online Education
• HPATH - Five diagnostic
HPATH/HPATH1 challenges/online, whole
Program Program Code Challenges per Shipment slide images with clinical
history; reporting with
HPATH/HPATH1
CME/SAM credit is available
Hematopathology online case for one pathologist/
z 5
review hematologist; for additional
Additional Information pathologist/hematologist,
order HPATH1
HPATH educates pathologists, hematolopathologists, and hematologists with
an interest in hematopathology to assess and improve their diagnostic skills in • HPATH1 - Reporting option
hematopathology. with CME/SAM credit for
each additional pathologist
• All cases have been specially selected to highlight important changes in the 2016
and hematologist (within
revision of the WHO Classification.
the same institution); must
• Clinical history and relevant laboratory data. order in conjunction with
• At least one online, whole slide image of peripheral blood, bone marrow, Survey HPATH
spleen, lymph node, or other tissue.
• Earn a maximum of 12.5
• Results of ancillary studies such as immunohistochemistry, flow cytometry, CME/SAM credits (AMA
FISH, karyotyping, and molecular studies, where appropriate. PRA Category 1 Credits™) per
• Case discussion and discussion of differential diagnoses. pathologist and a maximum
• Five SAM questions per case. of 12.5 CE credits per
• See system requirements on page 13. hematologist for completion
of an entire year
• This activity meets the
ABP MOC Part IV Practice
Performance Assessment
requirements 12
• Powered by DigitalScope
technology

will be notified via email
when the activity is available
800-323-4040 | 847-832-7000 Option 1 | cap.org 145

Clinical Microscopy
Third Page Filler
Clinical Microscopy
Program Information
Urinalysis and Clinical Microscopy CMP, CMP1
• CMP - Three 10.0-mL liquid
Analyte/Procedure Program Code Challenges per Shipment urine specimens; for use
CMP CMP1 with all instruments except
Bilirubin z z 3 iCHEM; six images, each
available as photographs and
Blood or hemoglobin z z 3 online images
Body fluid photographs z z 3
• CMP1 - Three 12.0-mL liquid
Glucose z z 3 urine specimens; for use
hCG urine, qualitative z z 3 with iCHEM instruments for
urinalysis; six images, each
Ketones z z 3
available as photographs and
Leukocyte esterase z z 3 online images
Nitrite z z 3 • Two shipments per year
Osmolality z z 3
pH z z 3
Protein, qualitative z z 3
Reducing substances z z 3
Specific gravity z z 3 1/3
Urine sediment photographs z z 3
Third Page Fillers

Urobilinogen z z 3
12 Additional Information
For second instrument reporting options, see the Quality Cross Check program, CMQ,
on page 147.

Item number: UABRG
34 images; 2014
800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Clinical Microscopy
Program Information
Quality Cross Check—Urinalysis CMQ
Analyte Program Code Challenges per Shipment specimens for use with all
CMQ instruments
Bilirubin z 3 • Report up to three
Blood or hemoglobin z 3 instruments
Glucose z 3 • Two shipments per year
hCG urine, qualitative z 3
Ketones z 3
Leukocyte esterase z 3
Nitrite z 3
Osmolality z 3
pH z 3
Protein, qualitative z 3
Reducing substances z 3
Urobilinogen z 3
This program does not meet regulatory requirements for proficiency testing; see Surveys CMP
and CMP1 on page 146. For additional information about the Quality Cross Check program,
see page 40.

• Provides a solution for monitoring performance across multiple instruments, and
instruments. 12

Program Information
Clinical Microscopy Miscellaneous Photopage CMMP
• Ten images, each available
Procedure Program Code Challenges per Shipment as photographs and online
CMMP images
Fern test (vaginal) z 1 • Two shipments per year
KOH preparation (skin) z 1
Nasal smear z 1
Pinworm preparation z 1
Spermatozoa z 1
Stool for leukocytes z 1
Urine sediment photographs z 3
Vaginal wet preparation photographs
(for clue cells, epithelial cells, z 1
trichomonas, or yeast)
800-323-4040 | 847-832-7000 Option 1 | cap.org 147

Clinical Microscopy
Program Information
Amniotic Fluid Leakage AFL
AFL • For use with nitrazine paper
pH interpretation z 3 and the AmniotestTM
Program Information
Automated Body Fluid Series ABF1, ABF2, ABF3
• Two 3.0-mL simulated body
Procedure Program Code Challenges per Shipment fluid specimens
ABF1 ABF2 ABF3 • Two shipments per year
Red blood cell fluid count z z z 2
White blood cell fluid count z z z 2
For method compatibility, see instrument matrix below.
Automated Body Fluid, Instrument Matrix

Instrument ABF Series
ABF1 ABF2 ABF3
Advanced Instruments GloCyte,
z
Siemens ADVIA 120/2120 series
Coulter LH 700 series,
z
Unicel DxH series
12 Sysmex XE-2100, XE-2100C,
XE-2100D, XE-2100DC,
XE-2100L, XE-5000, XN-series, z

XN-L series, XT-1800i, XT-2000i,
XT-4000i
IRIS iQ® 200 z
Program Information
Virtual Body Fluid VBF
• Two online, whole slide body
Procedure Program Code Challenges per Shipment fluid images that include
VBF 10 annotated cells for
Total nucleated cells differential z 2 identification
Body fluid cell identification z 10 • Powered by DigitalScope

technology
• Examine online, whole slide images that include a manual differential count and your CAP shipping contact
annotated cells for identification. will be notified via email
• Evaluate cell morphology and identify specific cells in a body fluid. when the activity is available
Clinical Microscopy
Program Information
Automated Urine Microscopy UAA, UAA1
• UAA - Two 10.0-mL liquid
Analyte Program Code Challenges per Shipment urine specimens for use with
UAA UAA1 IRIS and Roche instruments
Casts, semiquantitative z z 2 • UAA1 - Two 12.0-mL liquid
Crystals, semiquantitative z 2 urine specimens for use with
Sysmex instruments
Epithelial cells, semiquantitative z 2
Red blood cells, quantitative z z 2
White blood cells, quantitative z z 2
Automated Urine Microscopy, Instrument Matrix

Instrument UAA, UAA1
UAA UAA1
DIRUI FUS X
IRIS Iq200 X
Roche cobas u701 X
ARKRAY Auction Hybrid X
77 Elektronika X
Siemens Atellica UA5800 X
Sysmex UF 50, 100, 500i, 1000i, 5000 X
Sysmex UX 2000 X
12
Program Information
Crystals BCR, BFC, URC

• BFC - Two 1.5-mL simulated
Procedure Program Code Challenges per Shipment body fluid specimens (eg,
BCR BFC URC synovial fluid)
Bile crystal identification z 2 • URC - Two 1.5-mL urine
Body fluid crystal identification z 2 specimens
Urine crystal identification z 2 • BCR - Two photographs
Program Information
Dipstick Confirmatory DSC
• Two 12.0-mL liquid urine
DSC • For use with methods to
Bilirubin z 2 confirm positive bilirubin and
Sulfosalicylic acid (SSA) z 2 protein dipstick results
800-323-4040 | 847-832-7000 Option 1 | cap.org 149

Clinical Microscopy
Program Information
Fecal Fat FCFS
• Two 10.0-g simulated fecal
Analyte Program Code Challenges per Shipment fat specimens
FCFS • For microscopic detection
Fecal fat, qualitative z 2 of neutral fats (triglycerides)
and/or split fats (total free
fatty acids)
Program Information
Fetal Hemoglobin APT
• Two 1.2-mL simulated gastric
APT • Two shipments per year
Fetal hemoglobin (gastric fluid) z 2
Program Information
Gastric Occult Blood GOCB
Analyte Program Code Challenges per Shipment gastric specimens
GOCB • Two shipments per year
Gastric occult blood z 3
Gastric pH z 3
12
Program Information
Glucose-6-Phosphate Dehydrogenase G6PDS

Analyte Program Code Challenges per Shipment hemolysate specimens
G6PDS • Two shipments per year
G6PD, qualitative and quantitative z 2
Program Information
Hemocytometer Fluid Count HFC
• Three 1.0-mL simulated body
Procedure Program Code Challenges per Shipment fluid specimens
HFC • Two shipments per year
Cytopreparation differential z 3
Red blood cell fluid count z 3
White blood cell fluid count z 3
Clinical Microscopy
Program Information
Hemocytometer Fluid Count, International HFCI
• Three 2.0-mL simulated body
Procedure Program Code Challenges per Shipment fluid specimens; two online,
HFCI whole slide images for 2- and
Red blood cell fluid count z 3 5-part differential
White blood cell fluid count z 3 • Designed for international

laboratories that have
Body fluid differential z 2
experienced significant
This program meets the CAP’s Accreditation Program requirements. shipping and receiving
Additional Information issues and need longer
program stability
• Examine online, whole slide images that include a manual differential count.
• See system requirements on page 13. • Powered by DigitalScope
technology
Program Information
Lamellar Body Count LBC
Procedure Program Code Challenges per Shipment liquid amniotic fluid
LBC specimens
Lamellar body count z 3 • For use with LBC methods
performed on all hematology
analyzers
12
Program Information
Occult Blood OCB

OCB • Two shipments per year
Occult blood z 3
For second instrument reporting options, see the Quality Cross Check program, OCBQ,
on page 152.
800-323-4040 | 847-832-7000 Option 1 | cap.org 151

Clinical Microscopy
Program Information
Quality Cross Check—Occult Blood OCBQ
OCBQ • Report up to three
Occult blood z 3 instruments
This program does not meet regulatory requirements for proficiency testing; see Survey OCB • Two shipments per year

instruments.
Program Information
Placental Alpha Microglobulin 1 (PAMG-1) ROM1
Procedure Program Code Challenges per Shipment vaginal specimens for
ROM1 methods such as Actim
Placental Alpha Microglobulin 1 PROM, Amnisure, Clinical
z 3 Innovations, and PartoSure
(PAMG-1)
Program Information
12 Special Clinical Microscopy SCM1, SCM2
• Three images, each available
Analyte/Procedure Program Code Challenges per Shipment as photographs and online
SCM1 SCM2 images

Urine hemosiderin, Prussian blue z 3 • Two shipments per year
Urine eosinophils, Wright stain z 3
Program Information
Ticks, Mites, and Other Arthropods TMO
TMO images
Tick, mite, and arthropod identification z 3 • Two shipments per year
Program Information
Urine hCG UHCG
• Five 1.0-mL urine specimens
Procedure Program Code Challenges per Shipment
UHCG
Urine hCG, qualitative z 5
Clinical Microscopy
Third Page Filler
Program Information
Urine Albumin and Creatinine, Semiquant UMC
• Two 3.0-mL liquid urine
UMC • For use with dipstick and
Creatinine z 2 semiquantitative methods
Urine albumin (microalbumin): only
z 2
creatinine ratio • Two shipments per year
Urine albumin (microalbumin),
z 2
semiquantitative
For quantitative reporting, refer to Survey U, page 68.
Program Information
Worm Identification WID
WID images
Worm identification z 3 • Two shipments per year
1/3
Third Page Fillers
12

Your accreditation questions answered—quickly, easily, efficiently.
Find the information you need on our accreditation resource page
in e-LAB Solutions Suite (login required).
• Laboratory Inspection Preparation course—a series of short educational
modules to help you learn what to expect, and what to avoid
• Checklist Q&A’s—get the answers to the most common checklist questions
• Videos
• Webinars
• Checklists
• And more—all fully searchable
Log in to e-LAB Solutions Suite and select Accreditation Resources.
800-323-4040 | 847-832-7000 Option 1 | cap.org 153

Half
Clinical Microscopy
Semen Analysis Benchtop Reference Guide (SABRG)

Semen Analysis Benchtop Reference Guide is an illustrated guide to
sperm morphology. The content includes specimen collection and
macroscopic assessment, sperm count, and morphology assessment
and classification systems. Also included are 50 images representing
normal morphology, head defects, neck/midpiece defects, tail defects,
and residual cytoplasm defects, as well as images of nonsperm cells,
Pap-stained sperm, and equipment. The sturdy laminated guide
features tabbed sections for easy reference.
Add Semen Analysis Benchtop Reference Guide (SABRG)
to your order.
• printed books at estore.cap.org Item number: SABRG
• ebooks at ebooks.cap.org Spiral bound; 6½” x 7”; 2018

F36 Half
42453_2020 Surveys_Pickup Fillers.indd 36 5/23/19 11:44 AM
12
13 Reproductive Medicine
New PV1 program is designed for
laboratories using automated
analyzers for postvasectomy
sperm count.
• Employs the same stabilized sperm specimens
as the Postvasectomy for Manual Methods (PV)
program, but with an increased volume.
• Allows you to test PV1 specimens using automated
analyzers in the same mode used for patient
samples, eliminating the need to run PT in manual
mode.
13
Andrology and Embryology................................................................................................................. 156
Andrology and Embryology

Program Information
Semen Analysis SC, SC1, PV, PV1, SM, SV, ASA
• SC - Two 0.3-mL stabilized
Challenges per sperm specimens
Procedure Program Code
Shipment
• SC1 - Two 1.0-mL stabilized
SC SC1 PV PV1 SM SV ASA
sperm specimens
Sperm count and presence/
• PV - Two 0.3-mL stabilized
absence (manual methods z 2
sperm specimens with
and CASA systems)
counts appropriate for
Sperm count and presence/ postvasectomy testing
absence (automated z 2
methods) • PV1 - Two 1.0-mL stabilized
sperm specimens with
Postvasectomy sperm count counts appropriate for
z 2
and presence/absence postvasectomy testing
Postvasectomy sperm count • SM - Two prepared slides
and presence/absence z 2 for staining
(automated methods)
• SV - Two eosin-nigrosin-
Sperm morphology z 2
stained slides
Sperm viability z 2
• ASA - Two 0.3-mL serum
Antisperm antibody IgG z 2 specimens
13
Program Information
Sperm Motility, Morphology, and Viability
• SMCD - Online video clips

SMCD, SM1CD, SM2CD of sperm available for
Challenges per hemocytometer, Makler, and
Shipment disposable chambers
SMCD SM1CD SM2CD • SM1CD, SM2CD - Two online
Sperm count z 2 challenges that may be
viewed as whole slide images
Sperm motility/forward
z 2 by DigitalScope® technology
progression
or as static images
Sperm morphology z 2
• Two online activites per year;
Sperm viability z 2 your CAP shipping contact
Program Information
Embryology EMB
• Two online sets of five
Procedure Program Code Challenges per Shipment video clips
EMB • Two online activites per year;
Embryo transfer and quality assessment your CAP shipping contact
z 4
(three- and five-day-old embryos) will be notified via email
Program Information
Ligand—Special Y, YY, DY
• Y - Three 5.0-mL liquid serum
Analyte Program Code Challenges per Shipment specimens in duplicate
Y, YY DY • YY - Three 5.0-mL liquid
11-deoxycortisol z 3 serum specimens in
17-hydroxyprogesterone z 3 triplicate
Androstenedione z 3 • DY - Must order in
conjunction with Survey Y or
DHEA sulfate z 3
YY
Estradiol z 3
Estriol, unconjugated (uE3) z 3 International System of
Follicle-stimulating hormone (FSH) z 3 Units (SI) reporting offered
Growth hormone (GH) z 3 • Two shipments per year
IGF-1 (somatomedin C) z 3
Progesterone z 3
Prolactin z 3
Testosterone
Testosterone, bioavailable (measured)
z
z
3
3
13
Testosterone, free (measured) z 3
Sex hormone-binding globulin (SHBG) z 3
Program Information
Antimüllerian Hormone AMH
AMH • Two shipments per year
Antimüllerian hormone z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 157

Go ahead. Double check.
Rely on these Benchtop Reference Guides in your laboratory.

Hematology
Ruggedly constructed, these
Body Fluids Benchtop Reference Guide (BFBRG) handy, fully illustrated guides
Microbiology are built to withstand heavy
Mycology Benchtop Reference Guide (MBRG) use at the workbench.
Parasitology Benchtop Reference Guide (PBRG)
ADD THEM TO YOUR ORDER
Arthropod Benchtop Reference Guide (ABRG) OR PURCHASE ONLINE
Gram Stain Benchtop Reference Guide (GSBRG) Printed books at estore.cap.org
Reproductive Medicine Ebooks at ebooks.cap.org
Semen Analysis Benchtop Reference Guide (SABRG)

14 Coagulation
Meet requirements for calibration
verification and linearity for
coagulation testing.
• Hemostasis test methods that are calibrated and
directly measure the concentration of an analyte
require calibration verification/linearity (CVL).
• Coagulation programs available include Heparin CVL
(LN36), von Willebrand Factor Antigen CVL (LN37),
D-Dimer CVL (LN42), Thrombophilia CVL (LN35), and
Fibrinogen CVL (LN44).
14
Coagulation
Program Changes
Coagulation—Limited (CGL, CGDF) Additional analyte....................................................................... 160
Viscoelastometry (TEG) is now Viscoelastic Studies (VES) ................................................................. 166
Coagulation—Limited, Validated Material (CGM) Additional analyte ................................................. 169
Coagulation Special Testing Series (CGS6, CGS8)
Coagulation
Coagulation
Program Information
Coagulation—Limited CGB, CGL, CGDF
• CGB - Five 1.0-mL lyophilized
Challenges per plasma specimens; three
Shipment
shipments per year
CGB CGL CGDF
• CGL - Five 1.0-mL lyophilized
Activated partial thromboplastin time z z 5 plasma specimens; three
Fibrinogen z 5 shipments per year; two
1.0-mL plasma specimens
International normalized ratio (INR)* z z 5
and one 1.0-mL serum
Prothrombin time z z 5 specimen; three shipments
D-dimer z z 2 per year
Fibrin(ogen) degradation products, plasma z z 1 • CGDF - One 1.0-mL serum
Fibrin(ogen) degradation products, serum z z 1 specimen; two 1.0-mL
lyophilized plasma
*Participants reporting INR results will receive a special evaluation to assess the INR calculation.
specimens; three shipments
Additional Information per year
For second instrument reporting options, see the Quality Cross Check program, CGLQ,
below.
Program Information
Quality Cross Check—Coagulation CGLQ
Challenges per plasma specimens in
Shipment
triplicate, two 1.0-mL plasma
CGLQ specimens, and one 2.0-mL
Activated partial thromboplastin time z 3 serum specimen
14 Fibrinogen z 3 • Report up to three

instruments
International normalized ratio (INR) z 3
Coagulation
Prothrombin time z 3
D-dimer z 2
Fibrin(ogen) degradation products,
z 1
plasma
Fibrin(ogen) degradation products, serum z 1
This program does not meet regulatory requirements for proficiency testing; see Survey CGL

instruments.
Coagulation
Third Page Filler
Program Information
Coagulation—Extended CGE, CGEX
• CGE - Two 1.0-mL lyophilized
Challenges per plasma specimens (three
Shipment
vials each)
CGE, CGEX
• CGEX - Two 1.0-mL
See analyte listing below z 2 lyophilized plasma
specimens (five vials each)
Coagulation Analyte Listing (Quantitative Results)

50:50 mixing study, PT and aPTT Prekallikrein
Activated partial thromboplastin time Protein C
Activated protein C resistance Protein S
Alpha-2-antiplasmin Prothrombin time
Antithrombin activity/antigen Reptilase time
Dilute prothrombin time Thrombin time
Factors II, V, VII, VIII, IX, X, XI, XII, and XIII von Willebrand factor activity: 1/3
Fibrinogen antigen - Collagen binding
- Glycoprotein Ib binding
Third Page Fillers

Heparin-induced thrombocytopenia (HIT)
- Ristocetin cofactor
Plasminogen activator inhibitor
von Willebrand factor antigen
Plasminogen activity/antigen
14
Coagulation
Have you created or updated your own CAP Profile?
Each laboratory staff member should have their own profile. Your profile is transferable when you leave
your current position. Use it to maintain information about yourself, including:
• Business affiliations • Personal contact information

• Certifications • Specialties and skills
• Contact preferences • Addresses
• Inspector-related information
To create or update your profile, visit cap.org, log in, and click on UPDATE MY PROFILE.
800-323-4040 | 847-832-7000 Option 1 | cap.org 161

800-323-4040 | 847-832-7000 Option 1 | cap.org 7
Coagulation
Program Information
Coagulation Special Testing Series CGS1, CGS2,
• CGS1, CGS2, CGS3 - A total
CGS3, CGS4, CGS5, CGS7 of two 2.0-mL of lyophilized
Module/Analyte Challenges per Shipment plasma specimens
Program Code • CGS4 - Three 1.0-mL
CGS1 CGS2 CGS3 CGS4 CGS5 CGS7
lyophilized plasma
specimens
Activated partial thromboplastin
2 2 3 • CGS5 - Two 60.0-µL serum
time*
specimens
International normalized ratio
2 3 • CGS7 - Three 1.0-mL
(INR)
lyophilized plasma
Prothrombin time* 2 3
specimens in duplicate
Lupus Anticoagulant and Mixing Studies Module
Dilute Russell’s viper venom time 2
Lupus anticoagulant
2
(confirmation and screen)
50:50 mixing studies, PT and aPTT 2
Thrombophilia Module
Activated protein C resistance 2
Antithrombin (activity, antigen) 2
Protein C (activity, antigen) 2
Protein S (activity, free antigen,
2
total antigen)
von Willebrand Factor Antigen Module
Factor VIII assay 2
von Willebrand factor (antigen,
2
activity, multimers)
Factor VIII inhibitor 2
Fibrin monomer 2
14 Heparin Module
Heparin activities using
Coagulation
methodologies including Anti-Xa

3
(unfractionated, low molecular
weight, and hybrid curve)
Thrombin time 3
Heparin-Induced Thrombocytopenia Module
Appropriate with methods such
as Gen-Probe Lifecodes PF4 IgG
2
and Gen-Probe Lifecodes PF4
Enhanced® assays
ADAMTS13 Module
ADAMTS13 (activity, inhibitor
screen, titer, and anti 3
ADAMTS13 IgG)
*Not appropriate for meeting regulatory requirements, see page 160.
Coagulation
Program Information
Apixaban, Dabigatran, Fondaparinux,
Rivaroxaban Anticoagulant Monitoring specimens
APXBN, DBGN, FNPX, RVBN • Two shipments per year
Challenges
per Shipment
APXBN DBGN FNPX RVBN

Activated partial thromboplastin
z z z z 3
time*
Prothrombin time* z z z z 3
Thrombin time z 3
Apixaban z 3
Dabigatran z 3
Fondaparinux z 3
Rivaroxaban z 3
*Not appropriate for meeting regulatory requirements, see page 160.
14
Coagulation
800-323-4040 | 847-832-7000 Option 1 | cap.org 163

Coagulation
Program Information
Activated Clotting Time Series
• CT - Three 3.0-mL lyophilized
CT, CT1, CT2, CT3, CT5 whole blood specimens with
Challenges per corresponding diluents
Shipment
• CT1 - Three 1.7-mL
CT CT1 CT2 CT3 CT5 lyophilized whole
ITC Hemochron® CA510/FTCA510 z 3 blood specimens with
ITC Hemochron FTK-ACT z 3
ITC Hemochron Jr. Signature/ACT+ z 3 • CT2 - Three 0.5-mL
lyophilized whole blood/
ITC Hemochron Jr. Signature/ACT-LR z 3
diluent ampules
ITC Hemochron P214/P215 z 3
• CT3 - Three 0.5-mL
® ®
Medtronic HemoTec diluent ampules
z 3
ACT/ACTII/ACT Plus HR-ACT • CT5 - Three 1.7-mL
Medtronic HemoTec lyophilized whole
z 3
ACT/ACTII/ACT Plus LR-ACT blood specimens with
Medtronic HemoTec corresponding diluents
z 3
ACT/ACTII/ACT Plus R-ACT • Two shipments per year
For second instrument reporting options, see the Quality Cross Check programs
CTQ-CT3Q and CT5Q, on page 165.
14
Coagulation
Coagulation
Program Information
Quality Cross Check—
• CTQ - Three 3.0-mL
Activated Clotting Time Series lyophilized whole blood
CTQ, CT1Q, CT2Q, CT3Q, CT5Q specimens in triplicate with
Challenges per
Shipment • CT1Q - Three 1.7-mL
CTQ CT1Q CT2Q CT3Q CT5Q lyophilized whole blood
specimens in triplicate with
ITC Hemochron CA510/FTCA510
®
z 3
ITC Hemochron FTK-ACT z 3
• CT2Q - Three 0.5-mL
ITC Hemochron Jr. Signature/ACT+ z 3 lyophilized whole blood/
ITC Hemochron Jr. Signature/ACT-LR z 3 diluent ampules in triplicate
ITC Hemochron P214/P215 z 3 • CT3Q - Three 0.5-mL
®
Medtronic HemoTec diluent ampules in triplicate
z 3
ACT/ACTII/ACT Plus HR-ACT • CT5Q - Three 1.7-mL
Medtronic HemoTec lyophilized whole blood
z 3 specimens in triplicate with
ACT/ACTII/ACT Plus LR-ACT
Medtronic HemoTec
z 3 • Report up to three
ACT/ACTII/ACT Plus R-ACT
instruments
These programs do not meet regulatory requirements for proficiency testing; see Surveys CT-CT3
and CT5 on page 164. For additional information about the Quality Cross Check program,
see page 40.

instruments.
14
Coagulation
800-323-4040 | 847-832-7000 Option 1 | cap.org 165

Coagulation
Program Information
Platelet Function* PF, PF1
• PF - Four 3.2% sodium
Instrument/Method Program Code Challenges per Shipment citrate vacuum tubes; two
PF PF1 10.0-mL plastic tubes
Platelet aggregation z 2 • PF1 - Four 3.2% sodium
PFA-100 z 2 citrate vacuum tubes; two
10.0-mL plastic tubes
Helena Plateletworks ®
z 2
*This Survey requires the draw of a normal donor sample.
Program Information
Viscoelastic Studies VES
• Two 1.0-mL lyophilized whole
Instrument Program Code Challenges per Shipment blood specimens with
VES diluents
TEG®5000, TEG6s, ROTEM® z 2 • Two shipments per year
Program Information
Coagulation Calibration Verification/Linearity
• LN35, LN37 - Six 1.0-mL
LN35, LN36, LN37 frozen plasma specimens
Analyte Program Code per mailing
LN35 LN36 LN37 Target Ranges • LN36 - Twelve 1.0-mL
Antithrombin activity z 10%–130% frozen plasma specimens
per mailing, which include six
Protein C activity z 10%–100% for low molecular weight
Heparin, low molecular weight z 0.1–2.0 U/mL heparin and six for
Heparin, unfractionated z 0.1–1.3 U/mL unfractionated heparin
von Willebrand factor antigen z 5%–140% • Two shipments per year;
ships on dry ice
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements HEM.38009,
14 38010, and 38011.
Coagulation
Program Information
D-Dimer Calibration
• Six 1.0-mL plasma
D-dimer z 220–5,500 ng/mL FEU
Coagulation
Third Page Filler
Program Information
Fibrinogen Calibration
• Six 1.0-mL frozen plasma
LN44 LN 44 Target Range ships on dry ice
Fibrinogen z 80–900 mg/dL
Program Information
Drug-Specific Platelet Aggregation PIA, PIAX
• PIA - Three lyophilized
Procedure Program Code Challenges per Shipment specimens with diluents
PIA PIAX • PIAX - All Survey PIA
Aspirin assay z z 3 specimens in duplicate
PRU test z z 3 • For use with the Accumetrics
VerifyNow® System
• Kit includes sufficient
material to perform one
assay; multiple assay
reporting requires the
purchase of PIAX 1/3
Third Page Fillers

World-class recognition deserves to be displayed. 14
Coagulation
the CAP accreditation certification mark.
800-323-4040 | 847-832-7000 Option 1 | cap.org 167

800-323-4040 | 847-832-7000 Option 1 | cap.org 9
Coagulation
Program Information
Whole Blood Coagulation
• WP3 - Five 1.0-mL lyophilized
WP3, WP4, WP6, WP9, WP10 plasma specimens with
Analyte Challenges per Shipment corresponding diluents
Program Code • WP4, WP6 - Five 0.5-mL
WP3 WP4 WP6 WP9 WP10
unitized lyophilized blood
specimens
International normalized ratio (INR) 5 5 5 5 3
• WP9 - Five 0.3-mL lyophilized
Prothrombin time 5 5 5 5 – plasma specimens
For method compatibility, see instrument matrix below.
• WP10 - Three 0.3-mL
lyophilized plasma specimens
with corresponding diluents;
Whole Blood Coagulation, Instrument Matrix

Instrument Program Code
WP3 WP4 WP6 WP9 WP10
Abbott CoaguSense ™
z
ITC Hemochron Jr. Signature/Signature +, Signature
z
Elite and Jr. II – Citrated cuvette
ITC Hemochron Jr. Signature/Signature +, Signature
z
Elite and Jr. II – Noncitrated cuvette
i-STAT z
Roche CoaguChek XS Plus and XS Pro z
Roche CoaguChek XS System z
Siemens Xprecia Stride z
14
Coagulation
Coagulation
Third Page Filler
Program Information
Platelet Mapping* PLTM
• One 3.2% sodium citrate and
Analyte Program Code Challenges per Shipment two heparin vacuum tubes;
PLTM two 3.5-mL plastic tubes;
AA % aggregation/inhibition z 2 one vial of 0.2M CaCl2
ADP % aggregation/inhibition z 2 • For use with the

Haemonetics Platelet
*This Survey requires the draw of a normal donor sample.
Mapping® assay
Improve the reliability of your patient results with CAP Survey Validated
Materials
available results.
1/3
Coagulation—Limited, Validated Material Program Information
Validated Material Program Code Corresponding Survey Page
Third Page Fillers

Coagulation CGM CGL 160 plasma specimens, two
1.0-mL lyophilized plasma
specimens, and one 1.0-mL
serum specimen; three
shipments per year
14
Coagulation
Give better consultations for hemostasis diagnosis.
• Useful chapters on emergency assessment, consultation, antifibrinolytic
and thrombolytic agents, and more
• Insightful case studies
• Detailed algorithms to assist in diagnosis
Add An Algorithmic Approach to Hemostasis Testing,
2nd Edition (PUB223) to your order.
Hardcover; 480 pages;
175+ figures, tables,
and algorithms; 2016
800-323-4040 | 847-832-7000 Option 1 | cap.org 169

Can you spot them?
Accurately identify fungi, bugs, parasites, bacteria, and other

microorganisms quickly. Ruggedly constructed, these fully illustrated
guides are built to withstand heavy use at the workbench. Spiral-bound
and laminated, they are conveniently sized at 6 1/2" x 7".
Rely on these Benchtop Reference Guides in your laboratory.

Arthropod Benchtop Reference Guide (ABRG)
Gram Stain Benchtop Reference Guide (GSBRG) ADD THEM TO YOUR ORDER OR
PURCHASE THEM ONLINE.
Mycology Benchtop Reference Guide (MBRG)
Printed books at estore.cap.org
Filler #41
15 Microbiology
Microbiology testing is changing at a

rapid pace—so is our proficiency testing.
Introducing three new programs for:
• Molecular testing for Mycoplasma genitalium (MGEN)
• Molecular testing for herpes simplex virus and varicella
zoster virus, 5 challenges (ID5)
• Molecular testing for lower respiratory pneumonia
panel, 5 challenges (IDPN)
Microbiology
Microbiology ...................................................................................................................................... 172
Bacteriology....................................................................................................................................... 173
Mycobacteriology............................................................................................................................... 188
Mycology............................................................................................................................................ 189
Parasitology ....................................................................................................................................... 192
Virology .............................................................................................................................................. 195
Multidiscipline Microbiology .............................................................................................................. 201 15
Infectious Disease Serology ............................................................................................................... 205
Microbiology
New Programs
Routine Microbiology Combination (RMC) .......................................................................................... 176
Mycoplasma genitalium, Molecular (MGEN) ....................................................................................... 185
HSV, VZV—Molecular (ID5) ................................................................................................................ 198
Infectious Disease, Pneumonia Panel (IDPN) ..................................................................................... 203
Bacteriology—Limited (D4)
GC, Throat, and Urine Cultures (D7)
Microbiology—Combination w/GC (MC1, MC2)
Throat & Urine Culture/Rapid Strep A Antigen Detection (MC5)
Microbiology
Microbiology
Guide to Molecular Microbiology Testing
Use this flowchart as a guide for ordering the appropriate Molecular Microbiology Surveys for your laboratory’s testing
menu. Participants must report five specimens for each mailing to meet CLIA requirements for the subspecialties of
microbiology. See the following pages for more detailed information about each Survey.
Do you perform molecular Do you perform nucleic

Do you perform viral load Do you perform molecular
testing on Chlamydia or acid amplification other
testing only? multiplexing?
GC only? than GC?
YES YES YES YES
Select from the following: Select from the following: Select from the following: Select from the following:
HC6, HC6X,HC7
n IDO, ID1, ID1T,
n HV2
n ID3
n
Chlamydia/GC Nucleic ID2, ID5 , IDN HIV Viral Load (page 199) Influenza A, Influenza B,
Acid Amplification Nucleic Acid Amplification HCV2, HBVL, HBVL5
n RSV by NAA (page 198)
(page 186) (pages 197, 198, 201) Hepatitis Viral Load IDME
n
D1
n (page 198) Meningitis/Encephalitis
Throat Culture (page 175) VLS, VLS2
n Panel (page 202)
MRS2M/MRS5M
n Viral Load (page 199) IDPN
n
MRSA Screen, Infectious Disease

Molecular (page 182) Pneumonia Panel
BOR
n (page 203)
Bordetella pertussis/ IDR
n
parapertussis (page 180) Infectious Disease

CDF5
n Respiratory Panel
C. difficile Detection (page 202)
(page 181) GIP, GIP5
n
MGEN
n Gastrointestinal Panel
Mycoplasma genitalium (page 204)
15 (page 185) GNBC, GPBC
n
TVAG
n Blood Culture Panels
Microbiology
Trichomonas vaginalis (page 179)

(page 186) MVP
n
VBDM
n Molecular Vaginal Panel
Zika (page 200) (page 185)
Bacteriology
Bacteriology
Guide for Ordering Regulated Bacteriology Surveys

D D2 RMC D3 MC4 D1
Bacterial identification z z z z z z
Gram stain z z z z
Antimicrobial susceptibility testing z z z
Bacterial antigen detection z z z
Participants must report five specimens for each mailing to meet CLIA requirements for the
subspecialty of bacteriology. See the following pages for more detailed information about
each Survey.
Program Information
Bacteriology D
• Five swab specimens with
Procedure Program Code Challenges per Shipment diluents in duplicate for
D culture
Antimicrobial susceptibility testing z 1 graded, 1 ungraded • Culture sources may include
Bacterial antigen detection z 2 wounds, blood, respiratory,
urines, stools, and anaerobes
Bacterial identification z 5
on a rotational basis
Gram stain z 1
• Two specimens for bacterial
Additional Information antigen detection from the
Antigen detection challenges will be included in the following shipments: following:
• Shipment A: C. difficile antigen/toxin* and spinal fluid meningitis panel One swab for Group A
Streptococcus
• Shipment B: Spinal fluid meningitis panel and Group A Streptococcus
• Shipment C: C. difficile antigen/toxin* and Group A Streptococcus One 1.0-mL lyophilized
specimen for spinal fluid
*CMS has clarified that the C. difficile toxin test is not subject to CLIA regulations;
therefore, toxin results will not be sent to CMS. Only C. difficile antigen results meningitis testing
will be sent. One 0.5-mL lyophilized
specimen for Clostridium
difficile, for use with rapid 15
or molecular testing
methods
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 173

Bacteriology
Expanded Bacteriology DEX Program Information

• Two swab specimens in
Analyte Program Code Challenges per Shipment duplicate with diluents to
DEX perform bacterial
Live organisms z 2 identification and
susceptibility (when
Additional Information directed)
Expanded Bacteriology (DEX) is an educational opportunity that provides: • Three shipments per year
• Culture and susceptibility testing challenges for microbiology laboratories
that perform complete identification and susceptibility of bacterial isolates
including less common or problematic bacteria
• More exposure to emerging bacterial pathogens and novel resistance mechanisms
• Ability to recognize and identify organisms that exhibit multiple
drug-resistance patterns
• Recovery and identification of mixed pathogens such as yeast, aerobic,
and anaerobic bacteria in cultures containing multiple organisms
Program Information
Microbiology Bench Tools Competency MBT
• Six swab specimens with
Procedure Program Code Challenges per Shipment diluents for bacterial
MBT identification and
Bacterial identification z 6 susceptibility
Antimicrobial susceptibility testing z 2 • Culture sources will vary with

each shipment
• Results will be provided with
Microbiology Bench Tools Competency (MBT) is a supplemental module for competency the kit to assess personnel
assessment and an educational resource for microbiology laboratories. The module: competency
• Provides organisms that challenge the basic elements of testing at the • Two shipments per year
microbiology bench, including direct observation, monitoring, recording,
and reporting of test results
• Can be used for both competency and educational purposes, including teaching
and training pathology residents, new employees, and medical and MT/MLT
students
15 • Provides identification and susceptibility results for supervisor use
This is not a proficiency testing program and participants will not return results
Microbiology
to the CAP.
Third Page Filler
Bacteriology
Program Information
GC, Throat, and Urine Cultures D1, D2, D3
• D1- Five swab specimens
Challenges per with diluents in duplicate
Shipment
• D2 - Five loop specimens
D1 D2 D3
with diluents in duplicate,
Antimicrobial with one susceptibility
susceptibility z 1 challenge, and one Gram
testing stain challenge
Bacterial • D3 - Five loop specimens
z z z 5
identification with diluents in duplicate,
Gram stain z z 1 and one Gram stain
Culture source: Throat Urine Cervical challenge
Presence Organisms Presence or • Throat swabs compatible

or absence identified to absence of with molecular- and
Microbiologic of Group A the extent Neisseria culture-based methods
level: Streptococcus of your gonorrhoeae • Three shipments per year
determination laboratory’s determination
protocol
1/3
Third Page Fillers

15
Microbiology
in real time.
Refer to the Ordering Information provided for information regarding additional dangerous
800-323-4040 goodsOption
| 847-832-7000 and related fees.
1 | cap.org 1
F1 Third Black Dot New
800-323-4040 | 847-832-7000 Option 1 | cap.org 175
42453_2020 Surveys_Black Dot New Fillers.indd 1 6/6/19 3:38 PM
Bacteriology
Program Information
Routine Microbiology Combination RMC
• Five loop specimens with
Challenges per diluents in duplicate, three
Shipment
swab specimens with
RMC diluents in duplicate, and
Antimicrobial susceptibility testing z 1 one swab specimen for
bacterial antigen detection
GC culture z 2
• Urine culture will have one
Gram stain z 2
susceptibility challenge
Group A Streptococcus antigen detection* z 1
• Throat swabs compatible
Throat culture z 3 with molecular- and culture-
Urine culture z 3 based methods
*If your laboratory uses a waived method for Group A Streptococcus, these results will not count • Three shipments per year
toward the required five challenges for the subspecialty of bacteriology.
Program Information
Urine Colony Count MC3, MC4
• MC3 - Two urine specimens
Procedure Challenges per Shipment with diluents
Program Code • MC4 - Five urine specimens
MC3 MC4 with diluents, three swab
Urine colony count/urine culture identification 2 5 specimens with diluents in
duplicate, and three swab
Group A Streptococcus antigen detection* 3
specimens for bacterial
Throat culture 3 antigen detection
*If your laboratory uses a waived method for Group A Streptococcus, these results will not count • Throat swabs compatible
with molecular- and culture-
based methods
15
Microbiology
Program Information
Gram Stain D5
• Five air-dried, methanol-
Challenges per fixed unstained glass slides
Shipment
D5
Gram stain z 5
Bacteriology
Program Information
Virtual Gram Stain Competency VGS1, VGS2
• Three online, whole slide
Procedure Program Code Challenges per Shipment images
VGS1 VGS2 • Results included in the
Virtual gram stain basic z 3 kit to assess personnel
Virtual gram stain advanced z 3 competency
technology
• Virtual Gram Stain Basic Competency (VGS1) is for general and new laboratory
technologists/technicians. Participants will assess the quality of specimens and • Two shipments per year
stains and will report artifacts and detailed gram-positive and gram-negative
morphology. Challenges will include specimens such as CSF, body fluids, and
positive blood cultures.
• Virtual Gram Stain Advanced Competency (VGS2) is for experienced laboratory
technologists/technicians and microbiologists. Participants will receive challenging
images of sputum, body fluids, and other specimens to assess the quality, quantity,
and typical morphology of both gram-positive and gram-negative organisms
appropriate for the site.
Program Information
Rapid Group A Strep Antigen Detection D6
• Five swab specimens
• Not compatible with
D6 molecular- and culture-
Group A Streptococcus antigen detection* z 5 based methods
*If your laboratory uses a waived method for Group A Streptococcus, these results will not count • Three shipments per year
Program Information
Rapid Group A Strep Antigen Detection, Waived D9
• Two swab specimens 15
• Not compatible with
D9
Microbiology
molecular- and culture-
Group A Streptococcus antigen detection z 2 based methods
800-323-4040 | 847-832-7000 Option 1 | cap.org 177

Bacteriology
Program Information
Group B Strep Detection D8
Analyte Program Code Challenges per Shipment diluents
D8 • Compatible with molecular-
Group B Streptococcus z 5 and culture-based methods
Program Information
Bacterial Antigen Detection LBAS, SBAS
• Two 0.5-mL liquid simulated
Procedure Program Code Challenges per Shipment clinical specimens
LBAS SBAS • Two shipments per year
Legionella pneumophila
z 2
antigen detection
Streptococcus pneumoniae
z 2
antigen detection
Program Information
Bacterial Strain Typing, Staphylococcus BSTS
• Two sets of loops with
diluents
BSTS
Staphylococcus z 2
Program Information
Blood Culture BCS
15 • Two specimens with diluents
Procedure Program Code Challenges per Shipment for inoculation of blood
BCS culture bottles
Microbiology
Blood culture bacterial detection and • Two shipments per year

z 2
identification
Bacteriology
Program Information
Blood Culture, Staphylococcus aureus BCS1
• Three specimens with
Challenges per diluents for inoculation of
Shipment
blood culture bottles
BCS1
• Compatible with molecular
Staphylococcus aureus/MRSA z 3 methods for detection of
S. aureus/MRSA from
positive blood culture bottles
Program Information
Blood Culture Panel GNBC, GPBC
Challenges per simulated blood culture fluid
Shipment
specimens
GNBC GPBC
• For laboratories using
Identification of gram-negative organisms molecular multiplex panels
such as Acinetobacter, Citrobacter,
Enterobacter, Proteus, Haemophilus,
z 3
Klebsiella, Neisseria, Pseudomonas, Serratia,
E. coli, and common resistance mechanisms
isolated from positive blood culture bottles
Identification of gram-positive organisms
such as Staphylococcus, Streptococcus,
Enterococcus, Listeria, and common z 3
resistance mechanisms isolated from positive
These Surveys are not for the inoculation of blood culture bottles.
PNA FISH PNA1, PNA2 Program Information 15

• Three specimens with
Challenges per diluents for inoculation of
Microbiology
Shipment
PNA1 PNA2
Staphylococcus z 3
Yeast z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 179

Bacteriology
Program Information
Bordetella pertussis/parapertussis,
• Three swab specimens
Molecular BOR
• Designed for molecular
Analyte Program Code Challenges per Shipment techniques
BOR • Two shipments per year
Bordetella pertussis z 3
Bordetella parapertussis z 3
Program Information
Carbapenem-resistant Organisms CRO
• Three 130-μL specimens
• Compatible with Cepheid
CRO GeneXpert
KPC z 3 • Two shipments per year
IMP z 3
NDM z 3
OXA-48 z 3
VIM z 3
Program Information
Campylobacter CAMP
• Two swabs with diluents in
Analyte Program Code Challenges per Shipment duplicate
CAMP • For use with rapid antigen,
Campylobacter z 2 culture-based testing, and
molecular methods
15
Program Information
C. difficile, 2 Challenge CDF2
Microbiology

Analyte Program Code Challenges per Shipment specimens, for use with rapid
CDF2 or molecular testing methods
Clostridium difficile antigen/toxin z 2 • Two shipments per year
Bacteriology
Program Information
C. difficile, 5 Challenge CDF5
Analyte Program Code Challenges per Shipment specimens, for use with rapid
CDF5 or molecular testing methods
Clostridium difficile antigen/toxin z 5 • Three shipments per year
CMS has clarified that the C. difficile toxin test is not subject to CLIA regulations; therefore,
toxin results will not be sent to CMS. Only C. difficile antigen results will be sent.
Program Information
C. trachomatis Antigen Detection HC1, HC3
• HC1 - Five 5-well slide
Procedure Program Code Challenges per Shipment specimens; for the detection
HC1 HC3 of chlamydial elementary
C. trachomatis antigen detection (DFA) z 5 bodies by DFA
C. trachomatis antigen detection (EIA) z 5 • HC3 - Five 2.0-mL liquid

specimens for Chlamydia
antigen testing by EIA
Program Information
Fecal Lactoferrin FLAC
• Three 0.5-mL simulated stool
FLAC • For use with rapid methods
Fecal lactoferrin z 3 • Two shipments per year
Program Information
Helicobacter pylori Antigen, Stool HPS
• Two 0.5-mL fecal suspensions
HPS
Helicobacter pylori antigen detection z 2 15
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 181

Bacteriology
Program Information
Methicillin-resistant Staphylococcus aureus
• Two swab specimens with
Screen, 2 Challenge MRS diluents
Procedure Program Code Challenges per Shipment • For laboratories performing
MRS culture-based testing only or
MRSA/MSSA detection z 2 using culture and molecular
testing
Program Information
MRSA Screen, Molecular, 2 Challenge MRS2M
• Two swab specimens (in
Procedure Program Code Challenges per Shipment duplicate)
MRS2M • For use with molecular
MRSA/MSSA/SA detection z 2 methods that detect mecA
Program Information
Methicillin-resistant Staphylococcus aureus
Screen, 5 Challenge MRS5 diluents
Procedure Program Code Challenges per Shipment • For laboratories performing
MRS5 culture-based testing only or
MRSA/MSSA detection z 5 using culture and molecular
testing
15
Microbiology
Program Information
MRSA Screen, Molecular, 5 Challenge MRS5M
• Five swab specimens (in
Procedure Program Code Challenges per Shipment duplicate)
MRS5M • For use with molecular
MRSA/MSSA/SA detection z 5 methods that detect mecA
Third Page Filler
Bacteriology
Program Information
Laboratory Preparedness Exercise LPX
• Three swab specimens with
Analyte Program Code Challenges per Shipment diluents
LPX • Not available to international
Live organisms z 3 customers due to United
States export law
restrictions
The Laboratory Preparedness Exercise (LPX) was developed as a collaborative effort
between the College of American Pathologists, the Centers for Disease Control and • Two shipments per year
Prevention (CDC), and the Association of Public Health Laboratories (APHL).
Laboratories will be sent live organisms that either exhibit characteristics of
bioterrorism agents or demonstrate epidemiologic importance and will be expected to
respond following Laboratory Response Network Sentinel Laboratory Guidelines if a
bioterrorism agent is suspected. All agents provided are excluded from the CDC’s select
agent list. These may include strains of Bacillus anthracis, Yersinia pestis, Francisella
tularensis, and Brucella abortus that have been modified and are safe for testing in a
laboratory that contains a certified Class II Biological Safety Cabinet and is capable of
handling Category A and B agents.
Rapid Urease RUR Program Information 1/3

• Three simulated gastric
Analyte Program Code Challenges per Shipment biopsy specimens
RUR • For use with methods such
Urease z 3 as CLOTEST®

changing issues in clinical pathology. 15
The Clinical Pathology Improvement Program
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 3

CAP NEW 3 Third 800-323-4040 | 847-832-7000 Option 1 | cap.org 183
Bacteriology
Program Information
Stool Pathogen SP, SPN, SP1
• SP - Two 1.0-mL liquid
Analyte Program Code Challenges per Shipment specimens; for use with rapid
SP SPN SP1 or molecular testing methods;
Adenovirus 40/41 z z 2 not available to international
customers due to United
C. difficile antigen/toxin z z 2 States export law restrictions
Rotavirus z z 2
• SPN - Two 1.0-mL liquid
Shiga toxin z 2 specimens; for use with
Norovirus z 1 rapid or molecular testing
methods; intended for
international laboratories
• SP1 - One 1.0-mL liquid
specimen compatible with
molecular methods only
Program Information
Shiga Toxin ST
• For use with direct shiga toxin
ST testing only; not compatible
Shiga toxin z 2 with culture methods,
cytotoxicity assays, or PCR
• Not available to international
customers due to United
States export law
restrictions
Program Information
15 Bacterial Vaginosis BV
Microbiology
BV • For OSOM® BVBlue users

Bacterial vaginosis detection z 3 • Two shipments per year
Bacteriology
Vaginitis Screen VS, VS1 Program Information

• VS - Five swabs for DNA
Analyte Program Code Challenges per Shipment probe technology; BD
VS* VS1** Affirm™ VP III probe
Candida sp. z 5 detection method; three
shipments per year
Gardnerella vaginalis z 5
Trichomonas vaginalis z z 5
*The biohazard warning applies to Survey VS.
**Molecular users are encouraged to use Trichomonas vaginalis, Molecular (TVAG) on page 186.
• VS1 - Five swabs for
methods such as Sekisui
OSOM Trichomonas Rapid
Test, Trichomonas vaginalis
methods; two shipments
per year
Program Information
Mycoplasma genitalium, Molecular MGEN
MGEN • Designed for molecular
Mycoplasma genitalium z 3 techniques
Program Information
Molecular Vaginal Panel MVP
• Five 1.0-mL liquid simulated
Analyte Program Code Challenges per Shipment vaginal specimens
MVP • Designed for molecular
Candida species group z 5 methods such as BD MAX
Candida krusei z 5 and Hologic
Candida glabrata z 5 • Three shipments per year 15
Trichomonas vaginalis z 5
Microbiology
Bacterial vaginosis z 5
800-323-4040 | 847-832-7000 Option 1 | cap.org 185

Bacteriology
Program Information
C. trachomatis and N. gonorrhoeae by NAA
• HC6 - Three swab specimens
HC6, HC6X, HC7 and two 1.0-mL simulated
Procedure Program Code Challenges per Shipment urine specimens
HC6,* HC6X* HC7 • HC6X - Three swab
Nucleic acid amplification (NAA) specimens; two 1.0-mL
z 5
simulated urine specimens
Nucleic acid amplification in duplicate
z 5
(NAA/DNA)
*The biohazard warning applies to Surveys HC6 and HC6X.
• HC7 - Five 1.5-mL simulated

body fluid specimens;
designed for Cepheid users
Vaginitis Screen, Virtual Gram Stain VS2 Program Information

• Three online, whole slide
Procedure Program Code Challenges per Shipment images
VS2 • Powered by DigitalScope
Interpretation of Gram-stained vaginal technology
z 3
smears
• Two activities per year; your
Additional Information CAP shipping contact will be
See system requirements on page 13. notified via email when the
activity is available
Program Information
Trichomonas vaginalis, Molecular TVAG
15 Analyte Program Code Challenges per Shipment specimens
TVAG • Designed for molecular
Microbiology
Trichomonas vaginalis z 3 techniques

Half Page Filler
Bacteriology
Program Information
Vancomycin-resistant Enterococcus VRE
• Two swabs with diluents
• For use with molecular
VRE methods and culture-based
Vancomycin-resistant Enterococcus testing
z 2
(VRE) detection • Two shipments per year
1/2
Half Page Filler

Identify microorganisms quickly and confidently.
Gram Stain Benchtop Reference Guide is an illustrated guide to
gram-positive and gram-negative organisms. Its rugged construction
is well suited for students and medical technologists for heavy use
at the workbench.
Features include:
• Theory and application of the Gram stain
• Detailed descriptions of microbial morphology, quantitation,
and indicators of pathology
15
• Examples of more than 35 gram-positive and gram-negative
organisms found in blood, body fluids, CSF, urine, and the
Microbiology
genital and respiratory tracts
• Seven tabbed sections for easy reference
This sturdy, spiral-bound, laminated guide is conveniently
Item number: GSBRG
sized at 6½” x 7”.
Add it to your order. 115+ images and tables; 2017
800-323-4040 | 847-832-7000 Option 1 | cap.org 29
F29 Half
800-323-4040 | 847-832-7000 Option 1 | cap.org 187
Mycobacteriology
Mycobacteriology
Program Information
Mycobacteriology E
• Five simulated clinical
Procedure Program Code Challenges per Shipment isolates with diluents and
E one specimen for performing
Acid-fast smear z 1 an acid-fast bacillus smear
Antimycobacterial susceptibility testing z 1 graded, 1 ungraded • Identification may be

performed by culture or
Mycobacterial identification* z 5
molecular methods
*This procedure requires identification of Mycobacterium tuberculosis.
Program Information
Mycobacteriology—Limited E1
• Five simulated specimens
Procedure Program Code Challenges per Shipment for acid-fast smears and/or
E1 for the determination of the
Acid-fast smear z 5 presence or absence of
acid-fast bacillus by culture
Mycobacterial culture z 5
Molecular MTB Detection and Resistance MTBR Program Information

Procedure Program Code Challenges per Shipment sputum specimens for use
15 MTBR with molecular methods
Mycobacterium tuberculosis detection z 3 • Not suitable for culture
Microbiology
Rifampin resistance z 3 • Two shipments per year
Mycology
Mycology
Program Information
Mycology and Aerobic Actinomycetes F
• Five loops for culture with
Procedure Program Code Challenges per Shipment diluents in duplicate and
F one 1.0-mL simulated
Antifungal susceptibility testing z 1 cerebrospinal fluid specimen
(A and B shipments only)
Cryptococcal antigen detection z 2 per year
• Identification of yeasts,
Mold and yeast identification z 5
molds, and aerobic
actinomycetes may be
performed by molecular- and
culture-based methods
Program Information
Yeast F1
Procedure Program Code Challenges per Shipment diluents in duplicate and
F1 one 1.0-mL simulated
Antifungal susceptibility testing z 1 cerebrospinal fluid specimen
(A and B shipments only)
Cryptococcal antigen detection z 2 per year
• Identification of yeast may
Yeast identification z 5
be performed by molecular-
and culture-based methods
15
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 189

Mycology
Program Information
Candida Culture F3
Procedure Program Code Challenges per Shipment diluents in duplicate
F3 • Identification of Candida
Yeast identification z 5 species may be performed by
culture, molecular, and rapid
methods
Program Information
Cryptococcal Antigen Detection CRYP
• Five 1.0-mL simulated
Procedure Program Code Challenges per Shipment cerebral spinal fluids
CRYP • Three shipments per year
Cryptococcal antigen z 5
Program Information
Galactomannan FGAL
• Three liquid specimens
• For use with methods such
FGAL as Bio-Rad Platelia™
Galactomannan - Aspergillus z 3 • Two shipments per year
Program Information
Fungal Serology FSER
• Three serum specimens
• For use with
FSER immunodiffusion methods
15 Serological detection of specific
z 3 • Designed for the detection
fungal antibodies of antibodies to Aspergillus,
Microbiology
Blastomyces, Coccidioides,
and Histoplasma
Mycology
Third Page Filler
Program Information
Fungal Smear FSM
• Three unstained slides
FSM
KOH preparation/calcofluor white z 3
Program Information
India Ink IND
• Two liquid specimens
IND
India ink z 2
Program Information
Pneumocystis jirovecii PCP1, PCP2, PCP4
PCP1 PCP2 PCP4 images for Pneumocystis
PCP – Calcofluor white stain z 3 jirovecii
PCP – DFA stain z 3 • Two shipments per year

1/3 PCP – GMS stain z 3
Third Page Fillers
15
Microbiology
Color Atlas of Mycology (PUB226)
Built upon a foundation of more than 15 years of proficiency testing
data, this resource book is designed to assist pathologists and medical
technologists in the laboratory identification of fungi using the most recent
taxonomic classifications. The text highlights diagnostic clusters of incorrect
identifications and addresses conceptual classification issues. Comprehensive
and complete, this book merges in vitro mycology (colonies on plated media/
LPAB preparations) with in vivo mycology (histology/cytology).
Add Color Atlas of Mycology (PUB226) to your order.
Item number: PUB226
• printed books at estore.cap.org Hardcover; 2018
800-323-4040 | 847-832-7000 Option 1 | cap.org 191

Parasitology
Parasitology
Program Information
Parasitology P, P3, P4, P5
• P - Five specimens
Procedure Challenges per Shipment consisting of thin and thick
Program Code films for blood and tissue
P P3 P4 P5 parasite identification;
preserved slides for
Fecal suspension (wet mount) 2 5 2 permanent stain; 0.75-mL
Fecal suspension (Giardia and Cryptosporidium fecal suspensions for direct
2 1 1 5
immunoassays and/or modified acid-fast stain) wet mount examination,
Giemsa-stained blood smear 1 photographs, and/or online
images; two 0.75-mL fecal
Preserved slide (for permanent stain) 2 3
suspensions for Giardia
Additional Information and Cryptosporidium
• The proficiency testing materials used for the Parasitology Surveys contain immunoassays and/or
formalin as a preservative. modified acid-fast stain
• Modified acid-fast stain results do not meet CLIA requirements for parasite • P3 - Five 0.75-mL fecal
identification. suspensions for direct
• Number of specimen types are indicated in chart. wet mount examination,
photographs, and/or online
images; one 0.75-mL fecal
suspension for Giardia
and Cryptosporidium
immunoassays and/or
modified acid-fast stain
• P4 - Five specimens
consisting of 0.75-mL fecal
suspensions for direct wet
mount examination, preserved
slides for permanent stain,
photographs, and/or online
images; one 0.75-mL fecal
15 suspension for Giardia and

Cryptosporidium
immunoassays and/or
Microbiology

• P5 - Five 0.75-mL fecal
suspensions for Giardia
and Cryptosporidium
immunoassays and/or
Parasitology
Third Page Filler
Program Information
Blood Parasite BP
• Five Giemsa-stained blood
Procedure Program Code Challenges per Shipment film sets, photographs,
BP and/or online images
Thin/thick blood film sets* z 5 • A variety of blood parasites,
*This Survey will include corresponding thick films when available. including Plasmodium,
Babesia, Trypanosoma, and
filarial worms
Program Information
Rapid Malaria RMAL
• Three 0.5-mL antigen
RMAL • Two shipments per year
Rapid malaria detection z 3
*Detects Plasmodium falciparum specific histidine-rich protein 2 (HRP2). May not be compatible
with methods that use pLDH enzyme detection for mixed malaria infections.
Program Information
Expanded Parasitology PEX
1/3
Third Page Fillers

PEX images
Parasite identification z 3 • Two shipments per year
This program provides an educational opportunity to challenge laboratory professionals’
competency in the identification of parasites utilizing photo images.
15
Microbiology
• More than 70 identifications for parasites commonly
encountered in the clinical laboratory
• Five tabbed sections for easy reference
o Blood Parasites o Intestinal Protozoa o Intestinal Helminths
o Miscellaneous Specimens o Macroscopic Worms
years of benchtop use—6½” x 7”
Item number: PBRG
• ebooks at ebooks.cap.org 70+ images and tables; 2014
800-323-4040 | 847-832-7000 Option 1 | cap.org 193

800-323-4040 | 847-832-7000 Option 1 | cap.org 7
Parasitology
Half Page Filler
Program Information
Ticks, Mites, and Other Arthropods TMO
TMO images
Tick, mite, and arthropod identification z 3 • Two shipments per year
Program Information
Worm Identification WID
WID images
Worm identification z 3 • Two shipments per year
1/2
Half Page Filler

Arthropod Benchtop Reference Guide (ABRG)
• Numerous identifications of ectoparasites commonly
encountered in the clinical laboratory
15
• Detailed descriptions of the most significant
morphologic elements, ecology, and clinical significance
Microbiology

o Introduction o Bed Bugs
o Ticks o Kissing Bugs
o Mites o Fleas
o Lice o Myiasis-causing Fly Larvae
• A durable and water-resistant format to withstand years
of benchtop use—6½” x 7”
Item number: ABRG
• ebooks at ebooks.cap.org 65+ images and tables; 2016
800-323-4040 | 847-832-7000 Option 1 | cap.org 23

Virology
Virology
Guide for Ordering Regulated Virology Surveys

Procedure
Program Code
Viral Identification Viral Antigen Detection
VR1 z
VR2 z
VR4 z
HC2 z
HC4 z
ID3 z
ID5 z
Guide to Virology Testing

Use this flowchart as a guide for ordering the appropriate Virology Surveys for your laboratory’s
testing menu. For the subspecialty of virology, participants must test five specimens per mailing.
If you have any questions, please call the Customer Contact Center at 800-323-4040 or
847-832-7000 option 1.
For Comprehensive Virology Culture Testing Select VR1 (page 196)
For Virology Antigen Testing by Immunofluorescence Select VR2 (page 196)
Select VR3, VR3M

For Viral Serology Testing
(page 205)
For Virology Antigen by EIA or Latex Agglutination Select VR4 (page 196)
15
For Herpes Simplex Virus Antigen Detection by DFA Select HC2 (page 197)
Microbiology
For Herpes Simplex Virus Culture Testing Select HC4 (page 197)
Select HV2, HCV2, HBVL,

For Viral Load Testing HBVL5, VLS, VLS2
(pages 198-199)
Select ID1, ID1T,

For Nucleic Acid Amplification ID2, ID5, VBDM
(pages 197, 198, 200)
800-323-4040 | 847-832-7000 Option 1 | cap.org 195

Virology
Program Information
Virology Culture VR1
• Five 0.5-mL specimens for
Procedure Program Code Challenges per Shipment viral culture and one 0.5-mL
VR1 specimen for Chlamydia
Chlamydia trachomatis culture z 1 trachomatis culture
Viral isolation/identification z 5 • Three shipments per year
Program Information
Virology Antigen Detection (DFA) VR2
• Five 5-well slide specimens
Analyte/Procedure Program Code Challenges per Shipment
VR2 A B C
Adenovirus antigen z 1 1
Cytomegalovirus antigen z 1 1
Herpes simplex virus (HSV) antigen z 1 1
Influenza A antigen z 1 1
Influenza B antigen z 1
Parainfluenza antigen z 1 1
Respiratory syncytial virus (RSV)
z 1 1
antigen
Varicella-zoster antigen z 1 1
Educational challenge z 1
Program Information
Virology Antigen Detection (Non-DFA) VR4
• Five 1.5-mL specimens
• For use with enzyme
VR4 immunoassay and/or latex
15 Adenovirus (Not 40/41) antigen z 5 agglutination methods
Influenza A antigen z 5 • Three shipments per year
Microbiology
Influenza B antigen z 5
Respiratory syncytial virus (RSV)
z 5
antigen
Rotavirus antigen z 5
Virology
Program Information
Herpes Simplex Virus HC2, HC4
• HC2 - Five 5-well slide
HC2 HC4* • HC4 - Five 0.5-mL lyophilized
Herpes simplex virus antigen specimens
z 5
detection (DFA) • Three shipments per year
Herpes simplex virus culture z 5
*The biohazard warning applies to Survey HC4.
Program Information
Human Papillomavirus HPV
• Two simulated cervical
Analyte Program Code Challenges per Shipment specimens contained in
HPV Digene transport media
Human papillomavirus z 2 • For Digene Hybrid Capture
For laboratories using Digene, SurePath, and/or ThinPrep collection media, see page 287. only
Program Information
Nucleic Acid Amplification, Viruses ID1, ID1T
• ID1- Eight 1.0-mL liquid
ID1 ID1T • ID1T - Two 1.0-mL liquid
Cytomegalovirus z 1 specimens
Enterovirus z 1 • Two shipments per year
Epstein-Barr virus z 1
Herpes simplex virus z 1
Human herpesvirus 6 z 1
Human herpesvirus 8 z 1
Parvovirus B19 z 1 15
Varicella-zoster virus z 1
Microbiology
BK virus z 1
JC virus z 1
800-323-4040 | 847-832-7000 Option 1 | cap.org 197

Virology
Program Information
Nucleic Acid Amplification, Respiratory ID2
• Six 1.0-mL liquid specimens
ID2
Adenovirus z 1
Coronavirus/Rhinovirus* z 1
Human metapneumovirus z 1
Influenza virus* z 1
Parainfluenza virus z 1
Respiratory syncytial virus (RSV) z 1
*Coronavirus/Rhinovirus and Influenza virus will be included in the following shipments:
• Shipment A: Coronavirus and Influenza A
• Shipment B: Rhinovirus and Influenza B
Program Information
Influenza A, Influenza B, and RSV by
• Five 1.0-mL liquid specimens
Nucleic Acid Amplification ID3
Analyte Program Code Challenges per Shipment multiplex panel users
ID3 • Three shipments per year
Influenza A virus z 5
Influenza B virus z 5
Program Information
HSV, VZV—Molecular ID5
ID5 techniques
Herpes simplex virus z 5 • Three shipments per year
15 Varicella-zoster virus z 5
Microbiology
Program Information
Hepatitis Viral Load HCV2, HBVL, HBVL5
• HCV2 - Five 1.5-mL liquid
Procedure Challenges per Shipment plasma specimens; three
HCV2 HBVL HBVL5 • HBVL - Three 1.5-mL plasma
HCV genotyping 1 specimens; two shipments
per year
HCV, qualitative 1
• HBVL5 - Five 1.5-mL plasma
HCV viral load 5
HBV viral load 3 5 per year
Virology
Third Page Filler

Program Information
HIV Viral Load HV2, HIVG
• HV2 - Five 2.5-mL EDTA
Procedure Program Code Challenges per Shipment plasma specimens
HV2 HIVG • HIVG - One 1.0-mL liquid
HIV-RNA viral load z 5 specimen
HIV genotyping* z 1 • Three shipments per year
*HIV genotyping is for laboratories reporting reverse transcriptase, protease, and/or integrase
mutations.
Program Information
Viral Load VLS, VLS2
• VLS - Six 1.0-mL EDTA
Procedure Program Code Challenges per Shipment plasma specimens; two
VLS VLS2 shipments per year
BK viral load z z 2 • VLS2 - Ten 2.0-mL EDTA
CMV viral load z z 2 plasma specimens; three
shipments per year
EBV viral load z z 2
Adenovirus viral load z 2
HHV6 viral load z 2
1/3
Third Page Fillers
15
Atlas of Fundamental Infectious Diseases
Microbiology
Histopathology (PUB127)
This resource book is rich in detailed information and real-world examples
to help anatomic pathologists identify infectious organisms in tissue, study
patterns of inflammation for clues, understand which stains are best for
detecting specific micro-organisms, spot infectious disease mimics, and
select ancillary methods of detection.
• ebooks at ebooks.cap.org Softcover; 304 pages; 800+
images and tables; 2018
800-323-4040 | 847-832-7000 Option 1 | cap.org 199

Quarter Page Filler
Virology
Program Information
Viral Load Calibration Verification/Linearity
• LN38 - Six 1.5-mL frozen
LN38, LN39, LN45 plasma specimens
LN38* LN39 LN45 Target Ranges ships on dry ice
CMV viral load z 316–1.0M IU/mL
HIV viral load z 50–5.0M IU/mL
HCV viral load z 50–280M IU/mL
*The biohazard warning applies to Survey LN38. • LN39 - Six 2.5-mL plasma
View your expedited linearity evaluations within two business days by logging into specimens
• LN45 - Seven 2.5-mL frozen
DNA specimens
ships on dry ice (dry ice does
not apply to LN39)
1/4
Program Information
Vector-Borne Disease—Molecular VBDM
Quarter Page Filler

VBDM • Two shipments per year
Zika virus z 3
15
The CAP is your trusted calibration verification and linearity partner, providing
you with the most comprehensive menu of programs.
Microbiology
• Large peer groups—Maximize confidence in instrument calibration by using peer group data for a broader
view beyond your laboratory.
• Customized report package—Let our team of biostatisticians perform the statistical analysis of your
results so you do not have to.
• Expedited results—View your linearity evaluation for most CVL programs within two business days
of data submission.
See the Instrumentation Verification Tools section of this catalog to determine programs that best fit
your laboratory’s CVL needs.
F4 Quarter
Multidiscipline Microbiology
Guide for Ordering Regulated Molecular Multidiscipline Surveys

Program Code Procedure
Bacterial Identification Viral Identification
IDR z z
GIP5 z z
Program Information
Nucleic Acid Amplification, Organisms IDO, IDN
• IDO - Seven liquid or swab
Analyte/Procedure Program Code Challenges per Shipment simulated clinical isolate
IDO IDN specimens and two diluents
Bordetella pertussis/parapertussis z z 1 • IDN - Six liquid or swab
Legionella pneumophila/Chlamydia simulated clinical isolate
z z 1 specimens and two diluents;
pneumoniae*
designed for international
Methicillin-resistant
z z 1 laboratories that cannot
Staphylococcus aureus
receive MTB
Molecular typing (bacterial isolates) z z 1
Mycobacterium tuberculosis z 1
Mycoplasma pneumoniae z z 1
Vancomycin-resistant Enterococcus z z 1
*Legionella pneumophila/Chlamydia pneumoniae will be included in the following shipments:
• Shipment A: Chlamydia pneumoniae
• Shipment B: Legionella pneumophila
15
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 201

Program Information
Meningitis/Encephalitis Panel IDME
IDME • Designed for molecular
Escherichia coli K1 z 3 multiplex panel users
Haemophilus influenzae z 3 • Two shipments per year
Listeria monocytogenes z 3
Neisseria meningitidis z 3
Streptococcus agalactiae z 3
Streptococcus pneumoniae z 3
Cytomegalovirus (CMV) z 3
Enterovirus z 3
Herpes simplex virus 1 (HSV-1) z 3
Herpes simplex virus 2 (HSV-2) z 3
Human herpesvirus 6 (HHV-6) z 3
Human parechovirus z 3
Varicella-zoster virus (VZV) z 3
Cryptococcus neoformans/gattii z 3
Program Information
Infectious Disease, Respiratory Panel IDR
IDR multiplex panel users
Adenovirus z 5 • Three shipments per year
Bocavirus z 5
Bordetella (pertussis, parapertussis,
z 5
bronchiseptica, holmesii)
Chlamydia pneumoniae z 5
Coronavirus 5
15
z
Influenza A z 5
Microbiology
Influenza B z 5
Legionella pneumophila z 5
Mycoplasma pneumoniae z 5
Parainfluenza type 1, 2, 3 z 5
Parainfluenza type 4 z 5
Rhinovirus/Enterovirus z 5
Program Information
Infectious Disease, Pneumonia Panel IDPN
Challenges per
Analyte Program Code • Designed for molecular
Shipment
multiplex panel users
IDPN
Acinetobacter calcoaceticus-baumannii complex z 5
Adenovirus z 5
Coronavirus z 5
Chlamydia pneumoniae z 5
Enterobacter cloacae complex z 5
Escherichia coli z 5
Haemophilus influenzae z 5
Rhinovirus/Enterovirus z 5
Influenza A z 5
Influenza B z 5
Klebsiella aerogenes z 5
Klebsiella oxytoca z 5
Klebsiella pneumoniae group z 5
Legionella pneumophila z 5
Moraxella catarrhalis z 5
Mycoplasma pneumoniae z 5
Parainfluenza virus z 5
Proteus spp. z 5
Pseudomonas aeruginosa z 5
Serratia marcescens z 5
Staphylococcus aureus z 5
Streptococcus agalactiae z 5
Streptococcus pneumoniae z 5 15
Streptococcus pyogenes z 5
Microbiology
Includes antimicrobial resistance genes as appropriate.
800-323-4040 | 847-832-7000 Option 1 | cap.org 203

Program Information
Gastrointestinal Panel GIP5, GIP
• GIP5 - Five 1.0-mL simulated
Analyte Challenges per Shipment stool specimens; three
GIP5 GIP • GIP - Three 1.0-mL simulated
Adenovirus 5 3 stool specimens; two
shipments per year
Astrovirus 5 3
Campylobacter 5 3
multiplex panel users
Clostridium difficile, toxin A/B 5 3
• Not available to international
Cryptosporidium 5 3 customers due to United
Cyclospora cayetanensis 5 3 States export law
Entamoeba histolytica 5 3 restrictions
Enteroaggregative E. coli (EAEC) 5 3

Enteropathogenic E. coli (EPEC) 5 3
Enterotoxigenic E. coli (ETEC) LT/ST 5 3
Escherichia coli O157 5 3
Giardia 5 3
Norovirus GI/GII 5 3
Plesiomonas shigelloides 5 3
Rotavirus A 5 3
Salmonella 5 3
Sapovirus 5 3
Shiga-like toxin producing
5 3
E. coli (STEC) stx1/stx2
Shigella/Enteroinvasive E. coli (EIEC) 5 3
Shigella 5 3
Vibrio cholerae 5 3
Yersinia enterocolitica 5 3
Note: Only GIP5 analytes in bold type will meet CMS requirements for bacteriology and virology
15 identification.
Microbiology
Infectious Disease Serology

Program Information
Infectious Disease Serology VR3, VR3M
• VR3 - Eight 0.5-mL
Analyte Program Code Challenges per Shipment lyophilized defibrinated
VR3 VR3M plasma specimens
Cytomegalovirus (CMV) – IgG, IgM, and • VR3M - One 0.5-mL
z 1
total antibodies lyophilized defibrinated
Epstein-Barr virus (EBV) – VCA – IgG, IgM plasma specimen
EBNA – IgG, IgM, and total antibodies z 1 • Two shipments per year
EA – IgG
Helicobacter pylori – IgG, IgA, and
z 1
total antibodies
Herpes simplex virus (HSV) – IgG antibody z 1
Mycoplasma pneumoniae – IgG, IgM, and
z 1
total antibodies
Mumps – IgG z 1
Rubeola virus (English measles) – IgG
z 1
antibody
Toxoplasma gondii – IgG, IgM, and
z 1
total antibodies
Varicella-zoster virus – IgG and
z 1
total antibodies
Program Information
Tick-Transmitted Diseases TTD
TTD • Designed for the detection
Antibodies to tick-transmitted disease of antibodies to Borrelia
z 3
organisms burgdorferi, Babesia
microti, and Anaplasma
15
phagocytophilum
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 205

Half Page Fil
Rely on this reference for a rapidly growing field.

Flow Cytometry in Evaluation of Hematopoietic Neoplasms: A Case-Based
Approach is a practical, case-based guide to flow cytometric analysis
in the workup of hematopoietic neoplasms presenting in the peripheral
blood, marrow, lymphoid tissue, and extranodal sites. This text provides
pathologists, residents, laboratory technologists, and hematologists
with both a study guide and an atlas for regular consultation in the
clinical flow cytometry laboratory.

Item number: PUB221
Hardcover; 176 pages; 2012

F30 Half
15
Microbiology
16 Immunology and Flow Cytometry
Maintain your certification with

continuing education (CE) from
CAP Surveys.
• Offer your staff more than 100 CE credits.
• Enhance your learning with content that is tightly
• Meet certification and licensure requirements with
CE across multiple disciplines.

Immunology ....................................................................................................................................... 208
Flow Cytometry .................................................................................................................................. 215
New Programs
Flow Cytometry—Post-Immunotherapy Analysis (FL6)...................................................................... 216
16
Antiphosphatidylserine Antibody (APS).............................................................................................. 211
Cyclic Citrullinated Peptide Antibody (Anti-CCP) (CCP) ...................................................................... 212
Immunology
Immunology
Program Information
Immunology
• ANA and RUB - Five 0.5-mL
ANA, ASO, CRP, HCG, IM, RF/RFX, RUB/RUBX, IL serum specimens
Challenges per • ANA - Three educational
Shipment
pattern interpretation dry
RF/ RUB/ challenges per year
ANA ASO CRP HCG IM IL
RFX RUBX
• ASO, HCG, and RF - Five
Antinuclear antibody 1.0-mL serum specimens
z z 5
(ANA)*
• CRP - Two 0.5-mL serum
ANA dry challenge z z 1 specimens; not appropriate
Antistreptolysin O (ASO)* z z 5 for high-sensitivity CRP
C-reactive protein, (hsCRP) methods
z z 2
qualitative/quantitative • IM - Five 0.6-mL serum
hCG, serum, qualitative/ specimens
z z 5
quantitative • RFX - All Survey RF
Infectious mononucleosis z z 5 specimens in duplicate
Rheumatoid factor* z z 5 • RUBX - All Survey RUB
Rubella (IgG)* z z 5 specimens in duplicate

*ANA, ASO, Rheumatoid factor, and Rubella are regulated analytes and are graded for both • IL - All immunology
qualitative and quantitative methods. Semiquantitative and/or titer results for these analytes specimens except RFX and
are ungraded/educational in these Surveys and do not meet regulatory requirements. RUBX
Program Information
Immunology, General IG/IGX
• IG - Ten 1.0-mL serum
IG/IGX
16 Alpha-1 antitrypsin z 5
• IGX - All Survey IG specimens
in duplicate
Complement C3 z 5 • Three shipments per year
Complement C4 z 5
Haptoglobin z 5
IgA z 5
IgE z 5
IgG z 5
IgM z 5
Total kappa/lambda ratio z 5
Immunology
Program Information
Immunology, Special; Immunology Special, Limited;
• S2 - A minimum of seven
and H. pylori IgG Antibody S2, S4, S5 (0.5- to 1.0-mL/vial) serum
S2 S4 S5 A B C • S4 - A minimum of three
Anticentromere antibody z 1 1 (0.5- to 1.0-mL/vial) serum
specimens
Anti-DNA antibody double-stranded z z 1 1 1
• S2 and S4 - Three shipments
Antiglomerular basement membrane per year
z 1 1
(GBM), IgG antibody
• S5 - Two 1.0-mL serum
Antimitochondrial antibody z 1 1 1
specimens; two shipments
Antineutrophil cytoplasmic antibody per year
z 1 1
(ANCA, anti-MPO, anti-PR3)
Anti-RNP antibody z 1 1 1
Anti-Ro52 antibody z 1 1 1
Anti-Ro62 antibody z 1 1 1
Anti-Sm antibody z 1 1 1
Anti-Sm/RNP antibody z 1 1 1
Antismooth muscle antibody z 1 1 1
Anti-SSA antibody z 1 1 1

Anti-SSB antibody z 1 1 1
Anti-SSA/SSB antibody z 1 1 1
Antithyroglobulin antibody z z 1 1 1
Antithyroid microsomal antibody z z 1 1 1
Antithyroid peroxidase antibody z z 1 1 1
Ceruloplasmin z z 1 1 1
Haptoglobin z z 1 1 1
Helicobacter pylori, IgG antibody z z 1 1
z 2 2
IgD z z 1 1 1
IgG z z 1 1 1
IgG subclass proteins z z 1 1 1
Prealbumin (transthyretin) z z 1 1 1
16
Total kappa/lambda ratio z z 1 1 1
Transferrin z z 1 1 1
Survey S2 is not appropriate for antimitochondrial antibody assays that are specific for the M2
antibody. Refer to Survey H on page 210.
Program Information
Infectious Mononucleosis, Waived IMW
IMW • Two shipments per year
Infectious mononucleosis, waived z 3
800-323-4040 | 847-832-7000 Option 1 | cap.org 209

Immunology
Program Information
Alpha-2-Macroglobulin A2MG
A2MG • Two shipments per year
Alpha-2-macroglobulin z 3
Program Information
Antichromatin Antibody ACA
ACA • Two shipments per year
Antichromatin antibody z 3
Program Information
Antifilamentous Actin IgG Antibody
FCN specimens
FCN
Antifilamentous actin (f-actin)
3
z
IgG antibody
Program Information
Antihistone Antibody AHT
AHT • Two shipments per year
Antihistone antibody z 3
Program Information
Antimitochondrial M2 Antibody H
16 H • Two shipments per year
Antimitochondrial M2
z 2
antibody (AMA-M2)
Program Information
Autoimmune Gastritis Markers APC
APC • Two shipments per year
Antiparietal cell antibody z 2
Anti-intrinsic factor antibody z 2
Immunology
Program Information
Antiphospholipid Antibody ACL
ACL • Two shipments per year
Anticardiolipin antibody
z 3
(polyclonal, lgG, lgM, and lgA)
Beta-2-glycoprotein I
z 3
(polyclonal, lgG, lgM, and lgA)
Program Information
Antiphosphatidylserine Antibody APS
APS • Two shipments per year
Anticardiolipin antibody
z 3
(polyclonal, IgG, IgM, and IgA)
Antiphosphatidylserine antibody
z 3
(IgG, IgM, and IgA)
Beta-2-glycoprotein I
z 3
(polyclonal, IgG, IgM, and IgA)
Antiphosphatidylserine/prothrombin

z 3
antibody (aPS/PT)
Program Information
Antiribosomal P Antibody ARP
ARP • Two shipments per year
Antiribosomal P antibody z 3
Program Information
Anti-Saccharomyces cerevisiae Antibody ASC
ASC • Two shipments per year
16
Anti-Saccharomyces cerevisiae antibody
z 2
(lgG and lgA)
800-323-4040 | 847-832-7000 Option 1 | cap.org 211

Immunology
Program Information
Celiac Serology CES, CESX
• CES - Three 0.3-mL serum
Shipment
• CESX - All Survey CES
CES CESX
specimens in triplicate
Antiendomysial antibody (IgA and IgG) z z 3
Antiendomysial antibody screen (IgA and IgG) z z 3
Antigliadin antibody (IgA and IgG) z z 3
Antideamidated gliadin peptide (DGP)
z z 3
antibody (IgA and IgG)
Anti-DGP antibody screen (IgA and IgG) z z 3
Antitissue transglutaminase (tTG) antibody
z z 3
(IgA and IgG)
Anti-DGP and anti-tTG antibody screen
z z 3
(IgA and IgG)
Program Information
Cyclic Citrullinated Peptide
Antibody (Anti-CCP) CCP
specimens

CCP
Anti-CCP z 2
Rheumatoid factor isotypes
z 2
(IgA, IgM, IgG)
Program Information
Cytokines CTKN
• Nine 2.0- to 3.0-mL
Analyte Program Code Challenges per Shipment lyophilized serum specimens
CTKN • Two shipments per year
Interferon (IFN)-gamma z 3
Interleukin (IL)-1 beta z 3
16 IL-2 z 3
IL-6 z 3
IL-8 z 3
IL-10 z 3
Tumor necrosis factor (TNF)-alpha z 3
Vascular endothelial growth factor (VEGF) z 3
Immunology
Program Information
Diagnostic Allergy SE
• Five 2.0-mL serum
SE • Includes common allergens
IgE, multiallergen screen, qualitative z 5 from North America as well
IgE, total z 5 as less frequently tested
allergens
Specific allergens z 25
Program Information
High-Sensitivity C-Reactive Protein HSCRP
HSCRP • Two shipments per year
High-sensitivity C-reactive protein z 3
Program Information
Liver-Kidney Microsomal Antibody (Anti-LKM) LKM

LKM • Two shipments per year
Anti-LKM z 2
Program Information
M. tuberculosis-Stimulated Infection Detection QF
Analyte Program Code Challenges per Shipment serum specimens and one
QF lyophilized mitogen control
M. tuberculosis z 2 • For use with the
QuantiFERON®-TB Gold and
Gold Plus methods only
16
Program Information
Rheumatic Disease Special Serologies RDS
RDS • Two shipments per year
Anti-Jo-1 (antihistidyl t-RNA synthetase) z 1
Anti-Scl-70 (anti-DNA topoisomerase) z 1
800-323-4040 | 847-832-7000 Option 1 | cap.org 213

Immunology
Program Information
Syphilis Serology G
• Five 1.5-mL serum
G • Three shipments per year
Syphilis z 5
Use with VDRL, RPR, MHA-TP/TP-PA/PK-TP/TPHA, EIA, CMIA, multiplex flow immunoassay, TP-LIA
IgG, FTA-ABS, and USR methods. Laboratories performing syphilis serology on CSF specimens may
also use this Survey.
Program Information
Total Hemolytic Complement CH50
CH50 • Two shipments per year
Total hemolytic complement, 50% lysis z 2
Total hemolytic complement, 100% lysis z 2
Program Information
Viscosity V
V • Two shipments per year

Viscosity z 2
Program Information
Serum Free Light Chains SFLC
SFLC • Two shipments per year
Kappa serum free light chain z 3
Lambda serum free light chain z 3
Kappa/lambda serum free light
z 3
chain ratio and ratio interpretation
16
Flow Cytometry
Flow Cytometry
Program Information
Flow Cytometry FL, FL1, FL2
• FL1 - Three 1.5-mL whole
FL FL1 FL2 • FL2 - Three 1.1-mL
DNA content and cell cycle analysis z z 3 specimens; two fixed cell line
Lymphocyte immunophenotyping z z 3 specimens and one
calibrator for DNA content
These Surveys are not appropriate for hematology analyzers with monoclonal antibody analysis.
and cell cycle analysis
• FL - All Survey FL1 and FL2
specimens
Program Information
Flow Cytometry—Immunophenotypic
• Two 2.5-mL whole blood
Characterization of Leukemia/Lymphoma FL3 specimens and/or cell lines
Procedure Program Code Challenges per Shipment simulating leukemia/

lymphoma; images of tissue
FL3
sections, bone marrow, and/
Leukemia/lymphoma z 2 or peripheral blood smears
Survey FL3 is appropriate for laboratories that perform technical component-only flow cytometry with clinical histories
testing.
• Online, whole slide images
powered by DigitalScope®
technology
Program Information
Flow Cytometry, CD34+ FL4
• Two 1.5-mL stabilized human
Analyte Program Code Challenges per Shipment CD34+ specimens
FL4 • Two shipments per year 16
CD34+ z 2
800-323-4040 | 847-832-7000 Option 1 | cap.org 215

Flow Cytometry
Program Information
Flow Cytometry, Interpretation Only FL5
• Three cases consisting of
Procedure Program Code Challenges per Shipment gated dot plots, clinical
FL5 histories, and pertinent
Flow cytometry, interpretation only laboratory data, as well as
z 3 images of tissue sections,
of leukemia/lymphoma
bone marrow, and/or
Survey FL5 is for laboratories that receive ﬂow cytometry analyses from referring laboratories to
peripheral blood smears
perform the interpretation of patient results.
powered by DigitalScope
technology
Program Information
Flow Cytometry—Post-Immunotherapy
• Three cases consisting of
Analysis FL6 gated dot plots, clinical
Procedure Program Code Challenges per Shipment histories, and pertinent
laboratory data, as well as
FL6
images of tissue sections,
Post-immunotherapy flow bone marrow, and/or
z 3
cytometry analysis peripheral blood smears
Survey FL6 is appropriate for laboratories that perform flow cytometry analysis on samples from
patients treated with chimeric antigen receptor (CAR) T-cell or other immunotherapy regimens
that cause immunophenotypic changes to normal and/or neoplastic cells. powered by DigitalScope
technology
Program Information
Flow Cytometry—B-ALL Minimal
• One 1.1-mL specimen
Residual Disease BALL containing a cell line/whole
Analyte Program Code Challenges per Shipment blood mixture simulating
B lymphoblastic leukemia/
BALL
lymphoma minimal residual
B-ALL minimal residual disease z 3 disease with clinical history
16 Survey BALL is intended for laboratories that currently or will begin to perform minimal residual
• Two cases with ungated list
disease (MRD) testing (rare event analysis) for B lymphoblastic leukemia/lymphoma. The cases
presented will be based on Children’s Oncology Group (COG) approved B-ALL MRD method. mode files that allow users
to examine gating strategies
Minimum Requirements and interpret antibody
• For ungated list mode files, each challenge will include 2-3 “virtual tubes” staining patterns; files are
performed by a 6-color method. The participant will download the files from a CAP in standard format (see
website and analyze the data on a MAC or PC using standard software, including Minimum Requirements)
FlowJo, FACSDiva, Kaluza, Woodlist, etc. The files will be large as each tube will • Two shipments per year
have collected hundreds of thousands of events. Boolean gating will be necessary
to see if there is an atypical population.
• Demo list mode files are available for download to determine software
compatibility prior to enrollment. Go to fileshare.cap.org (user name: demo-b-all-
mrd; password: ProductTest1).
Flow Cytometry
Program Information
Flow Cytometry—Plasma Cell Neoplasms PCNEO
• One 2.5-mL whole blood
Analyte Program Code Challenges per Shipment specimen and/or cell line
PCNEO simulating a plasma cell
Plasma cell neoplasms neoplasm with clinical
z 3
history and pertinent
Survey PCNEO is especially helpful for laboratories that have leukemia/lymphoma assays that
laboratory data
target plasma cell neoplasms, including cytoplasmic light chain staining.
• Two cases consisting of
gated dot plots, clinical
histories, and pertinent
laboratory data
• Each challenge includes
images of tissue sections,
bone marrow, and/or
peripheral blood smears
technology

Program Information
Flow Cytometry—Immunophenotypic Characterization
of Paroxysmal Nocturnal Hemoglobinuria PNH specimens for RBC and
Analyte Program Code Challenges per Shipment WBC analysis
PNH • Two shipments per year
PNH RBC analysis z 2
PNH WBC analysis z 2
• The PNH Survey complies with the recommendations from the Guidelines for the
Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria and Related
Disorders by Flow Cytometry for RBC and WBC analysis. Due to the unique nature
of these human, donor-based materials, the shipping dates are subject to change.
If this should occur, the CAP will provide notification prior to the originally
scheduled shipping date.
• This Survey is appropriate for high-sensitivity testing (≤0.01% PNH type clone in
16
red cells and/or granulocytes).
800-323-4040 | 847-832-7000 Option 1 | cap.org 217

Flow Cytometry
Program Information
Acid elution whole slide image z 1 images per year with optional
technology
Program Information
Rare Flow Antigen Validation RFAV1, RFAV2
• RFAV1 - One 4.5-mL cell line
Analyte Program Code Challenges per Shipment specimen
RFAV1 RFAV2 • RFAV2 - One 1.0-mL
CD1a z 1 stabilized cell specimen
CD103 z 1 • Two shipments per year
Surveys RFAV1 and RFAV2 do not meet the regulatory requirements for proficiency testing.
These Surveys meet the CAP Accreditation Checklist item FLO.23737, which requires
semiannual testing of antigens.
Program Information
ZAP-70/CD49d Analysis by Flow Cytometry ZAP70
• Three 4.5-mL cell line
ZAP70 • Two shipments per year
Zeta chain-associated protein kinase 70 z 3
CD49d z 3
• This Survey tests for intracellular ZAP-70 staining of a cell line. It allows for
16 assessment of the laboratory’s staining techniques and the antibody clone used for
ZAP-70 detection.
• CD49d is an important prognostic marker for CLL by flow cytometry. This Survey
allows assessment of the laboratory’s ability to detect CD49d.
17 Transfusion Medicine, Viral Markers, and
Parentage Testing
Confirm all your instruments are in

working order.
Monitor performance across multiple instruments
between proficiency testing events with Quality
Cross Check.
• Gain an early indication of instrument problems.

• Assess comparability across multiple automated
and manual methods with the Quality Cross Check—
Transfusion Medicine program (JATQ).

Transfusion Medicine......................................................................................................................... 220
Viral Markers...................................................................................................................................... 230
Parentage Testing .............................................................................................................................. 233
17
New Programs
Antibody Titer—Automated (AABT, AABT1, AABT2, AABT3)................................................................ 224
Program Information
Transfusion Medicine J, J1
• J - Five 3.0-mL 3% red blood
Procedure Program Code Challenges per Shipment cell suspensions; five 3.0-mL
J J1 corresponding serum
specimens; one 3.0-mL
ABO grouping z z 5
donor red blood cell
Rh typing z z 5 suspension
Antibody detection z 5 • J1 - Five 3.0-mL 3% red
Antibody identification z 5 blood cell suspensions; five
Compatibility testing z 5 3.0-mL corresponding serum
specimens
Red blood cell antigen typing z 1

Program Information
Transfusion Medicine—Educational Challenge JE1
• One educational challenge,
Procedure Program Code Challenges per Shipment which may consist of a
JE1 paper challenge and/or wet
Educational challenge z 1 specimen for ABO grouping,
Rh typing, antibody detection,
antibody identification,
compatibility testing, antigen
typing, and/or direct
antiglobulin testing
• Must order in conjunction
with Survey J
17
Program Information
Electronic Crossmatch EXM
• Three simulated, ISBT-128
Procedure Program Code Challenges per Shipment labeled donor unit
EXM challenges and three
Electronic crossmatch z 3 corresponding red blood cell
suspensions
Survey EXM assists laboratories in monitoring the performance of their electronic
crossmatching system. • Must order in conjunction
with Survey J

Program Information
Transfusion Medicine—Automated JAT
• Five bar-coded 4.0-mL
Procedure Program Code Challenges per Shipment 18%–22% whole blood
JAT specimens and one 4.0-mL
ABO grouping z 5 18%–22% whole blood
specimen for compatibility
Antibody detection z 5 testing
Antibody identification z 5
Compatibility testing z 5
Rh typing z 5
Program Information
Transfusion Medicine—Automated
• One educational challenge,
Education Challenge JATE1 which may consist of a
Procedure Program Code Challenges per Shipment paper challenge and/or wet
specimen for ABO grouping,
JATE1
Rh typing, antibody detection,
Educational challenge z 1 antibody identification,
and/or compatibility testing
• Must order in conjunction
with Survey JAT
• Three shipments per year 17
800-323-4040 | 847-832-7000 Option 1 | cap.org 221

Program Information
Quality Cross Check—Transfusion
• Three 7.0-mL 13-17% whole
Medicine JATQ blood specimens
Procedure Program Code Challenges per Shipment • May be used with automated
JATQ and manual procedures
ABO grouping z 3
Antibody detection z 3
Rh typing z 3
This program does not meet regulatory requirements for proficiency testing; see Survey JAT
Program Information
Electronic Crossmatch, Automated EXM2
• Three simulated, ISBT-128

Procedure Program Code Challenges per Shipment labeled donor unit
EXM2 challenges and three
Electronic crossmatch z 3 corresponding red blood cell
suspensions
Survey EXM2 assists laboratories in monitoring the performance of their electronic
crossmatching system. • Must order in conjunction
with Survey JAT
Program Information
ABO Subgroup Typing ABOSG
• Three 2.0-mL 3% red blood
Procedure Program Code Challenges per Shipment cell suspensions; three
ABOSG 2.0-mL corresponding
ABO subgroup typing z 3 serum specimens
Rh typing z 3 • Two shipments per year
17
Program Information
Red Blood Cell Antigen Genotyping RAG
RAG • Two shipments per year
Red blood cell antigen genotype
z 3
with predictive phenotype
Program Information
Red Blood Cell Antigen Typing RBCAT
• Two 2.0-mL 2%–4% red
Procedure Program Code Challenges per Shipment blood cell suspensions
RBCAT • Two shipments per year
Red blood cell antigen typing z 2

Survey RBCAT is for donor centers and transfusion laboratories performing
non-automated/manual red cell phenotyping for the management of patients with
complex serology (ie, alloimmunization, sickle cell disease, warm autoimmune
hemolytic anemia). Challenges will include antigens such as Rh, Kell, MNSs, Duffy, and
Kidd blood group system.
Program Information
Antibody Titer ABT, ABT1, ABT2, ABT3
• ABT - One 2.0-mL plasma
Procedure Program Code Challenges per Shipment specimen for anti-A titer
ABT ABT1 ABT2 ABT3 with one corresponding titer
Anti-A titer z z 1 cell (3%–4% red blood cell
suspension); one 2.0-mL
Anti-B titer z 1 plasma specimen for anti-D
Anti-D titer z z 1 titer with one corresponding
titer cell (3%–4% red blood
cell suspension)
• ABT1- One 2.0-mL plasma
specimen for anti-A titer
with one corresponding titer
cell (3%–4% red blood cell
suspension)
• ABT2 - One 2.0-mL plasma
specimen for anti-D titer
with one corresponding titer 17
suspension)
specimen for anti-B titer
suspension)
800-323-4040 | 847-832-7000 Option 1 | cap.org 223

Program Information
Antibody Titer—Automated AABT, AABT1,
• AABT - One 2.0-mL plasma
AABT2, AABT3 specimen for anti-A titer; one
Procedure Program Code Challenges per Shipment 2.0-mL plasma specimen for
anti-D titer
AABT AABT1 AABT2 AABT3
Anti-A titer z z 1 • AABT1 - One 2.0-mL plasma
Anti-B titer z 1
• AABT2 - One 2.0-mL plasma
Anti-D titer z z 1 specimen for anti-D titer
Program Information
Transfusion-Related Cell Count TRC
• Five 1.2-mL suspensions of
Procedure Program Code Challenges per Shipment platelet-rich plasma
TRC • Two 1.0-mL vials leukocyte-
Platelet count (platelet-rich reduced platelet material
z 5
plasma) • Two 1.0-mL vials leukocyte-
WBC count z 4 reduced red blood cells
Dry challenge z 2 • Three shipments per year
WBC counts must be performed using a Nageotte chamber, fluorescence microscopy, or by
flow cytometry.
Program Information
Direct Antiglobulin Testing DAT
• Three 2.0-mL 3% red blood
Procedure Program Code Challenges per Shipment cell suspensions
DAT • For use with manual method
Direct antiglobulin testing z 3 • Two shipments per year
Program Information
Eluate Survey ELU
• Two 2.0-mL 50% red blood
17 Procedure Program Code
ELU
Challenges per Shipment cell suspensions
Antibody elution z 2
Program Information
Acid elution whole slide image z 1 images per year with optional
technology

Program Information
Platelet Serology PS
• Three 3.0-mL plasma
PS • For use with solid-phase
Antibody detection z 3 red cell adherence, flow
Platelet crossmatch z 3 cytometry, and EIA/ELISA
methods
Platelet antibody identification z 3
A low concentration of sodium azide may be present in the specimens and may affect
lymphocytotoxicity methods.
Program Information
Transfusion Medicine Comprehensive—Competency
Assessment TMCA cell suspensions
Procedure Program Code Challenges per Shipment • Two 3.0-mL corresponding
TMCA serum specimens
ABO grouping z 2 • One 2.0-mL donor 3% red
Antibody detection z 2 blood cell suspension
Antibody identification z 2 • Three shipments per year;

order shipments individually
Compatibility testing z 2
or for an entire year
Rh typing z 2
Survey TMCA does not meet the regulatory requirements for proficiency testing.
17
Program Information
Direct Antiglobulin Test—Competency
Assessment TMCAD cell suspensions
Procedure Program Code Challenges per Shipment • Two shipments per year;
TMCAD order shipments individually
Direct antiglobulin testing z 2 or for an entire year
Survey TMCAD does not meet the regulatory requirements for proficiency testing.
800-323-4040 | 847-832-7000 Option 1 | cap.org 225

Half Page Filler
Program Information
Eluate Competency Assessment TMCAE
Procedure Program Code Challenges per Shipment cell suspensions
TMCAE • Two shipments per year;
Antibody elution z 2 order shipments individually
Survey TMCAE does not meet the regulatory requirements for proficiency testing. or for an entire year
Program Information
Fetal Red Cell Quantitation—Competency
Assessment TMCAF specimens
Procedure Program Code Challenges per Shipment • Two online, whole slide
TMCAF images per year with optional
Kleihauer-Betke, flow cytometry z 2 grids for cell counting
Rosette fetal screen z 2 • Powered by DigitalScope

technology
Acid elution whole slide image z 1
Survey TMCAF does not meet the regulatory requirements for proficiency testing.
order shipments individually
or for an entire year
1/2
Half Page Filler

Make critical transfusion decisions with confidence.
Transfusion Medicine in the Hot Seat is a valuable educational
resource for pathology trainees and pathologists practicing
transfusion medicine. The text presents a total of 26 realistic
transfusion scenarios divided into three sections:
• Antibodies
• Blood Components
17
• Complications
The short-case format makes the information easily accessible
and can serve as the basis for a transfusion medicine curriculum in
clinical pathology.
Add Transfusion Medicine in the Hot Seat (PUB224) to your order.

• ebooks at ebooks.cap.org Softcover; 123 pages
800-323-4040 | 847-832-7000 Option 1 | cap.org 31

Program Information
Cord Blood and Stem Cell Processing CBT, SCP
• CBT - Two 2.5-mL cord
Procedure Program Code Challenges per Shipment blood specimens; designed
CBT SCP for assays required for the
Absolute CD3 z 2 production of umbilical cord
blood stem cell programs
Absolute CD34 z z 2
• SCP - Two 3.0-mL peripheral
Absolute CD45 z 2
blood specimens; designed
Bacterial culture z z 2 for laboratories that process
%CD3+ z 2 and assess the suitability of
stem cells
%CD34+ z z 2
%CD45+ z z 2 • Two shipments per year
BFU-E z z 2

CFU-E z z 2
CFU-GEMM z z 2
CFU-GM z z 2
Total CFC z z 2
Fungal culture z z 2
Hematocrit z z 2
Hemoglobin z z 2
Mononuclear cell count z z 2
Nucleated red cells z z 2
Number of CD34 positive events z z 2
Number of CD45 positive events z z 2
Total nucleated cells z z 2
Viability z z 2
WBC count z z 2
• Because these materials are human donor-based, the ship date is subject to
change. If this should occur, notification will be provided prior to the scheduled
date. In some instances, the program may ship in two installments.
• Due to material stability, no replacements will be available.
• See International Shipping information section in the Ordering Information
Supplement regarding additional dangerous goods shipping fees.
17
800-323-4040 | 847-832-7000 Option 1 | cap.org 227

Program Information
Bacterial Detection in Platelets BDP, BDP5
• BDP - Two lyophilized pellet
Procedure Program Code Challenges per Shipment specimens with diluents; two
BDP BDP5 shipments per year
Bacterial culture and detection • BDP5 - Five lyophilized pellet
z 2
systems specimens with diluents;
Bacterial culture and detection three shipments per year
z 5
systems
• The Centers for Medicare & Medicaid Services (CMS) requires proficiency testing
for bacterial detection/identification. Please select the appropriate program for
your laboratory based on the information below.
• Survey BDP is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and are
participating in an approved proficiency testing program for bacterial detection.
• Survey BDP5 is designed for donor centers/laboratories that are performing
bacterial detection for the purposes of platelet unit screening and are not
associated with a CMS-certified microbiology laboratory with the same CLIA
number.
Program Information
Bacterial Detection in Platelets, Rapid
• BDPV - Two frozen
BDPV, BDPV5 specimens; two shipments
Procedure Challenges per Shipment per year
Program Code • BDPV5 - Five frozen
BDPV BDPV5
per year
CMS certified rapid immunoassay 2 5
• For use with methods such
Additional Information as Verax Biomedical
• The Centers for Medicare & Medicaid Services (CMS) requires proficiency testing
for bacterial detection in platelets.
• Survey BDPV is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and are
participating in an approved proficiency testing program for bacterial detection.
• Survey BDPV5 is designed for donor centers/laboratories that are performing
17 bacterial detection for the purposes of platelet unit screening and are not
associated with a CMS-certified microbiology laboratory with the same CLIA
number.
Third Page Filler

Program Information
Expanded Transfusion
• One paper challenge and one
Medicine Exercises ETME1 wet challenge consisting of
Procedure Program Code Challenges per Shipment a serum specimen(s) and/or
red blood cell suspensions
ETME1
Expanded challenges z 2 • Two shipments per year
Survey ETME1 is an educational opportunity that offers:
• More challenging and/or complex antibody identification
• Comprehensive case studies in transfusion medicine
• Simulated collaboration with other professionals, including those within or outside
your institution
• A method for determining the laboratory’s ability to recognize and integrate

problem solving skills in transfusion medicine
The wet challenge may consist of specimens for ABO grouping, Rh typing, antibody
detection, antibody identification, compatibility testing, antigen typing, direct
antiglobulin testing, antibody titer, and/or antibody elution.
1/3

learning opportunities, publications, and more. 17
on your 2019 order)

800-323-4040 | 847-832-7000 Option 1 | cap.org 229
Viral Markers
Viral Markers
Program Information
Viral Markers—Series 1 VM1
• Five 3.5-mL plasma
VM1 • Three shipments per year
Anti-HAV (total: IgM and IgG) z 5
Anti-HAV (IgG) z 5
Anti-HBc (total: IgM and IgG) z 5
Anti-HBs z 5
Anti-HBs, quantitative z 5
Anti-HCV z 5
Anti-HIV-1 z 5
Anti-HIV-1/2 z 5
Anti-HIV-2 z 5
HBsAg z 5
Do not use Survey VM1 with rapid anti-HCV, anti-HIV-1, or anti-HIV-1/2 kits. See page 231 for
Surveys appropriate for rapid methods.
Program Information
Anti-HBe z 5
HBeAg z 5
Program Information
VM3 • Two shipments per year
Anti-CMV z 3
Anti-HTLV-I/II z 3
17 HIV-1 p24 antigen z 3
Program Information
• Two 1.0-mL plasma
VM4 • Two shipments per year
Anti-Trypanosoma cruzi (Chagas disease) z 2
Viral Markers
Program Information
Anti-HAV (IgM) z 5
Anti-HBc (IgM) z 5
Program Information
Viral Markers—Series 6 VM6, VM6X
• VM6 - Five 0.5-mL plasma
VM6 VM6X • VM6X - All Survey VM6
Anti-HIV-1/2 z z 5 specimens in duplicate

HIV-1 p24 antigen z z 5 • Three shipments per year
Program Information
Anti-HIV 1/2 AHIV, AHIVW
• AHIV - Five 0.5-mL plasma
Analyte/Procedure Program Code Challenges per Shipment specimens; three shipments
AHIV AHIVW per year
Anti-HIV-1, Anti-HIV-2, Anti-HIV-1/2 z 5 • AHIVW - Two 0.5-mL plasma
Anti-HIV-1, Anti-HIV-1/2, specimens; two shipments
z 2 per year
waived methods only
Program Information
Anti-HCV, Rapid Methods, Waived RHCVW
RHCVW • Two shipments per year
Anti-HCV, waived methods only z 3
17
800-323-4040 | 847-832-7000 Option 1 | cap.org 231

Viral Markers
Third Page Filler

Program Information
Nucleic Acid Testing NAT
NAT • Designed for blood donor
HBV z 5 centers performing nucleic
HCV z 5 acid testing on donor units
HIV z 5 • Compatible with HIV, HCV,
and HBV multiplex assays
West Nile virus z 5
Program Information
Vector-Borne Disease—Molecular VBDM

VBDM • Two shipments per year
Zika virus z 3
1/3

changing issues in clinical pathology.
17 The Clinical Pathology Improvement Program
Parentage Testing
Half Page Filler

Parentage Testing
Program Information
Parentage/Relationship Test—Filter Paper PARF
• Three blood-stained filter
Analyte/Procedure Program Code Challenges per Shipment paper paternity trio
PARF specimens; two buccal
Calculation challenge (paper challenge) z 1 swabs for a second alleged-
father challenge
DNA testing (PCR) z 4
• Reporting for short tandem
repeats (STRs), XSTRs,
Y-STRs, as well as the
conclusions provided

1/2
Half Page Filler
Where will your CAP Publications

library take you?
Most CAP Publications titles are available
as ebooks.
Enjoy the flexibility that ebooks provide.

They are available immediately and never
get misplaced. Free up precious shelf
space and take them with you everywhere. 17
View sample pages and order online:

800-323-4040 | 847-832-7000 Option 1 | cap.org 233



18 Histocompatibility
Use the CAP’s Participant Summary

Reports to take your laboratory to the
next level.
• Compare your results and methods against large peer
groups for greater diagnostic confidence.
• Review the extensive discussion to further educate
staff on testing trends and best practices.
• Earn continuing education credit with content that
aligns with the proficiency testing challenge.
New Programs
Antibody Titer—Automated (AABT, AABT1, AABT2, AABT3)................................................................ 238
Histocompatibility
18
Histocompatibility
Histocompatibility
Program Information
HLA Crossmatching, Antibody Screen, and Antibody
• MX1B - Three 0.25-mL
Identification (Class I) MX1B, MX1C, MX1E plasma specimens; two
Procedure Program Code Challenges per Shipment (approximately 1.0 x 106
cells) purified peripheral
MX1B MX1C MX1E
blood lymphocyte specimens
Crossmatching z z 6
• MX1C - Three 0.50-mL
Antibody screen z z z 3 plasma specimens; two
Antibody identification z z z 3 (approximately 4.0 x 106
Blood donor screening is now a reporting option for antibody screening results. This
change covers the use of HLA testing in blood centers/hospital laboratories for the • MX1E - Three 0.25-mL
purpose of donor qualification. plasma specimens; must be
ordered in conjunction with
Survey MX1B or MX1C
Program Information
• MX2B - Three 0.25-mL
Identification (Class II) MX2B, MX2C, MX2E plasma specimens; two
Procedure Program Code Challenges per Shipment (approximately 7.2 x 106
MX2B MX2C MX2E
Crossmatching z z 6
• MX2C - Three 0.50-mL
Antibody screen z z z 3 plasma specimens; two
Antibody identification z z z 3 (approximately 9.6 x 106
Histocompatibility

Blood donor screening is now a reporting option for antibody screening results. This
change covers the use of HLA testing in blood centers/hospital laboratories for the • MX2E - Three 0.25-mL
purpose of donor qualification. plasma specimens; must be
ordered in conjunction with
Survey MX2B or MX2C
18
For laboratories conducting BOTH Class I and Class II HLA testing, see next page.
Histocompatibility
Program Information
• MXB - Class I: three 0.25-mL
Identification (Class I/II) Combinations MXB, MXC plasma specimens, two
Procedure Corresponding Survey Program Code purified peripheral blood
lymphocyte specimens;
MXB MXC
Class II: three 0.25-mL
Crossmatching, antibody screen, and plasma specimens, two
MX1B* z
antibody identification (Class I) purified peripheral blood
Crossmatching, antibody screen, and lymphocyte specimens
MX2B* z
antibody identification (Class II) • MXC - Class I: three 0.50-mL
Crossmatching, antibody screen, and plasma specimens, two
MX1C* z
antibody identification (Class I) purified peripheral blood
Crossmatching, antibody screen, and lymphocyte specimens;
MX2C* z Class II: three 0.50-mL
antibody identification (Class II)
plasma specimens, two
*See page 236 for specimen and analyte information.
purified peripheral blood
lymphocyte specimens
Program Information
Class I & II HLA Molecular Typing DML
• Ten approximately 1.0-mL
Challenges per whole blood specimens in
Shipment
CPD-A
DML
• Serologic equivalents and
Molecular HLA-A, -B, and -C typing (Class I) z 5 MICA reporting available
Molecular HLA-DR, -DQ, and -DP typing • Three shipments per year
z 5
(Class II)
Program Information
HLA-B27 Typing B27
Histocompatibility
Challenges per specimens in CPD-A
Shipment
B27
HLA-B27 typing z 5
18
800-323-4040 | 847-832-7000 Option 1 | cap.org 237

Histocompatibility
Program Information
Antibody Titer ABT, ABT1, ABT2, ABT3
• ABT - One 2.0-mL plasma
Procedure Program Code Challenges per Shipment specimen for anti-A titer
ABT ABT1 ABT2 ABT3 with one corresponding titer
Anti-A titer z z 1 cell (3%–4% red blood cell
suspension); one 2.0-mL
Anti-B titer z 1 plasma specimen for anti-D
Anti-D titer z z 1 titer with one corresponding
titer cell (3%–4% red blood
cell suspension)
• ABT1- One 2.0-mL plasma
suspension)
specimen for anti-D titer
suspension)
suspension)
Program Information
Antibody Titer—Automated AABT, AABT1,
• AABT - One 2.0-mL plasma
AABT2, AABT3 specimen for anti-A titer; one
Procedure Program Code Challenges per Shipment 2.0-mL plasma specimen for
Histocompatibility
anti-D titer
AABT AABT1 AABT2 AABT3
Anti-A titer z z 1 • AABT1 - One 2.0-mL plasma
Anti-B titer z 1
Anti-D titer z z 1 specimen for anti-D titer
18
Histocompatibility
Half Page Filler Program Information

Monitoring Engraftment ME
ME • Designed for laboratories
Stem cell monitoring engraftment z 3 supporting stem cell
transplant and laboratories
monitoring chimerism after
organ transplantation
1/2
Half Page Filler
Histocompatibility
Atlas of Transplant Pathology (PUB124)
This atlas serves as a handy resource for practical
interpretation of solid organ transplant biopsies
and other specimens by general pathologists
as well as subspecialists.
Includes over 600+ photomicrographs and tables.
18

View sample pages and purchase online:
Item number: PUB124
254 pages; 2015
800-323-4040 | 847-832-7000 Option 1 | cap.org 239

Histocompatibility
Program Information
HLA Disease Association-Drug Risk DADR1, DADR2
• Three 0.1-mL specimens,
Analyte Program Code Challenges per Shipment each containing 200 µg/mL
DADR1 DADR2 of human DNA in media
HLA-A*31:01 z 3 • Two shipments per year
HLA-B*13:01 z 3
HLA-B*15:02 z 3
HLA-B*57:01 z 3
HLA-B*58:01 z 3
HLA-A*29:01 z 3
HLA-A*29:02 z 3
HLA-DQA1*04:01 z 3
HLA-DQA1*05:01 z 3
HLA-DQB1*03:02 z 3
HLA-DQB1*06:02 z 3
HLA-DRB1*03:01 z 3
HLA-DRB1*03:02 z 3
HLA-DRB1*04:02 z 3
HLA-DRB1*04:03 z 3
HLA-DRB1*04:06 z 3
HLA-DRB1*08:02 z 3
HLA-DRB1*08:04 z 3
HLA-DRB1*14:04 z 3
HLA-DRB1*14:05 z 3
HLA-DRB1*14:08 z 3
HLA-DRB1*15:01 z 3
HLA-DRB1*15:02 z 3
DQA1*02 z 3
Histocompatibility
DQA1*03 z 3
DQA1*05 z 3
DQB1*02:01 z 3
DQB1*02:02 z 3
These Surveys will challenge the laboratory to accurately identify the presence or
absence of alleles associated with a variety of disease states (listed below) and/or the
18 adverse reactions to specific drugs.
DADR1 DADR2
o Carbamezepine induced Stevens- o Celiac disease (CD)
Johnson syndrome (CSJ) o Narcolepsy (N)
o Allopurinol Stevens-Johnson o Pemphigus vulgaris (PV)
syndrome (ASJ) o Psoriasis (P)
o Hypersensitivity to abacavir (HA) o Antiglomerular basement
o Dapsone hypersensitivity (DH) membrane disease (ABM)
o Birdshot retinochoroidopathy (BR)
o Idiopathic myopathy (IM)
19 Genetics and Molecular Pathology
The CAP broadens its network of
laboratory experts through its
collaborations.
Among the organizations with which we partner:
• American Association for Clinical Chemistry (AACC)
• American College of Medical Genetics and Genomics
(ACMG)
• Association for Molecular Pathology (AMP)
• National Society for Histotechnology (NSH)

Cytogenetics ...................................................................................................................................... 242
Biochemical and Molecular Genetics ................................................................................................. 245
Next-Generation Sequencing ............................................................................................................. 254
Molecular Oncology—Solid Tumors ................................................................................................... 258
Molecular Oncology—Hematologic.................................................................................................... 262
Program Changes
Next-Generation Sequencing—Germline (NGS) New dry challenge ................................................... 254
19
Cytogenetics
Cytogenetics
Program Information
CAP/ACMG Cytogenetics CY, CYBK
• CY - Online images of
Analyte/Procedure Program Code Challenges per Shipment metaphase cells; delivered
CY CYBK two times a year; your CAP
shipping contact will be
Chromosome abnormality z z 6
notified via email when the
Karyotype nomenclature z z 6 activity is available
Educational challenge, ungraded z z 1 per year • CYBK - Prints of metaphase
Additional Information cells; two shipments per year
Each challenge includes a case history and images of metaphase cells that are
representative of each case. Each mailing will include three constitutional and three
neoplastic challenges.
Program Information
CAP/ACMG Fluorescence In Situ Hybridization
• CYF - Four slides and
CYF, CYI four paper/photograph
Disease/Procedure Program Code Challenges per Shipment challenges
CYF CYI A B • CYI - Two 250-µL cell
Constitutional and Hematologic samples suspended in
Disorders ethanol from two different
specimens; participants use
FISH for constitutional disorder - slides z 1 1 FISH to detect chromosome
FISH for constitutional disorder - paper/ abnormalities
z 2 2
photograph challenge • Two shipments per year
FISH for hematologic disorder - slides z 1 1

FISH for hematologic disorder - paper/
z 2 2
photograph challenge
Urothelial Carcinoma
FISH for urothelial carcinoma z 2 2
• CYF 2020-A:
Constitutional disorder - Prenatal aneuploidy probes (interphase cells) (two slides)
Constitutional disorder - (two paper/photograph challenges)
Hematologic disorder - MLL gene rearrangement (two slides)
Hematologic disorder - (two paper/photograph challenges)
• CYF 2020-B:
Constitutional disorder - SHOX (two slides)
Constitutional disorder - (two paper/photograph challenges)
19 Hematologic disorder - BCR/ABL1 gene rearrangement (two slides)
Hematologic disorder - (two paper/photograph challenges)
• CYF is prepared from cell suspension samples. For FISH in paraffin-embedded
tissues, see page 243.
• These programs are only for laboratories that perform both hybridization and
interpretation under the same CLIA number.
Cytogenetics
Third Page Filler
Program Information
CAP/ACMG Fluorescence In Situ Hybridization
• CYH - Two unstained, five-
for Paraffin-Embedded Tissue CYH, CYJ, CYK, CYL core tissue microarray slides
Challenges per equivalent to 10 paraffin-
Shipment embedded breast tissue
CYH CYJ CYK CYL A B specimens; two H&E stained
tissue microarray slides will
Breast Cancer
also be provided
HER2 gene amplification z 10 10
• CYJ - Four unstained slides;
Brain/Glioma Tissue one H&E stained slide
1p/19q z 1 1 • CYK, CYL - Two unstained
Solid Tumor slides; one H&E stained slide
SS18 gene rearrangement z 1 • All CYJ, CYK, CYL specimens
EWSR1 gene rearrangement z 1 will be 4.0-micron tissue
sections mounted on
Lymphoma Tissue
positively charged glass
MALT1 gene rearrangement z 1 slides
MYC gene rearrangement z 1
• These programs are only for laboratories that perform both hybridization and
interpretation under the same CLIA number.
• For HER2 FISH, interpretation only, for breast cancer, see page 282. 1/3
Third Page Genetics

Fillers and Molecular Pathology
Bone Marrow Benchtop Reference Guide is an illustrated guide to common
and rare cells. With more than 60 different identifications and a detailed
description for each cell morphology, it’s an affordable, convenient way
to identify various cell types quickly and confidently. Its rugged construction
is well suited for heavy use at the workbench.
Or, view sample pages and purchase online: 19
Item number: BMBRG

Spiral bound; 2018
800-323-4040 | 847-832-7000 Option 1 | cap.org 243
800-323-4040 | 847-832-7000 Option 1 | cap.org 19
Cytogenetics
Third Page Filler
Program Information
CAP/ACMG Constitutional Microarray CYCGH
• Two 3.0-µg DNA specimens;
Procedure Program Code Challenges per Shipment one dry challenge
CYCGH • Two shipments per year
Cytogenomic microarray analysis
z 2
for constitutional abnormality
Educational dry challenge for
z 1
constitutional abnormality
Participants will identify and characterize gains or losses and the cytogenetic location
of abnormalities detected.
This Survey is not appropriate for low resolution arrays that are designed to detect only
aneuploidy.
Program Information
CAP/ACMG Oncology Microarray CYCMA
• One 2.0-ug DNA specimen;
Procedure Program Code Challenges per Shipment one dry challenge
CYCMA • Two shipments per year
Cytogenomic microarray analysis
z 1
for oncologic abnormality
1/3
Educational dry challenge for
z 1
oncologic abnormality
Third Page Fillers

Participants will identify and characterize gains or losses and the cytogenetic location
of abnormalities detected.
World-class recognition deserves to be displayed.
19 the CAP accreditation certification mark.
800-323-4040 | 847-832-7000 Option 1 | cap.org 9
Biochemical and Molecular Genetics

Program Information
CAP/ACMG Biochemical Genetics BGL, BGL1
• BGL -
Analyte/Procedure Program Code Challenges per Shipment Acylcarnitines: One 0.1-mL
BGL BGL1 plasma specimen
Acylcarnitines, qualitative and Amino acids: One 1.0-mL
z 1
quantitative plasma or 2.0-mL urine
Amino acids, qualitative and specimen
z 1
quantitative Glycosaminoglycans
Carnitine, qualitative and quantitative z 3 (mucopolysaccharides):
One 2.0-mL urine specimen
Glycosaminoglycans
(mucopolysaccharides), qualitative z 1 Organic acids: One 7.5-mL
and quantitative urine specimen
Organic acids, qualitative and Educational challenge: Will
z 1
quantitative consist of any one of the
Educational challenge z 1 BGL analytes
• BGL1 - Three 0.3-mL serum
specimens
Program Information
CAP/ACMG Alpha-1 Antitrypsin Genotyping AAT

• Three 10.0-µg extracted
Analyte/Procedure Program Code Challenges per Shipment DNA specimens
AAT • Two shipments per year
Alpha-1 antitrypsin (SERPINA1)
z 3
genotyping
This Survey will test for the M, S, and Z alleles.
Program Information
CAP/ACMG Apolipoprotein E
Genotyping APOE DNA specimens
Analyte/Procedure Program Code Challenges per Shipment • Two shipments per year
APOE
Apolipoprotein E (APOE) genotyping z 3 19
This Survey is designed for laboratories utilizing APOE testing for hyperlipoproteinemia
type III and Alzheimer diseases and will test for APOE e2, APOE e3, and APOE e4.
800-323-4040 | 847-832-7000 Option 1 | cap.org 245

Third Page Filler
Program Information
CAP/ACMG BRCA1/2 Sequencing BRCA
Analyte/Procedure Program Code Challenges per Shipment DNA specimens
BRCA • Results for this program
BRCA1/2 DNA sequencing and variant must be submitted online
z 3
interpretation through e-LAB Solutions
BRCA1/2 duplication/deletion Suite
z 3
analysis • Two shipments per year
• Test your skill at reporting and interpreting DNA sequence variants for BRCA1/2
using standard nomenclature.
• Receive a summary and discussion of responses, including comments on the
variant nomenclature and known or expected outcomes from identified variants.
• Primers are not included; laboratories are expected to utilize the primers used in
routine clinical testing.
Program Information
CAP/ACMG Cardiomyopathy
• Three 80.0-µL purified
Sequencing Panel CMSP extracted DNA specimens
(50 ng/µL)
CMSP
Challenges per Shipment
• Results for this program
1/3
Cardiomyopathy sequencing panel z 3 must be submitted online
Third Page Fillers

through e-LAB Solutions
Additional Information Suite
• This proficiency challenge is for laboratories performing gene panels, exome • Two shipments per year
sequencing, and whole genome sequencing to detect germline variants associated
with inherited forms of cardiomyopathy.
• Participants will be asked to identify variants in the following genes: MYBPC3,

MYH7, TNNI3, TNNT2, and TPM1.

in real time.
19 your laboratory’s information.
800-323-4040 | 847-832-7000 Option 1 | cap.org 1
Third Page Filler

Program Information
CAP/ACMG Hemoglobinopathies
Genotyping HGM DNA specimens
Analyte/Procedure Program Code Challenges per Shipment • Two shipments per year
HGM
Alpha-thalassemia z 3
Beta-thalassemia z 3
Hemoglobin S/C z 3
Program Information
CAP/ACMG Inherited Cancer
• Three 80.0-µL purified
Sequencing Panel ICSP extracted DNA specimens
Analyte/Procedure Program Code Challenges per Shipment (50 ng/µL)
ICSP • Results for this program
Inherited cancer sequencing panel z 3 must be submitted online
Additional Information Suite
• This proficiency challenge is for laboratories performing gene panels, exome • Two shipments per year
sequencing, and whole genome sequencing to detect germline variants
associated with inherited forms of cancer.
1/3 • Participants will be asked to identify variants in the following genes: BRCA1,
BRCA2, CDKN2A, MLH1, MSH2, MSH6, and PMS2.
Third Page Fillers

Atlas of Fundamental Infectious Diseases
Histopathology (PUB127)
This resource book is rich in detailed information and real-world examples
to help anatomic pathologists identify infectious organisms in tissue, study
patterns of inflammation for clues, understand which stains are best for
detecting specific micro-organisms, spot infectious disease mimics, and
select ancillary methods of detection.
19
• ebooks at ebooks.cap.org Softcover; 304 pages; 800+
images and tables; 2018
800-323-4040 | 847-832-7000 Option 1 | cap.org 247

Program Information
CAP/ACMG Molecular Genetics Series
• MGL1, MGL2, MGL3,
MGL1, MGL2, MGL3, MGL4, MGL5 MGL4 - Three 50.0-µg
Program Code Challenges per
extracted DNA specimens
Disease/Gene per disease/gene
MGL1 MGL2 MGL3 MGL4 MGL5 Shipment
Bloom syndrome (BLM gene) z 3 • MGL5 - Two 50.0-µg

BRCA1/2 z 3
Canavan (ASPA gene) z 3
Connexin 26 (GJB2 gene) z 3
Cystic fibrosis (CFTR gene) z z 3/2(MGL5)
DMD/Becker (DMD gene) z 3
Factor V Leiden (F5 gene) z 3
Familial dysautonomia (IKBKAP gene) z 3
Fanconi anemia complementation
z 3
group C (FANCC gene)
Fragile X (FMR1 gene) z 3
Friedreich ataxia (FXN gene) z 3
Gaucher (GBA gene) z 3
Glycogen storage disease type IA
z 3
(G6PC gene)
Hemochromatosis (HFE gene) z 3
Hemoglobin S/C z 3
Huntington (HTT gene) z 3
Methylene tetrahydrofolate reductase
(MTHFR gene) c.665C>T (677C>T) and z 3
c.1286A>C (1298A>C)
Mucolipidosis IV (MCOLN1 gene) z 3

Multiple endocrine neoplasia
z 3
type 2 (RET gene)
Myotonic dystrophy (DMPK gene) z 3
Niemann-Pick type A/B (SMPD1 gene) z 3
Plasminogen activator inhibitor (PAI)-1
z 3
(SERPINE1 gene)
• The BRCA1/2 program (module MGL3) is designed for laboratories testing for the
three Ashkenazi Jewish founder mutations.
• The cystic fibrosis programs (modules MGL2 and MGL5) are designed for
laboratories that are testing for the minimum mutation panel for population-based
19 carrier screening (ie, the ACMG-23 mutation panel) from the ACMG Technical
Standards and Guidelines for CFTR Mutation Testing, expanded panels, PolyT
variant analysis, and/or full gene sequencing.
• Module MGL4 is designed for laboratories testing for diseases/disorders related to
Ashkenazi Jewish ancestry.
• The Prader-Willi/Angelman syndrome program is designed for laboratories using
methylation techniques for analysis.
Program Information
CAP/ACMG Molecular Genetics Series
• MGL1, MGL2, MGL3,
MGL1, MGL2, MGL3, MGL4, MGL5 continued MGL4 - Three 50.0-µg
Program Code Challenges per
Disease/Gene per disease/gene
MGL1 MGL2 MGL3 MGL4 MGL5 Shipment
Prader-Willi/Angelman syndrome z 3 • MGL5 - Two 50.0-µg

Prothrombin (F2 gene) z 3
RhD z 3
Spinal muscular atrophy (SMN1 and
z 3
SMN2 genes)
Spinocerebellar ataxia (ATXN1, ATXN2,
z 3
ATXN3, CACNA1A, and ATXN7 genes)
Tay-Sachs (HEXA gene) z 3
• The BRCA1/2 program (module MGL3) is designed for laboratories testing for the
three Ashkenazi Jewish founder mutations.
• The cystic fibrosis programs (modules MGL2 and MGL5) are designed for
laboratories that are testing for the minimum mutation panel for population-based
carrier screening (ie, the ACMG-23 mutation panel) from the ACMG Technical
Standards and Guidelines for CFTR Mutation Testing, expanded panels, PolyT
variant analysis, and/or full gene sequencing.
• Module MGL4 is designed for laboratories testing for diseases/disorders related to
Ashkenazi Jewish ancestry.
• The Prader-Willi/Angelman syndrome program is designed for laboratories using
methylation techniques for analysis.

Program Information
CAP/ACMG Inherited Metabolic
• IMD1 - Three 50.0-µL
Diseases IMD1, IMD2, IMD3 DNA specimens (50.0 ng/
Analyte/Procedure Program Code Challenges per Shipment µL DNA PCR product that
encompasses the entire
IMD1 IMD2 IMD3
mitochondrial genome)
Mitochondrial DNA deletion syndromes z 3
• IMD2, IMD3 - Three 50.0-µg
MCAD z 3 extracted DNA specimens
Mitochondrial cytopathies* z 3 • Two shipments per year
*Includes disorders/diseases such as Leber hereditary optic neuropathy and myoclonus epilepsy
with ragged red fibers (MERRF).
19
800-323-4040 | 847-832-7000 Option 1 | cap.org 249

Third Page Filler
CAP/ACMG Molecular Genetics Sequencing Program Information

• SEC - DNA sequence
SEC, SEC1 electropherogram files with
Procedure Program Code Challenges per Shipment a range of variants, suitable
for base-calling and analysis
SEC SEC1
using a range of commercial
DNA sequencing interpretation challenge z 3 or public domain software
DNA sequencing z 3 programs; also includes
nomenclature/variant
references. Two online
• Test your skill at interpreting and reporting DNA sequence variants for inherited acitivities per year; your CAP
diseases using standard nomenclature. shipping contact will be
• Receive a summary and discussion of responses, including comments on notified via email when the
nomenclature, known or expected outcomes from identified variants, and teaching activity is available
points about genes/disorders represented.
• SEC1 - Three 30.0-µg
extracted DNA specimens;
forward and reverse
lyophilized primers are
provided. Two shipments
per year
• Results for both programs
must be submitted online
1/3 through e-LAB Solutions
Suite
Third Page Fillers
Give the CAP’s complimentary Sample Exchange Registry service a try!

Sign up for this unique and complimentary service for those rare analytes for which proficiency
testing is not yet available. This service now includes all clinical laboratory disciplines.
• The CAP connects labs performing testing for which no formal proficiency testing is available.
• There is no charge for this service.
• Participate at any time, no contract required.
19 • A minimum of three labs performing the same analyte test must participate before the CAP can
facilitate the sample exchange.
• Each individual laboratory will receive its own results along with an anonymized summary report
for all participants.
Register today! Visit cap.org and from the Laboratory Improvement tab,
choose Proficiency Testing > Sample Exchange Registry.

Program Information
Pharmacogenetics PGX, PGX1, PGX2, PGX3
• Three 25.0-µg extracted DNA
Shipment
• Includes allele detection
PGX PGX1 PGX2 PGX3
(genotyping) and/or
CYP2C19 z 3 interpretive challenges
CYP2C9 z 3 • Two shipments per year
CYP2D6 z 3
CYP3A4 z 3
CYP3A5 z 3
SLCO1B1 (rs4149056) z 3
VKORC1 z 3
IL28B (rs12979860) z 3
HLA-B*15:02 z 3
HLA-B*57:01 z 3
DPYD z 3
TPMT z 3
UGT1A1 z 3
• UGT1A1 (PGX3 Survey) tests the laboratory’s ability to detect variants in the TATA
repeat sequence in the UGT1A1 promotor (eg, UGT1A1*28 with seven TA repeats).
The ability to detect variants in other regions of the UGT1A1 gene is not part of this
program.
• Survey PGX2 is designed for laboratories that provide HLA-B*57:01 testing to
identify risk of hypersensitivity to abacavir and HLA-B*15:02 testing to identify
risk of hypersensitivity to carbamazepine. The intended response is qualitative

(presence/absence of the allele). This Survey is not appropriate for laboratories that
perform molecular HLA typing. For HLA typing proficiency testing, please consult
the HLA Molecular Typing (DML) Survey.
Program Information
CAP/ACMG Rett Syndrome (MECP2) RETT
• Three 10.0-µg extracted DNA
RETT • Two shipments per year
Rett (MECP2) genotyping z 3
Rett (MECP2) duplication/deletion
z 3
analysis
19
800-323-4040 | 847-832-7000 Option 1 | cap.org 251

Program Information
CAP/ACMG Thrombophilia Mutations TPM
• Three 250.0-µL synthetic
Analyte/Procedure Program Code Challenges per Shipment whole blood specimens
TPM • Two shipments per year
Factor II (F2 gene, Prothrombin) z 3
Factor V Leiden (F5 gene) z 3
This Survey is designed for the Cepheid GeneXpert factor II and factor V assays. DNA
extraction for other assays/methods is NOT recommended.
Program Information
Red Blood Cell Antigen Genotyping RAG
RAG • Two shipments per year
Red blood cell antigen genotype
z 3
with predictive phenotype
Program Information
Variant Interpretation Only Program VIP/VIP1
• VIP - Three germline
Analyte/Procedure Program Code Challenges per Shipment diagnostic challenges;
VIP/VIP1 reporting with CME/CE credit
Variant interpretation online case is available for one
z 3 pathologist, MD, PhD,
review
technologist, or genetic
Additional Information counselor
VIP is an educational activity for pathologists, PhDs, genetic counselors, technologists,
• VIP1 - Reporting option with

and any other laboratory staff with an interest in germline variant interpretation to CME/CE credit for each
assess and improve their diagnostic skills. All cases will comply with the 2015 ACMG additional pathologist, MD,
standards and guidelines for the interpretation of sequence variants and will include: PhD, technologist, or genetic
• A clinical history with relevant laboratory data counselor (within the same
• Results of ancillary studies, where appropriate institution); must order in
conjunction with Survey VIP
• Case discussion and discussion of interpretive criteria
• A variety of germline variants, diseases, and disorders • Earn a maximum of 3 CME
credits (AMA PRA Category
1 Credits™) per pathologist/
MD/PhD and a maximum of 3
CE credits per technologist/
genetic counselor for
completion of an entire year
• One online educational
activity per year; your CAP
19 shipping contact will be
notified via email when the
activity is available
Half Page Filler Biochemical and Molecular Genetics
Program Information
Noninvasive Prenatal Testing NIPT
• Three maternal plasma
Analyte Program Code Challenges per Shipment samples
NIPT • Two shipments per year
Cell-free DNA screening for fetal
z 3
aneuploidy
Noninvasive prenatal testing is an exercise and is not considered proficiency testing. This exercise
may be used to meet the requirements for alternative assessment
1/2
Half Page Filler

• More than 50 different cell identifications, including
• Six tabbed sections for easy reference
o Erythrocytes
o Erythrocyte Inclusions
o Granulocytic (Myeloid) and Monocytic Cells
o Lymphocytic Cells
o Platelets and Megakaryocytic Cells
o Microorganisms and Artifacts
19
Item number: HBRG
• ebooks at ebooks.cap.org 50+ images; 2012
22 College of American Pathologists 800-323-4040 | 847-832-7000 Option 1

2020 Surveys Pickup | cap.org
Filler Pages 253
F22 Half
Next-Generation Sequencing
All laboratories subject to US Clinical Laboratory Improvement Amendments (CLIA) Regulations: Proficiency testing (PT) challenges
must NOT be referred to another laboratory for any portion of NGS testing, even if this is how patient testing is routinely performed.
For PT challenges, any referral is strictly prohibited by CMS.
Program Information
Next-Generation Sequencing—Germline NGS
• One 10.0-µg extracted gDNA
Procedure Program Code Challenges per Shipment specimen; one educational
NGS variant interpretation paper
Next-generation sequencing z 1 challenge
• Methods-based challenge
for germline variants for
Laboratories will have the ability to analyze up to 200 preselected chromosomal laboratories using gene
positions within various genes; for a full list of genes in this program, please go to panels, exome, and whole
cap.org. Under the Laboratory Improvement tab, click on Catalog and Ordering genome sequencing
Information. The list is located under the PT Order Supplements header.
• Results for this program
must be submitted online
Suite
Program Information
Next-Generation Sequencing—Solid Tumor NGSST
• Three 1.0-µg gDNA (50 ng/µL)
NGSST • Two shipments per year
Next-generation sequencing 3
• This is a methods-based proficiency challenge for laboratories performing targeted
next-generation sequencing of cancer genes or mutation hotspots in solid tumors.
Laboratories will be asked to identify somatic single nucleotide variants and small
insertions or deletions in some of these genes: AKT1, ALK, APC, ATM, BRAF, CDH1,
CTNNB1, EGFR, ERBB2, FBXW7, FGFR2, GNAQ, GNAS, HRAS, IDH1, KIT, KRAS, MET,
NRAS, PDGFRA, PIK3CA, PTEN, SMAD4, SMARCB1, SMO, SRC, STK11, TP53.
• This Survey includes variants present with a variant allele fraction (VAF)
potentially as low as 5%.
19
Program Information
Next-Generation Sequencing—Hematologic
• Three 1.0-µg gDNA (50 ng/µL)
Malignancies NGSHM specimens
Procedure Program Code Challenges per Shipment • Two shipments per year
NGSHM
Next-generation sequencing z 3
• This is a methods-based proficiency challenge for laboratories performing
targeted next-generation sequencing of genes or mutation hotspots in hematologic
malignancies. Laboratories will be asked to identify somatic single nucleotide
variants and small insertions or deletions in some of these genes: ASXL1, ATM,
BRAF, CALR, CEBPA, CREBBP, CSF3R, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KIT,
KMT2D, MPL, MYD88, NOTCH1, NPM1, SF3B1, SRSF2, TET2, TP53, U2AF1.
Program Information
Next-Generation Sequencing Bioinformatics
• Sequencing files containing
NGSB1, NGSB2 somatic variants to be
Procedure Program Code Challenges per Shipment downloaded into your
laboratory bioinformatics
NGSB1 NGSB2
pipeline for analysis and
Illumina TruSeq Amplicon Cancer Panel z 1 reporting; file sizes range
Ion Torrent AmpliSeq Cancer Hotspot v2 z 1 from 100MB to 1GB
Additional Information • NGSB1 - FASTQ file format

for the Illumina TruSeq
• This in silico bioinformatics program is designed to complement and augment
Amplicon Cancer Panel
somatic variant wet bench NGS proficiency testing programs by testing a greater

diversity of variants at a greater range of variant allele fractions. • NGSB2 - BAM and FASTQ file
• The BAM and/or FASTQ files are platform-specific and may not be compatible formats for the Ion Torrent
with other instruments/software. AmpliSeq Cancer Hotspot v2
Panel
• Laboratories will be asked to identify somatic single nucelotide variants and
small insertions/deletions/indels in some of these genes: ABL1, AKT1, ALK, APC, • Two online activities per
ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, FBXW7, FGFR1, year; your CAP shipping
FGFR2, FGFR3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, JAK3, KDR, KIT, KRAS, contact will be notified via
MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, email when the activity is
RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, VHL. available
19
800-323-4040 | 847-832-7000 Option 1 | cap.org 255

Program Information
Next-Generation Sequencing Undiagnosed
• One exome sequencing
Disorders—Exome NGSE data file, originating from
Analyte/Procedure Program Code Challenges per Shipment your laboratory and provided
to the CAP, for in silico
NGSE
mutagenesis. The
Exome analysis for germline mutagenized exome
z 1
undiagnosed disorders sequencing data file is to be
Additional Information/Minimum Requirements downloaded and analyzed by
your bioinformatics pipeline
• This in silico based Survey will assess the ability of the laboratory to identify
germline variants responsible for a provided clinic phenotype as is encountered in • The mutagenized exome
an undiagnosed disease scenario. In addition to analyzing the in silico mutagenized sequencing file will be
file to identify a genetic diagnosis for the provided clinical scenario, pathogenic or accompanied by a clinical
likely pathogenic ACMG secondary findings may also be reported. history, relevant laboratory
• Laboratories must provide an exome sequencing data file that has been generated data, and results of ancillary
using one of the following sources: a specimen from the NGS Survey program (see studies, where appropriate
page 254) or from one of the NIST Reference Material cell lines: RM 8398 (NA12878), • Two online activities per year;
RM 8391, RM 8392, or RM 8393. Specimens from the NGSST and NGSHM Surveys your CAP shipping contact
cannot be used for this program. will be notified via email
• FASTQs or unaligned BAMs must be submitted along with a BED file describing the when the activity is available
regions targeted and interrogated by your laboratory. Additionally, >90% of exons
targeted and interrogated by your laboratory must have a minimum read coverage
of 10X.
• Laboratories can transfer and download files from most modern browsers/
operating systems. For the most up-to-date information on system requirements,
go to cap.org and click System Requirements, located at the bottom of the home
page.
• Due to the extremely large file sizes, a minimum allowable transfer speed of 40 Mbps
or higher is needed to ensure successful transfer of your laboratory’s sequencing
files to the CAP. Contact your IT department for allowable transfer speeds to
determine estimated transfer time and browser/operating system access.

• Laboratories must comply with all of the above requirements to participate in this
program. Additional information and steps to provide your laboratory’s exome file
will be included in the kit materials.
19
Program Information
Next-Generation Sequencing Bioinformatics
• One panel or exome
Somatic Validated Materials NGSBV sequencing data file,
Analyte/Procedure Program Code Challenges per Shipment originating from your
laboratory and provided to
NGSBV
the CAP, for in silico
Somatic in silico mutagenized mutagenesis
z 1
sequencing file
• The mutagenized panel or
Additional Information/Minimum Requirements exome sequencing data file
• This in silico program is designed to optimize bioinformatics pipelines, augment is to be downloaded and
validations, and assist with pipeline verification after changes to NGS/ analyzed by your laboratory
bioinformatics processes. This is not traditional proficiency testing and no results bioinformatics pipeline and
will be returned to the CAP; information regarding the variants introduced will be compared with the variant
sent along with the mutagenized file. information provided by CAP
• Laboratories must provide a gene panel or exome sequencing data file that has • Two online activities per year;
been generated using one of the following sources: a specimen from the NGS your CAP shipping contact
Survey program (see page 254) or from one of the following NIST Reference Material will be notified via email
cell lines: RM 8398 (NA12878), RM 8391, RM 8392, or RM 8393. Specimens from the when the activity is available
NGSST and NGSHM Surveys cannot be used for this program.
• FASTQs or unaligned BAMs must be submitted along with a BED file describing the
regions targeted and interrogated by your laboratory.
• The mutagenized sequencing file will contain up to 75 somatic variants (depending
on the size of the panel/exome provided) at allele fractions from 3% to 99% (higher
allele fractions to mimic loss of heterozygosity or homozygosity) and will include:
o Single nucleotide variants
o Insertions, deletions, delins, and/or duplications ranging from 1-100bp (1-15bp,
15-50bp, 51-100bp)
o Copy number variants of single exons, partial or whole genes, and/or partial or
whole chromosomes

o DNA fusions (if a laboratory indicates that they detect such structural
rearrangements, if the rearrangements are specified and submitted in the BED
file, and there is appropriate intronic coverage)
o Microsatellite instability at mono nucleotide tracts included in the submitted
capture design
o Simulated artifactual sequence
All variants will be modeled based on actual somatic mutations from the COSMIC
and/or cBIOPORTAL databases.
• Laboratories can transfer and download files from most modern browsers/
operating systems. For the most up-to-date information on system requirements,
go to cap.org and click System Requirements, located at the bottom of the home
page.
• Due to the extremely large file sizes, a minimum allowable transfer speed of 40 Mbps
or higher is needed to ensure successful transfer of your laboratory’s sequencing
files to the CAP. Contact your IT department for allowable transfer speeds to
determine estimated transfer time and browser/operating system access. 19
• Laboratories must comply with all of the above requirements to participate in this
program. Additional information and steps to provide your laboratory’s sequencing
file will be included in the kit materials.
800-323-4040 | 847-832-7000 Option 1 | cap.org 257

Molecular Oncology—Solid Tumors

Program Information
Microsatellite Instability (HNPCC) MSI
• Two 10.0-micron unstained
Procedure Program Code Challenges per Shipment paraffin section slides
MSI and one H&E slide; two
Microsatellite instability testing photograph challenges
z 3
(DNA amplification) • For laboratories performing
MLH1 promoter methylation analysis z 1 molecular testing using PCR
Laboratories performing DNA mismatch repair assessment by immunohistochemistry methods • Two shipments per year
should see Survey MMR on page 278.
Program Information
IGHV Mutation Analysis IGHV
• Three 20-µg DNA specimens
Analyte/Procedure Program Code Challenges per Shipment (200 ng/µL)
IGHV • Two shipments per year
IGHV z 3
• Sequence analysis of the clonal immunoglobulin heavy chain V gene (IGHV) to
determine somatic hypermutation (SHM) status.
• Any sequencing method may be used.
• Report V-gene allele, percent similarity and mutation status (SHM).
Program Information
In Situ Hybridization ISH, ISH2
• ISH -
Analyte/Procedure Program Code Challenges per Shipment
EBV, HPV: Three 4-core
ISH ISH2 tissue microarray slides
Epstein-Barr virus (EBV) z 4 and one H&E slide (each)
Human papillomavirus (HPV) z 4 Kappa/Lambda: Four
Kappa/Lambda (IGK/IGL) z 4 4-core tissue microarray
slides and one H&E slide
HER2 (ERBB2) gene amplification
z 10 • ISH2 - Two 5-core tissue
(brightfield)
microarray slides in
Laboratories performing FISH for interphase chromosomal targets in paraffin sections refer to the
Cytogenetics Surveys, page 243.
duplicate
Survey ISH2 is only for laboratories that perform both hybridization and interpretation
under the same CLIA number.
19
Program Information
DNA Extraction & Amplification FFPE MHO5
• Three 10.0-micron paraffin
Procedure Program Code Challenges per Shipment sections
MHO5 • Two shipments per year
DNA purification z 1
Methods-based proficiency challenge to examine DNA purification from formalin-fixed,
paraffin-embedded tissues (FFPET). Laboratories will be able to purify DNA from FFPET
sections and amplify control targets using laboratory-provided reagents.
Program Information
Neoplastic Cellularity NEO
• Ten Regions of Interests
Procedure Program Code Challenges per Shipment (ROIs) using online, whole
NEO slide images
Online assessment of percent • A method-based preanalytic
z 10
neoplastic cellularity Survey to assess competency
for determining percent
neoplastic cellularity
technology
• Individual reporting fields for
up to five pathologists are
available

Program Information
Sarcoma Translocation SARC
• Three snap-frozen cell
Gene Program Code Challenges per Shipment pellets from which
SARC approximately 5.0-µg of RNA
Sarcoma translocation* (RT-PCR) z 3 can be extracted
*See translocation listing below. • Two shipments per year

Laboratories performing FISH for sarcoma translocation refer to the Cytogenetics Surveys,
page 243.
Sarcoma Translocation Listing

COL1A1/PDGFB, t(17;22) EWSR1/FLI1 or EWSR1/ERG PAX3/FOXO1 or PAX7/FOXO1
19
ETV6/NTRK3, t(12;15) EWSR1/WT1, t(11;22) SS18/SSX1, t(X;18)
EWSR1/ATF1, t(12;22) FUS/DDIT3, t(12;16) SS18/SSX2, t(X;18)
EWSR1/ERG, t(21;22) PAX3/FOXO1, t(2;13) SS18/SSX1 or SS18/SSX2
EWSR1/FLI1, t(11;22) PAX7/FOXO1, t(1;13)
800-323-4040 | 847-832-7000 Option 1 | cap.org 259

Program Information
Cell-free Tumor DNA CFDNA
• Three 125-ng DNA (25 ng/mL)
CFDNA • Two shipments per year
cfDNA z 3
• DNA fragments stabilized in simulated plasma.
• This is not intended for laboratories that perform circulating tumor cell (CTC)
analysis.
• Potential targets included in this Survey are BRAF V600E, EGFR T790M, IDH1
R132C, KRAS G12C, KRAS G12D, and NRAS Q61R, all within a range of 0.1 to 1.0%.
Program Information
Fusion RNA Sequencing RNA
• Three 500-ng RNA (20 ng/µL)
RNA • Two shipments per year
RNA z 3
• Total RNA from a cell line engineered to contain desired fusion RNA.
• This is for laboratories using RNAseq to detect gene fusion transcripts.
• This is not intended to replace the current Survey (SARC) for reverse transcription
(RT)-PCR based detection (see page 259).
• Potential fusion variants include: CD74-ROS1, EML4-ALK, ETV6-NTRK3, FGFR3-
TACC3, PAX8-PPARG, SLC45A3-BRAF.
• Specific intragenic fusion/exon skipping variants may also be included, specifically
EGFRvIII and MET exon 14 skipping.
Program Information
Solid Tumor—Other BRAF, EGFR, KRAS, KIT
• BRAF, EGFR, KRAS -
Analyte Program Code Challenges per Shipment Paraffin-embedded
BRAF EGFR KRAS KIT sections or shavings
BRAF z 3 • KIT/PDGFRA -
EGFR z 3 One specimen containing
four 10.0-micron unstained
KRAS z 3
paraffin section slides and
KIT z 3 one H&E slide
PDGFRA z 3 Two 1.0-µg gDNA
(50 ng/µL) specimens
19 molecular testing using PCR
Program Information
Multigene Tumor Panel MTP
• Three 2.0-µg gDNA
Analyte Program Code Challenges per Shipment (50 ng/µL) specimens for
MTP laboratories performing
BRAF z 3 molecular testing on multiple
targets
EGFR z 3
HER2 (ERBB2) z 3
KIT z 3
KRAS z 3
NRAS z 3
PDGFRA z 3
PIK3CA z 3
BRAF, EGFR, and KRAS are required analytes. Laboratories that perform testing for the
detection of somatic single nucleotide variants, insertions, and deletions in these genes
are required to enroll in either MTP or the respective single gene Surveys. This includes
laboratories that perform NGS-based assays, non-NGS-based multiplexed assays, and
nonmultiplexed assays (eg, Sanger sequencing). Laboratories that perform NGS-based
testing are encouraged to also enroll in NGSST (on page 254), as this proficiency testing
program provides challenges with lower variant allele fractions as well as challenges in
other genes commonly included in NGS-based panels for the identification of somatic
variants in solid tumors.
Program Information
Glioma GLI
• Four 2.0-µg gDNA (50 ng/µL)

GLI • One specimen containing
MGMT z 3 four 10.0-micron unstained
IDH1, IDH2 z 3 paraffin section slides and
one H&E slide
10q (PTEN) deletion z 1
molecular testing using PCR
19
800-323-4040 | 847-832-7000 Option 1 | cap.org 261

Molecular Oncology—Hematologic
Molecular Oncology—Hematologic
Program Information
Molecular Hematologic Oncology
• MHO - One sample vial
MHO, MHO1, MHO2, MHO3, MHO5 containing purified DNA
Challenges per (200 μg/mL per vial) for each
Procedure/Gene Program Code
Shipment specimen
MHO, MHO1 MHO2, MHO3 MHO5 • MHO1 - MHO specimens in
Lymphoid malignancy genotyping duplicate for additional DNA
testing
IGH z 3
• MHO2 - Two sample vials;
IGH/BCL2 major z 3
one with purified DNA
IGH/BCL2 minor z 3 containing 200 μg/mL and
IGH/CCND1 z 3 one with purified RNA
IGK z 3 containing 400 μg/mL
TRB z 3 • MHO3 - MHO2 specimen in

duplicate for additional DNA
TRG z 3
and RNA testing
Myeloid malignancy genotyping
• MHO5 - Three 10.0-micron
BCR/ABL1 p190 z 3 paraffin sections; extraction
BCR/ABL1 p210 z 3 and amplification from FFPE
CALR z 3 tissue will be assessed by a
method-based challenge
CBFB/MYH11 z 3
FLT3 ITD z 3
ships on dry ice (dry ice
FLT3 TKD z 3 does not apply to MHO5 or
JAK2 c.1849G>T(p.V617F) z 3 international shipments)
MLL-PTD (KMT2A-PTD) z 3
NPM1 z 3
PML/RARA z 3
RUNX1/RUNX1T1 z 3
DNA extraction and
amplification from formalin-
z 1
fixed, paraffin-embedded
(FFPE) tissue
Program Information
Minimal Residual Disease MRD, MRD1, MRD2
• Three RNA specimens
Challenges per in sterile water
Shipment
19 MRD MRD1 MRD2
• For laboratories diagnosing
and monitoring leukemia
BCR/ABL1 p190 z 3 tumor burden by measuring
BCR/ABL1 p210 z 3 the quantity of BCR/ABL1 or
PML/RARA fusion transcripts
PML/RARA z 3
ships on dry ice
20 Anatomic Pathology
Depend on our commitment to slide
quality for PAP PT and PAP Education
programs.
• Every slide is reviewed and approved by pathologists
and cytotechnologists before it is put in circulation.
• All slide sets are reviewed every six months by a
staff cytotechnologist.
• Slides that do not maintain consensus grading
are removed from the program and reviewed by a
committee of pathologist experts.
Anatomic Pathology
Surgical Pathology ............................................................................................................................. 264
General Immunohistochemistry ......................................................................................................... 278
Predictive Markers............................................................................................................................. 281
Specialty Anatomic Pathology............................................................................................................ 283
Cytopathology .................................................................................................................................... 285
New Programs
Anatomic Pathology
CAP/NSH HistoQIP Central Nervous System IHC (HQNEU) ................................................................. 272
CAP/NSH HistoQIP In Situ Hybridization (Kappa/Lambda) (HQISH).................................................... 272
CAP/NSH HistoQIP Melanoma IHC (HQMEL)....................................................................................... 273
Dermatopathology Immunohistochemistry (DPIHC) ........................................................................... 278
c-Myc/Bcl-2 Immunohistochemistry Tissue Microarray (MYBC) ........................................................ 279
CAP/ACMG HER2 Gene Amplification by FISH, Interpretation Only (CYHI).......................................... 282
Program Changes
BRAF V600E (BRAFV) Additional Mailing ............................................................................................ 278
20
CD20 Immunohistochemistry Tissue Microarray (PM3) Additional Mailing......................................... 279
PD-L1 (PDL1) Additional Mailing ........................................................................................................ 279
Highly Sensitive Anaplastic Lymphoma Kinase IHC (PM6) Additional Mailing .................................... 280
Surgical Pathology
Surgical Pathology
Program Information
Online Performance Improvement Program
• PIPW - Ten diagnostic
in Surgical Pathology PIPW/PIPW1 challenges/whole slide
Program Program Code Challenges per Shipment H&E images with clinical
PIPW/PIPW1
CME credit is available for
Surgical pathology case review z 10 one pathologist; for each
Additional Information additional pathologist, order
PIPW1
PIPW educates pathologists in general surgical pathology.
• PIPW1 - Reporting option
• Pathologists can assess their diagnostic skills and compare their performance with
with CME credit for each
that of their peers.
additional pathologist (within
• Included PIPW case selections feature: the same institution); must
o A variety of neoplastic and nonneoplastic lesions order in conjunction with
o Inflammatory and infectious diseases Survey PIPW
o Various sites, encompassing a variety of organ systems • Earn a maximum of 40 CME
• See system requirements on page 13. credits (AMA PRA Category
1 Credits™) per pathologist for
ABP CC Part IV Practice
requirements
technology
• Four online activities per
year; your CAP shipping
contact will be notified via
email when the activity is
available
Anatomic Pathology
20
Surgical Pathology
Half Page Filler
Program Information
Performance Improvement Program
• PIP - Ten diagnostic
in Surgical Pathology PIP/PIP1 challenges/H&E stained
Program Program Code Challenges per Shipment glass slides with clinical
PIP/PIP1
CME credit is available for
Surgical pathology case review z 10 one pathologist; for each
PIP1
PIP educates pathologists in general surgical pathology. This program:
• PIP1 - Reporting option
• Provides a practical approach to continuing education
with CME credit for each
• Gives pathologists a method to assess their diagnostic skills and compare their additional pathologist (within
performance with that of their peers the same institution); must
• Features PIP case selections that include: order in conjunction with
o A variety of neoplastic and nonneoplastic lesions Survey PIP
o Inflammatory and infectious diseases • Earn a maximum of 40 CME
o Various sites, encompassing a variety of organ systems credits (AMA PRA Category
1 Credits™) per pathologist for
Performance Assessment 1/2
requirements
Half Page Filler

Medical Kidney Diseases: Morphology-Based Novel

Approach to Renal Biopsy (PUB129)
This book is designed to provide brief and concise yet comprehensive
information for practicing pathologists, pathology residents, and
nephrology fellows. It presents a simple and practical approach
Anatomic Pathology
to renal biopsy by providing a pertinent differential diagnosis
related to various patterns of injuries involving renal parenchyma
by light microscopy, reaching a correct diagnosis by assimilating
immunofluorescence and electron microscopy findings. The book is
divided into sections on glomerular, vascular, tubulointerstitial, and
transplant renal pathology.
Item number: PUB129
Or, view sample pages and purchase online: Softcover; 92 pages; 20
• printed books at estore.cap.org 245+ photomicrographs,
• ebooks at ebooks.cap.org exhibits, and tables; 2019
800-323-4040 || 847-832-7000
800-323-4040 847-832-7000 Option
Option 1
1 || cap.org
cap.org 265
3
F3 Half
Surgical Pathology
Program Information
Virtual Biopsy Program VBP/VBP1
• VBP - Five diagnostic
Program Program Code Challenges per Shipment challenges/whole slide
VBP/VBP1 images with clinical history;
Online biopsy case review z 5 reporting with CME/SAM
credit is available for
Additional Information one pathologist; for each
VBP educates pathologists to assess and improve their diagnostic skills in surgical additional pathologist, order
pathology. VBP1
• Cases may include gross, radiographic, or endoscopic images. • VBP1 - Reporting option with
• Cases are from selected organ systems and may include a variety of CME/SAM credit for each
specimen types (eg, core biopsies, endoscopic biopsies, curettings, aspirate additional pathologist (within
smears). Activities with their corresponding topics are: the same institution); must
o 2020-A Upper Gastrointestinal Tract Biopsy order in conjunction with
Survey VBP
o 2020-B Bone Biopsy
o 2020-C Lymph Node Biopsy • Earn a maximum of
25 CME/SAM credits
o 2020-D Surgical Pathology Biopsy (various sites)
(AMA PRA Category 1
• See system requirements on page 13. Credits™) per pathologist for
requirements
technology
• Four online activities per
year; your CAP shipping
contact will be notified via
email when the activity is
available
Anatomic Pathology
20
Surgical Pathology
Program Information
Digital Slide Program—Dermatopathology
• DPATH - Six diagnostic
DPATH/DPATH1 challenges/whole slide
Program Program Code Challenges per Shipment images with clinical history;
reporting with CME/SAM
DPATH/DPATH1
credit is available for
Online dermatopathology case review z 6 one pathologist; for each
DPATH1
DPATH educates pathologists, dermatopathologists, and dermatologists to assess
and improve their diagnostic skills in dermatopathology. • DPATH1 - Reporting option
with CME/SAM credit for
• Cases include static images.
• See system requirements on page 13. (within the same institution);
with Survey DPATH
• Earn a maximum of
15 CME/SAM credits
(AMA PRA Category 1
Credits™) per pathologist for
requirements
technology
Anatomic Pathology
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 267

Surgical Pathology
Program Information
Hematopathology Online Education
• HPATH - Five diagnostic
HPATH/HPATH1 challenges/online, whole
Program Program Code Challenges per Shipment slide images with clinical
HPATH/HPATH1
CME/SAM credit is available
Hematopathology online case for one pathologist/
z 5
review hematologist; for additional
Additional Information pathologist/hematologist,
order HPATH1
HPATH educates pathologists, hematolopathologists, and hematologists with
an interest in hematopathology to assess and improve their diagnostic skills in • HPATH1 - Reporting option
hematopathology. with CME/SAM credit for
• All cases have been specially selected to highlight important changes in the 2016
and hematologist (within
revision of the WHO Classification.
the same institution); must
• Clinical history and relevant laboratory data. order in conjunction with
• At least one online, whole slide image of peripheral blood, bone marrow, Survey HPATH
spleen, lymph node, or other tissue.
• Results of ancillary studies such as immunohistochemistry, flow cytometry, CME/SAM credits (AMA
FISH, karyotyping, and molecular studies, where appropriate. PRA Category 1 Credits™) per
• Case discussion and discussion of differential diagnoses. pathologist and a maximum
• Five SAM questions per case. of 12.5 CE credits per
• See system requirements on page 13. hematologist for completion
of an entire year
ABP MOC Part IV Practice
requirements
technology
Anatomic Pathology
20
Surgical Pathology
Clinical Pathology Improvement Programs (CPIP/CPIP1)

CPIP supports pathologists who principally practice clinical pathology as well as those who primarily practice anatomic
pathology but cover clinical pathology. A diverse portfolio of real-life case scenarios, including images and clinical background,
help pathologists to stay abreast of issues and advances in the lab.
Designed for pathologists, by pathologists. Each case is developed and peer-reviewed ensuring what you learn is practical and
easily applied to your work. Thought provoking questions with feedback and a multiple-choice post-test allow you to assess
and confirm your diagnostic skills. Participants who earn a passing score on the post-test may apply their earned credits to the
ABP’s CC requirements.
Program Information
Clinical Pathology Improvement Program
• CPIP - One online clinical
CPIP/CPIP1 laboratory case per month
Program Name Program Code Cases/Year • CPIP1 - Reporting option
CPIP/CPIP1 with CME/SAM credit for
Online cases in 12 (One per month. each additional pathologist
clinical pathology
z
See below.) (within the same institution);
Additional Information with CPIP
Consider the CPIP program if you are a: • Earn a maximum of 15 CME/
• Medical director seeking to continuously improve the clinical pathology knowledge SAM credits (AMA PRA
and collective skills of your pathology team. Category 1 Credits™) per year
• Pathologist with clinical and/or laboratory management responsibilities. • This activity meets the
• Pathologist seeking CME/SAM or CC credits in clinical pathology. ABP CC Part IV Practice
• Subspecialty clinical pathologist who needs to keep current. Performance Assessment
requirements
To learn more visit www.cap.org and search CPIP.
• Twelve cases per year; your
Case Schedule CAP shipping contact will be
Discipline Month 2020
(subject to change) notified via email when the
Lab Management How to retire a test January activity is available
Toxicology Non-cancer pain management February

Molecular approach to
Hematology March
myeloid neoplasms
Chemistry Growth hormone testing April
Blood bank education
Transfusion Medicine May
for clinical staff
Hematology Neutrophilia June
Anatomic Pathology
Microbiology Automation in clinical microbiology July
Transfusion Medicine Utilization of platelets and plasma August
Hematology Flow/lymphocytosis September
Cell-free and/or circulating tumor
Molecular Pathology October
cell DNA testing for solid tumors
Chemistry Adrenal function testing November
Lab Management Physician wellness December
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 269

Surgical Pathology
Program Information
Touch Imprint/Crush Preparation TICP/TICP1
• TICP - Four online
Procedure Program Code Challenges per Shipment assessment challenges
TICP/TICP1 with clinical history; TICP
Online slide and image program in rapid provides CME/SAM/CE
z 4 credit for one pathologist or
assessment case review
cytotechnologist; for each
Additional Information additional pathologist or
• The TICP Program is designed to familiarize surgical pathologists, cytopathologists, cytotechnologist, order TICP1
and cytotechnologists with the cytomorphologic features of pathologic processes • TICP1 - Reporting option
and tumors in touch imprints and crush or scrape preparations. These specimens with CME/SAM/CE credit for
are prepared either for intraoperative consultation (frozen section) or rapid each additional pathologist/
on-site evaluation (ROSE) of tissue biopsies for adequacy and/or interpretation. cytotechnologist (within the
Participants will learn to make an immediate adequacy assessment, assign the same institution); must
process to a general category, and triage the specimen to appropriate ancillary order in conjunction with
studies. Participants will review digital whole slides of the TICP preparations Survey TICP
(hematoxylin & eosin, modified Wright-Giemsa, and/or Papanicolaou stains), static
• Earn a maximum of 10
images of the preparation and ancillary studies, and clinical history/radiographic
CME/SAM credits (AMA
findings to reach a diagnosis. Each case has a complete description of entities in
PRA Category 1 CreditsTM)
the differential diagnosis along with a discussion of the correct interpretation.
per pathologist and a
• Participants will receive immediate feedback on interpretations, ancillary studies, maximum of 10 CE credits
and case-related adequate assessment. per cytotechnologist for
• The cases will be comprised of specimens from gastrointestinal and completion of an entire year
miscellaneous topics.
• May include rarely captured cases that may not be available on the glass slide. ABP CC Part IV Practice
• See system requirements on page 13. Performance Assessment
requirements
technology
Anatomic Pathology
20
Third Page Filler
Surgical Pathology
Program Information
CAP/NSH HistoQIP HQIP
• Participant laboratories may
Challenges per submit up to five stained
Stain/Tissue Program Code
Shipment
coverslipped glass slides
HQIP A B (one from each category) per
H&E – Bone marrow needle core biopsy z 1 mailing
H&E – Lymph node, excision specimen z 1 • Includes photographs and
online learning assessment
IHC – Podoplanin, appendix specimen z 1
questions
IHC – CD5, lymph node nonneoplastic specimen z 1
Special stain – Reticulin, liver biopsy specimen z 1
H&E – Colon resection z 1
H&E – Stomach resection z 1
IHC – SOX10, skin resection z 1
IHC – E-cadherin, ductal carcinoma (breast)
z 1
resection
Special stain – Elastin, lung resection z 1
1/3 Additional Information

HistoQIP improves the preparation of histologic slides in all anatomic pathology
laboratories. In this educational program, participants will receive an evaluation
Third Page Fillers
specific to their laboratory, an education critique, and a participant summary that

includes peer comparison data, evaluators’ comments, and performance benchmarking
data. An expert panel of pathologists, histotechnologists, and histotechnicians will
evaluate submitted slides for histologic technique using uniform grading criteria.
Learn the secret to good slide technique.

Histologic Preparations: Common Problems and Their Solutions is a how-to
guide to good slide preparation. Building on data and images from the CAP/NSH
HistoQIP program, the book presents photographic examples of well-prepared
slides followed by numerous examples of associated problems and their solutions.
Anatomic Pathology
The text contains troubleshooting techniques for the most common artifacts
and problems incurred in routine histologic preparations, including fixation and
processing; microtomy; frozen sections; hematoxylin-eosin, trichrome, reticulin,
elastin, basement membrane, mucin, amyloid, immunohistochemical, and Gram
stains, along with mycobacteria, Helicobacter pylori, spirochetes, and fungi.
Add Histologic Preparations: Common Problems and Their Solutions Item number: PUB123
(PUB123) to your order. Or, view sample pages and purchase online: Softcover; 168 pages;
• printed books at estore.cap.org 300+ photomicrographs,
• ebooks at ebooks.cap.org figures, and tables; 2009 20
HistoQIP IHC programs assess preanalytic steps. For immunohistochemistry programs that focus on analytic
10 Collegeand postanalytic
of American (interpretive) steps, see the immunohistochemistry programs on pages
Pathologists 2020272-276.
Surveys Pickup Filler Pages
F10 Third
800-323-4040 | 847-832-7000 Option 1 | cap.org 271
Surgical Pathology
Program Information
CAP/NSH HistoQIP
• Participants may submit
Central Nervous System IHC HQNEU up to three IHC and two
Challenges per H&E stained coverslipped
Shipment glass slides (one from each
HQNEU A B category) per mailing
H&E – Glioblastoma z 1 • Two shipments per year
IHC – GFAP positive glioblastoma z 1
IHC – p53 positive glioblastoma z 1
H&E – IDH1 positive mutant glioma z 1
IHC – IDH1 (R132H) positive mutant glioma z 1
H&E – Low grade astrocytoma z 1
IHC – S100 positive low grade astrocytoma z 1
IHC – Ki-67 positive low grade astrocytoma z 1
H&E – ATRX positive wild-type glioma z 1
IHC – ATRX positive wild-type glioma z 1
This program augments efforts to improve the preparation of H&E and
immunohistochemical slides in all anatomic pathology laboratories involved in the
handling of central nervous system gliomas.
Program Information
CAP/NSH HistoQIP In Situ
• Participants are to submit an
Hybridization (Kappa/Lambda) HQISH H&E, positive and negative
Challenges per reagent control slides and
Shipment kappa and lambda DNA/RNA
HQISH A B ISH stained coverslipped
glass slides (one from each
H&E – Nonneoplastic tonsil z 1
category) per mailing
DNA/RNA positive control probe (ISH) z 1
DNA/RNA negative control probe (ISH) z 1
Kappa ISH (Kappa probe, ISH) z 1
Lambda ISH (Lambda probe, ISH) z 1
Anatomic Pathology
H&E – Bone marrow core biopsy z 1

DNA/RNA positive control probe (ISH) z 1
DNA/RNA negative control probe (ISH) z 1
Kappa ISH (Kappa probe, ISH) z 1
Lambda ISH (Lambda probe, ISH) z 1
This program augments efforts to improve the preparation of ISH slides in all anatomic
pathology laboratories involved in the handling of specimens undergoing analysis for
20 kappa and lambda expression by chromogenic in situ hybridization.
and postanalytic (interpretive) steps, see the immunohistochemistry programs on pages 272-276.
Third Page Filler
Surgical Pathology
Program Information
CAP/NSH HistoQIP Melanoma IHC HQMEL
Challenges per up to three IHC and two
Shipment
H&E stained coverslipped
HQMEL A B glass slides (one from each
H&E – Melanoma, skin biopsy z 1 category) per mailing
IHC – Melan A/MART-1 positive melanoma, • Two shipments per year
z 1
skin biopsy
IHC – SOX10 positive melanoma, skin biopsy z 1
H&E – PD-L1 positive melanoma, skin biopsy z 1
IHC – PD-L1 positive melanoma, skin biopsy z 1
H&E – Melanoma, skin resection z 1
IHC – S100 positive melanoma, skin resection z 1
IHC – HMB-45 positive melanoma, skin resection z 1
H&E – BRAF V600E positive mutated melanoma z 1
IHC – BRAF V600E positive mutated melanoma z 1
1/3 This program augments efforts to improve the preparation of H&E and
handling of skin specimens containing melanoma.
Third Page Fillers
Practice Management Resources will help

you successfully advance your practice.
Enhance the profitability of your practice while
sharpening your skillset with our practice
management training, tools, and resources,
Anatomic Pathology
including:
• Business development and marketing
• Coding and payment
• Compliance and risk management
• Human Resources
Learn what medical school didn’t teach you by
searching Practice Management on cap.org.
20
227581_Pract ManagThird_filler.indd 1 5/6/19 8:50 AM
2 College of American Pathologists 2019 NEW Fillers
CAP NEW 2 Third 800-323-4040 | 847-832-7000 Option 1 | cap.org 273
Surgical Pathology
Program Information
HQIP Whole Slide Image Quality
Improvement Program HQWSI submit up to four stained
Challenges per coverslipped glass slides and
Shipment upload their scanned whole
HQWSI A B slide images per mailing
H&E – Breast resection z 1 • Two shipments per year
H&E – Lung resection z 1
H&E – Breast needle core biopsy z 1
H&E – Prostate needle core biopsy z 1
H&E – Colon resection z 1
H&E – Kidney resection z 1
H&E – Colon biopsy z 1
H&E – Skin punch biopsy z 1
Program Information
CAP/NSH HistoQIP—IHC HQIHC
Challenges per submit up to five IHC stained
Shipment
and coverslipped glass slides
HQIHC A B (one from each category)
IHC – Desmin, leiomyoma z 1 per mailing
IHC – CD20, tonsil resection z 1 • Two shipments per year
IHC – ER, tonsil resection z 1
IHC – BCL6, follicular lymphoma z 1
IHC – GATA3, bladder biopsy z 1
IHC – Calretinin, appendix z 1
IHC – Pancytokeratin, liver resection z 1
IHC – PR, breast core biopsy z 1
IHC – PAX5, tonsil resection z 1
IHC – NKX3.1, prostatic adenocarcinoma z 1
Anatomic Pathology
HistoQIP – IHC improves the preparation of immunohistochemistry slides in all

anatomic laboratories involved in the handling of gastrointestinal, dermatologic,
and urological tract biopsies. Participants will receive an evaluation specific
to their laboratory and a participant summary. An expert panel of pathologists,
histotechnologists, and histotechnicians will evaluate submitted slides for
histologic technique using uniform grading criteria.
20
Half Page Filler
Surgical Pathology
Program Information
CAP/NSH HistoQIP Mismatch Repair IHC HQMMR
• Participants may submit up
Stain/Tissue Program Code Challenges per Shipment to four IHC and one
HQMMR A B H&E stained coverslipped
H&E – Colon adenocarcinoma z 1 glass slides (one from each
IHC – MLH1 (colon adenocarcinoma) z 1
IHC – MSH2 (colon adenocarcinoma) z 1
IHC – MSH6 (colon adenocarcinoma) z 1
IHC – PMS2 (colon adenocarcinoma) z 1
H&E – Endometrial adenocarcinoma z 1
IHC – MLH1 (endometrial adenocarcinoma) z 1
IHC – MSH2 (endometrial adenocarcinoma) z 1
IHC – MSH6 (endometrial adenocarcinoma) z 1
IHC – PMS2 (endometrial adenocarcinoma) z 1
1/2 This program augments efforts to improve the preparation of H&E and
handling of colonic and endometrial tumors performing mismatch repair IHC.
Half Page Filler
Laboratory Administration for Pathologists, Second Edition (PUB312)

Laboratory Administration for Pathologists is designed to provide 2nd
pathologists with an overview of the fundamentals of management Edition
and leadership, addressing the specific role and responsibility of the
pathologist in directing the laboratory.
• Provides information for both clinical and anatomic pathology practice
Anatomic Pathology
• Includes an overview of patient safety not available in the first edition
• Covers financial management of the laboratory and the pathology practice
• Geared for trainees and those entering practice while appropriate
for all pathologists
• ebooks at ebooks.cap.org Hardcover; 296 pages; 2019 20
4 Collegeand
of American Pathologists
postanalytic 2020 Surveys
(interpretive) steps, see the immunohistochemistry & Anatomic
programs Pathology
on pages 272-276.Education Programs
F4 Half
800-323-4040 | 847-832-7000 Option 1 | cap.org 275
42453_2020 Surveys_Black Dot New Fillers.indd 4 6/6/19 3:38 PM
Surgical Pathology
Program Information
CAP/NSH HistoQIP Non-small Cell Lung
Carcinoma IHC HQNSC up to three IHC and two
Stain/Tissue Program Code Challenges per Shipment H&E stained coverslipped
glass slides (one from each
HQNSC A B
H&E – Lung adenocarcinoma z 1
IHC – TTF-1 (lung adenocarcinoma) z 1
IHC – Napsin-A (lung adenocarcinoma) z 1
H&E – ALK (positive lung adenocarcinoma) z 1
IHC – ALK (positive lung adenocarcinoma) z 1
H&E – Lung squamous cell carcinoma z 1
IHC – p40/p63 (lung squamous cell
z 1
carcinoma)
IHC – CK5/6 (lung squamous cell carcinoma) z 1
H&E – PD-L1 (positive lung squamous cell
z 1
carcinoma)
IHC – PD-L1 (positive lung squamous cell
z 1
carcinoma)
This program augments efforts to improve the preparation of H&E and
handling of non-small cell lung carcinoma.
Program Information
CAP/NSH HistoQIP Biopsy Series HQIPBX
Stain/Tissue Program Code Challenges per Shipment up to four H&E stained and
HQIPBX A B coverslipped glass slides
H&E – Bladder biopsy z 1 (one from each category)
per mailing
H&E – Cervical biopsy z 1
H&E – Skin punch biopsy z 1
H&E – Stomach biopsy z 1
H&E – Colon biopsy z 1
Anatomic Pathology
H&E – Endometrial biopsy z 1

H&E – Prostate needle biopsy z 1
H&E – Breast core biopsy z 1
The HistoQIP Biopsy Series is an additional program to improve the preparation of
histologic slides in all anatomic pathology laboratories. Participants will receive an
evaluation specific to their laboratory and a participant summary. An expert panel of
pathologists, histotechnologists, and histotechnicians will evaluate submitted slides
for histologic technique using uniform grading criteria.
20
Surgical Pathology
Program Information
CAP/NSH HistoQIP Specialty Series
• HQBX1, HQBX2, HQBX3,
HQBX1, HQBX2, HQBX3, HQBX4 HQBX4 - Participants may
Challenges per submit up to four H&E
Shipment stained and coverslipped
HQBX1 HQBX2 HQBX3 HQBX4 A B glass slides (one from each
Gastrointestinal Biopsy Module
H&E – Colon biopsy z 1 1
H&E – Esophageal biopsy z 1 1
H&E – Small intestinal biopsy z 1 1
H&E – Stomach biopsy z 1 1
Dermatologic Biopsy Module
H&E – Alopecia z 1 1
H&E – Skin excisional biopsy
z 1 1
(large excision)
H&E – Skin punch biopsy z 1 1
H&E – Skin shave biopsy z 1 1
Urogenital Tract Biopsy Module
H&E – Bladder biopsy
z 1 1
(nonneoplastic)
H&E – Bladder biopsy (with
z 1 1
carcinoma)
H&E – Prostate needle biopsy
z 1 1
(nonneoplastic)
H&E – Prostate needle biopsy
z 1 1
(with carcinoma)
Gynecological Biopsy
H&E – Cervical biopsy z 1 1
H&E – Endometrial biopsy z 1 1
H&E – Cone/Leep biopsy z 1 1
H&E – Vagina biopsy z 1 1
The HistoQIP Specialty Series includes modules to improve the preparation of
Anatomic Pathology
histologic slides in all anatomic pathology laboratories involved in the handling of
gastrointestinal, dermatologic, gynecologic, and urogenital tract biopsies. Participants
will receive an evaluation specific to their laboratory and a participant summary. An
expert panel of pathologists, histotechnologists, and histotechnicians will evaluate
submitted slides for histologic technique using uniform grading criteria.
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 277

General Immunohistochemistry
Program Information
Immunohistochemistry MK
• Seven glass slides with
Procedure Program Code Challenges per Shipment unstained tissue sections
MK from four separate cases;
Immunohistochemistry z 16 additional slides provided
for an H&E stain and
The MK program allows laboratories to compare their assay methodology and results negative control
with all participating laboratories.
Program Information
BRAF V600E BRAFV
• One 10-core tissue
Procedure Program Code Challenges per Shipment microarray slide
BRAFV • Two shipments per year
BRAF V600E z 10
Program Information
Dermatopathology Immunohistochemistry
• Six glass slides with
DPIHC unstained tissue sections
Procedure Program Code Challenges per Shipment from two separate cases;
additional slides provided
DPIHC
for an H&E stain, four to
Dermatopathology z 8 be stained and one for
negative control
Program Information
DNA Mismatch Repair MMR
• Four unstained paraffin
Procedure Program Code Challenges per Shipment section slides and
Anatomic Pathology
MMR one H&E slide for the

DNA mismatch repair by immunohistochemical
z 4 analysis of DNA mismatch
immunohistochemistry
repair proteins MLH1, MSH2,
If your laboratory performs DNA mismatch repair by molecular methods, MSH6, and PMS2
see the MSI program on page 258.
20
These general immunohistochemistry Surveys assess analytic and postanalytic (interpretive) steps.
For Surveys focusing on preanalytic steps, see the HistoQIP IHC programs on pages 272-276.
Program Information
PD-L1 PDL1
Procedure Program Code Challenges per Shipment microarray slide; additional
PDL1 slides provided for H&E and
PD-L1 z 10 PD-L1 control
Program Information
CD117, CD20 Immunohistochemistry
• PM1, PM3 — One 10-core
Tissue Microarray PM1, PM3 tissue microarray slide per
Analyte Program Code Challenges per Shipment predictive marker
PM1 PM3 • PM1: One shipment per year;
CD117 z 10 PM3: Two shipments per year
CD20 z 10
For ER/PgR testing, see the PM2 program on page 281.
Program Information
CD30 Immunohistochemistry
Tissue Microarray CD30 microarray slide
CD30
CD30 z 10
c-Myc/Bcl-2 Immunohistochemistry Program Information

• Two 10-core tissue
Tissue Microarray MYBC microarray slides, one for
Analyte Program Code Challenges per Shipment c-Myc and one for Bcl-2
MYBC • Two shipments per year
c-Myc z 10
Bcl-2 z 10
Anatomic Pathology
Program Information
p16 Immunohistochemistry
Tissue Microarray P16 microarray slide
P16
p16 z 10
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 279

Quarter Page Filler
Program Information
Immunohistochemistry Tissue
Microarray Series PM5 microarray slides, one for
Analyte Program Code Challenges per Shipment pan-TRK and one for Ki-67
PM5 • One shipment per year
pan-TRK z 10
Ki-67 z 10
Each year, the PM5 program will feature two different markers for
immunohistochemistry laboratories to evaluate assay performance on a variety
of tissue and/or tumor types. The IHC markers for this Survey may change from those
listed above due to development constraints.
Program Information
Highly Sensitive Anaplastic Lymphoma Kinase IHC PM6
Procedure Program Code Challenges per Shipment microarray slide
PM6 • Two shipments per year
1/4
Highly sensitive anaplastic
z 10
Quarter Page Filler

lymphoma kinase IHC (ALK)
Let the CAP connect you to the IHC samples you need.
CAP Immunohistochemistry (IHC) Validation Program
Anatomic Pathology
• The CAP will facilitate the exchange of tissue samples once a sufficient number of laboratories
performing the same marker are identified.
• Samples will be exchanged twice a year based on availability.
• Each laboratory will receive its own individual results along with an anonymized
summary report for all participants.
Sign up for this complimentary service to access those hard-to-obtain specimens.
To get started, visit cap.org and from the Laboratory Improvement tab, choose Proficiency Testing > Sample
20 Exchange Registry to learn more and download a Contact Information Form.
800-323-4040
For Surveys focusing on preanalytic steps, see the HistoQIP IHC programs | 847-832-7000
on pages 272-276. Option 1 | cap.org 1
F1 Quarter
Predictive Markers
Predictive Markers
Program Information
HER2 Immunohistochemistry HER2
Analyte Program Code Challenges per Shipment microarray slides
HER2 • Two shipments per year
HER2 z 20
The HER2 program fulfills the proficiency testing requirement stated in the ASCO/CAP
HER2 Testing Guideline. Due to the unique nature of these human, donor-based
materials, the shipping date is subject to change. If this should occur, the CAP will
provide notification prior to the originally scheduled shipping date.
Program Information
Gastric HER2 GHER2
Analyte Program Code Challenges per Shipment microarray slide
GHER2 • Two shipments per year
HER2 z 10
The interpretive criteria for HER2 immunohistochemistry performed on
gastroesophageal adenocarcinomas differs significantly from breast carcinoma. The
GHER2 program will help participating laboratories understand these differences.
Program Information
ER/PgR Immunohistochemistry
• Four 10-core microarray
Tissue Microarray PM2 slides, two for ER and
Analyte Program Code Challenges per Shipment two for PgR
PM2 • Two shipments per year
Estrogen receptor (ER) z 20
Progesterone receptor (PgR) z 20
Anatomic Pathology
The PM2 program fulfills the proficiency testing requirement stated in the
ASCO/CAP ER/PgR Testing Guideline. Due to the unique nature of these human,
donor-based materials, the shipping date is subject to change. If this should occur,
the CAP will provide notification prior to the originally scheduled shipping date.
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 281

Predictive Markers
Program Information
CAP/ACMG HER2 Gene Amplification by FISH,
• Three online, educational
Interpretation Only CYHI interpretation dry
Analyte/Procedure Program Code Challenges per Shipment challenges; your CAP
shipping contact will be
CYHI
notified via email when
HER2 gene amplification in breast the activity is available
z 3
cancer, interpretation only
• HER2 Gene Amplification by FISH, Interpretation Only, is an exercise and is not
considered proficiency testing. This exercise may be used to meet the requirements
for alternative assessment.
• This program is for laboratories that perform interpretation only for HER2 FISH
for breast cancer.
• For laboratories that perform both hybridization and interpretation for HER2 FISH
for breast cancer under the same CLIA number, see page 243.
Anatomic Pathology
20
Specialty Anatomic Pathology

Program Information
Autopsy Pathology AUP/AUP1
• AUP - Online activity
Procedure Program Code Challenges per Shipment providing five cases;
AUP/AUP1 reporting with CME/SAM or
Autopsy online case analysis z 5 CE credit is available for one
pathologist or pathologists’
Each case includes case description, gross and/or microscopic images, and case assistant; for each additional
discussion with sample death certificate, key teaching points, and current references. pathologist/pathologists’
assistant order AUP1
• Includes the option to
download program content
• AUP1 - Reporting option with
CME/SAM or CE credit for
or pathologists’ assistant
(within the same institution);
must order in conjuction with
Survey AUP
• Earn a maximum of
12.5 CME/SAM credits (AMA
PRA Category 1 Credits™)
maximum of 12.5 CE credits
per pathologists’ assistant
for completion of entire year
requirements
• Two online activities per year
Anatomic Pathology
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 283

Third Page Filler

Neuropathology Program NP/NP1 Program Information
• NP - Online activity providing
Challenges per eight cases and a mini-
Program Program Code
Shipment
symposium; reporting with
NP/NP1 CME/SAM credit is available
Neuropathology online case review z 8 for one pathologist; for each
additional pathologist, order
Additional Information NP1
The Neuropathology program helps anatomic pathologists, neuropathologists, and
• Includes option to download
trainees assess and improve their diagnostic skills and learn about new developments
program content
in neuropathology. Each shipment of this educational program includes eight cases
that cover the spectrum of neoplastic and nonneoplastic disorders affecting the central • NP1 - Reporting option with
and peripheral nervous systems, including infectious, degenerative, developmental, CME/SAM credit for each
demyelinating, traumatic, toxic-metabolic, vascular, and neuromuscular diseases. additional pathologist (within
In addition, each mailing will include a mini-symposium that focuses on a specific the same institution); must
problem area in neuropathology, which relates to at least four of the eight cases. order in conjunction with
Survey NP
• Earn a maximum of 10
CME/SAM credits (AMA
PRA Category 1 Credits™)
per pathologist
requirements
1/3
technology

Anatomic Pathology

on your 2019 order)
20 To get started, visit cap.org and select SHOP
284 College of American Pathologists

27686_OnlineStoreThird_filler.indd 1
2020 Surveys & Anatomic Pathology Education Programs
5/22/19 4:13 PM
Cytopathology
Cytopathology
Program Information
Glass Slide Gynecologic Cytopathology PT
• Ten glass slides for
Program with Glass Slide PAP Education PAP PT proficiency testing and ten
Slide Type Program Code Challenges per Year glass slides for education
Proficiency • APAPCPT/APAPKPT/
PAPCPT PAPKPT PAPMPT PAPLPT PAPJPT Education
Testing APAPMPT/APAPLPT/
Conventional z z APAPJPT - Reporting option
with CME/CE credit for each
SurePath z z z
pathologist/cytotechnologist
ThinPrep z z z 10 10 (within the same institution);
Individual must order in conjunction
Participant APAPCPT APAPKPT APAPMPT APAPLPT APAPJPT with Survey PAPCPT/PAPKPT/
Response Form PAPMPT/PAPLPT/PAPJPT
Ordering Information • Earn a maximum of 8 CME

credits (AMA PRA Category
You will receive one shipment for proficiency testing (10 slides) and two additional
1 CreditsTM) per pathologist
shipments for your education (five slides each).
and a maximum of 8 CE
Follow these steps to order your PAP Proficiency Testing and PAP Education: credits per cytotechnologist
for completing all challenges
1. Choose the following:
a. Slide Type program code (refer to table above) • This activity meets the
b. PAP Education series shipment dates (choose one)
• Series 1 requirements
o A mailing ships February
• Three shipments per year;
o B mailing ships August
one shipment for proficiency
• Series 2 testing (10 slides) and two
o A mailing ships May shipments for education (five
o B mailing ships November slides each)
c. Add the PAP Education series number after the slide type program code
(eg, PAPCPT1, PAPCPT2).
2. Order one Individual Participant Response Form code for each participating
pathologist/cytotechnologist. Also include the PAP Education Series number after
the program code (eg, APAPCPT1).
3. Select primary testing session option with two alternative date options using the
Anatomic Pathology
Gynecologic Cytology Proficiency Testing Order Details Form.
4. Order PPTENR only if you are a laboratory possessing a CLIA license to perform
gynecologic cytology where all personnel are performing proficiency testing at
another CLIA location.
• Participants can receive laboratory reference interpretations and performance for
the PAP Education slides within 20 minutes by fax.
• The PAP Education component meets the CAP Laboratory Accreditation Program
requirement for participation in a peer educational program.
20
800-323-4040 | 847-832-7000 Option 1 | cap.org 285

Cytopathology
Program Information
Cytopathology Glass Slide Education Program
• Ten glass slides for
PAPCE, PAPJE, PAPKE, PAPLE, PAPME Series 1 or 2 education
Education Challenges • APAPCE/APAPJE/APAPKE/
Slide Type Program Code
per Year
APAPLE/APAPME - Reporting
PAPCE PAPKE PAPME PAPLE PAPJE option with CME/CE credit
for each pathologist/
Conventional z z cytotechnologist (within the
SurePath z z z same institution); must order
in conjunction with Survey
ThinPrep z z z PAPCE/PAPJE/PAPKE/
10 PAPLE/PAPME
Individual
Participant • Earn a maximum of 8 CME
APAPCE APAPKE APAPME APAPLE APAPJE
Response credits (AMA PRA Category
Form 1 CreditsTM) per pathologist
Ordering Information and a maximum of 8 CE
credits per cytotechnologist
Follow these steps to order your PAP Education: for completing all challenges
1. Choose the following: • This activity meets the
a. Slide Type program code (refer to table above) ABP CC Part IV Practice
b. PAP Education series shipment dates (choose one) Performance Assessment
• Series 1 requirements
o A mailing ships February • Two shipments (five slides
o B mailing ships August each)
• Series 2
o A mailing ships May
o B mailing ships November
c. Add the PAP Education series number after the slide type program code
(eg, PAPCE1, PAPCE2)
2. Order one Individual Participant Response Form code for each participating
pathologist/cytotechnologist. Also include the PAP Education series number after
the program code (eg, APAPCE1).
• Participants can receive laboratory reference interpretations and performance for
the PAP Education slides within 20 minutes by fax.
• The PAP Education component meets the CAP Laboratory Accreditation Program
Anatomic Pathology
requirement for participation in a peer educational program.
20
Cytopathology
Half Page Filler
Human Papillomavirus (High Risk) for Cytopathology Program Information

• Five simulated cervical
CHPVD, CHPVM, CHPVK, CHPVJ specimens
Analyte/Procedure Program Code Challenges per Shipment • CHPVD - Digene® Specimen
CHPVD CHPVM CHPVK CHPVJ Transport Medium™ (STM)
HPV z z z z 5 • CHPVM - ThinPrep
High-risk HPV PreservCyt® Transport
z z 5 Medium
genotyping (optional)
• CHPVK - SurePath
Preservative Fluid Transport
• Each laboratory should choose the Survey that best reflects the transport media Medium and corresponding
received in its facility. For Survey CHPVJ, participants must provide results for all vial of diluent
three media types. If your laboratory receives two types of media, order the Survey
that is most appropriate for your specific laboratory (CHPVD, CHPVM, or CHPVK). • CHPVJ - Combination of
Digene, ThinPrep
• For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transport
PreservCyt, and SurePath
medium on site, Survey CHPVM and select samples of Survey CHPVJ provide an
transport mediums
opportunity to report specific HPV genotypes.
• The CAP does not report genotyping responses to the CMS. • Three shipments per year
1/2
Half Page Filler

How current is your laboratory
quality management plan?
Created specifically for the needs of the anatomic pathology
laboratory, this comprehensive manual can help you develop,
implement, and maintain a comprehensive quality program.
Anatomic Pathology
Learn valuable tips for designing your own laboratory quality
plan that documents regulatory compliance. Text includes
cross-references to the CAP’s Laboratory Accreditation Program
checklists, Joint Commission standards, and CLIA '88.
Add Quality Management In Anatomic Pathology (PUB125)
to your order.
• printed books at estore.cap.org Item number: PUB125 20
• ebooks at ebooks.cap.org Hardcover; 228 pages;
135+ figures and
tables; 2017
800-323-4040 | 847-832-7000 Option 1 | cap.org 287

800-323-4040 | 847-832-7000 Option 1 | cap.org 35
Quarter Page Filler
Cytopathology
Program Information
Touch Imprint/Crush Preparation TICP/TICP1
• TICP - Four online
Procedure Program Code Challenges per Shipment assessment challenges
TICP/TICP1 with clinical history; TICP
Online slide and image program in rapid provides CME/SAM/CE
z 4 credit for one pathologist or
assessment case review
Additional Information additional pathologist or
• The TICP Program is designed to familiarize surgical pathologists, cytopathologists, cytotechnologist, order TICP1
and cytotechnologists with the cytomorphologic features of pathologic processes • TICP1 - Reporting option
and tumors in touch imprints and crush or scrape preparations. These specimens with CME/SAM/CE credit for
are prepared either for intraoperative consultation (frozen section) or rapid each additional pathologist/
on-site evaluation (ROSE) of tissue biopsies for adequacy and/or interpretation. cytotechnologist (within the
Participants will learn to make an immediate adequacy assessment, assign the same institution); must
process to a general category, and triage the specimen to appropriate ancillary order in conjunction with
studies. Participants will review digital whole slides of the TICP preparations Survey TICP
(hematoxylin & eosin, modified Wright-Giemsa, and/or Papanicolaou stains), static
images of the preparation and ancillary studies, and clinical history/radiographic • Earn a maximum of 10
findings to reach a diagnosis. Each case has a complete description of entities in CME/SAM credits (AMA
the differential diagnosis along with a discussion of the correct interpretation. PRA Category 1 CreditsTM)
• Participants will receive immediate feedback on interpretations, ancillary studies,
maximum of 10 CE credits
1/4 and case-related adequate assessment.
per cytotechnologist for
• The cases will be comprised of specimens from gastrointestinal and completion of an entire year
miscellaneous topics.
Quarter Page Filler

• May include rarely captured cases that may not be available on the glass slide.
requirements
technology
Anatomic Pathology
Experience a new level of pathology education

with SAM courses from the CAP.
• Outcome-based learning at the cutting edge of pathology science
• Peer reviewed by at least two subject matter experts
20
• Highly interactive formats with immediate feedback
Visit cap.org and choose the Learning tab, then search SAM Courses.
2882 College
College of
of American
American Pathologists
Pathologists 2020
2020 Surveys & Anatomic SurveysEducation
Pathology Pickup Filler Pages
Programs
F2 Quarter
Cytopathology
Third Page Filler
Program Information
Nongynecologic Cytopathology
• NGC - Five glass slides; five
Education Program NGC/NGC1 online advanced education
Procedure Program Code Challenges per Shipment cases; one laboratory
response form and two
NGC/NGC1
individual response forms
Nongynecologic cytopathology
z 5 • NGC1 - Reporting option
case review – glass slides
with CME/CE credit for each
Nongynecologic cytopathology additional pathologist/
z 5 per year
case review – online cytotechnologist (within the
Additional Information same institution); must order
in conjunction with Survey
• The Nongynecologic Cytopathology Education (NGC) program is an interlaboratory
NGC
educational opportunity to assess participants’ screening and interpretive skills.
The NGC program is unsuitable for proficiency testing as these cases are chosen for • Earn a maximum of
their educational value. Cases may incorporate static online images that 25 CME credits (AMA PRA
incorporate radiology and multiple aspects of pathology to enhance the Category 1 Credits™)
interpretation. per pathologist and a
• Participants can access laboratory reference interpretations and performance for maximum of 25 CE credits
the glass slides within 20 minutes by fax, providing rapid educational feedback, per cytotechnologist for
peer comparison, and additional review time. completing the glass slides
and online cases
• Additional online advanced education cases provide immediate feedback on
interpretation selection, follow-up recommendations, and case-related educational • This activity meets the 1/3
questions. ABP CC Part IV Practice
Third Page Fillers

requirements
technology
Anatomic Pathology
Have you created or updated your own CAP Profile?
Each laboratory staff member should have their own profile. Your profile is transferable when you leave
your current position. Use it to maintain information about yourself, including:
• Business affiliations • Personal contact information

• Certifications • Specialties and skills
• Contact preferences • Addresses
• Inspector-related information 20
To create or update your profile, visit cap.org, log in, and click on UPDATE MY PROFILE.
800-323-4040 | 847-832-7000 Option 1 | cap.org 7

289
F7 Third
Cytopathology
Program Information
Digital Slide Program in Fine-Needle Aspiration
• FNA - Five online
FNA/FNA1 diagnostic challenges; FNA
Procedure Program Code Challenges per Shipment provides CME/CE credit
for one pathologist or
FNA/FNA1
Online program in fine-needle additional pathologist or
z 5
aspiration case review cytotechnologist, order FNA1
Additional Information • FNA1 - Reporting option
• This program focuses on FNA diagnostic dilemmas in practice. Online cases, which with CME/CE credit for each
consist of whole slide images and static images, provide immediate feedback on additional pathologist/
interpretation selection, ancillary studies selection, and case-related educational cytotechnologist (within the
questions. same institution); must order
• Cases will focus on FNA of unusual variants of common tumors and EBUS/EUS in conjuction with Survey
topics. FNA
• May include rarely captured cases that may not be available on the glass slide. • Earn a maximum of 10 CME
• See system requirements on page 13. credits (AMA PRA Category
1 Credits™) per pathologist and
a maximum of 10 CE credits
per cytotechnologist
requirements
technology
Anatomic Pathology
20
Cytopathology
Third Page Filler
Program Information
Fine-Needle Aspiration Glass Slide FNAG/FNAG1
• FNAG - Five cases consisting
Procedure Program Code Challenges per Shipment of glass slides and selected
FNAG/FNAG1 online images, representing
Fine-needle aspiration glass a variety of conditions; one
z 5 laboratory response form
slide case review
and two individual response
Additional Information forms
• The Fine-Needle Aspiration Glass Slide Education program is an interlaboratory • FNAG1 - Reporting option
educational opportunity to assess participants’ screening and interpretive skills. with CME/CE credit for
FNAG cases may include more than one slide of varying stains and/or each additional pathologist/
preparations used on fine-needle aspirations. cytotechnologist (within the
• Cases may include static online images that incorporate radiology and multiple same institution); must order
aspects of pathology to support the interpretation. in conjunction with Survey
• Participants can access laboratory reference interpretations and performance for FNAG
the glass slides within 20 minutes by fax, providing rapid educational feedback, • Earn a maximum of 10 CME
peer comparison, and additional review time. credits (AMA PRA Category
1 Credits™) per pathologist
and a maximum of 10 CE
credits per cytotechnologist
ABP CC Part IV Practice 1/3
Third Page Fillers

requirements
Ultrasound Features of Superficial

and Palpable Lesions (PUB128)
This ruggedly constructed guide is the ideal reference tool
Anatomic Pathology
for clinicians to use while performing ultrasound-guided
fine-needle aspiration (USFNA). Compact and easy-to-follow,
it includes hundreds of comparative images and concise
descriptions covering normal anatomy and abnormalities
of superficial body sites. Helpful clinical hints are offered
throughout the book.
Add Ultrasound Features of Superficial and Item number: PUB128
Palpable Lesions (PUB128) to your order. Spiral bound; 200 pages;
375 images and 20
illustrations; 2018
800-323-4040 || 847-832-7000 Option 1 | cap.org

800-323-4040 291
21
F21 Third
Take a modern
approach to autopsy pathology.
With more than 1,000 high-quality color images, the third edition of Autopsy Performance &
Autopsy Performance & Reporting includes: Reporting
• Numerous tables and checklists for fast, thorough reference Item number: PUB126
• Role of new technology, including molecular pathology, ancillary Hardcover; 472 pages; 1,000+ color
laboratory studies, and 3-D radiography images and tables; 2017
• Detailed autopsy procedures for specific organ systems and patient

VIEW SAMPLE PAGES
populations
AND ORDER ONLINE.
• Guidelines for autopsy reporting and quality assurance Printed books at estore.cap.org
Filler #39
21 Forensic Sciences
We live our mission of quality.

• More than 8,000 CAP-accredited laboratories
• Approximately 4,000 CAP inspections annually
• More than 22,500 laboratory sites using CAP
proficiency testing
Forensic Sciences
21
Forensic Sciences
Forensic Sciences
Program Information
Forensic Pathology FR/FR1
• FR - Online activity
Procedure Program Code Challenges per Shipment containing five case studies
FR/FR1 illustrating gross and/or
Forensic pathology cases z 5 microscopic slides and
questions related to
Additional Information medicolegal decision
• Cases may include or reflect anthropologic materials, ballistics, dental making; CME/SAM or CE
identification, DNA identification, environmental pathology, forensic evidence, credit is available for one
injury pattern, medicolegal issues, toxicology, and trace evidence. pathologist or investigator.
• FR/FR1 is for hospital-based pathologists, forensic pathologists, residents, fellows, For each additional
and medical examiners/coroners. This educational program is also designed for pathologist/investigator,
investigators, analysts, and technicians/technologists. order FR1
• FR1 - Additional pathologist
or investigator (within the
same institution) reporting
option with CME/SAM or
CE credit; must order in
conjunction with Survey FR
• Includes option to download
program content
CME/SAM credits (AMA PRA
Category 1 Credits™) per
pathologist and a maximum
of 12.5 CE credits per
investigator for completion of
an entire year
requirements
Forensic Sciences
21
Forensic Sciences
Half Page Filler
Program Information
Vitreous Fluid, Postmortem VF
Challenges per vitreous fluid specimens
Shipment
• For forensic and other
VF
toxicology laboratories
Acetone z 3 that perform quantitative
Chloride z 3 analysis of vitreous fluid
Creatinine z 3 • Conventional and
Ethanol z 3 International System of Units
Glucose z 3
Potassium z 3
Sodium z 3
Vitreous urea nitrogen z 3
1/2
Half Page Filler

Clinical Toxicology Testing: A Guide for Laboratory Professionals,
Second Edition (PUB227)
This book is a practical guide, written for pathologists, to directing hospital toxicology laboratory
operations. This new edition features expanded sections on testing in the clinical setting,
methodologies, and more user-friendly information on specific analytes. It provides the reader with
a comprehensive view of what is needed—and expected—when offering a clinical toxicology service.
Contents include:
• Toxicology testing in the clinical setting, including new chapters on
2nd
pediatric testing and chronic opioid therapy
Edition
• Toxicokinetics and methodologies, with new and expanded information
on laboratory-developed tests, screening assays, targeted tests, and
oral fluids and alternative matrices
• Specific analytes, including novel psychoactive substances and the use
Forensic Sciences
of medical cannabis
• Appendices on such useful topics as urine and serum screens,
therapeutic drug monitoring, and proficiency testing
• ebooks at ebooks.cap.org Softcover; 2019 21
800-323-4040 | 847-832-7000
800-323-4040 Option 11 | cap.org
847-832-7000 Option cap.org 5295
F5 Half
Forensic Sciences
Program Information
Forensic Toxicology, Criminalistics FTC
Analyte Program Code Challenges per Shipment specimens and one 20.0-mL
FTC synthetic urine specimen
See drug listing below z 4 • For crime and hospital
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board Proficiency laboratories that have
Review Committee (ASCLD/LAB PRC) has approved Survey FTC. forensic toxicology divisions
performing qualitative
and quantitative analysis
of drugs in whole blood
specimens along with a urine
qualitative challenge
FTC Program Drug Listing

6-acetylmorphine (6-AM) Ecgonine ethyl ester Norfluoxetine

7-aminoclonazepam Ecgonine methyl ester Norketamine
7-aminoflunitrazepam Ephedrine Norpropoxyphene
Acetaminophen Fentanyl* Norsertraline
Alpha-hydroxyalprazolam Fluoxetine Nortriptyline
Alprazolam Flurazepam* Oxazepam
Amitriptyline Gamma-hydroxybutyrate (GHB) Oxycodone
Amphetamine Hydrocodone Oxymorphone
Benzoylecgonine Hydromorphone Paroxetine
Brompheniramine Imipramine Phencyclidine
Butalbital Ketamine Phenethylamine
Carisoprodol Lorazepam Phenobarbital
Chlorpheniramine Lysergic acid diethylamide (LSD) Phentermine
Clonazepam Meperidine* Phenytoin
Cocaethylene Meprobamate Propoxyphene
Cocaine Methadone Pseudoephedrine
Codeine Methadone metabolite (EDDP) Salicylate
Cyclobenzaprine* Methamphetamine Secobarbital
Delta-9-THC Methylenedioxyamphetamine (MDA) Sertraline
Forensic Sciences
Delta-9-THC-COOH Methylenedioxymethamphetamine Temazepam

Desipramine (MDMA) Tramadol*
Desmethylcyclobenzaprine Morphine* Trazodone
Dextromethorphan N-desmethyltramadol Zolpidem
Diazepam Nordiazepam
Diphenhydramine Nordoxepin
Doxepin Norfentanyl *and/or metabolite(s)

21
Refer to Section 9, Toxicology, for a more comprehensive selection of toxicology offerings.
22 Analyte/Procedure Index
Simplify analysis and reporting of PT 22
and accreditation performance using
the Performance Analytics Dashboard.
Analyte/Procedure Index
The complimentary dashboard helps you manage your
CAP PT and accreditation performance.
• Quickly identify trends to mitigate risk by accessing up
to three years or three accreditation cycles of data.
• Benchmark your laboratory against your peers and
CAP-wide performance.
• Consolidate multiple CAP numbers to view a single
dashboard for an entire system.
The following Analyte/Procedure Index is a comprehensive listing of analytes and corresponding CAP program options.
Analytes/procedures in bold type whose corresponding program codes are bold are regulated for proficiency testing by the Centers
for Medicare & Medicaid Services (CMS).
22 Laboratories must perform five challenges three times per year (as noted by boldface) for analytes that are regulated by the CMS.
The X in the LAP ENR column denotes the CAP programs that can be used to fulfill the proficiency testing enrollment requirements
for CAP-accredited laboratories. Refer to program descriptions in this catalog to determine compatibility with your specific
methodologies.
Analyte/Procedure LAP Program Description Pg Analyte/Procedure LAP Program Description Pg

ENR Code ENR Code
1,25 dihydroxy BMV1 Bone Markers and 86 25-OH vitamin D, total X VITD 25-OH Vitamin D 84
Vitamin D Vitamins (cont.)
1,5-anhydroglucitol AG 1,5-Anhydroglucitol 71 50:50 mixing study, APTT CGE/CGEX Coagulation, Extended 161
3-methoxytyramines N/NX Urine Chemistry, Special 69 CGS1 Coag Special, Series 1 162
4-hydroxytriazolam DFC Drug-Facilitated Crime 108 50:50 mixing study, PT CGE/CGEX Coagulation, Extended 161
5-hydroxyindoleacetic N/NX Urine Chemistry, Special 69 CGS1 Coag Special, Series 1 162
acid, qualitative ABO grouping X J, J1 Transfusion Medicine 220
5-hydroxyindoleacetic X N/NX Urine Chemistry, Special 69 X JAT Transfusion Medicine, 221
acid, quantitative Automated
6-acetylmorphine (6-AM) DMPM Drug Monitoring for Pain 107 JATE1 Transfusion Medicine, 221
Management Automated, Educational
FTC Forensic Toxicology, 104 JATQ Quality Cross Check, 49
Criminalistics Transfusion Medicine
OFD Oral Fluid for Drugs of 100 TMCA Transfusion Medicine, 225
Abuse Competency
T Toxicology 96 Assessment
UDC Forensic Urine Drug 99 ABO subgroup typing ABOSG ABO Subgroup Typing 222
Testing, Confirmatory Acetaminophen X CZ, CZ2X, Chemistry and TDM 56–58
UT Urine Toxicology 96 CZX, Z
7-aminoclonazepam DFC Drug-Facilitated Crime 108 CZQ Quality Cross Check, 41
DMPM Drug Monitoring for Pain 107 Chemistry and TDM
Management FTC Forensic Toxicology, 104
FTC Forensic Toxicology, 104 Criminalistics
Criminalistics LN3 TDM Cal Ver/Lin 121
T Toxicology 96 X SDS Serum Drug Screen 101
UT Urine Toxicology 96 T Toxicology 96
7-aminoflunitrazepam DFC Drug-Facilitated Crime 108 UDS, UDS6 Urine Drug Screen 98
FTC Forensic Toxicology, 104 UT Urine Toxicology 96
Criminalistics Acetone X AL1 Whole Blood Alcohol/ 101
T Toxicology 96 Volatiles
UT Urine Toxicology 96 X AL2 Serum Alcohol/Volatiles 101
10q (PTEN) deletion GLI Glioma 261 SDS Serum Drug Screen 101
11-deoxycortisol Y/YY Ligand Assay, Special 84 VF Vitreous Fluid, Post- 101
11-hydroxy-THC THCB Blood Cannabinoids 106 mortem
17-hydroxycorticosteroids N/NX Urine Chemistry, Special 69 Acid phosphatase X C3, C3X, CZ, Chemistry and TDM 56–58
17-hydroxyprogesterone X Y/YY Ligand Assay, Special 84 CZ2X, CZX
17-ketosteroids N/NX Urine Chemistry, Special 69 CZQ Quality Cross Check, 41
Chemistry and TDM
25-OH vitamin D, total X ABVD Accuracy-Based 112
Vitamin D Acid-fast smear X E Mycobacteriology 188
LN40 Vitamin D Cal Ver/Lin 130 X E1 Mycobacteriology, Ltd 188

ENR Code ENR Code
Acinetobacter IDPN Infectious Disease, 203 Alanine X C1, C3, C3X, Chemistry and TDM 56–58
calcoaceticus-baumannii Pneumonia Panel aminotransferase (ALT/ CZ, CZ2X,
complex SGPT) CZX
Activated clotting time X CT, CT1, CT2,
CT3, CT5
ACT 164 CZQ Quality Cross Check,
Chemistry and TDM
41
22
CTQ, CT1Q, Quality Cross Check, 48 IFS Interfering Substances 133
CT2Q, CT3Q, ACT LN2 Chemistry, Lipid, 120
CT5Q Enzyme Cal Ver/Lin
POC14, Competency Activated 54 LN2BV Chemistry, Lipid, 120
POC15, Clotting Time Enzyme all Beckman
POC16 except AU, Vitros Cal
Activated partial X CGB Basic Coagulation 160 Ver/Lin
thromboplastin time Albumin X C1, C3, C3X, Chemistry and TDM 56–58
CGE/CGEX Coagulation, Extended 161 CZ, CZ2X,
X CGL Coagulation, Limited 160 CZX
CGLQ Quality Cross Check, 47 CZQ Quality Cross Check, 41
Coagulation, Limited Chemistry and TDM
CGS1 Coag Special, Series 1 162 FLD Body Fluid 72
CGS3 Coag Special, Series 3 162 FLDQ Quality Cross Check, 42
Body Fluid Chemistry
CGS4 Coag Special, Series 4 162
IFS Interfering Substances 133
DBGN Anticoagulant 163
Monitoring, Dabigatran LN2 Chemistry, Lipid, 120
Enzyme Cal Ver/Lin
FNPX Anticoagulant 163
Monitoring, LN2BV Chemistry, Lipid, 120
Fondaparinux Enzyme all Beckman
except AU, Vitros Cal
RVBN Anticoagulant 163
Ver/Lin
Monitoring, Rivaroxaban
SPE Protein Electrophoresis 76
Activated protein C CGE/CGEX Coagulation, Extended 161
resistance Albumin, CSF X M, OLI CSF Chemistry and 74
Oligoclonal Bands
Albumin, urine ABU Accuracy-Based Urine 113
Active vitamin B12 MMA MMA and Active Vitamin 82
B12 LN20 Urine Albumin 126
Acylcarnitine BGL Biochemical Genetics 245 X U Urine Chemistry, 68
General
ADAMTS13 CGS7 ADAMTS13 162
Albumin: creatinine ratio ABU Accuracy-Based Urine 113
Adenovirus GIP Gastrointestinal Panel 204
LN20 Urine Albumin Cal Ver/ 126
X GIP5 Gastrointestinal Panel 204
Lin
ID2 Nucleic Acid Amp, 198
U Urine Chemistry, 68
Respiratory
General
IDPN Infectious Disease, 203
UMC Urine Albumin 153
Pneumonia Panel
Creatinine
X IDR Infectious Disease 202
Alcohol, serum X AL2 Serum Alcohol/Volatiles 101
Respiratory Panel
LN11 Serum Ethanol Cal Ver/ 124
VLS2 Viral Load 199
Lin
X VR1 Virology Culture 196
Alcohol, whole blood X AL1 Whole Blood Alcohol/ 101
X VR2 Viral Antigen by DFA 196 Volatiles
X VR4 Viral Antigen by EIA and 196 Aldolase ADL Aldolase 71
Latex
Aldosterone, serum X RAP Renin and Aldosterone 89
Adenovirus 40/41 SP, SPN Stool Pathogen 184
Aldosterone, urine X N/NX Urine Chemistry, Special 69
Adjustable micropipette I Instrumentation 132
Alkaline phosphatase X C1, C3, C3X, Chemistry and TDM 56–58
cal ver/lin
(ALP) CZ, CZ2X,
Adrenocorticotropic X TM/TMX Tumor Markers 89 CZX
hormone (ACTH)
CZQ Quality Cross Check, 41
Chemistry and TDM
800-323-4040 | 847-832-7000 Option 1 | cap.org 299


ENR Code ENR Code
Alkaline phosphatase FLD2 Body Fluid Chemistry 2 73 Amikacin (cont.) LN3 TDM Cal Ver/Lin 121
(ALP) (cont.) Amino acids, qualitative X BGL Biochemical Genetics 245
IFS Interfering Substances 133 Amino acids, quantitative BGL Biochemical Genetics 245
22 LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin
120 Amitriptyline DFC Drug-Facilitated Crime 108
FTC Forensic Toxicology, 104
LN2BV Chemistry, Lipid, 120 Criminalistics
Enzyme all Beckman
T Toxicology 96
Ver/Lin UT Urine Toxicology 96

Allergens (specific) SE Diagnostic Allergy 213 X ZT TDM, Special 60
Alpha-1 antitrypsin X IG/IGX Immunology, General 208 Ammonia C3, C3X, CZ, Chemistry and TDM 56–58
CZ2X, CZX
LN7 Immunology Cal Ver/Lin 123
Alpha-1 antitrypsin X AAT Alpha-1 Antitrypsin 245
Chemistry and TDM
genotyping Genotyping
LN32 Ammonia Cal Ver/Lin 128
Alpha-1 globulin SPE Protein Electrophoresis 76
Amniotic fluid leakage AFL Amniotic Fluid Leakage 148
Alpha-2 globulin SPE Protein Electrophoresis 76
(nitrazine)
Alpha-2-antiplasmin CGE/CGEX Coagulation, Extended 161
Amobarbital DFC Drug-Facilitated Crime 108
Alpha-2-macroglobulin A2MG Alpha-2-Macroglobulin 210
Amphetamine DFC Drug-Facilitated Crime 108
Alpha-fetoprotein (AFP), X FP/FPX Maternal Screen 87
DMPM Drug Monitoring for Pain 107
amniotic fluid
Management
Alpha-fetoprotein (AFP), X FP/FPX Maternal Screen 87
serum
Criminalistics
X K/KK Ligand Assay, General 82
OFD Oral Fluid for Drugs of 100
LN5 Ligand Assay Cal Ver/Lin 121- Abuse
122
T Toxicology 96
LN5S Ligand Assay, Siemens 121-
UDC Forensic Urine Drug 99
Cal Ver/Lin 122
Testing, Confirmatory
Alpha-hydroxyalprazolam DFC Drug-Facilitated Crime 108
UDS, UDS6 Urine Drug Screen 98
Management UT Urine Toxicology 96
FTC Forensic Toxicology, 104 UTCO Urine Toxicology 134
Criminalistics Carryover
T Toxicology 96 Amphetamine group DMPM Drug Monitoring for Pain 107
Management
Testing, Confirmatory OFD Oral Fluid for Drugs of 100
Abuse
UT Urine Toxicology 96
T Toxicology 96
Alpha-thalassemia HGM Hemoglobinopathies, 247
Molecular Methods UDS, UDS6 Urine Drug Screen 98
Alprazolam DMPM Drug Monitoring for Pain 107 UT Urine Toxicology 96
Management Amylase X C1, C3, C3X, Chemistry and TDM 56–58
FTC Forensic Toxicology, 104 CZ, CZ2X,
Criminalistics CZX
OFD Oral Fluid for Drugs of 100 CZQ Quality Cross Check, 41
Abuse Chemistry and TDM
T Toxicology 96 FLD Body Fluid 72
UT Urine Toxicology 96 FLDQ Quality Cross Check, 42
Aluminum X R Trace Metals 78
TMU Trace Metals, Urine 103
LN2 Chemistry, Lipid, 120
Aluminum, whole blood TMWB Trace Metals, Whole 103
Enzyme Cal Ver/Lin
Blood
LN2BV Chemistry, Lipid, 120
Amikacin X CZ, CZ2X, Chemistry and TDM 56–58
Enzyme all Beckman
CZX, Z
CZQ Quality Cross Check, 41 Ver/Lin
Chemistry and TDM

ENR Code ENR Code
Amylase, pancreatic X C1, C3, C3X, Chemistry and TDM 56–58 Antibody screen (HLA) MX1B, MX1C, HLA Analysis, Class I 236–
CZ, CZ2X, MX1E, MXB, 237
CZX MXC
CZQ Quality Cross Check,
Chemistry and TDM
41 MX2B, MX2C, HLA Analysis, Class II
MX2E, MXB,
236–
237
22
Amylase, urine LN6 Urine Chemistry Cal 122 MXC
Ver/Lin Antibody titer ABT, ABT1, Antibody Titer 223
X U Urine Chemistry, 68 ABT2, ABT3
General Antibody titer, automated AABT, AABT1, Antibody Titer, 224
Anabasine NTA Nicotine and Tobacco 102 AABT2, Automated
Alkaloids AABT3
Analytical balance I Instrumentation 132 Anticardiolipin IgA, ACL, APS Antiphospholipid 211
qualitative Antibody
Anaplasma TTD Antibody Detection- 205
phagocytophilum Tick-Transmitted Anticardiolipin IgA, ACL, APS Antiphospholipid 211
Diseases quantitative Antibody
Anaplastic lymphoma PM6 Anaplastic Lymphoma 280 Anticardiolipin IgG, IgM, X ACL, APS Antiphospholipid 211
kinase Kinase IHC polyclonal; qualitative Antibody
Androstenedione X Y/YY Ligand Assay, Special 84 Anticardiolipin IgG, IgM, ACL, APS Antiphospholipid 211
polyclonal; quantitative Antibody
Angiotensin converting ACE Angiotensin Converting 71
enzyme Enzyme Anti-CCP CCP Cyclic Citrullinated 212
Peptide Antibody
Anti ADAMTS13 IgG CGS7 ADAMTS13 162
Anticentromere antibody S2 Immunology, Special 209
Anti-A titer AABT, AABT1 Antibody Titer, 224
Automated Antichromatin antibody ACA Antichromatin Antibody 210
ABT, ABT1 Antibody Titer 223 Anti-CMV, IgG, IgM X VR3 Infectious Disease 205
Serology
Anti-B titer AABT3 Antibody Titer, 224
Automated Anti-CMV, total X VM3 Viral Markers-Series 3 230
ABT3 Antibody Titer 223 X VR3 Infectious Disease 205
Serology
Antibody detection X J, JAT Transfusion Medicine 220–
221 Anti-D titer AABT, AABT2 Antibody Titer, 224
Automated
JATE1 Transfusion Medicine, 221
Automated, Educational ABT, ABT2 Antibody Titer 223
JATQ Quality Cross Check, 49 Anti-DNA (ds) antibody, X S2, S4 Immunology, Special 209
Transfusion Medicine qualitative
X PS Platelet Serology 225 Anti-DNA (ds) antibody, S2, S4 Immunology, Special 209
quantitative
TMCA Transfusion Medicine, 225
Competency Anti-DNA topoisomerase RDS Rheumatic Disease 213
Assessment (Anti-Scl-70) Special Serologies
Antibody detection/ X MX1B, MX1C, HLA Analysis, Class I 236– Antideamidated gliadin CES, CESX Celiac Serology 212
identification (HLA) MX1E, MXB, 237 peptide antibody screen,
MXC IgA, IgG
X MX2B, MX2C, HLA Analysis, Class II 236– Antideamidated gliadin X CES, CESX Celiac Serology 212
MX2E, MXB, 237 peptide antibody, IgA,
MXC IgG; qualitative
Antibody identification ETME1 Expanded Transfusion 229 Antideamidated gliadin CES, CESX Celiac Serology 212
Medicine Exercises peptide antibody, IgA,
IgG; quantitative
X J, JAT Transfusion Medicine 220–
221 Antideamidated CES, CESX Celiac Serology 212
gliadin peptide/tissue
transglutaminase
Automated, Educational
antibody screen, IgA, IgG
Antiendomysial antibody CES, CESX Celiac Serology 212
Competency
IgA, qualitative
Assessment
Antiendomysial antibody CES, CESX Celiac Serology 212
IgA, quantitative
800-323-4040 | 847-832-7000 Option 1 | cap.org 301


ENR Code ENR Code
Antiendomysial antibody CES, CESX Celiac Serology 212 Anti-HBs, qualitative X VM1 Viral Markers-Series 1 230
IgG, qualitative Anti-HBs, quantitative VM1 Viral Markers-Series 1 230
Antiendomysial antibody CES, CESX Celiac Serology 212 Anti-HCV X RHCVW Anti-HCV, Rapid 231
22 IgG, quantitative
Antifilamentous actin IgG FCN Antifilamentous Actin 210 X VM1
Methods, Waived
Viral Markers-Series 1 230
antibody Antibody
Antihistidyl t-RNA RDS Rheumatic Disease 213
Antifungal drugs AFD Antifungal Drugs 106 synthetase (Jo-1) Special Serologies
monitoring Monitoring
Antihistone antibody AHT Antihistone Antibody 210

Antifungal susceptibility X F Mycology and Aerobic 189
Anti-HIV-1 X AHIV Anti-HIV Rapid Methods 231
testing Actinomycetes
X AHIVW Anti-HIV Rapid Methods 231
X F1 Yeast 189
X VM1 Viral Markers-Series 1 230
Antigen detection, CDF2 Clostridium difficile 180
bacterial Detection Anti-HIV-2 X AHIV Anti-HIV Rapid Methods 231
X CDF5 Clostridium difficile 181 X VM1 Viral Markers-Series 1 230
Detection Anti-HIV-1/2 X AHIV Anti-HIV Rapid Methods 231
X D Bacteriology 173 X AHIVW Anti-HIV Rapid Methods 231
X D6 Rapid Group A Strep 177 X VM1 Viral Markers-Series 1 230
X D8 Group B Strep 178 Anti-HIV-1/2, HIV-1 p24 X VM6, VM6X Viral Markers-Series 6 231
X D9 Rapid Group A Strep, 177 antigen
Waived Anti-HTLV-I/II VM3 Viral Markers-Series 3 230
X HC1 C. trachomatis by DFA 181 Anti-Jo-1 (antihistidyl RDS Rheumatic Disease 213
X HC3 C. trachomatis by EIA 181 t-RNA synthetase) Special Serologies
LBAS Legionella pneumophila 178 Anti-LKM LKM Liver-Kidney 213
Microsomal Antibody
X MC4 Urine Colony Count 176
Combination Antimicrobial X D Bacteriology 173
susceptibility testing
POC4 POC Strep Screen 52
Competency X D2 Urine Cultures 175
X RMC Routine Microbiology 176 MBT Microbiology Bench 174
Combination Tools Competency
SBAS Streptococcus 178 X RMC Routine Microbiology 176
pneumoniae Combination
X VS Vaginitis Screen 185 Antimitochondrial X S2 Immunology, Special 209
antibody, qualitative
Antigen detection, viral X HC2 HSV by DFA 197
Antimitochondrial S2 Immunology, Special 209
X VR2 Viral Antigen Detection 196
antibody, quantitative
by DFA
Antimitochondrial M2 H Antimitochondrial M2 210
antibody Antibody
by EIA and Latex
Anti-MPO S2 Immunology, Special 209
Antigliadin antibody IgA, CES, CESX Celiac Serology 212
IgG, qualitative Antimüllerian hormone X AMH Antimüllerian Hormone 84
Antigliadin antibody IgA, CES, CESX Celiac Serology 212 Antimycobacterial X E Mycobacteriology 188
IgG, quantitative susceptibility testing
Antiglomerular basement X S2 Immunology, Special 209 MTBR Molecular MTB 188
membrane, qualitative Detection and
Resistance
Antiglomerular basement S2 Immunology, Special 209
membrane, quantitative Antineutrophil S2 Immunology, Special 209
cytoplasmic antibody
Anti-HAV, IgG X VM1 Viral Markers-Series 1 230
(ANCA)
Anti-HAV, IgM X VM5 Viral Markers-Series 5 231
Antinuclear antibody X ANA, IL Immunology 208
Anti-HAV, total VM1 Viral Markers-Series 1 230 (ANA)
Anti-HBc, IgM X VM5 Viral Markers-Series 5 231 Antiparietal cell antibody APC Autoimmune Gastritis 210
Anti-HBc, total X VM1 Viral Markers-Series 1 230 Markers
Anti-Hbe X VM2 Viral Markers-Series 2 230 Antiphosphatidylserine APS Antiphosphatidylserine 211
antibodies (IgG, IgM, and Antibodies
IgA)

ENR Code ENR Code
Antiphosphatidylserine/ APS Antiphosphatidylserine 211 Antithyroid peroxidase, X S2, S4 Immunology, Special 209
prothrombin complex Antibodies qualitative
Antiphospholipid ACL Antiphospholipid 211 Antithyroid peroxidase, S2, S4 Immunology, Special 209
antibody
Anti-PR3 S2
Antibody
Immunology, Special 209
quantitative
Antitissue X CES, CESX Celiac Serology 212
22
Antiribosomal P antibody ARP Antiribosomal P 211 transglutaminase
Antibody antibody IgA, qualitative
Anti-RNP antibody, X S2 Immunology, Special 209 Antitissue CES, CESX Celiac Serology 212
qualitative transglutaminase
antibody IgA,
Anti-RNP antibody, S2 Immunology, Special 209
quantitative
quantitative
Antitissue CES, CESX Celiac Serology 212
Anti-Saccharomyces ASC Anti-Saccharomyces 211
transglutaminase
cerevisiae antibody cerevisiae Antibody
antibody IgG, qualitative
Anti-Scl-70 (anti-DNA RDS Rheumatic Disease 213
Antitissue CES, CESX Celiac Serology 212
topoisomerase) Special Serologies
transglutaminase
Anti-Sm antibody, X S2 Immunology, Special 209 antibody IgG,
qualitative quantitative
Anti-Sm antibody, S2 Immunology, Special 209 Anti-Trypanosoma cruzi VM4 Viral Markers-Series 4 230
quantitative
Apixaban APXBN Anticoagulant 163
Anti-Sm/RNP antibody, X S2 Immunology, Special 209 Monitoring, Apixaban
qualitative
Apolipoprotein A1 X ABL Accuracy-Based Lipids 112
Anti-Sm/RNP antibody, S2 Immunology, Special 209
X C3, C3X, CZ, Chemistry and TDM 56–58
quantitative
CZ2X, CZX
Antismooth muscle X S2 Immunology, Special 209
antibody, qualitative
Chemistry and TDM
Antismooth muscle S2 Immunology, Special 209
Apolipoprotein B X ABL Accuracy-Based Lipids 112
antibody, quantitative
X C3, C3X, CZ, Chemistry and TDM 56–58
Antisperm antibody IgG ASA Semen Analysis 156
CZ2X, CZX
Anti-SSA antibody, X S2 Immunology, Special 209
qualitative
Chemistry and TDM
Anti-SSA antibody, S2 Immunology, Special 209
Apolipoprotein E (APOE) X APOE Apolipoprotein E 245
quantitative
genotyping (APOE) genotyping
Anti-SSA/SSB antibody, X S2 Immunology, Special 209
Arsenic, urine TMU Trace Metals, Urine 103
qualitative
Arsenic, whole blood TMWB Trace Metals, Whole 103
Anti-SSA/SSB antibody, S2 Immunology, Special 209
Blood
quantitative
Arthropod identification TMO Ticks, Mites, and Other 194
Anti-SSB antibody, X S2 Immunology, Special 209
Arthropods
qualitative
Aspartate X C1, C3, C3X, Chemistry and TDM 56–58
Anti-SSB antibody, S2 Immunology, Special 209
aminotransferase (AST/ CZ, CZ2X,
quantitative
SGOT) CZX
Antistreptolysin O (ASO) X ASO, IL Immunology 208
Antithrombin (activity, CGE/CGEX Coagulation, Extended 161 Chemistry and TDM
Ag)
LN35 Thrombophilia Cal Ver/ 129 Enzyme Cal Ver/Lin
Lin
Antithyroglobulin X S2, S4 Immunology, Special 209 Enzyme all Beckman
antibody, qualitative except AU, Vitros Cal
Antithyroglobulin S2, S4 Immunology, Special 209 Ver/Lin
antibody, quantitative Aspirin assay PIA, PIAX Drug-Specific Platelet 167
Antithyroid microsomal, X S2, S4 Immunology, Special 209 Aggregation
qualitative Astrovirus GIP Gastrointestinal Panel 204
Antithyroid microsomal, S2, S4 Immunology, Special 209 X GIP5 Gastrointestinal Panel 204
quantitative
800-323-4040 | 847-832-7000 Option 1 | cap.org 303


ENR Code ENR Code
Atenolol T Toxicology 96 Bacterial detection in BDP, BDPV Bacterial Detection, 228

UT Urine Toxicology 96 platelets Platelets
Atropine T Toxicology 96 X BDP5, BDPV5 Bacterial Detection, 228
22 UT Urine Toxicology 96
Bacterial identification X D
Platelets
Bacteriology 173
Automated WBC X FH1-FH4, Hematology Automated 136
differential FH6, FH9, Differential X D1, D2, D3, Throat, Urine, GC 175–
FH10, FH13, RMC Cultures 176
FH1P-FH4P, D8
X Group B Strep 178

FH6P, FH9P, DEX Expanded Bacteriology 174
FH10P,
X HC6/HC6X C. trachomatis/GC by 186
FH13P
Nucleic Acid Amp
FH3Q, FH4Q, Quality Cross Check, 45
X HC7 C. trachomatis/GC DNA 186
FH6Q, FH9Q Automated Hematology
by NAA
Series
X IDR Infectious Disease, 202
Autopsy pathology AUP/AUP1 Autopsy Pathology 283
Respiratory Panel
B-ALL BALL B-ALL Minimal Residual 216
MBT Microbiology Bench 174
Disease
Tools Competency
B-type natriuretic X BNP B-Type Natriuretic 61
peptides Peptides, 2 Chall
Combination
X BNP5 B-Type Natriuretic 61
MRS Methicillin-resistant 182
Peptides, 5 Chall
BNPQ Quality Cross Check, 41 Screen
B-Type Natriuretic
MRS2M MRSA Screen, 182
Peptides
Molecular, 2 Challenge
LN30 B-Type Natriuretic 128
X MRS5 Methicillin-resistant 182
Peptides Cal Ver/Lin
X PCARI, Plasma Cardiac Markers 65 Screen
PCARM,
X MRS5M MRSA Screen, 182
PCARMX
POC12 Competency Plasma 53
Bacterial strain typing BSTS Bacterial Strain Typing- 178
Cardiac Markers
Staphylococcus
Babesia microti TTD Antibody Detection 205
Bacterial vaginosis BV Bacterial Vaginosis 184
of Tick-Transmitted
screen
Diseases
MVP Molecular Vaginal Panel 185
Bacterial antigen CDF2 Clostridium difficile 180
detection Detection VS2 Vaginitis Screen, Virtual 186
Gram Stain
X CDF5 Clostridium difficile 181
Detection Barbiturate group DMPM Drug Monitoring for Pain 107
Management
X D Bacteriology 173
SDS Serum Drug Screen 101
X D6 Rapid Group A Strep 177
T Toxicology 96
X HC1 C. trachomatis by DFA 181
X HC3 C. trachomatis by EIA 181
LBAS Legionella pneumophila 178
Antigen Detection BCR/ABL1 p190 MHO2, MHO3 Molecular Hematologic 262
Oncology
Combination MRD1 Minimal Residual 262
Disease
POC4 POC Strep Screen 52
Competency BCR/ABL1 p210 MHO2, MHO3 Molecular Hematologic 262
Oncology
X RMC Routine Microbiology 176
Combination MRD Minimal Residual 262
Disease
SBAS S. pneumoniae Antigen 178
Detection Bence Jones protein UBJP Urinary Bence Jones 76
Protein
X VS Vaginitis Screen 185
Benzodiazepine group DMPM Drug Monitoring for Pain 107
Management

ENR Code ENR Code
Benzodiazepine group OFD Oral Fluid for Drugs of 100 Bilirubin, total (cont.) LN2 Chemistry, Lipid, 120
(cont.) Abuse Enzyme Cal Ver/Lin
SDS Serum Drug Screen 101 LN2BV Chemistry, Lipid, 120
T Toxicology 96 Enzyme all Beckman
22
Ver/Lin
X NB, NB2 Neonatal Bilirubin 65
Benzoylecgonine DFC Drug-Facilitated Crime 108
Bilirubin, urine X CMP, CMP1 Clinical Microscopy 146
CMQ Quality Cross Check, 46
Management
Urinalysis
DSC Dipstick Confirmatory 149
Criminalistics
X HCC2 Waived Combination 66
Abuse POC3 POC Urine Dipstick 52
Competency
T Toxicology 96
Bioavailable testosterone DY Ligand Assay, Special 84
Testing, Confirmatory Biochemical genetics BGL, BGL1 Biochemical Genetics 245
UDS, UDS6 Urine Drug Screen 98 Bioterrorism agents LPX Laboratory 183
Preparedness Exercise
BK virus ID1T Nucleic Acid Amp, JC 197
UTCO Urine Toxicology 134
and BK
Carryover
VLS, VLS2 Viral Load 199
Beta-2-glycoprotein I ACL, APS Antiphospholipid 211
Antibody Blood cannabinoids THCB Blood Cannabinoids 106
Beta-2-microglobulin, X TM/TMX Tumor Markers 89 Blood cell identification VPBS Virtual Peripheral Blood 143
serum Smear
Beta-2-microglobulin, CD Cadmium 102 Blood cell identification X BCP, BCP2 Blood Cell Identification 139
urine photographs
Beta globulin SPE Serum Electrophoresis 76 X FH1-FH4, Hematology Automated 136
FH6, FH9, Differential
Beta-hydroxybutyrate X KET Ketones 64
FH10, FH13,
Beta-thalassemia HGM Hemoglobinopathies, 247 FH1P-FH4P,
Molecular Methods FH6P, FH9P,
Bile crystal identification, BCR Bile Crystals 149 FH10P,
photographs FH13P
Bilirubin, confirmatory DSC Dipstick Confirmatory 149 X HEP Basic Hematology 136
urine Blood culture X BCS Blood Culture 178
Bilirubin, direct X C1, C3, C3X, Chemistry and TDM 56–58 GNBC Gram-Negative Blood 179
C4, CZ, CZ2X, Culture Panel
CZX
GPBC Gram-Positive Blood 179
CZQ Quality Cross Check, 41 Culture Panel
Chemistry and TDM
Blood culture X BCS1 Blood Culture 179
LN2 Chemistry, Lipid, 120 Staphylococcus aureus Staphylococcus aureus
Enzyme Cal Ver/Lin
Blood or hemoglobin, X CMP, CMP1 Clinical Microscopy 146
LN2BV Chemistry, Lipid, 120 urine
Enzyme all Beckman
Blood parasite X BP Blood Parasite 193
Ver/Lin X P Parasitology 192
X NB, NB2 Neonatal Bilirubin 65 Blood parasite, rapid RMAL Rapid Malaria 193
Bilirubin, total X C1, C3, C3X, Chemistry and TDM 56–58 Bloom syndrome (BLM X MGL4 Molecular Genetics 248–
C4, CZ, CZ2X, gene) 249
CZX Bocavirus IDR Infectious Disease 202
CZQ Quality Cross Check, 41 Respiratory Panel
Chemistry and TDM Body fluid (cell count) ABF1, ABF2, Automated Body Fluid 148
FLD2 Body Fluid Chemistry 2 73 ABF3
IFS Interfering Substances 133 Body fluid (cell count) X HFC, HFCI Hemocytometer Fluid 150–
manual Count 151
800-323-4040 | 847-832-7000 Option 1 | cap.org 305


ENR Code ENR Code
Body fluid cell CMP/CMP1 Clinical Microscopy 146 Buprenorphine (cont.) OFD Oral Fluid for Drugs of 100
identification Abuse
VBF Virtual Body Fluid 148 T Toxicology 96
22 Body fluid (chemistry)
Body fluid crystal
FLD, FLD2
BFC
Body Fluid
Crystals
72–73
149
UDC Forensic Urine Drug
99
identification UDS, UDS6 Urine Drug Screen 98

Body fluid photographs CMP, CMP1 Clinical Microscopy 146 UT Urine Toxicology 96
Bone marrow cell BMD Bone Marrow Cell 139 Bupropion T Toxicology 96
differential Differential UT Urine Toxicology 96
Bone marrow cell BMD Bone Marrow Cell 139 Butalbital DFC Drug-Facilitated Crime 108
identification Differential
Bone specific alkaline BMV2 Bone Markers and 86 Management
phosphatase Vitamins
Bordetella holmesii X IDR Nucleic Acid Amp, 202 Criminalistics
Organisms
T Toxicology 96
Bordetella parapertussis BOR Bordetella pertussis/ 180
parapertussis,
Molecular
IDN, IDO Nucleic Acid Amp, 201
Organisms C. difficile antigen CDF2 Clostridium difficile 180
Detection
X IDR Infectious Disease 202
Respiratory Panel SP, SPN Stool Pathogens-Rapid 184
and Molecular
Bordetella pertussis BOR Bordetella pertussis/ 180
parapertussis, X CDF5 Clostridium difficile 181
Molecular Detection
IDN, IDO Nucleic Acid Amp, 201 X D Bacteriology, Antigen 173
Organisms Detection
X IDR Infectious Disease 202 C. difficile toxin CDF2 Clostridum difficile 180
Respiratory Panel Detection
Borrelia burgdorferi TTD Antibody Detection 205 CDF5 Clostridum difficile 181
of Tick-Transmitted Detection
Diseases D Bacteriology-Antigen 173
BRAF X BRAF Mutation Testing 260 Detection
X MTP Multigene Tumor Panel 261 GIP Gastrointestinal Panel 204
BRAF V600E BRAFV BRAF V600E 278 GIP5 Gastrointestinal Panel 204
BRCA1/2 X MGL3 Molecular Genetics 248– SP, SPN Stool Pathogens, Rapid 184
249 and Molecular
BRCA1/2 duplication/ X BRCA BRCA1/2 Sequencing 246 CA 15-3 LN34 Tumor Markers Cal Ver/ 129
deletion analysis Lin
BRCA1/2 sequencing X BRCA BRCA1/2 Sequencing 246 X TM/TMX Tumor Markers 89
Brain tissue by FISH CYJ Fluorescence In 243 CA 19-9 FLD Body Fluid 72
Situ Hybrid and FLDQ Quality Cross Check, 42
Interpretation on Site, Body Fluid Chemistry
Brain/Glioma Tissue LN34 Tumor Markers Cal Ver/ 129
Brightfield in situ X ISH2 In Situ Hybridization 258 Lin
hybridization X TM/TMX Tumor Markers 89
Bromazepam DFC Drug-Facilitated Crime 108 CA 27.29 X TM/TMX Tumor Markers 89
Brompheniramine DFC Drug-Facilitated Crime 108 CA 72-4 TM/TMX Tumor Markers 89
FTC Forensic Toxicology, 104 CA 125 LN34 Tumor Markers Cal Ver/ 129
Criminalistics Lin
T Toxicology 96 X TM/TMX Tumor Markers 89
UT Urine Toxicology 96 Cadmium, urine X CD Cadmium 102
Buprenorphine DMPM Drug Monitoring for Pain 107 Cadmium, whole blood X CD Cadmium 102
Management Caffeine X CZ2X, CZX, Chemistry and TDM 56–58
CZ, Z

ENR Code ENR Code
Caffeine (cont.) CZQ Quality Cross Check, 41 Carbamazepine (cont.) CZQ Quality Cross Check, 41
Chemistry and TDM Chemistry and TDM
Calcitonin X TM/TMX Tumor Markers 89 LN3 TDM Cal Ver/Lin 121
Calcium ABVD Accuracy-Based
Vitamin D
112 T Toxicology 96 22
X C1, C3, C3X, Chemistry and TDM 56–58 Carbamazepine-10,11- T Toxicology 96
C4, CZ, CZ2X, epoxide
CZX
Carbamazepine, free X CZ, CZ2X, Chemistry and TDM 56–58
Chemistry and TDM
CZX, Z
FLD2 Body Fluid Chemistry 2 73
IFS Interfering Substances 133 Chemistry and TDM
LN2 Chemistry, Lipid, 120 Carbapenem-resistant CRO Carbapenem-resistant 180
Enzyme Cal Ver/Lin organisms Organisms
LN2BV Chemistry, Lipid, 120 Carboxyhemoglobin X SO Blood Oximetry 94
Enzyme all Beckman
SOQ Quality Cross Check, 44
Blood Oximetry
Ver/Lin
Cardiomyopathy CMSP Cardiomyopathy 246
Calcium, ionized X AQ, AQ2, AQ3, Aqueous Blood Gas 92
sequencing panel Sequencing Panel
AQ4
Carisoprodol DFC Drug-Facilitated Crime 108
AQQ, AQ2Q, Quality Cross Check, 44
AQ3Q, AQ4Q Critical Care Aqueous DMPM Drug Monitoring for Pain 107
Blood Gas Series Management
X C3, C3X, CZ, Chemistry and TDM 56–58 FTC Forensic Toxicology, 104
CZ2X, CZX Criminalistics
CZQ Quality Cross Check, 41 T Toxicology 96
Chemistry and TDM UT Urine Toxicology 96
LN13C Blood Gas Cal Ver/Lin 124- Carnitine X BGL1 Biochemical Genetics 245
125 Casts, urine, UAA, UAA1 Automated Urinalysis 149
POC10, POC Competency Blood 53 semiquantitative
POC11 Gases CD1a RFAV1 Rare Flow Antigen 218
Calcium, urine ABU Accuracy-Based Urine 113 Validation CD1a
LN6 Urine Chemistry Cal 122 CD3 X FL, FL1 Lymphocyte Subset 215
Ver/Lin Immunophenotyping
X U Urine Chemistry, 68 LN22 Flow Cytometry Cal 126
General Ver/Lin
Calcofluor white FSM Fungal Smear 191 SCP Stem Cell Processing 227
Campylobacter CAMP Campylobacter 180 CD4 X FL, FL1 Lymphocyte Subset 215
GIP Gastrointestinal Panel 204 Immunophenotyping
X GIP5 Gastrointestinal Panel 204 LN22 Flow Cytometry Cal 126
Ver/Lin
Canavan disease (ASPA X MGL4 Molecular Genetics 248–
gene) 249 CD8 X FL, FL1 Lymphocyte Subset 215
Immunophenotyping
Candida culture X F3 Candida Culture 190
LN22 Flow Cytometry Cal 126
Candida glabrata vaginal, MVP Molecular Vaginal Panel 185
Ver/Lin
molecular
CD20 PM3 Immunohistochemistry 279
Candida krusei vaginal, MVP Molecular Vaginal Panel 185
molecular CD30 CD30 CD30 279
Immunohistochemistry
Candida sp., DNA probe X VS Vaginitis Screen 185
CD34 CBT Cord Blood Testing 227
Candida sp. group, MVP Molecular Vaginal Panel 185
vaginal, molecular X FL4 Flow Cytometry CD34+ 215
Cannabinoids See Delta-9-THC-COOH SCP Stem Cell Processing 227
and Delta-9-THC CD45 CBT Cord Blood Testing 227
Carbamazepine X CZ, CZ2X, Chemistry and TDM 56–58 X FL, FL1 Lymphocyte Subset 215
CZX, Z Immunophenotyping
800-323-4040 | 847-832-7000 Option 1 | cap.org 307


ENR Code ENR Code
CD45 (cont.) FL4 Flow Cytometry CD34+ 215 Chloride (cont.) LN2BV Chemistry, Lipid, 120
SCP Stem Cell Processing 227 Enzyme all Beckman
CD49d ZAP70 ZAP-70 Analysis by Flow 218
22 CD103 RFAV2
Cytometry
Rare Flow Antigen 218
POC10,
Ver/Lin
POC Competency Blood 53
POC11 Gases
Validation, CD103
Chloride, sweat X SW1, SW2, Sweat Analysis Series 79
CD117 (c-kit) PM1 Immunohistochemistry 279
SW4
CEA FLD Body Fluid 72

Chloride, urine LN6 Urine Chemistry Cal 122
FLDQ Quality Cross Check, 42 Ver/Lin
X U Urine Chemistry, 68
X K, KK, K2 Ligand Assay, General 82 General
LN5 Ligand Assay Cal Ver/Lin 121 Chloride, vitreous fluid VF Vitreous Fluid, Post- 101
LN5S Ligand Assay, Siemens 121 mortem
Cal Ver/Lin Chlorpheniramine DFC Drug-Facilitated Crime 108
Cell free DNA CFDNA Cell-Free Tumor DNA 260 FTC Forensic Toxicology, 104
NIPT Noninvasive Prenatal 88 Criminalistics
Testing T Toxicology 96
Ceruloplasmin X S2, S4 Immunology, Special 209 UT Urine Toxicology 96
CFU-GM SCP Stem Cell Processing 227 Cholesterol ABL Accuracy-Based Lipids 112
CH50 CH50 Total Hemolytic 214 X C1, C3, C3X, Chemistry and TDM 56–58
Complement C4, CZ, CZ2X,
CH100 CH50 CH100 214 CZX
Chlamydia trachomatis X HC1 C. trachomatis by DFA 181 CZQ Quality Cross Check, 41
X HC3 C. trachomatis by EIA 181 Chemistry and TDM
X HC6, HC6X C. trachomatis/GC by 186 FLD Body Fluid 72
Nucleic Acid Amp FLDQ Quality Cross Check, 42
X HC7 C. trachomatis/GC DNA 186 Body Fluid Chemistry
by NAA X LCW Ltd Chem, Waived 64
VR1 Virology Culture 196 LN2 Chemistry, Lipid, 120
Chlamydia pneumoniae IDN, IDO Nucleic Acid Amp, 201 Enzyme Cal Ver/Lin
Organisms LN2BV Chemistry, Lipid, 120
IDPN Infectious Disease, 203 Enzyme all Beckman
Pneumonia Panel except AU, Vitros Cal
X IDR Infectious Disease, 202 Ver/Lin
Respiratory Panel Chromium X R Trace Metals 78
Chlordiazepoxide T Toxicology 96 Chromium, urine TMU Trace Metals, Urine 103
UT Urine Toxicology 96 Chromium, whole blood TMWB Trace Metals, Whole 103
Chloride X AQ, AQ2, AQ3, Aqueous Blood Gas 92 Blood
AQ4 Chromosomal X CY, CYBK Cytogenetics 242
AQQ, AQ2Q, Quality Cross Check, 44 abnormalities
AQ3Q, AQ4Q Critical Care Aqueous Citalopram DFC Drug-Facilitated Crime 108
Blood Gas Series T Toxicology 96
X C1, C3, C3X, Chemistry and TDM 56–58 UT Urine Toxicology 96
C4, CZ, CZ2X, Citrate KSA Kidney Stone Risk 69
CZX Assessment
CZQ Quality Cross Check, 41 CK isoenzymes X CRTI Cardiac Markers 62
Chemistry and TDM
CK-MB X CRT, CRTI Cardiac Markers 62
FLD2 Body Fluid Chemistry 2 73 (immunochemical)
IFS Interfering Substances 133 CRTQ Quality Cross Check, 42
LN13C Blood Gas Cal Ver/Lin 124- Cardiac Markers
125 IFS Interfering Substances 133
LN2 Chemistry, Lipid, 120 LN2 Chemistry, Lipid, 120
Enzyme Cal Ver/Lin Enzyme Cal Ver/Lin

ENR Code ENR Code
CK-MB LN2BV Chemistry, Lipid, 120 CMV (cont.) X VM3 Viral Markers-Series 3 230
(immunochemical) Enzyme all Beckman X VR1 Virology Culture 196
(cont.) except AU, Vitros Cal
X PCARI,
Ver/Lin
Plasma Cardiac Markers 65
by DFA 22
X VR3 Infectious Disease 205
PCARM,
Serology
PCARMX
c-Myc/Bcl-2 MYBC c-Myc/Bcl-2 279
immunohistochemistry Immunohistochemistry
Cardiac Markers
tumor markers Tumor Markers
CK2 (MB) IFS Interfering Substances 133
Cobalt TMU Trace Metals, Urine 103
Cobalt, whole blood TMWB Trace Metals, Whole 103
Enzyme Cal Ver/Lin
Blood
Cocaethylene FTC Forensic Toxicology, 104
Enzyme all Beckman
Criminalistics
Ver/Lin T Toxicology 96
Clinical pathology CPIP/CPIP1 Quality Management, 14 UT Urine Toxicology 96
improvement program Education Cocaine DMPM Drug Monitoring for Pain 107
Clobazam DFC Drug-Facilitated Crime 108 Management
Clomipramine T Toxicology 96 FTC Forensic Toxicology, 104
Criminalistics
Clonazepam DMPM Drug Monitoring for Pain 107
Abuse
Management
T Toxicology 96
Criminalistics UDS, UDS6 Urine Drug Screen 98
T Toxicology 96 UT Urine Toxicology 96
UT Urine Toxicology 96 Codeine DFC Drug-Facilitated Crime 108
Clonidine DFC Drug-Facilitated Crime 108 DMPM Drug Monitoring for Pain 107
Management
Clostridium difficile CDF2 C. diff, 2 Challenge 180
antigen FTC Forensic Toxicology, 104
Criminalistics
X CDF5 C. diff, 5 Challenge 181
X D Bacteriology-Antigen 173
Abuse
Detection
T Toxicology 96
SP, SPN Stool Pathogens-Rapid 184
and Molecular UDC Forensic Urine Drug 99
Clostridium difficile toxin CDF2 Clostridum difficile 180
Detection UT Urine Toxicology 96
CDF5 Clostridum difficile 181 Compatibility testing X J, JAT Transfusion Medicine 220–
Detection 221
D Bacteriology-Antigen 173 JATE1 Transfusion Medicine, 221
Detection Automated, Educational
GIP Gastrointestinal Panel 204 TMCA Transfusion Medicine, 225
Competency
GIP5 Gastrointestinal Panel 204
Assessment
SP, SPN Stool Pathogens-Rapid 184
Complement C3 X IG/IGX Immunology, General 208
and Molecular
Clozapine T Toxicology 96
Complement C4 X IG/IGX Immunology, General 208
ZE Therapeutic Drug 60
Monitoring, Extended Complexed PSA X K/KK Ligand Assay, General 82
CMV ID1 Nucleic Acid Amp, 197 Conductivity, sweat X SW1, SW2, Sweat Analysis Series 79
Viruses SW4
LN38 CMV Viral Load Cal 130 Connexin 26 (GJB2 gene) X MGL3 Molecular Genetics 248–
249
Copper X R Trace Metals 78
800-323-4040 | 847-832-7000 Option 1 | cap.org 309


ENR Code ENR Code
Copper, urine TMU Trace Metals, Urine 103 Creatine kinase (CK) LN2BV Chemistry, Lipid, 120
Copper, whole blood TMWB Trace Metals, Whole 103 (cont.) Enzyme all Beckman
Blood except AU, Vitros Cal
22 Coproporphyrins
Coronavirus
X N/NX
ID2
Urine Chemistry, Special
Nucleic Acid Amp,
69
198
Creatinine X AQ2, AQ4
Ver/Lin
Aqueous Blood Gas 92
Respiratory AQ2Q, AQ4Q Quality Cross Check, 44
Critical Care Aqueous
Blood Gas Series
Pneumonia Panel
X C1, C3, C3X, Chemistry and TDM 56–58
C4, CZ, CZ2X,
Respiratory Panel
CZX
Cortisol ABS Accuracy-Based 113
Testosterone and
Chemistry and TDM
Estradiol
FLD Body Fluid 72
CZ, CZ2X, FLDQ Quality Cross Check, 42
CZX Body Fluid Chemistry
CZQ Quality Cross Check, 41 IFS Interfering Substances 133
Chemistry and TDM LN2 Chemistry, Lipid, 120
X K/KK Ligand Assay, General 82 Enzyme Cal Ver/Lin
LN5 Ligand Assay Cal Ver/Lin 121- LN24 Creatinine Accuracy Cal 127
122 Ver/Lin
LN5S Ligand Assay, Siemens 121- LN2BV Chemistry, Lipid, 120
Cal Ver/Lin 122 Enzyme all Beckman
Cortisol, salivary SALC Salivary Cortisol 77
Ver/Lin
Cortisol, urinary free X N/NX Urine Chemistry, Special 69
SCO Serum Carryover 134
Cotinine NTA Nicotine and Tobacco 102
Creatinine, urine ABU Accuracy-Based Urine 113
Alkaloids
X BU Bone and Mineral, Urine 85
T Toxicology 96
X CD Cadmium 102
DAI Urine Drug Adulterant/ 98
C-peptide ABGIC Accuracy-Based 115
Integrity Testing
Glucose, Insulin, and
C-Peptide LN20 Urine Albumin Cal Ver/ 126
Lin
X ING Insulin, Gastrin, 86
C-Peptide, PTH LN6 Urine Chemistry Cal 122
Ver/Lin
LN46 C-Peptide/Insulin Cal 131
Ver/Lin X U Urine Chemistry, 68
General
C-reactive protein (CRP) X CRP, IL Immunology 208
LN12, LN12E C-Reactive Protein Cal 124
Ver/Lin
X UMC Urine Albumin/ 153
C-reactive protein, high- X HSCRP High-Sensitivity 64
Creatinine
sensitivity (hsCRP) C-Reactive Protein
Creatinine, vitreous fluid VF Vitreous Fluid, Post- 101
LN21 High-Sensitivity 126
mortem
C-Reactive Protein Cal
Ver/Lin Creatinine, whole blood X WBCR Whole Blood Creatinine 66
Creatine kinase (CK) X C1, C3, C3X, Chemistry and TDM 56–58 Crossmatching EXM, EXM2 Electronic Crossmatch 221–
CZ, CZ2X, 222
CZX X J, JAT Transfusion Medicine 220–
CZQ Quality Cross Check, 41 221
Chemistry and TDM X MX1B, MX1C, HLA Analysis, Class I 236–
IFS Interfering Substances 133 MXB, MXC 237
LN2 Chemistry, Lipid, 120 X MX2B, MX2C, HLA Analysis Class II 236–
Enzyme Cal Ver/Lin MXB, MXC 237

ENR Code ENR Code
Crossmatching (cont.) TMCA Transfusion Medicine, 225 Cytogenomic microarray CYCGH Constitutional 244
Competency Microarray Analysis
Assessment CYCMA Cytogenomic Microarray 244
Cryptococcal antigen
detection
X CRYP Cryptococcal Antigen
Detection
190 Analysis for Oncologic
Abnormality
22
F Mycology and Aerobic 189 Cytology proficiency See Cytopathology GYN
Actinomycetes testing proficiency testing
F1 Yeast 189 Cytomegalovirus (CMV) ID1 Nucleic Acid Amp, 197
Cryptococcus IDME Meningitis/Encephalitis 202 Viruses
neoformans/gatti Panel IDME Meningitis/Encephalitis 202
Cryptosporidium GIP Gastrointestinal Panel 204 Panel
GIP5 Gastrointestinal Panel 204 LN38 CMV Viral Load Cal Ver/ 130
Lin
Cryptosporidium X P, P3, P4, P5 Parasitology 192
immunoassay, preserved VLS, VLS2 Viral Load 199
specimen X VM3 Viral Markers-Series 3 230
Crystal identification BCR Bile crystals 149 X VR1 Virology Culture 196
(bile) X VR2 Virology by DFA 196
Crystal identification BFC Body Fluid Crystals 149 X VR3 Infectious Disease 205
(body fluid) Serology
Crystal identification URC Urine Crystals 149 Cytopathology GYN PAPCE1 PAP Edu, Conventional 286
(urine) education
Crystals, urine UAA Automated Urinalysis 149 PAPJE1 PAP Edu, All 286
(semiquantitative) Technologies
CSF antigen detection X D Bacteriology 173 PAPKE1 PAP Edu, SurePath 286
CSF IgG calculations OLI CSF Chemistry and 74 PAPME1 PAP Edu, ThinPrep 286
Oligoclonal Bands
Cytopathology GYN PAPCPT PAP PT, Conventional 285
C-telopeptide (CTX) BMV5 Bone Markers and 86 proficiency testing
Vitamin
PAPJPT PAP PT, Combination 285
BU Bone and Mineral, Urine 85
PAPKPT PAP PT, SurePath 285
Cyclic citrullinated CCP Anti-cyclic Citrullinated 212
PAPLPT PAP PT, Combination 285
peptide antibody Peptide Antibody
PAPMPT PAP PT, ThinPrep 285
Cyclobenzaprine DFC Drug-Facilitated Crime 108
Cytopathology, FNA/FNA1 Fine-Needle Aspiration- 290
nongynecologic Online
Criminalistics
FNAG/FNAG1 Fine-Needle Aspiration- 291
T Toxicology 96
Glass
NGC/NGC1 Nongynecologic 289
Cyclospora cayatanensis GIP Gastrointestinal Panel 204 Cytopath Edu Prgm
GIP5 Gastrointestinal Panel 204 Cytopreparation HFC Hemocytometer Fluid 150
Cyclosporine X CS Immunosuppressive 59 differential manual Count
Drugs Dabigatran DBGN Anticoagulant 163
LN31 Immunosuppressive 128 Monitoring, Dabigatran
Drugs Cal Ver/Lin D-dimer, qualitative CGDF Coagulation, D-dimer/ 160
CYP2C9 PGX Pharmacogenetics 251 FDP
CYP2C19 PGX Pharmacogenetics 251 CGL Coagulation, Limited 160
CYP2D6 PGX Pharmacogenetics 251 D-dimer, quantitative X CGDF Coagulation, D-dimer/ 160
CYP3A4 PGX Pharmacogenetics 251 FDP
CYP3A5 PGX Pharmacogenetics 251 X CGL Coagulation, Limited 160
Cystatin C CYS Cystatin C 74 CGLQ Quality Cross Check, 47
Coagulation, Limited
Cystic fibrosis (CFTR X MGL2, MGL5 Molecular Genetics 248–
gene) 249 LN42 D-dimer Cal Ver/Lin 131
Cystine KSA Kidney Stone Risk 69 X PCARM, Plasma Cardiac Markers 65
Assessment PCARMX
Cardiac Markers
800-323-4040 | 847-832-7000 Option 1 | cap.org 311


ENR Code ENR Code
Delta-9-THC FTC Forensic Toxicology, 104 Diazepam DMPM Drug Monitoring for Pain 107
Criminalistics Management
OFD Oral Fluid for Drugs of 100 FTC Forensic Toxicology, 104
22 T
Abuse
Toxicology 96 OFD
Criminalistics
Oral Fluid for Drugs of 100
THCB Blood Cannabinoids 106 Abuse
Delta-9-THC-COOH DFC Drug-Facilitated Crime 108 UT Urine Toxicology 96

DMPM Drug Monitoring for Pain 107 Differential, automated X FH1-FH4, Hematology Automated 136
Management FH6, FH9, Differential
FH10, FH13
Criminalistics FH1P-FH4P, 136
FH6P, FH9P,
FH10P,
Abuse
FH13P
T Toxicology 96
THCB Blood Cannabinoids 106 FH6Q, FH9Q Automated Hematology
UDC Forensic Urine Drug 99 Series
Testing, Confirmatory Differential (bone BMD Bone Marrow Cell 139
UDS, UDS6 Urine Drug Screen 98 marrow), manual Differential
UT Urine Toxicology 96 Differential (fluid), HFC, HFCI Hemocytometer Fluid 150–
UTCO Urine Toxicology 134 manual Count 151
Carryover Differential (peripheral EHE1 Expanded Virtual 144
Demoxepam T Toxicology 96 blood), manual Peripheral Blood Smear
Deoxypyridinoline (DPD) BU Bone and Mineral, Urine 85 VPBS Virtual Peripheral Blood 143
Dermatopathology DPATH/ Online Digital Slide 267 Smear
DPATH1 Program Digital slide program in FNA/FNA1 Online Digital Slide 290
Dermatopathology DPIHC Dermatophathology 278 fine-needle aspiration, Program
immunohistochemistry Immunohistochemistry online
Dermatophyte X F Mycology and Aerobic 189 Digoxin X CZ, CZ2X, Chemistry and TDM 56–58
identification Actinomycetes CZX, Z
Desipramine DFC Drug-Facilitated Crime 108 CZQ Quality Cross Check, 41
Chemistry and TDM
Criminalistics LN3 TDM Cal Ver/Lin 121
T Toxicology 96 Digoxin, free X CZ, CZ2X, Chemistry and TDM 56–58
CZX, Z
X ZT TDM, Special 60
Chemistry and TDM
Desmethylclomipramine T Toxicology 96
Dihydrocodeine T Toxicology 96
Desmethylcycloben- FTC Forensic Toxicology, 104
Diltiazem T Toxicology 96
zaprine Criminalistics
T Toxicology 96
Dilute prothrombin time CGE/CGEX Coagulation, Extended 161
Dilute Russell’s viper CGS1 Coag Special, Series 1 162
Desmethylsertraline T Toxicology 96
venom time
Dimeric inhibin A (DIA) X FP, FPX Maternal Screen 87
Dextromethorphan DFC Drug-Facilitated Crime 108
Diphenhydramine DFC Drug-Facilitated Crime 108
Criminalistics
Criminalistics
T Toxicology 96
T Toxicology 96
DHEA sulfate X Y/YY Ligand Assay, Special 84
Diphenylhydantoin See Phenytoin
DIA (Dimeric inhibin A) X FP/FPX Maternal Screen 87
Direct antiglobulin X DAT Direct Antiglobulin 224
testing Testing

ENR Code ENR Code
Direct antiglobulin TMCAD Transfusion Medicine, 225 Ecgonine methyl ester FTC Forensic Toxicology, 104
testing (cont.) Competency Criminalistics
Assessment T Toxicology 96
Direct bilirubin X C1, C3, C3X, Chemistry and TDM
C4, CZ, CZ2X,
56–58 UT Urine Toxicology 96 22
E. coli O157 GIP Gastrointestinal Panel 204
CZX
Chemistry and TDM eGFR LN24 Creatinine Accuracy 127
CalVer/Lin
Enzyme Cal Ver/Lin EGFR—epidermal growth X EGFR Mutation Testing 260
factor receptor
Enzyme all Beckman X MTP Multigene Tumor Panel 261
except AU, Vitros Cal Electronic crossmatch EXM, EXM2 Electronic Crossmatch 221–
Ver/Lin 222
X NB, NB2 Neonatal Bilirubin 65 Electrophoresis X HG Hemoglobinopathy 140
Disease association/ DADR1, Disease Association/ 240 LPE Lipoprotein 76
drug risk DADR2 Drug Risk Electrophoresis
Disopyramide X CZ, CZ2X, Chemistry and TDM 56–58 X M, OLI CSF Chemistry and 74
CZX, Z Oligoclonal Bands
CZQ Quality Cross Check, 41 SPE Protein Electrophoresis 76
Chemistry and TDM UBJP Urinary Bence Jones 76
DMD/Becker (DMD gene) X MGL2 Molecular Genetics 248– Proteins
249 Elution, antibody ELU Eluate 224
DNA analysis X DML HLA Molecular Typing 237 TMCAE Eluate Competency 226
MHO Molecular Oncology 262 Assessment
X PARF Parentage/Relationship 233 Embryology EMB Embryology 157
DNA content/cell cycle FL, FL2 Flow Cytometry 215 Enteroaggregative E. coli GIP Gastrointestinal Panel 204
analysis (EAEC)
DNA extraction and MHO5 Molecular Oncology 259, X GIP5 Gastrointestinal Panel 204
amplification Hematologic 262 Enterobacter cloacae IDPN Infectious Disease, 203
DNA fingerprinting IDN, IDO Nucelic Acid Amp, 201 complex Pneumonia Panel
Organisms Enteropathogenic E. coli GIP Gastrointestinal Panel 204
DNA mismatch repair HQMMR HistoQIP Mismatch 275 (EPEC)
Repair IHC X GIP5 Gastrointestinal Panel 204
MMR DNA Mismatch Repair 278 Enterotoxigenic E. coli GIP Gastrointestinal Panel 204
DNA sequencing SEC, SEC1 DNA Sequencing 250 (ETEC)
Dopamine X N/NX Urine Chemistry, Special 69 X GIP5 Gastrointestinal Panel 204
Doxepin DFC Drug-Facilitated Crime 108 Enterovirus ID1 Nucleic Acid Amp, 197
FTC Forensic Toxicology, 104 Viruses
Criminalistics IDME Meningitis/Encephalitis 202
T Toxicology 96 Panel
UT Urine Toxicology 96 X IDR Infectious Disease, 202
Respiratory Panel
Doxylamine DFC Drug-Facilitated Crime 108
T Toxicology 96
Eosinophils, urine SCM2 Special Clinical 152
Microscopy
DPYD PGX3 Pharmacogenetics 251
Ephedrine FTC Forensic Toxicology, 104
Duloxetine T Toxicology 96 Criminalistics
Ecgonine ethyl ester FTC Forensic Toxicology, 104 UT Urine Toxicology 96
Criminalistics
Epidermal growth factor X EGFR Mutation Testing 260
T Toxicology 96 receptor (EGFR)
UT Urine Toxicology 96 X MTP Multigene Tumor Panel 261
Epinephrine X N/NX Urine Chemistry, Special 69
800-323-4040 | 847-832-7000 Option 1 | cap.org 313


ENR Code ENR Code
Epithelial cells, urine, UAA1 Automated Urinalysis 149 Factor II mutation X MGL1 Molecular Genetics 248–
semiquantitative 249
Epstein-Barr virus (EBV) ID1 Nucleic Acid Amp, 197 X TPM Thrombophilia 252
22 X ISH
Viruses
In Situ Hybridization 258 Factor V CGE/CGEX
Mutations
Coagulation, Extended 161
VLS, VLS2 Viral Load 199 Factor V Leiden mutation X MGL1 Molecular Genetics 248–
VR3 Antibody Detection- 205 (F5 gene) 249
Infectious Disease X TPM Thrombophilia 252

Serology Mutations
ER, PgR by X PM2 ER, PgR by 281 Factor VII CGE/CGEX Coagulation, Extended 161
immunohistochemistry Immunohistochemistry Factor VIII CGE/CGEX Coagulation, Extended 161
Erythrocyte ESR, ESR1, Erythrocyte 140 CGS3 Coag Special, Series 3 162
sedimentation rate ESR2, ESR3 Sedimentation Rate
Factor VIII inhibitor CGS3 Coag Special, Series 3 162
Erythropoietin EPO Erythropoietin 88
Factor IX CGE/CGEX Coagulation, Extended 161
Eschericia coli IDPN Infectious Disease, 203
Factor X CGE/CGEX Coagulation, Extended 161
Pneumonia Panel
Factor XI CGE/CGEX Coagulation, Extended 161
Escherichia coli K1 IDME Meningitis/Encephalitis 202
Panel Factor XII CGE/CGEX Coagulation, Extended 161
Escherichia coli O157 GIP Gastrointestinal Panel 204 Factor XIII CGE/CGEX Coagulation, Extended 161
X GIP5 Gastrointestinal Panel 204 Familial dysautonomia X MGL4 Molecular Genetics 248–
(IKBKAP gene) 249
Estazolam DFC Drug-Facilitated Crime 108
Fanconi anemia, X MGL4 Molecular Genetics 248–
Estradiol ABS Accuracy-Based 113 complementation grp. C 249
Testosterone and (FANCC gene)
Estradiol
Fecal calprotectin FCAL Fecal Calprotectin 75
LN8 Reproductive 123
Endocrinology Cal Ver/ Fecal fat, qualitative FCFS Fecal Fat 75
Lin Fecal lactoferrin FLAC Fecal Lactoferrin 181
X Y/YY Ligand Assay, Special 84 Fecal occult blood OCB Occult Blood 151
Estriol, unconjugated X FP/FPX Maternal Screen 87 OCBQ Quality Cross Check 46
(uE3) Occult Blood
X Y/YY Ligand Assay, Special 84 Fentanyl DFC Drug-Facilitated Crime 108
Estrogen receptors by X PM2 ER, PgR by 281 DMPM Drug Monitoring for Pain 107
immunohistochemistry Immunohistochemistry Management
Ethanol X AL1 Whole Blood Alcohol/ 101 FTC Forensic Toxicology, 104
Volatiles Criminalistics
X AL2 Serum Alcohol/Volatiles 101 OFD Oral Fluid for Drugs of 100
LN11 Serum Ethanol Cal Ver/ 124 Abuse
Lin T Toxicology 96
Ethanol, urine UDS, UDS6 Urine Drug Screen 98 UDC Forensic Urine Drug 99
Ethanol, vitreous fluid VF Vitreous Fluid, Post- 101 Testing, Confirmatory
mortem UDS, UDS6 Urine Drug Screen 98
Ethosuximide X CZ, CZ2X, Chemistry and TDM 56–58 UT Urine Toxicology 96
CZX, Z Fern test (vaginal) X CMMP Clinical Microscopy, 147
CZQ Quality Cross Check, 41 Misc
Chemistry and TDM Ferritin X C3, C3X, CZ, Chemistry and TDM 56–58
Ethyl glucuronide (EtG) ETB Ethanol Biomarkers 102 CZ2X, CZX
Ethyl sulfate (EtS) ETB Ethanol Biomarkers 102 CZQ Quality Cross Check, 41
Ethylene glycol AL1 Whole Blood Alcohol/ 101 Chemistry and TDM
Volatiles X K, KK, K2 Ligand Assay, General 82
AL2 Serum Alcohol/Volatiles 101 LN5 Ligand Assay Cal Ver/Lin 121-
Everolimus EV Everolimus 60 122
Factor II CGE/CGEX Coagulation, Extended 161 LN5S Ligand Assay, Siemens 121-
Cal Ver/Lin 122
Fetal fibronectin X FF Fetal Fibronectin 88

ENR Code ENR Code
Fetal hemoglobin (gastric APT Fetal Hemoglobin 150 FISH for lymphoma CYL Fluorescence In Situ 243
fluid) Hybridization and
Fetal hemoglobin X HG Hemoglobinopathy 140 Interpretation on Site,
identification
Fetal membrane rupture ROM1 Placental Alpha 152 FISH for paraffin- X CYH
Lymphoma
Fluorescence In Situ 243
22
Microglobulin 1 embedded tissue Hybridization and
(PAMG-1) Interpretation on Site,
Breast Cancer
Fetal red cell X HBF Fetal Red Cell Detection 225
quantitation CYJ Fluorescence In Situ 243
Hybridization and
TMCAF Transfusion Medicine, 226
Interpretation on Site,
Competency
Brain/Glioma Tissue
Assessment
CYK Fluorescence In Situ 243
Fetal screen (Rosette X HBF Fetal Red Cell Detection 225
Hybridization and
testing)
Interpretation on Site,
TMCAF Transfusion Medicine, 226 Solid Tumor
Competency
CYL Fluorescence In Situ 243
Assessment
Hybridization and
Fibrin degradation CGDF Coagulation, D-dimer/ 160 Interpretation on Site,
products, plasma FDP Lymphoma
CGL Coagulation, Limited 160 FISH for solid tumor CYK Fluorescence In Situ 243
CGLQ Quality Cross Check, 47 Hybridization and
Coagulation, Limited Interpretation on Site,
Fibrin degradation CGDF Coagulation, D-dimer/ 160 Solid Tumor
products, serum FDP FISH for urothelial X CYI Fluorescence In Situ 242
CGL Coagulation, Limited 160 carcinoma hybridization Hybridization and
CGLQ Quality Cross Check, 47 and interpretation Interpretation on Site,
Coagulation, Limited Urothelial Carcinoma
Fibrin monomer CGS3 Coag Special, Series 3 162 Flow cytometry, post- FL6 Flow Cytometry, 216
immunotherapy analysis Post-Immunotherapy
Fibrinogen X CGL Coagulation, Limited 160
Analysis
CGLQ Quality Cross Check, 47
Fluconazole AFD Antifungal Drugs 106
Monitoring
LN44 Fibrinogen, Cal Ver/Lin 131
Flunitrazepam T Toxicology 96
Fibrinogen antigen CGE/CGEX Coagulation, Extended 161
Fine-needle aspiration, FNA/FNA1 Online Digital Slide 290
Fluorescent microscope I Instrumentation 132
digital slide program Program
check
Fine-needle aspiration, FNAG/FNAG1 Fine-Needle Aspiration 291
Fluoxetine DFC Drug-Facilitated Crime 108
glass slides
FISH for brain/glioma CYJ Fluorescence In Situ 243
Criminalistics
Hybridization and
Interpretation on Site, Folate, RBC X FOL RBC Folate 88
Brain/Glioma Tissue Folate, serum X K, KK, K2 Ligand Assay, General 82
FISH for breast X CYH Fluorescence In Situ 243 LN5 Ligand Assay Cal Ver/Lin 121
carcinoma hybridization Hybridization and LN5S Ligand Assay, Siemens 121
and interpretation Interpretation on Site, Cal Ver/Lin
on site (HER2 gene Breast Cancer Follicle-stimulating ABS Accuracy-Based 113
amplification) hormone (FSH) Testosterone, Estradiol
FISH for breast CYHI Interpetation Only, HER2 282 LN8 Reproductive 123
carcinoma, interpretation FISH, Breast Cancer Endocrinology Cal Ver/
only (HER2 gene Lin
amplification)
X Y/YY Ligand Assay, Special 84
FISH for constitutional CYF Fluorescence In Situ 242
Fondaparinux FNPX Anticoagulant 163
and hematologic Hybridization and
Monitoring,
disorders Interpretation on Site
Fondaparinux
Forensic pathology FR/FR1 Forensic Pathology 294
800-323-4040 | 847-832-7000 Option 1 | cap.org 315


ENR Code ENR Code
Forensic toxicology FTC Forensic Toxicology, 104 Gentamicin X CZ, CZ2X, Chemistry and TDM 56–58
Criminalistics CZX, Z
Fragile X (FMR1 gene) X MGL1 Molecular Genetics 248– CZQ Quality Cross Check, 41
22 Free beta hCG FP1B First Trimester Maternal
249
87 LN3
Chemistry and TDM
TDM Cal Ver/Lin 121
Screening, Free Beta Giardia GIP Gastrointestinal Panel 204
Free Kappa/Lambda ratio SFLC Serum Free Light Chains 214 GIP5 Gastrointestinal Panel 204
Free testosterone X DY Ligand Assay, Special 84 Giardia immunoassay, X P, P3, P4, P5 Parasitology 192
Friedreich ataxia (FXN X MGL2 Molecular Genetics 248– preserved specimen
gene) 249 Giemsa stain X BP Blood Parasite 193
Fructosamine FT Fructosamine 75 X P Parasitology 192
Fungal culture CBT Cord Blood Testing 227 Glioma by FISH CYJ Fluorescence In Situ 243
SCP Stem Cell Processing 227 Hybridization and
Fungal serology FSER Fungal Serology 190 Interpretation on Site,
Brain/Glioma Tissue
Fungus identification X F Mycology and Aerobic 189
Actinomycetes Glucose ABGIC Accuracy-Based 115
Glucose, Insulin, and
X F1 Yeast 189 C-Peptide
X F3 Candida culture 190 X AQ2, AQ4 Aqueous Blood Gas 92
Gabapentin DFC Drug-Facilitated Crime 108 AQ2Q, AQ4Q Quality Cross Check, 44
DMPM Drug Monitoring for Pain 107 Critical Care Aqueous
Management Blood Gas Series
T Toxicology 96 X C1, C3, C3X, Chemistry and TDM 56–58
UT Urine Toxicology 96 C4, CZ, CZ2X,
ZE Therapeutic Drug 60 CZX
Monitoring, Extended CZQ Quality Cross Check, 41
Chemistry and TDM
Galactomannan FGAL Galactomannan 190
FLD Body Fluid 72
Gamma globulin M, OL1 CSF Chemistry 74
FLDQ Quality Cross Check, 42
SPE Serum Electrophoresis 76
Gamma glutamyl X C3, C3X, CZ, Chemistry and TDM 56–58
transferase (GGT) CZ2X, CZX
LN13, LN13C Blood Gas Cal Ver/Lin 124-
125
Chemistry and TDM
Enzyme Cal Ver/Lin
Enzyme Cal Ver/Lin
Enzyme all Beckman
LN2BV Chemistry, Lipid, 120 except AU, Vitros Cal
Enzyme all Beckman Ver/Lin
except AU, Vitros Cal Glucose, CSF X M, OLI CSF Chemistry and 74
Ver/Lin Oligoclonal Bands
Gamma hydroxybutyrate DFC Drug-Facilitated Crime 108 Glucose, urine X CMP, CMP1 Clinical Microscopy 146
(GHB)
FTC Forensic Toxicology, 104 Urinalysis
Criminalistics
Gardnerella vaginalis, X VS Vaginitis Screen 185
LN6 Urine Chemistry Cal 122
DNA probe
Ver/Lin
Gastric occult blood GOCB Gastric Occult Blood 150
POC3 POC Urine Dipstick 52
Gastric pH GOCB Gastric Occult Blood 150 Competency
Gastrin X ING Insulin, Gastrin, 86 X U Urine Chemistry, 68
C-Peptide, PTH General
Gaucher disease (GBA X MGL4 Molecular Genetics 248– Glucose, vitreous fluid VF Vitreous Fluid, Post- 101
gene) 249 mortem
Genomic copy number CYCGH Constitutional 244 Glucose, whole blood X HCC Waived Combination 66
array Microarray Analysis
HCC2 Waived Combination 66

ENR Code ENR Code
Glucose, whole blood X LCW Ltd Chem, Waived 64 Gyn cytopathology See Cytopathology GYN
(cont.) education Education
LN17 Whole Blood Glucose 125 Haemophilus influenzae IDME Meningitis/Encephalitis 202
POC2
Cal Ver/Lin
POC Glucose 52 IDPN
Panel
Infectious Disease, 203
22
Competency Pneumonia Panel
POC7 POC/Waived Glucose 52 Haptoglobin X IG/IGX Immunology, General 208
and Hemoglobin X S2/S4 Immunology, Special 209
Competency
HBeAg X VM2 Viral Markers, Series 2 230
WBGQ Quality Cross Check, 41
HBsAg X VM1 Viral Markers, Series 1 230
Whole Blood Glucose
HBV X HBVL, HBVL5 Hepatitis Viral Load 198
Glucose-6-phosphate G6PDS Glucose-6 Phosphate 75
dehydrogenase Dehydrogenase X NAT Nucleic Acid Testing 232
(qualitative and HCV X HCV2 Hepatitis Viral Load, 198
quantitative) Genotyping and
Glutaraldehyde, urine DAI Urine Drug Adulterant/ 98 Qualitative
Integrity Testing LN45 HCV Viral Load Cal Ver/ 130
Glycated serum albumin GSA Glycated Serum 64 Lin
Albumin X NAT Nucleic Acid Testing 232
Glycogen storage disease X MGL4 Molecular Genetics 248– HDL cholesterol ABL Accuracy-Based Lipid 112
type IA (G6PC gene) 249 X C1, C3, C3X, Chemistry and TDM 56–58
Glycohemoglobin X GH2, GH5, Hemoglobin A1c 63 C4, CZ, CZ3X,
GH5I CZX
GHQ Quality Cross Check, 42 CZQ Quality Cross Check, 41
Hemoglobin A1c Chemistry and TDM
LN15 Hemoglobin A1c Cal 125 X LCW Ltd Chem, Waived 64
Ver/Lin LN2 Chemistry, Lipid, 120
Glycosaminoglycans X BGL Biochemical Genetics 245 Enzyme Cal Ver/Lin
(mucopolysaccharides) LN2BV Chemistry, Lipid, 120
Gram stain X D Bacteriology 173 Enzyme all Beckman
X D2, D3, RMC Throat, Urine, GC 175– except AU, Vitros Cal
Cultures 176 Ver/Lin
X D5 Gram Stain 176 Helicobacter pylori X HPS H. pylori Antigen, Stool 181
VGS1 Virtual Gram Stain Basic 177 X S2, S4 H. pylori IgG Antibody 209
VGS2 Virtual Gram Stain 177 X S5 H. pylori IgG Antibody 209
Advanced X VR3 H. pylori IgG Antibody 205
VS2 Vaginitis Screen, Virtual 186 Hematocrit X AQ, AQ2, AQ3, Aqueous Blood Gas 92
Gram stain AQ4
Group A Streptococcus X D Bacteriology 173 AQQ, AQ2Q, Quality Cross Check, 44
antigen detection AQ3Q, AQ4Q Critical Care Aqueous
X D6 Rapid Group A Strep 177 Blood Gas Series
X D9 Rapid Group A Strep, 177 CBT Cord Blood Testing 227
Waived X FH15 Centrifugal Hematology 137
X MC4 Urine Colony Count 176 X FH1-FH4, Hematology Automated 136
Combination FH6, FH9, Differential
POC4 POC Strep Screen 52 FH10, FH13,
Competency FH1P-FH4P,
FH6P, FH9P,
X RMC Routine Microbiology 176
FH10P,
Combination
FH13P
Group B Streptococcus X D8 Group B Strep 178
Growth hormone X Y/YY Ligand Assay, Special 84 FH6Q, FH9Q Automated Hematology
Gyn cytopathology See Cytopathology GYN Series
Proficiency Testing X HCC2 Waived Combination 66
X HE, HEP Basic Hematology 136
800-323-4040 | 847-832-7000 Option 1 | cap.org 317


ENR Code ENR Code
Hematocrit (cont.) POC10, POC Competency Blood 53 Hemoglobin, estimated X AQ, AQ2, AQ3, Aqueous Blood Gas 92
POC11 Gases AQ4
SCP Stem Cell Processing 227 AQQ, AQ2Q, Quality Cross Check, 44
22 X SO
SOQ
Blood Oximetry
Quality Cross Check,
94
44
AQ3Q, AQ4Q Critical Care Aqueous
Blood Gas Series
Blood Oximetry POC10, POC Competency Blood 53
POC11 Gases
Hematologic disorders CYF Fluorescence In Situ 242
Hemoglobin F X HG Hemoglobinopathy 140
by FISH Hybridization and

Interpretation on Site quantitation
Hematology bone marrow BMD Bone Marrow Cell 139 Hemoglobin, plasma PHG Plasma Hemoglobin 76
case studies Differential Hemoglobin S/C X HGM Hemoglobinopathies 247
Hematology case studies VPBS Virtual Periperal Blood 143 Genotyping
Smear X MGL2 Molecular Genetics 248–
Hematology peripheral EHE1 Expanded Virtual 144 249
blood case studies Peripheral Blood Smear Hemoglobin, urine X CMP, CMP1 Clinical Microscopy 146
Hematopathology online HPATH, Hematopathology 145 CMQ Quality Cross Check, 46
education HPATH1 Online Education Urinalysis
Hemochromatosis (HFE X MGL1 Molecular Genetics 248– X HCC2 Waived Combination 66
gene) 249 POC3 POC Urine Dipstick 52
Hemocytometer fluid X HFC, HFCI Hemocytometer Fluid 150– Competency
count Count 151 Hemolytic complement, CH50 Total Hemolytic 214
Hemoglobin CBT Cord Blood Testing 227 total Complement
X FH15 Centrifugal Hematology 137 Hemosiderin, urine SCM1 Special Clinical 152
X FH1-FH4, Hematology Automated 136 Microscopy
FH6, FH9, Differential Heparin assay CGS4 Coag Special, Series 4 162
FH10, FH13, Heparin-induced CGE/CGEX Coagulation, Extended 161
FH1P-FH4P, thrombocytopenia
FH6P, FH9P,
CGS5 Coag Special, HIT 162
FH10P,
FH13P Heparin, low molecular LN36 Heparin Cal Ver/Lin 129
weight
FH6Q, FH9Q Automated Hematology Heparin, unfractionated LN36 Heparin Cal/Ver Lin 129
Series Heparin/platelet Factor CGS5 Coag Special, HIT 162
X HCC Waived Combination 66 IV
X HCC2 Waived Combination 66 Hepatitis B virus X HBVL, HBVL5 Hepatitis Viral Load 198
X HE, HEP Basic Hematology 136 Hepatitis C virus X HCV2 Hepatitis Viral Load, 198
Genotyping and
LN9 Hematology Cal Ver/Lin 123
Qualitative
POC7 POC/Waived Glucose 52
LN45 HCV Viral Load Cal Ver/ 130
and Hemoglobin
Lin
Competency
HER2 by X HER2 HER2 by 281
SCP Stem Cell Processing 227
immunohistochemistry Immunohistochemistry
X SO Blood Oximetry 94
HER2 by molecular MTP Multigene Tumor Panel 261
SOQ Quality Cross Check, 44 testing
Blood Oximetry
HER2, gastric GHER2 Gastric HER2 281
Hemoglobin A1c X GH2, GH5, Hemoglobin A1c 63
HER2 gene amplification X CYH Fluorescence In Situ 243
GH5I
by FISH, hybridization Hybridization and
GHQ Quality Cross Check, 42 and interpretation on site Interpretation on Site,
Hemoglobin A1c Breast Cancer
LN15 Hemoglobin A1c Cal 125 HER2 gene amplification CYHI Interpetation Only, HER2 282
Ver/Lin by FISH, interpretation FISH, Breast Cancer
Hemoglobin A2 X HG Hemoglobinopathy 140 only
quantitation HER2 gene amplification X ISH2 In Situ Hybridization 258
Hemoglobin X HG Hemoglobinopathy 140 by ISH
electrophoresis

ENR Code ENR Code
Herpes simplex virus X HC2 HSV by DFA 197 HIV (cont.) X NAT Nucleic Acid Testing 232
(HSV) HIV genotyping HIVG HIV Viral Genotyping 199
X HC4 HSV Culture 197 HIV-1 p24 antigen X VM3 Viral Markers-Series 3 230
ID1 Nucleic Acid Amp,
Viruses
197 HIV-1 p24 antigen, anti- X VM6, VM6X Viral Markers-Series 6 231 22
HIV-1/2
X ID5 HSV, Molecular 198 HLA-A, -B, -C antibody X MX1B, MX1C, HLA Analysis, Class I 236–
IDME Meningitis/Encephalitis 202 identification MX1E, MXB, 237
Panel MXC
X VR1 Virology Culture 196 X MX2B, MX2C, HLA Analysis, Class II 236–
X VR2 Viral Antigen by DFA 196 MX2E, MXB, 237
MXC
X VR3 Antibody Detection- 205
Infectious Disease HLA-(class I/II) antibody MX1B, MX1C, HLA Analysis, Class I/II 236–
Serology screen MX1E, MX2B, 237
MX2C, MX2E,
HHV6 ID1 Nucleic Acid Amp, 197
MXB, MXC
Viruses
HLA-(class I/II) X MX1B, MX1C, HLA Analysis, Class I 236–
IDME Meningitis/Encephalitis 202
crossmatching MX1E, MXB, 237
Panel
MXC
VLS2 Viral Load 199
X MX2B, MX2C, HLA Analysis, Class II 236–
HHV8 ID1 Nucleic Acid Amp, 197 MX2E, MXB, 237
Viruses MXC
High-sensitivity X HSCRP hsCRP 64 HLA-B*1502 PGX2 Pharmacogenetics 251
C-reactive protein
HLA-B27 typing X B27 HLA-B27 Typing 237
HLA-B*57:01 DADR1 Disease Association, 240
C-Reactive Protein Cal
Drug Risk
Ver/Lin
PGX2 Pharmacogenetics 251
Histotechnology quality HQIP HistoQIP 271
improvement HLA-B*58:01 DADR1 Disease Association, 240
Drug Risk
Histotechnology quality HQIPBX, HistoQIP Biopsy Series 276–
improvement, biopsy HQPBX1, 277 HLA-DQA1*03/ DADR2 Disease Association, 240
HQBX2, DQB1*03:02 Drug Risk
HQBX3, HLA-DQA1*05/DQB1*02 DADR2 Disease Association, 240
HQBX4 Drug Risk
Histotechnology quality HQNEU HistoQIP Central 272 HLA molecular typing X DML HLA Molecular Typing 237
improvement, central Nervous System IHC Homocysteine X HMS Homocysteine 64
nervous system IHC
LN16 Homocysteine Cal Ver/ 125
Histotechnology quality HQIHC HistoQIP IHC 274 Lin
improvement, IHC
Homovanillic acid X N/NX Urine Chemistry, Special 69
Histotechnology quality HQMMR HistoQIP Mismatch 275
HPV (cytopathology), X CHPVD Digene Specimen 287
improvement, mismatch Repair IHC
high-risk Transport Medium
repair IHC
X CHPVJ Mixed Medium 287
Histotechnology quality HQNSC HistoQIP Non-small Cell 276
improvement, non-small Lung Carcinoma IHC X CHPVK SurePath Preservative 287
cell lung carcinoma IHC Fluid Transport Medium
Histotechnology quality HQISH HistoQIP In Situ 272 X CHPVM ThinPrep PreservCyt 287
improvement, ISH Hybridization (Kappa/ Transport Medium
Lambda) HPV Digene Hybrid Capture 197
Histotechnology quality HQMEL HistoQIP Melanoma IHC 273 Technology Only
improvement, melanoma ISH In Situ Hybridization 258
IHC HSV X HC2 HSV by DFA 197
Histotechnology quality HQWSI HistoQIP Whole Slide 274 X HC4 HSV Culture 197
improvement, whole Image ID1 Nucleic Acid Amp, 197
slide image Viruses
HIV X HIVG, HV2 HIV Viral Load 199 X ID5 Herpes Simplex Virus, 198
LN39 HIV Viral Load Cal Ver/ 130 Molecular
Lin X VR1 Virology Culture 196
800-323-4040 | 847-832-7000 Option 1 | cap.org 319


ENR Code ENR Code
HSV (cont.) X VR2 Viral Antigen by DFA 196 Human papillomavirus X CHPVM ThinPrep PreservCyt 287
X VR3 Antibody Detection- 205 (cytology) high-risk Transport Medium
Infectious Disease (cont.)
22 Human chorionic X
Serology
C1, C3, C3X, Chemistry and TDM 56–58
HPV Digene Hybrid Capture
Technology Only
197
gonadotropin (hCG), C4, CZ, CZ2X, ISH In Situ Hybridization 258

serum CZX CHPVJ Mixed Medium 287
CHPVM ThinPrep PreservCyt 287

Chemistry and TDM Transport Medium
X FP/FPX, FP1T Maternal Screen 87 Human parechovirus IDME Meningitis/Encephalitis 202
X HCG, IL Immunology 208 Panel
X K/KK Ligand Assay, General 82 Huntington disease (HTT X MGL2 Molecular Genetics 248–
LN5 Ligand Assay Cal Ver/Lin 121- gene) 249
122 Hydrocodone DFC Drug-Facilitated Crime 108
LN5S Ligand Assay, Siemens 121- DMPM Drug Monitoring for Pain 107
Cal Ver/Lin 122 Management
LN8 Reproductive 123 FTC Forensic Toxicology, 104
Endocrinology Cal Ver/ Criminalistics
Lin OFD Oral Fluid for Drugs of 100
SCO Serum Carryover 134 Abuse
Human chorionic X CMP, CMP1 Clinical Microscopy 146 T Toxicology 96
gonadotropin (hCG),urine UDC Forensic Urine Drug 99
CMQ Quality Cross Check, 46 Testing, Confirmatory
Urinalysis UT Urine Toxicology 96
X HCC2 Waived Combination 66 Hydromorphone DFC Drug-Facilitated Crime 108
POC1 POC hCG Competency 52 DMPM Drug Monitoring for Pain 107
POC3 POC Urine Dipstick 52 Management
Competency FTC Forensic Toxicology, 104
X UHCG Urine HCG 152 Criminalistics
Human epididymis HUEP Human Epididymis 89 OFD Oral Fluid for Drugs of 100
protein 4 Protein 4 Abuse
Human herpesvirus 6 ID1 Nucleic Acid Amp, 197 T Toxicology 96
Viruses UDC Forensic Urine Drug 99
IDME Meningitis/Encephalitis 202 Testing, Confirmatory
Panel UT Urine Toxicology 96
VLS2 Viral Load 199 Hydroxybupropion T Toxicology 96
Human herpesvirus 8 ID1 Nucleic Acid Amp, 197 Hydroxyzine DFC Drug-Facilitated Crime 108
Viruses
T Toxicology 96
Human immuno- HIVG HIV Genotyping 199
deficiency virus (HIV)
Ibuprofen T Toxicology 96
X HIVG, HV2 HIV Viral Load 199
LN39 HIV Viral Load Cal Ver/ 130
Lin IDH1 GLI Glioma 261
Human ID2 Nucleic Acid Amp, 198 IDH2 GLI Glioma 261
metapneumovirus Respiratory IgA X IG/IGX Immunology, General 208
IDPN Infectious Disease, 203 LN7 Immunology Cal Ver/Lin 123
Pneumonia Panel IgA, electrophoresis X SPE Protein Electrophoresis 76
X IDR Infectious Disease, 202 IgD S2, S4 Immunology, Special 209
Respiratory Panel IgE X IG/IGX Immunology, General 208
Human papillomavirus X CHPVD Digene Specimen 287 X K/KK Ligand Assay, General 82
(cytology) high-risk Transport Medium
X SE Diagnostic Allergy 213
X CHPVJ Mixed Medium 287
IgE allergen-specific, SE Diagnostic Allergy 213
X CHPVK SurePath Preservative 287 quantitative
Fluid Transport Medium

ENR Code ENR Code
IgE multi-allergen screen X SE Diagnostic Allergy 213 In situ hybridization X ISH In Situ Hybridization 258
IGF-1 (somatomedin C) X BGS Bone and Growth 85 X ISH2 In Situ Hybridization 258
X Y/YY Ligand Assay, Special 84 HER2
IgG X IG/IGX Immunology, General 208 India ink IND India Ink 191 22
LN7 Immunology Cal Ver/Lin 123 Infectious disease, IDPN Infectious Disease, 203
S2, S4 Immunology, Special 209 pneumonia panel Pneumonia Panel
IgG subclass proteins S2, S4 Immunology, Special 209 Infectious X IL, IM Immunology 208
mononucleosis (IM)
IgG, CSF X M, OLI CSF Chemistry and 74
Oligoclonal Bands X IMW Infectious 209
Mononucleosis, Waived
IgG, electrophoresis X SPE Protein Electrophoresis 76
Influenza virus ID2 Nucleic Acid Amp, Resp 198
IGHV IGHV Mutation Analysis 258
X ID3 Influenza A, Influenza B, 198
IgM X IG/IGX Immunology, General 208
RSV by NAA
IgM, electrophoresis X SPE Protein Electrophoresis 76 Pneumonia Panel
IL-2 CTKN Cytokines 212 X IDR Infectious Disease, 202
IL-6 CTKN Cytokines 212 Respiratory Panel
IL-8 CTKN Cytokines 212 POC8 POC Influenza A/B Ag 52
IL-10 CTKN Cytokines 212 X VR1 Virology Culture 196
IL28B PGX1 Pharmacogenetics 251 X VR2 Viral Antigen Detection 196
Imipramine DFC Drug-Facilitated Crime 108 by DFA
FTC Forensic Toxicology, 104 X VR4 Viral Antigen Detection 196
Criminalistics by EIA and Latex
T Toxicology 96 Inherited cancer ICSP Inherited Cancer 247
UT Urine Toxicology 96 sequencing panel Sequencing Panel
X ZT TDM, Special 60 Instrument function I Instrumentation 132
Immature granulocyte FH9, FH9P Hematology, Auto Diff 136 Instrument linearity I Instrumentation 132
parameter LN11 Serum Ethanol Cal Ver/ 124
Immature platelet FH9, FH9P Hematology, Auto Diff 136 Lin
fraction (IPF) LN12, LN12E C-Reactive Protein Cal 124
Immature reticulocyte RT, RT3, RT4 Reticulocyte 141 Ver/Lin
fraction (IRF) LN13, LN13C Blood Gas Cal Ver/Lin 124-
Immunohistochemistry BRAFV BRAF V600E 278 125
CD30 CD30 279 LN15 Hemoglobin A1c Cal 125
Immunohistochemistry Ver/Lin
DPIHC Dermatophathology 278 LN16 Homocysteine Cal Ver/ 125
Immunohistochemistry Lin
GHER2 Gastric HER2 281 LN17 Whole Blood Glucose 125
Cal Ver/Lin
X HER2 HER2 by 281
Immunohistochemistry LN18, LN19 Reticulocyte Cal Ver/Lin 126
MK Immunohistochemistry 278 LN2 Chemistry, Lipid, 120
Enzyme Cal Ver/Lin
MMR DNA Mismatch Repair 278
LN20 Urine Albumin Cal Ver/ 126
PDL1 PDL1 279
Lin
PM1 CD117 by 279
Immunohistochemistry C-Reactive Protein Cal
X PM2 ER, PR by 281 Ver/Lin
Immunohistochemistry LN22 Flow Cytometry Cal 126
PM3 CD20 by 279 Ver/Lin
Immunohistochemistry LN23 PSA Cal Ver/Lin 127
PM5 Immunohistochemistry 280 LN24 Creatinine Accuracy Cal 127
TMA Ver/Lin
PM6 Anaplastic Lymphoma 280 LN25 Troponin I Cal Ver/Lin 127
Kinase IHC
LN27 Troponin T Cal Ver/Lin 127
800-323-4040 | 847-832-7000 Option 1 | cap.org 321


ENR Code ENR Code
Instrument linearity LN2BV Chemistry, Lipid, 120 International normalized X CGL Coagulation, Limited 160
(cont.) Enzyme all Beckman ratio (INR) (cont.)
except AU, Vitros Cal CGLQ Quality Cross Check, 47
Ver/Lin
22 LN3 TDM Cal Ver/Lin 121 CGS1
Coag Special, Series 1 162
LN30 BNP Cal Ver/Lin 128 CGS4 Coag Special, Series 4 162
LN31 Immunosuppressive 128 POC6 POC PT/INR, CoaguChek 52
Drugs Cal Ver/Lin
XS Plus
LN32 Ammonia Cal Ver/Lin 128
WP10 Whole Blood 168
LN33 Serum Myoglobin Cal 128 Coagulation
Ver/Lin
X WP3, WP4, Whole Blood 168
LN34 Tumor Markers Cal Ver/ 129 WP6, WP9 Coagulation
Lin
Ionized calcium X AQ, AQ2, AQ3, Aqueous Blood Gas 92
LN35 Thrombophilia Cal Ver/ 129 AQ4
Lin
LN36 Heparin Cal Ver/Lin 129 AQ3Q, AQ4Q Critical Care Aqueous
LN37 von Willebrand Factor 129 Blood Gas Series
Ag Cal Ver/Lin
X C3, CZ, CZX Chemistry and TDM 56–58
LN38 CMV Viral Load Cal Ver/ 130
POC10, POC Competency Blood 53
Lin
POC11 Gases
LN39 HIV Viral Load Cal Ver/ 130
Iron X C1, C3, C3X, Chemistry and TDM 56–58
Lin
CZ, CZ2X,
LN40 Vitamin D Cal Ver/Lin 130 CZX
LN41 Procalcitonin Cal Ver/ 130 CZQ Quality Cross Check, 41
Lin Chemistry and TDM
LN42 D-Dimer Cal Ver/Lin 131 IFS Interfering Substances 133
LN43 Lamellar Body Count 131 LN2 Chemistry, Lipid, 120
Cal Ver/Lin Enzyme Cal Ver/Lin
LN44 Fibrinogen Cal Ver/Lin 131 LN2BV Chemistry, Lipid, 120
LN45 HCV Viral Load Cal Ver/ 130 Enzyme all Beckman
Lin except AU, Vitros Cal
LN46 C-Peptide/Insulin Cal 131 Ver/Lin
Ver/Lin Isopropanol X AL1 Whole Blood Alcohol/ 101
LN5 Ligand Assay Cal Ver/Lin 121- Volatiles
122 X AL2 Serum Alcohol/Volatiles 101
LN5S Ligand Assay, Siemens 121- Itraconazole AFD Antifungal Drugs 106
Cal Ver/Lin 122 Monitoring
LN6 Urine Chemistry Cal 122 JC virus ID1T Nucleic Acid Amp, JC 197
Ver/Lin and BK
LN7 Immunology Cal Ver/Lin 123 Jo-1 (antihistidyl t-RNA RDS Rheumatic Disease 213
LN8 Reproductive 123 synthetase) Special
Endocrinology Cal Ver/ Kaolin-activated CT CGE/CGEX Coagluation, Extended 161
Lin
Kappa/Lambda X ISH In Situ Hybridization 258
Kappa/Lambda ratio IG/IGX Immunology, General 208
Insulin ABGIC Accuracy-Based 115
Glucose, Insulin, and S2, S4 Immunology, Special 209
C-Peptide Karyotype nomenclature X CY, CYBK Cytogenetics 242
X ING Insulin, Gastrin, 86 Ketamine DFC Drug-Facilitated Crime 108
C-Peptide, PTH FTC Forensic Toxicology, 104
LN46 C-Peptide/Insulin Cal 131 Criminalistics
Interferon (IFN) gamma CTKN Cytokines 212 UT Urine Toxicology 96
Interleukin (IL)-1 beta CTKN Cytokines 212 Ketones, serum KET Ketones 64
International normalized X CGB Basic Coagulation 160 Ketones, urine X CMP, CMP1 Clinical Microscopy 146
ratio (INR)

ENR Code ENR Code
Ketones, urine (cont.) CMQ Quality Cross Check, 46 Lactate dehydrogenase LN2BV Chemistry, Lipid, 120
Urinalysis (LD) (cont.) Enzyme all Beckman
X HCC2 Waived Combination 66 except AU, Vitros Cal
POC3 POC Urine Dipstick
Competency
52
SCO
Ver/Lin
Serum Carryover 134
22
Kidney stone assessment KSA Kidney Stone 69 Lactate dehydrogenase X M, OLI CSF Chemistry and 74
Assessment (LD), CSF Oligclonal Bands
KIT KIT KIT/PDGFRA 260 Lamellar body count LBC Lamellar Body Count 151
MTP Multigene Tumor Panel 261 LN43 Lamellar Body Count 131
Klebsiella aerogenes IDPN Infectious Disease, 203 Cal Ver/Lin
Pneumonia Panel Lamotrigine T Toxicology 96
Klebsiella oxytoca IDPN Infectious Disease, 203 UT Urine Toxicology 96
Pneumonia Panel ZE Therapeutic Drug 60
Klebsiella pneumoniae IDPN Infectious Disease, 203 Monitoring, Extended
group Pneumonia Panel Large unclassified cells FH4, FH4P Hematology, Auto Diff
KOH prep (skin) X CMMP Clinical Microscopy, 147 (LUC)
Misc LD isoenzymes X CRTI Cardiac Markers 62
KOH prep (skin or X FSM Fungal Smear 191 LD1/LD2 ratio X CRTI Cardiac Markers 62
vaginal)
LDL cholesterol X ABL Accuracy-Based Lipid 112
KRAS X KRAS Colorectal Cancer 260
LDL cholesterol, X C1, C3, C3X, Chemistry and TDM 56–58
Mutation
measured C4, CZ, CZ2X,
X MTP Multigene Tumor Panel 261 CZX
Laboratory preparedness LPX Laboratory 183 CZQ Quality Cross Check, 41
exercise Preparedness Exercise
Chemistry and TDM
Lacosamide ZE Therapeutic Drug 60
LDL cholesterol, waived X LCW Ltd Chem, Waived 64
Monitoring, Extended
Lead (blood) X BL Blood Lead 102
Lactate X AQ, AQ2, AQ3, Aqueous Blood Gas 92
AQ4 Lead, urine TMU Trace Metals, Urine 103
AQQ, AQ2Q, Quality Cross Check, 44 Legionella LBAS Legionella Ag 178
AQ3Q, AQ4Q Critical Care Aqueous Legionella pneumophila IDN, IDO Nucleic Acid Amp, 201
Blood Gas Series Organisms
X C3, C3X, CZ, Chemistry and TDM 56–58 IDPN Infectious Disease, 203
CZ2X, CZX Pneumonia Panel
CZQ Quality Cross Check, 41 X IDR Infectious Disease, 202
Chemistry and TDM Respiratory Panel
FLD Body Fluid 72 Leukemia/lymphoma FL3 Flow Cytometry 215
FLDQ Quality Cross Check, 42 immunophenotype
Body Fluid Chemistry Leukemia/lymphoma FL5 Flow Cytometry 216
LN13C Blood Gas Cal Ver/Lin 124- interpretation only Interpretation Only
125 Leukocyte esterase, urine X CMP, CMP1 Clinical Microscopy 146
POC10, POC Competency Blood 53 CMQ Quality Cross Check, 46
POC11 Gases Urinalysis
Lactate, CSF X M, OLI CSF Chemistry and 74 X HCC2 Waived Combination 66
Oligoclonal Bands POC3 POC Urine Dipstick 52
Lactate dehydrogenase X C1, C3, C3X, Chemistry and TDM 56–58 Competency
(LD) CZ, CZ2X, Leukocyte-reduced TRC Transfusion-Related 224
CZX platelets Cell Count
CZQ Quality Cross Check, 41 Leukocyte-reduced RBC TRC Transfusion-Related 224
Chemistry and TDM Cell Count
FLD Body Fluid 72 Leukocyte, stool, Wright- X CMMP Clinical Microscopy, 147
FLDQ Quality Cross Check, 42 Giemsa Misc
Body Fluid Chemistry Levetiracetam T Toxicology 96
IFS Interfering Substances 133 UT Urine Toxicology 96
Enzyme Cal Ver/Lin
800-323-4040 | 847-832-7000 Option 1 | cap.org 323


ENR Code ENR Code
Levetiracetam (cont.) ZE Therapeutic Drug 60 Lorazepam (cont.) DMPM Drug Monitoring for Pain 107
Monitoring, Extended Management
Lidocaine X CZ, CZ2X, Chemistry and TDM 56–58 FTC Forensic Toxicology, 104
22 CZX, Z
CZQ Quality Cross Check, 41 T
Criminalistics
Toxicology 96
Chemistry and TDM UDC Forensic Urine Drug 99
LN3 TDM Cal Ver/Lin 121 Testing, Confirmatory
T Toxicology 96 UT Urine Toxicology 96

UT Urine Toxicology 96 Lorazepam glucuronide DMPM Drug Monitoring for Pain 107
Lipase X C3, C3X, CZ, Chemistry and TDM 56–58 Management
CZ2X, CZX Lupus anticoagulant CGS1 Coag Special, Series 1 162
CZQ Quality Cross Check, 41 (screen, conf)
Chemistry and TDM Luteinizing hormone (LH) ABS Accuracy-Based 113
FLD2 Body Fluid Chemistry 2 73 Testosterone, Estradiol
IFS Interfering Substances 133 LN8 Reproductive 123
Endocrinology Cal Ver/
Lin
Enzyme Cal Ver/Lin
X Y/YY Ligand Assay, Special 84
Enzyme all Beckman Lyme disease TTD Tick-Transmitted 205
except AU, Vitros Cal Disease
Ver/Lin Lymphocyte X FL, FL1 Flow Cytometry 215
Lipids ABL Accuracy-Based Lipid 112 immunophenotyping
X C1, C3, C3X, Chemistry and TDM 56–58 Lymphoma by FISH CYL Fluorescence In Situ 243
CZ, CZ2X, Hybridization and
CZX Interpretation on Site,
Lymphoma
Chemistry and TDM Lysergic acid FTC Forensic Toxicology, 104
diethylamide (LSD) Criminalistics
Enzyme Cal Ver/Lin T Toxicology 96
LN2BV Chemistry, Lipid, 120 UDS, UDS6 Urine Drug Screen 98
Enzyme all Beckman UT Urine Toxicology 96
except AU, Vitros Cal Magnesium X C1, C3, C3X, Chemistry and TDM 56–58
Ver/Lin CZ, CZ2X,
Lipoprotein (a) X ABL Accuracy-Based Lipid 112 CZX
X C1, C3, C3X, Chemistry and TDM 56–58 CZQ Quality Cross Check, 41
CZ, CZ2X, Chemistry and TDM
CZX IFS Interfering Substances 133
CZQ Quality Cross Check, 41 LN2 Chemistry, Lipid, 120
Chemistry and TDM Enzyme Cal Ver/Lin
Lipoprotein-associated PLA Lp-PLA2 75 LN2BV Chemistry, Lipid, 120
phospholipase Enzyme all Beckman
Lipoprotein LPE Lipoprotein 76 except AU, Vitros Cal
electrophoresis Electrophoresis Ver/Lin
Listeria monocytogenes IDME Meningitis/Encephalitis 202 Magnesium, ionized X AQ, AQ2 Aqueous Blood Gas 92
Panel AQQ, AQ2Q Quality Cross Check, 44
Lithium X C1, C3, C3X, Chemistry and TDM 56–58 Critical Care Aqueous
CZ, CZ2X, Blood Gas Series
CZX, Z POC10, POC Competency Blood 53
CZQ Quality Cross Check, 41 POC11 Gases
Chemistry and TDM Magnesium, urine X U Urine Chemistry, 68
LN3 TDM Cal Ver/Lin 121 General
Liver-kidney microsomal LKM Liver-Kidney 213 Malaria RMAL Rapid Malaria 193
antibody Microsomal Antibody Manganese R Trace Metals 78
Lorazepam DFC Drug-Facilitated Crime 108 Manganese, urine TMU Trace Metals, Urine 103

ENR Code ENR Code
Manganese, whole blood TMWB Trace Metals, Whole 103 Meprobamate (cont.) FTC Forensic Toxicology, 104
Blood Criminalistics
MCAD X IMD2 MCAD 249 T Toxicology 96
MCH FH1-FH4,
FH6, FH9,
Hematology Automated
Differential
136 UT Urine Toxicology 96 22
Meprobamate/ UDS, UDS6 Urine Drug Screen 98
FH10, FH13, Carisoprodol
FH1P-FH4P,
Mercury, urine TMU Trace Metals, Urine 103
FH6P, FH9P,
FH10P, Mercury, whole blood TMWB Trace Metals, Whole 103
FH13P Blood
FH3Q, FH4Q, Quality Cross Check, 45 Metabolic disease BGL Biochemical Genetics 245
FH6Q, FH9Q Automated Hematology testing
Series Metanephrine X N/NX Urine Chemistry, Special 69
HE, HEP Basic Hematology 136 Methadone DFC Drug-Facilitated Crime 108
MCHC FH1-FH4, Hematology Automated 136 DMPM Drug Monitoring for Pain 107
FH6, FH9, Differential Management
FH10, FH13, FTC Forensic Toxicology, 104
FH1P-FH4P, Criminalistics
FH6P, FH9P, OFD Oral Fluid for Drugs of 100
FH10P, Abuse
FH13P
T Toxicology 96
Series
HE, HEP Basic Hematology 136
MCV FH1-FH4, Hematology Automated 136
FH6, FH9, Differential Methadone metabolite DFC Drug-Facilitated Crime 108
FH10, FH13, (EDDP)
FH1P-FH4P, DMPM Drug Monitoring for Pain 107
FH6P, FH9P, Management
FH10P, FTC Forensic Toxicology, 104
FH13P Criminalistics
FH3Q, FH4Q, Quality Cross Check, 45 T Toxicology 96
FH6Q, FH9Q Automated Hematology UDC Forensic Urine Drug 99
Series Testing, Confirmatory
HE, HEP Basic Hematology 136 UDS, UDS6 Urine Drug Screen 98
MECP2 deletion/ X RETT RETT Syndrome 251 UT Urine Toxicology 96
duplication analysis Genotyping
Methamphetamine DFC Drug-Facilitated Crime 108
MECP2 genotyping X RETT RETT Syndrome 251
Genotyping
Management
MEN2 (multiple X MGL3 Molecular Genetics 248–
endocrine neoplasia 249
Criminalistics
type 2)
Meperidine DFC Drug-Facilitated Crime 108
Abuse
T Toxicology 96
Management
Criminalistics
T Toxicology 96
Methanol X AL1 Whole Blood Alcohol/ 101
Mephedrone T Toxicology 96
Volatiles
X AL2 Serum Alcohol/Volatiles 101
Meprobamate DFC Drug-Facilitated Crime 108
Methaqualone UDC Forensic Urine Drug 99
DMPM Drug Monitoring for Pain 107 Testing, Confirmatory
Management
800-323-4040 | 847-832-7000 Option 1 | cap.org 325


ENR Code ENR Code
Methemoglobin X SO Blood Oximetry 94 Methylenetetra- X MGL1 Molecular Genetics 248–

SOQ Quality Cross Check, 44 hydrofolate reductase 249
Blood Oximetry (MTHFR gene)
22 Methicillin-resistant
BCS1 Blood Culture
179 Methylmalonic acid
Methylphenidate
MMA
T
MMA and Active B12
Toxicology
82
96
(MRSA) UT Urine Toxicology 96
IDN, IDO Nucleic Acid Amp, 201 Metoprolol T Toxicology 96
Organisms
MRS Methicillin-resistant S. 182
MGMT GLI Glioma 261
aureus Screen
Microalbumin, urine LN20 Urine AlbuminCal Ver/ 126
Lin
X U Urine Chemistry 68
X MRS5 Methicillin-resistant S. 182
aureus Screen X UMC Urine Albumin 153
(Microalbumin)/
Creatinine
Microarray, constitutional CYCGH Constitutional 244
Methotrexate X CZ, CZ2X, Chemistry and TDM 56–58
disorders Microarray Analysis
CZX, Z
Microarray, neoplastic CYCMA Cytogenomic Microarray 244
disorders Analysis for Oncologic
Chemistry and TDM
Abnormality
Methylenedioxy- DFC Drug-Facilitated Crime 108
Microsatellite instability MSI Microsatellite Instability 258
amphetamine (MDA)
Microtiter plate reader I Instrumentation 132
linearity
Management
Midazolam DFC Drug-Facilitated Crime 108
Criminalistics Minimal residual disease BALL B-ALL Minimal Residual 216
Disease
Abuse MRD Minimal Residual 262
Disease, BCR/ABL1
T Toxicology 96
p210
MRD1 Minimal Residual 262
Disease, BCR/ABL1
UT Urine Toxicology 96 p190
Methylenedioxyethyl- OFD Oral Fluid for Drugs of 100 MRD2 Minimal Residual 262
amphetamine (MDEA) Abuse Disease, PML/RARA
UDC Forensic Urine Drug 99 Mirtazapine T Toxicology 96
Methylenedioxymeth- DFC Drug-Facilitated Crime 108
Mite identification TMO Ticks, Mites, and Other 194
amphetamine (MDMA)
Arthropods
Mitochondrial X IMD3 Mitochondrial 249
Management
cytopathies Cytopathies
Mitochondrial DNA X IMD1 Mitochondrial DNA 249
Criminalistics
deletion syndromes Deletion Syndromes
Mixing studies, APTT CGE/CGEX Coagulation, Extended 161
Abuse
T Toxicology 96
Mixing studies, PT CGE/CGEX Coagulation, Extended 161
Testing, Confirmatory MLH1 promoter MSI Defective DNA 258
methylation analysis Mismatch Repair/
Hereditary
UT Urine Toxicology 96 Nonpolyposis Colorectal
Methylenedioxy- T Toxicology 96 Cancer (HNPCC)
pyrovalerone (MDPV) Modified acid-fast stain X P, P3, P4, P5 Parasitology 192
UT Urine Toxicology 96 Mold identification X F Mycology and Aerobic 189
Actinomycetes

ENR Code ENR Code
Molecular genetics X MGL1, MGL2, Molecular Genetics 248– Multiple endocrine X MGL3 Molecular Genetics 248–
MGL3, MGL4, 249 neoplasia type 2 (RET 249
MGL5 gene)
Molecular hematologic
oncology
MHO, MHO1, Molecular Hematologic
MHO2, Oncology
259,
262
Mumps-IgG
Mycobacterial culture X
VR3M
E1
Virology
Mycobacteriology, Ltd
205
188
22
MHO3, MHO5
Mycobacterial X E Mycobacteriology 188
Molecular HLA typing X DML HLA Molecular Typing 237 identification
Molecular typing IDN, IDO Nucleic Acid Amp, 201 Mycobacterium IDO Nucleic Acid Amp, 201
Organisms tuberculosis Organisms
Monitoring engraftment X ME Monitoring Engraftment 239 Mycobacterium QF M. tuberculosis 213
Mononuclear cell count CBT Cord Blood Testing 227 tuberculosis antibody Infection Detection
SCP Stem Cell Processing 227 detection
Moraxella catarrhalis IDPN Infectious Disease, 203 Mycobacterium MTBR Molecular MTB 188
Pneumonia Panel tuberculosis Identification and
identification and Resistance Detection
Morphine DFC Drug-Facilitated Crime 108
resistance detection
Mycophenolic acid X MPA Mycophenolic Acid 60
Management
Mycoplasma genitalium MGEN Mycoplasma genitalium, 185
Molecular
Criminalistics
Mycoplasma IDN, IDO Nucleic Acid Amp, 201
pneumoniae Organisms
Abuse
T Toxicology 96
Pneumonia Panel
Respiratory Panel
VR3 Antibody Detection, 205
M-protein (paraprotein) X SPE Protein Electrophoresis 76 Infectious Disease
identification Serology
MPV FH1-FH4, Hematology Automated 136 Myoglobin X CRT, CRTI Cardiac Markers 62
CRTQ Quality Cross Check, 42
FH10, FH13,
Cardiac Markers
FH1P-FH4P,
FH6P, FH9P, LN33 Serum Myoglobin Cal 128
FH10P, Ver/Lin
FH13P X PCARM, Plasma Cardiac Markers 65
FH3Q, FH4Q, Quality Cross Check, 45 PCARMX
FH6Q, FH9Q Automated Hematology POC12 Competency Plasma 53
Series Cardiac Markers
HE, HEP Basic Hematology 136 Myoglobin, urine MYG Myoglobin, Urine 69
MRSA BCS1 Blood Culture 179 Myotonic dystrophy X MGL2 Molecular Genetics 248–
Staphylococcus aureus (DMPK gene) 249
IDN, IDO Nucleic Acid Amp, 201 N-acetylprocainamide X CZ, CZ2X, Chemistry and TDM 56–58
Organisms (NAPA) CZX, Z
MRS Methicillin-resistant S. 182 CZQ Quality Cross Check, 41
aureus Screen Chemistry and TDM
MRS2M MRSA Screen, 182 LN3 TDM Cal Ver/Lin 121
Molecular, 2 Challenge N-desmethyltramadol DMPM Drug Monitoring for Pain 107
X MRS5 Methicillin-resistant S. 182 Management
aureus Screen FTC Forensic Toxicology, 104
X MRS5M MRSA Screen, 182 Criminalistics
Molecular, 5 Challenge T Toxicology 96
Mucolipidosis IV X MGL4 Molecular Genetics 248– UT Urine Toxicology 96
(MCOLN1 gene) 249
Naproxen T Toxicology 96
Mucopolysaccharide X BGL Biochemical Genetics 245
(Glycosaminoglycan)
800-323-4040 | 847-832-7000 Option 1 | cap.org 327


ENR Code ENR Code
Nasal smears, eosinophil X CMMP Clinical Microscopy, 147 Nongynecologic FNAG/FNAG1 Fine-Needle Aspiration, 291
Misc cytopathology (cont.) Glass
Neisseria gonorrhoeae X D3 GC Cultures 175 NGC/NGC1 Nongynecologic 289
22 X HC6/HC6X C. trachomatis/GC by
Nucleic Acid Amp
186 Cytopathology
Education Program
X HC7 C. trachomatis/GC DNA 186 Noninvasive prenatal NIPT Noninvasive Prenatal 88
by NAA testing Testing
RMC Norbuprenorphine DFC Drug-Facilitated Crime 108
X Routine Microbiology 176

Combination DMPM Drug Monitoring for Pain 107
Neisseria meningitidis IDME Meningitis/Encephalitis 202 Management
Panel OFD Oral Fluid for Drugs of 100
Neoplastic cellularity NEO Neoplastic Cellularity 259 Abuse
Neuropathology NP/NP1 Neuropathology 284 T Toxicology 96
Program UDC Forensic Urine Drug 99
Neutral fats FCFS Fecal Fat 75 Testing, Confirmatory
Next-generation NGS Next-Generation 254 UT Urine Toxicology 96
sequencing Sequencing Norchlordiazepoxide T Toxicology 96
NGSB1 NGS Bioinformatics for 255 UT Urine Toxicology 96
Illumina Platforms Norclomipramine T Toxicology 96
NGSB2 NGS Bioinformations for 255 UT Urine Toxicology 96
Ion Torrent Platforms
Norcodeine T Toxicology 96
NGSBV NGS Bioinformatics 257
Somatic Validated
Materials Norcyclobenzaprine T Toxicology 96
NGSE NGS Undiagnosed 256 UT Urine Toxicology 96
Disorders-Exome Nordiazepam DMPM Drug Monitoring for Pain 107
NGSHM Next Generation 255 Management
Sequencing, FTC Forensic Toxicology, 104
Hematologic Criminalistics
Malignancies OFD Oral Fluid for Drugs of 100
NGSST Next Generation 254 Abuse
Sequencing, Solid T Toxicology 96
Tumor UDC Forensic Urine Drug 99
Nicotine NTA Nicotine and Tobacco 102 Testing, Confirmatory
Alkaloids UT Urine Toxicology 96
T Toxicology 96 Nordoxepin DFC Drug-Facilitated Crime 108
UT Urine Toxicology 96 FTC Forensic Toxicology, 104
Niemann-Pick type A/B X MGL4 Molecular Genetics 248– Criminalistics
(SMPD1 gene) 249 T Toxicology 96
NIPT NIPT Noninvasive Prenatal 88 UT Urine Toxicology 96
Testing
Norepinephrine X N/NX Urine Chemistry, Special 69
Nitrite, urine X CMP, CMP1 Clinical Microscopy 146
Norfentanyl DMPM Drug Monitoring for Pain 107
CMQ Quality Cross Check, 46 Management
Urinalysis
DAI Urine Drug Adulterant/ 98 Criminalistics
Integrity Testing
X HCC2 Waived Combination 66 Abuse
POC3 POC Urine Dipstick 52 T Toxicology 96
Competency
Nitrogen, total, urine U Urine Chemistry, 68 Testing, Confirmatory
General
Nongynecologic FNA/FNA1 Fine-Needle Aspiration, 290
Norfluoxetine DFC Drug-Facilitated Crime 108
cytopathology Digital
Criminalistics

ENR Code ENR Code
Norfluoxetine (cont.) T Toxicology 96 nRBC FH3, FH3P, Hematology, Auto Diff 136
UT Urine Toxicology 96 FH9, FH9P,
FH13, FH13P
Norhydrocodone DMPM Drug Monitoring for Pain 107
Management N-telopeptide (NTX) BMV6 Bone Markers and
Vitamin
86
22
Norketamine DFC Drug-Facilitated Crime 108
X BU Bone and Mineral, Urine 85
Criminalistics NT-pro B-type natriuretic BNP B-Type Natriuretic 61
T Toxicology 96
Peptides, 5 Chall
Normeperidine DFC Drug-Facilitated Crime 108
BNPQ Quality Cross Check, 41
DMPM Drug Monitoring for Pain 107 B-Type Natriuretic
Management Peptides
T Toxicology 96 LN30 BNP Cal Ver/Lin 128
UT Urine Toxicology 96 Nucleated cells, total ABF3 Automated Body Fluid 148
Normetanephrine X N/NX Urine Chemistry Special 69 CBT Cord Blood Testing 227
Norovirus GIP Gastrointestinal Panel 204 SCP Stem Cell Processing 227
X GIP5 Gastrointestinal Panel 204 Nucleated red blood cell FH3, FH3P, Hematology, Auto Diff 136
SP1 Stool Pathogens 184 count FH9, FH9P,
Noroxycodone DMPM Drug Monitoring for Pain 107 FH13, FH13P
Management Nucleated red cells, total CBT Cord Blood Testing 227
T Toxicology 96 SCP Stem Cell Processing 227
UT Urine Toxicology 96 Nucleic acid BSTS Bacterial Strain Typing 178
Noroxymorphone DMPM Drug Monitoring for Pain 107 amplification Staphylococcus
Management X HBVL, Hepatitis Viral Load 198
Norpropoxyphene DFC Drug-Facilitated Crime 108 HBVL5, HCV2
DMPM Drug Monitoring for Pain 107 X HC6/HC6X C. trachomatis/GC by 186
Management Nucleic Acid Amp
FTC Forensic Toxicology, 104 X HC7 C. trachomatis/GC DNA 186
Criminalistics by NAA
T Toxicology 96 X HIVG, HV2 HIV Viral Load 199
UDC Forensic Urine Drug 99 ID1, ID1T Nucleic Acid Amp, 197
Testing, Confirmatory Viruses
UT Urine Toxicology 96 ID2 Nucleic Acid Amp, 198
Norsertraline DFC Drug-Facilitated Crime 108 Respiratory
FTC Forensic Toxicology, 104 X ID3 Influenza A, Influenza B, 198
Criminalistics RSV by NAA
T Toxicology 96 IDN, IDO Nucleic Acid Amp, 201
Organisms
Nortrimipramine T Toxicology 96
Nortriptyline DFC Drug-Facilitated Crime 108 Molecular, 5 Challenge
FTC Forensic Toxicology, 104 SP, SPN, SP1 Stool Pathogens 184
Criminalistics
T Toxicology 96
VRE Vancomycin-Resistant 187
UT Urine Toxicology 96 Enterococcus
X ZT TDM, Special 60 Nucleic acid testing X NAT Nucleic Acid Testing 232
Norvenlafaxine DFC Drug-Facilitated Crime 108 Nugent scoring VS2 Vaginitis Screen, Virtual 186
Norverapamil T Toxicology 96 Gram Stain
UT Urine Toxicology 96 Occult blood OCB Occult Blood 151
Novel opioids and NOB Novel Opioids and 105 OCBQ Quality Cross Check, 46
benzodiazepines Benzodiazepines Occult Blood
NRAS MTP Multigene Tumor Panel 261
800-323-4040 | 847-832-7000 Option 1 | cap.org 329


ENR Code ENR Code
Occult blood (cont.) POC9 POC Fecal Occult Blood 52 Oxazepam (cont.) DMPM Drug Monitoring for Pain 107
Occult blood, gastric GOCB Gastric Occult Blood 150 Management
Ocular micrometer check I Instrumentation 132 FTC Forensic Toxicology, 104
22 O-desmethyltramadol DFC Drug-Facilitated Crime 108
OFD
Criminalistics
Oral Fluid for Drugs of 100
Abuse
Management
T Toxicology 96
Criminalistics UDC Forensic Urine Drug 99

T Toxicology 96
Oxcarbazepine ZE Therapeutic Drug 60
Olanzapine T Toxicology 96
metabolite Monitoring, Extended
Oxidants, urine DAI Urine Drug Adulterant/ 98
Oligoclonal bands OLI Oligoclonal Bands 74 Integrity Testing
Opiate group DMPM Drug Monitoring for Pain 107 Oxycodone DFC Drug-Facilitated Crime 108
Management
OFD Oral Fluid for Drugs of 100 Management
Abuse
T Toxicology 96 Criminalistics
UDS, UDS6 Urine Drug Screen 98 OFD Oral Fluid for Drugs of 100
UT Urine Toxicology 96 Abuse
UTCO Urine Toxicology 134 T Toxicology 96
Carryover UDC Forensic Urine Drug 99
Organic acids, urine X BGL Biochemical Genetics 245 Testing, Confirmatory
qualitative UDS, UDS6 Urine Drug Screen 98
Organic acids, urine BGL Biochemical Genetics 245 UT Urine Toxicology 96
quantitative
Oxyhemoglobin X SO Blood Oximetry 94
Osmolality, measured X C3, C3X, CZ, Chemistry and TDM 56–58
SOQ Quality Cross Check, 44
CZ2X, CZX
Blood Oximetry
Oxymorphone DFC Drug-Facilitated Crime 108
Chemistry and TDM
Management
Enzyme Cal Ver/Lin
Criminalistics
Enzyme all Beckman
Abuse
Osmolality, urine X CMP, CMP1 Clinical Microscopy 146 UDC Forensic Urine Drug 99
Urinalysis UT Urine Toxicology 96
LN6 Urine Chemistry Cal 122 p16 P16 P16 279
Ver/Lin Immunohistochemistry
TMA
Competency Pancreatic amylase X C1, C3, C3X, Chemistry and TDM 56–58
CZ, CZ2X,
CZX
General
Osmometer check I Instrumentation 132
Chemistry and TDM
Osteocalcin BGS Bone and Growth 85
PAPP-A FP1B First Trimester Maternal 87
Oxalate KSA Kidney Stone Risk 69 Screening, Free Beta
Assessment
FP1T First Trimester Maternal 87
Oxazepam DFC Drug-Facilitated Crime 108 Screening, Total hCG

ENR Code ENR Code
Parainfluenza virus ID2 Nucleic Acid Amp, 198 pH (cont.) AQQ, AQ2Q, Quality Cross Check, 44
Respiratory AQ3Q, AQ4Q Critical Care Aqueous
IDPN Infectious Disease, 203 Blood Gas Series
X IDR
Pneumonia Panel
FLD
FLDQ
Body Fluid
Quality Cross Check,
72
42
22
Respiratory Panel Body Fluid Chemistry
X VR1 Virology Culture 196 GOCB Gastric Occult Blood 150
X VR2 Viral Antigen Detection 196 LN13, LN13C Blood Gas Cal Ver/Lin 124-
by DFA 125
Paraprotein X SPE Protein Electrophoresis 76 POC10, POC Competency Blood 53
identification POC11 Gases
Parasite identification X BP Blood Parasite 193 pH, gastric GOCB Gastric Occult Blood 150
X P, P3, P4, P5 Parasitology 192 pH interpretation AFL Amniotic Fluid Leakage 148
PEX Expanded Parasitology 193 pH meters I Instrumentation 132
Parathyroid hormone X ING Insulin, Gastrin, 86 pH, urine X CMP, CMP1 Clinical Microscopy 146
(PTH) C-Peptide, PTH CMQ Quality Cross Check, 46
PTHQ Quality Cross Check, 43 Urinalysis
PTH DAI Urine Drug Adulterant/ 98
Parentage/relationship X PARF Parentage/Relationship 233 Integrity Testing
testing X HCC2 Waived Combination 66
Paroxetine DFC Drug-Facilitated Crime 108 POC3 POC Urine Dipstick 52
FTC Forensic Toxicology, 104 Competency
Criminalistics UDC Forensic Urine Drug 99
T Toxicology 96 Testing, Confirmatory
UT Urine Toxicology 96 Phencyclidine DFC Drug-Facilitated Crime 108
Parvovirus B19 ID1 Nucleic Acid Amp, 197 FTC Forensic Toxicology, 104
Viruses Criminalistics
pCO2 X AQ, AQ2, AQ3, Aqueous Blood Gas 92 OFD Oral Fluid for Drugs of 100
AQ4 Abuse
AQQ, AQ2Q, Quality Cross Check, 44 T Toxicology 96
AQ3Q, AQ4Q Critical Care Aqueous UDC Forensic Urine Drug 99
Blood Gas Series Testing, Confirmatory
LN13, LN13C Blood Gas Cal Ver/Lin 124- UDS, UDS6 Urine Drug Screen 98
125 UT Urine Toxicology 96
POC10, POC Competency Blood 53 Phenethylamine FTC Forensic Toxicology, 104
POC11 Gases Criminalistics
PDGFRA KIT KIT/PDGFRA 260 T Toxicology 96
MTP Multigene Tumor Panel 261 UT Urine Toxicology 96
PDL1 PDL1 PDL1 279 Pheniramine T Toxicology 96
Pentobarbital DFC Drug-Facilitated Crime 108 UT Urine Toxicology 96
FTC Forensic Toxicology, 104 Phenobarbital X CZ, CZ2X, Chemistry and TDM 56–58
Criminalistics CZX, Z
T Toxicology 96 CZQ Quality Cross Check, 41
UT Urine Toxicology 96 Chemistry and TDM
Performance PIP/PIP1, Performance 264– DFC Drug-Facilitated Crime 108
improvement program in PIPW/PIPW1 Improvement Program 265 DMPM Drug Monitoring for Pain 107
surgical pathology in Surgical Pathology Management
Peripheral blood cell EHE1 Expanded Virtual 144 FTC Forensic Toxicology, 104
identification Peripheral Blood Smear Criminalistics
Peripheral blood smear, VPBS Virtual Peripheral Blood 143 LN3 TDM Cal Ver/Lin 121
virtual Smear T Toxicology 96
pH AFL Amniotic Fluid Leakage 148 UDC Forensic Urine Drug 99
X AQ, AQ2, AQ3, Aqueous Blood Gas 92 Testing, Confirmatory
AQ4 UT Urine Toxicology 96
800-323-4040 | 847-832-7000 Option 1 | cap.org 331


ENR Code ENR Code
Phentermine FTC Forensic Toxicology, 104 Platelet calculator TRC Transfusion-Related 224
Criminalistics Cell Count
T Toxicology 96 Platelet count X FH15 Centrifugal Hematology 137
22 Phenylephrine
UT
T
Urine Toxicology
Toxicology
96
96
X FH1-FH4,
FH6, FH9,
Hematology Automated
Differential
136
FH10, FH13,
FH1P-FH4P,
Phenytoin X CZ, CZ2X, Chemistry and TDM 56–58 FH6P, FH9P,
CZX, Z FH10P,
CZQ Quality Cross Check, 41 FH13P
Chemistry and TDM FH3Q, FH4Q, Quality Cross Check, 45
DFC Drug-Facilitated Crime 108 FH6Q, FH9Q Automated Hematology
FTC Forensic Toxicology, 104 Series
Criminalistics X HE, HEP Basic Hematology 136
LN3 TDM Cal Ver/Lin 121 LN9 Hematology Cal Ver/Lin 123
SCO Serum Carryover 134 Platelet count EHE1 Expanded Virtual 144
T Toxicology 96 (estimated) Peripheral Blood Smear
UT Urine Toxicology 96 VPBS Virtual Peripheral Blood 143
Smear
Phenytoin, free X CZ, CZ2X, Chemistry and TDM 56–58
CZX, Z Platelet count (platelet- X TRC Transfusion-Related 224
rich plasma) Cell Count
Chemistry and TDM Platelet crossmatch PS Platelet Serology 225
Phosphorus X C3, C3X, CZ, Chemistry and TDM 56–58 Platelet function PF1 Platelet Function 166
CZX, CZ2X Platelet mapping PLTM Platelet Mapping 169
CZQ Quality Cross Check, 41 Plesiomonas shigelloides GIP Gastrointestinal Panel 204
Chemistry and TDM X GIP5 Gastrointestinal Panel 204
IFS Interfering Substances 133 PML/RARA MHO2, MHO3 Molecular Hematologic 262
LN2 Chemistry, Lipid, 120 Oncology
Enzyme Cal Ver/Lin MRD2 Minimal Residual 262
LN2BV Chemistry, Lipid, 120 Disease
Enzyme all Beckman PNA FISH— PNA1 PNA FISH for 179
except AU, Vitros Cal Staphylococcus Staphylococcus
Ver/Lin PNA FISH—yeast PNA2 PNA FISH for Yeast 179
Phosphorus, urine LN6 Urine Chemistry Cal 122 Pneumocystis detection PCP1 Pneumocystis jiroveci, 191
Ver/Lin Calcofluor White Stain
X U Urine Chemistry, 68 PCP2 Pneumocystis jiroveci, 191
General DFA Stain
PIK3CA MTP Multigene Tumor Panel 261 PCP4 Pneumocystis jiroveci, 191
Pinworm prep X CMMP Clinical Microscopy, 147 GMS Stain
Misc PNH immunophenotype PNH Paroxysmal Nocturnal 217
Pipette calibration- I Instrumentation 132 Hemoglobinuria, RBC
gravimetric pO2 X AQ, AQ2, AQ3, Aqueous Blood Gas 92
Plasma cell neoplasms PCNEO Flow Cytometry, Plasma 217 AQ4
Cell Neoplasms AQQ, AQ2Q, Quality Cross Check, 44
Plasma hemogloblin PHG Plasma Hemoglobin 76 AQ3Q, AQ4Q Critical Care Aqueous
Plasminogen activator CGE/CGEX Coagulation, Extended 161 Blood Gas Series
inhibitor LN13, LN13C Blood Gas Cal Ver/Lin 124-
Plasminogen activator MGL1 Molecular Genetics 248– 125
inhibitor (PAI)-1 249 POC10, POC Competency Blood 53
(SERPINE1 gene) POC11 Gases
Plasminogen antigen CGE/CGEX Coagulation, Extended 161 Porphobilinogen, urine UPBG Porphobilinogen, Urine 70
Platelet aggregation PF Platelet Function 166 Posaconazole AFD Antifungal Drugs 106
Platelet antibody X PS Platelet Serology 225 Monitoring
detection Post-immunotherapy FL6 Post-Immunotherapy 216
analysis, flow cytometry Flow Analysis

ENR Code ENR Code
Postanalytical DNA SEC DNA Sequencing Count 250 Predictive markers by X PM2 ER, PgR by 281
sequencing immunohistochemistry Immunohistochemistry
Postvasectomy sperm PV1 Postvasectomy Sperm 156 (cont.)
count, automated
Postvasectomy sperm X PV
Count
Postvasectomy Sperm 156
PM3 CD20 by
Immunohistochemistry
279
22
count, manual Count PM5 Immunohistochemistry 280
Postvasectomy sperm X PV Postvasectomy Sperm 156 TMA
presence/absence, Count Pregabalin DMPM Drug Monitoring for Pain 107
manual Management
Potassium X AQ, AQ2, AQ3, Aqueous Blood Gas 92 T Toxicology 96
AQ4 UT Urine Toxicology 96
AQQ, AQ2Q, Quality Cross Check, 44 ZE Therapeutic Drug 60
AQ3Q, AQ4Q Critical Care Aqueous Monitoring, Extended
Blood Gas Series
Prekallikrein CGE/CGEX Coagulation, Extended 161
Primidone X CZ, CZX, Chemistry and TDM 56–58
C4, CZ, CZX,
CZ2X, Z
CZ2X
Chemistry and TDM
Chemistry and TDM
LN3 TDM Cal Ver/Lin 121
FLD2 Body Fluid Chemistry 2 73
Pro B-type natriuretic BNP B-Type Natriuretic 61
LN13C Blood Gas Cal Ver/Lin 124
LN2 Chemistry, Lipid, 120 Peptides, 5 Chall
Enzyme Cal Ver/Lin
BNPQ Quality Cross Check, 41
LN2BV Chemistry, Lipid, 120 B-Type Natriuretic
Enzyme all Beckman Peptides
Procainamide X CZ, CZX, Chemistry and TDM 56–58
Ver/Lin
CZ2X, Z
POC10, POC Competency Blood 53
POC11 Gases
Chemistry and TDM
Potassium, urine LN6 Urine Chemistry Cal 122
LN3 TDM Cal Ver/Lin 121
Ver/Lin
Procalcitonin LN41 Procalcitonin Cal Ver/ 130
Lin
General
X PCT Procalcitonin 77
Potassium, vitreous fluid VF Vitreous Fluid, Post- 101
mortem Progesterone LN8 Reproductive 123
Endocrinology Cal Ver/
PRA MX1B, MX1C, HLA Analysis, Class I 236–
Lin
MX1E, MXB, 237
MXC X Y/YY Ligand Assay, Special 84
MX2B, MX2C, HLA Analysis, Class II 236– Progesterone X PM2 ER, PgR by 281
MX2E, MXB, 237 receptors by Immunohistochemistry
MXC immunohistochemistry
Prader-Willi/Angelman X MGL1 Molecular Genetics 248– Prolactin LN8 Reproductive 123
syndrome 249 Endocrinology Cal Ver/
Lin
Prealbumin X C3, C3X, CZ, Chemistry and TDM 56–58
(transthyretin) CZX, CZ2X X Y/YY Ligand Assay, Special 84
CZQ Quality Cross Check, 41 Propoxyphene DFC Drug-Facilitated Crime 108
Chemistry and TDM DMPM Drug Monitoring for Pain 107
X S2, S4 Immunology, Special 209 Management
Predictive markers by GHER2 Gastric HER2 281 FTC Forensic Toxicology, 104
immunohistochemistry Criminalistics
X HER2 HER2 by 281 T Toxicology 96
Immunohistochemistry UDC Forensic Urine Drug 99
PM1 CD117 by 279 Testing, Confirmatory
Immunohistochemistry UDS, UDS6 Urine Drug Screen 98
800-323-4040 | 847-832-7000 Option 1 | cap.org 333


ENR Code ENR Code
Propoxyphene (cont.) UT Urine Toxicology 96 Proteus spp. IDPN Infectious Disease, 203
Propranolol T Toxicology 96 Pneumonia Panel
UT Urine Toxicology 96 Prothrombin mutation X MGL1 Molecular Genetics 248–
22 Prostate-specific antigen
(PSA)
X K, KK, K2 Ligand Assay, General 82
(F2 gene)
X TPM Thrombophilia
249
252
Mutations
LN23 PSA Cal Ver/Lin 127
Prothrombin time X CGB Basic Coagulation 160
Prostate-specific X K/KK Ligand Assay, General 82
CGL
antigen, complexed X Coagulation, Limited 160

(cPSA) CGLQ Quality Cross Check, 47
Prostate-specific X K/KK Ligand Assay, General 82 Coagulation, Limited
antigen, free (PSA, free) CGS1 Coag Special, Series 1 162
Prostatic acid X K/KK Ligand Assay, General 82 CGS4 Coag Special, Series 4 162
phosphatase (PAP) DBGN Anticoagulant 163
Protein C CGE/CGEX Coagulation, Extended 161 Monitoring, Dabigatran
CGS2 Coag Special, Series 2 162 FNPX Anticoagulant 163
LN35 Thrombophilia Cal Ver/ 129 Monitoring,
Lin Fondaparinux
Protein, confirmatory DSC Dipstick Confirmatory 149 POC6 POC PT/INR, CoaguChek 52
urine XS Plus
Protein electrophoresis, SPE Protein Electrophoresis 76 RVBN Anticoagulant 163
serum, interpretation Monitoring Rivaroxaban
Protein S CGE/CGEX Coagulation, Extended 161 X WP3, WP4, Whole Blood 168
WP6, WP9 Coagulation
Prothrombin time, dilute CGE/CGEX Coagulation, Extended 161
Protein, CSF X M, OLI CSF Chemistry and 74
Oligoclonal Bands Provider-performed CMMP Clinical Microscopy, 147
microscopy Misc
Protein, total X C1, C3, C3X, Chemistry and TDM 56–58
CZ, CZX, PRU test PIA, PIAX Drug-Specific Platelet 167
CZ2X Aggregation
CZQ Quality Cross Check, 41 Pseudocholinesterase X C7 Pseudocholinesterase 77
Chemistry and TDM Pseudoephedrine FTC Forensic Toxicology, 104
FLD Body Fluid 72 Criminalistics
FLDQ Quality Cross Check, 42 T Toxicology 96
Body Fluid Chemistry UT Urine Toxicology 96
IFS Interfering Substances 133 Pseudomonas aeruginosa IDPN Infectious Disease, 203
LN2 Chemistry, Lipid, 120 Pneumonia Panel
Enzyme Cal Ver/Lin PTEN GLI Glioma 261
LN2BV Chemistry, Lipid, 120 Pyridinoline (PYD) BU Bone and Mineral, Urine 85
Enzyme all Beckman Q-PROBES QP201 Technical Competency 25
except AU, Vitros Cal Assessment of
Ver/Lin Peripheral Blood
SPE Lipoprotein and Protein 76 Smears
Electrophoresis QP202 Red Blood Cell 26
Protein, urine X CMP, CMP1 Clinical Microscopy 146 Utilization: Single
CMQ Quality Cross Check, 46 and Double Unit
Urinalysis Transfusions
DSC Dipstick Confirmatory 149 QP203 Inpatient Test 27
Utilization and Volume
Benchmarking
LN6 Urine Chemistry Cal 122
QP204 Turnaround Time 28
Ver/Lin
for Image-Guided
POC3 POC Urine Dipstick 52 Breast Needle Biopsy
Competency Specimens
X U Urine Chemistry, 68 Q-TRACKS QT1 Patient Identification 31
General Accuracy

ENR Code ENR Code
Q-TRACKS (cont.) QT10 Critical Values 34 RBC count (cont.) X FH1-FH4, Hematology Automated 136
Reporting FH6, FH9, Differential
QT15 TATs of Troponin 35 FH10, FH13,
QT16 Corrected Results 36
FH1P-FH4P,
FH6P, FH9P, 22
QT17 Outpatient Order Entry 36 FH10P,
Errors FH13P
QT2 Blood Culture 31 FH3Q, FH4Q, Quality Cross Check, 45
Contamination
QT3 Laboratory Specimen 32 Series
Acceptability X HE, HEP Basic Hematology 136
QT4 In-Date Blood Product 32 LN9 Hematology Cal Ver/Lin 123
Wastage
RBC count, automated, UAA, UAA1 Automated Urinalysis 149
QT5 Gynecologic Cytology 37 urine (quantitative)
Outcomes—Biopsy
RBC folate X FOL RBC Folate 88
Correlation
Performance RBC manual count, fluid X HFC, HFCI Hemocytometer Fluid 150–
Count 151
QT7 Satisfaction with 33
Outpatient Specimen RBC morphology EHE1 Expanded Virtual 144
Collection Peripheral Blood Smear
QT8 State Test TAT Outliers 33 VPBS Virtual Peripheral Blood 143
Smear
Quetiapine DFC Drug-Facilitated Crime 108
RDW FH1-FH4, Hematology Automated 136
T Toxicology 96
UT Urine Toxicology 96 FH10, FH13,
Quinidine X CZ, CZX, Chemistry and TDM 56–58 FH1P-FH4P,
CZ2X, Z FH6P, FH9P,
CZQ Quality Cross Check, 41 FH10P,
Chemistry and TDM FH13P
LN3 TDM Cal Ver/Lin 121 FH3Q, FH4Q, Quality Cross Check, 45
T Toxicology 96 FH6Q, FH9Q Automated Hematology
Series
HE, HEP Basic Hematology 136
Quinine T Toxicology 96
Red blood cell antigen J, J1 Transfusion Medicine 220
detection
Ranitidine T Toxicology 96
Red blood cell antigen RAG Red Blood Cell Antigen 223
UT Urine Toxicology 96 genotyping Genotyping
Rapamycin (sirolimus) X CS Immunosuppressive 59 Red blood cell antigen RBCAT Red Blood Cell Antigen 223
Drugs typing Typing
Rapid group A strep X D Bacteriology 173 Reducing substance, X CMP, CMP1 Clinical Microscopy 146
X D6 Rapid Group A Strep 177 urine
X D9 Rapid Group A Strep, 177 CMQ Quality Cross Check, 46
Waived Urinalysis
X MC4 Urine Colony Count 176 X HCC2 Waived Combination 66
Combination POC3 POC Urine Dipstick 52
X RMC Routine Microbiology 176 Competency
Combination Refractometer check I Instrumentation 132
RBC automated count, ABF1, ABF2, Automated Body Fluid 148 Renin X RAP Renin and Aldosterone 89
fluid ABF3
Reptilase time CGE/CGEX Coagulation, Extended 161
RBC count ABF1, ABF2, Automated Body Fluid 148
Respiratory syncytial ID2 Nucleic Acid Amp, 198
ABF3
virus (RSV) Respiratory
X ID3 Influenza A, Influenza B, 198
RSV by NAA
Pneumonia Panel
800-323-4040 | 847-832-7000 Option 1 | cap.org 335


ENR Code ENR Code
Respiratory syncytial X IDR Infectious Disease, 202 RSV ID2 Nucleic Acid Amp, 198
virus (RSV) (cont.) Respiratory Panel Respiratory
X VR1 Virology Culture 196 X ID3 Influenza A, Influenza B, 198
22 X VR2 Viral Antigen Detection
by DFA
196
IDPN
RSV by NAA
X VR4 Virology Antigen 196 Pneumonia Panel
Detection by EIA and X IDR Infectious Disease, 202
Latex Respiratory Panel
Reticulocyte count, X RT, RT2, RT3, Reticulocyte 141 X VR1 Virology Culture 196
absolute RT4 X VR2 Viral Antigen Detection 196
RTQ, RT3Q, Quality Cross Check, 45 by DFA
RT4Q Reticulocyte X VR4 Viral Antigen Detection 196
Reticulocyte count, LN18, LN19 Reticulocyte Cal Ver/Lin 126 by EIA and Latex
percent Rubella antibody, IgG X IL, RUB/ Immunology 208
X RT, RT2, RT3, Reticulocyte 141 RUBX
RT4 Rubeola antibody X VR3 Antibody Detection- 205
RTQ, RT3Q, Quality Cross Check, 45 (English measles) Infectious Disease
RT4Q Reticulocyte Serology
Reticulocyte hemoglobin RT4 Reticulocyte 141 Rufinamide ZE Therapeutic Drug 60
(RET-He) Monitoring, Extended
Reticulocyte hemoglobin RT3 Reticulocyte 141 Rupture of fetal ROM1 Placental Alpha 152
concentration (CHr) membranes Microglobulin 1
RETT syndrome X RETT RETT Syndrome 251 (PAMG-1)
Genotyping Russell’s viper venom CGE/CGEX Coagulation, Extended 161
RETT syndrome MECP2 X RETT RETT Syndrome 251 time, dilute
duplication deletion Genotyping Salicylate X CZ, CZX, Chemistry and TDM 56–58
analysis CZ2X, Z
RhD X MGL2 Molecular Genetics 248– CZQ Quality Cross Check, 41
249 Chemistry and TDM
RhD typing X J, J1 Transfusion Medicine 220 FTC Forensic Toxicology, 104
X JAT Transfusion Medicine, 221 Criminalistics
Automated LN3 TDM Cal Ver/Lin 121
JATE1 Transfusion Medicine, 221 X SDS Serum Drug Screen 101
Automated, Educational T Toxicology 96
JATQ Quality Cross Check, 49 UT Urine Toxicology 96
Salmonella GIP Gastrointestinal Panel 204
Competency
Assessment Sapovirus (I, II, IV, V) GIP Gastrointestinal Panel 204
Rheumatoid factor X IL, RF/RFX Immunology 208 X GIP5 Gastrointestinal Panel 204
Rheumatoid factor CCP Cyclic Citrullinated 212 Sarcoma by FISH CYK Fluorescence In Situ 243
isotypes, IgA, IgG, and IgM Peptide Antibody Hybridization
Rhinovirus ID2 Nucleic Acid Amp, 198 Sarcoma translocation SARC Sarcoma Translocation 259
Respiratory Scl-70 (anti-DNA RDS Rheumatic Disease 213
X IDR Infectious Disease, 202 topoisomerase) Special
Respiratory Panel Scopolamine DFC Drug-Facilitated Crime 108
Rhinovrus/enterovirus IDPN Infectious Disease, 203 Secobarbital DFC Drug-Facilitated Crime 108
Pneumonia Panel FTC Forensic Toxicology, 104
RNA sequencing RNA RNA Sequencing 260 Criminalistics
Rotavirus GIP Gastrointestinal Panel 204 UDC Forensic Urine Drug 99
X GIP5 Gastrointestinal Panel 204 Testing, Confirmatory
SP, SPN Stool Pathogens 184 Selenium X R Trace Metals 78
X VR4 Viral Antigen Detection 196 Selenium, urine TMU Trace Metals, Urine 103
by EIA and Latex

ENR Code ENR Code
Selenium, whole blood TMWB Trace Metals, Whole 103 Sodium (cont.) LN2BV Chemistry, Lipid, 120
Blood Enzyme all Beckman
Semen analysis ASA, SM Semen Analysis 156 except AU, Vitros Cal
X SC, SC1, SV,
PV
Semen Analysis 156
POC10,
Ver/Lin
POC Competency Blood 53
22
POC11 Gases
X SMCD Semen Analysis, Online 156
Sodium, urine LN6 Urine Chemistry Cal 122
SM1CD, Semen Analysis, Online 156
Ver/Lin
SM2CD
SERPINA1 genotyping X AAT Alpah-1 Antitrypsin 245
General
Genotyping
Sodium, vitreous fluid VF Vitreous Fluid, Post- 101
Serratia marcescens IDPN Infectious Disease, 203
mortem
Pneumonia Panel
Soluble transferrin STFR Soluble Transferrin 80
Sertraline DFC Drug-Facilitated Crime 108
receptor Receptor
Criminalistics Somatomedin C (IGF-1) X Y, YY Ligand Assay, Special 84
T Toxicology 96 SOX10 PM5 Immunohistochemistry 280
TMA
Specific gravity X CMP, CMP1 Clinical Microscopy 146
Serum free light chains SFLC Serum Free Light Chains 214
Sex hormone-binding ABS Testosterone and 113
Urinalysis
globulin (SHBG) Estradiol Accuracy
DAI Urine Drug Adulterant/ 98
X DY Ligand Assay, Special 84
Integrity Testing
Shiga toxin SP Stool Pathogens, Rapid 184
and Molecular
ST Shiga Toxin 184
Competency
Shiga-like toxin GIP Gastrointestinal Panel 204
producing E. coli (STEC)
GIP5 Gastrointestinal Panel 204
Spectrophotometer I Instrumentation 132
Shigella GIP Gastrointestinal Panel 204 linearity
X GIP5 Gastrointestinal Panel 204 Sperm count X SMCD Semen Analysis, Online 156
Sickle cell screen, X HG Hemoglobinopathy 140 Sperm count, automated PV1 Semen Analysis 156
qualitative
X SC1 Semen Analysis 156
X SCS Sickle Cell Screen 142
Sperm count, manual X PV Postvasectomy Sperm 156
Sirolimus (Rapamycin) X CS Immunosuppressive 59 Count
Drugs
X SC Semen Analysis 156
SLCO1B1 PGX Pharmacogenetics 251
Sperm morphology SM Semen Analysis 156
Sodium X AQ, AQ2, AQ3, Aqueous Blood Gas 92
SM1CD Semen Analysis, Online 156
AQ4
Sperm motility SMCD Semen Analysis, Online 156
AQ3Q, AQ4Q Critical Care Aqueous Sperm presence/ SC Semen Analysis 156
Blood Gas Series absence
X C1, C3, C3X, Chemistry and TDM 56–58 Sperm presence/ X PV Semen Analysis 156
C4, CZ, CZ2X, absence, postvasectomy
CZX Sperm viability SM2CD Semen Analysis, Online 156
CZQ Quality Cross Check, 41 X SV Semen Analysis 156
Chemistry and TDM Spinal fluid meningitis X D Bacteriology 173
FLD2 Body Fluid Chemistry 2 73 panel
IFS Interfering Substances 133 Spinal muscular atrophy X MGL2 Molecular Genetics 248–
LN13C Blood Gas Cal Ver/Lin 124- (SMN1 and SMN2 genes) 249
125 Spinocerebellar ataxia X MGL2 Molecular Genetics 248–
LN2 Chemistry, Lipid, 120 (ATXN1, ATXN2, ATXN3, 249
Enzyme Cal Ver/Lin CACNA1A, and ATXN7
genes)
Split fats FCFS Fecal Fat 75
800-323-4040 | 847-832-7000 Option 1 | cap.org 337


ENR Code ENR Code
Staphylococcus aureus IDPN Infectious Disease, 203 T3, total ABTH Harmonized Thyroid 114
Pneumonia Panel (triiodothyronine)
Staphylococcus aureus- BCS1 Blood Culture 179 X C1, C3, C3X, Chemistry and TDM 56–58
22 blood culture
STEC (Shiga-like toxin GIP
Gastrointestinal Panel 204
CZ, CZX,
CZ2X
producing E. coli) CZQ Quality Cross Check, 41
GIP5 Gastrointestinal Panel 204 Chemistry and TDM
Strep screen POC4 POC/Waived Strep 52

Screen Competency LN5 Ligand Assay Cal Ver/Lin 121-
Streptococcus agalactiae X D8 Group B Strep 178 122
IDME Meningitis/Encephalitis 202 LN5S Ligand Assay, Siemens 121-
Panel Cal Ver/Lin 122
IDPN Infectious Disease, 203 T3, uptake and related X C1, C3, C3X, Chemistry and TDM 56–58
Pneumonia Panel tests CZ, CZX,
CZ2X
Streptococcus IDME Meningitis/Encephalitis 202
pneumoniae Panel CZQ Quality Cross Check, 41
Chemistry and TDM
Pneumonia Panel X K/KK Ligand Assay, General 82
SBAS S. pneumoniae Ag 178 T4, free (thyroxine) ABTH Harmonized Thyroid 114
Detection X C1, C3, C3X, Chemistry and TDM 56–58
Streptococcus pyogenes X D Bacteriology 173 CZ, CZX,
CZ2X
X D1 Throat 175
X D6 Rapid Group A Strep 177 Chemistry and TDM
X D9 Rapid Group A Strep, 177 X K/KK Ligand Assay, General 82
Waived
T4, total (thyroxine) ABTH Harmonized Thyroid 114
Pneumonia Panel
CZ, CZX,
X MC4 Urine Colony Count 176 CZ2X
Combination
X RMC Routine Microbiology 176 Chemistry and TDM
Combination
Strychnine T Toxicology 96
LN5 Ligand Assay Cal Ver/Lin 121-
UT Urine Toxicology 96 122
Sulfate KSA Kidney Stone Risk 69 LN5S Ligand Assay, Siemens 121-
Assessment Cal Ver/Lin 122
Sulfosalicylic acid (SSA) DSC Dipstick Confirmatory 149 Tacrolimus X CS Immunosuppressive 59
Surgical pathology DPATH/ Online Digital Slide 267 Drugs
DPATH1 Program LN31 Immunosuppressive 128
PIP/PIP1, Performance 264– Drugs Cal Ver/Lin
PIPW/PIPW1 Improvement Program 265 Tapentadol DFC Drug-Facilitated Crime 108
in Surgical Pathology
VBP/VBP1 Online Virtual Biopsies 266 Management
Program
Tapentadol-O-sulfate DMPM Drug Monitoring for Pain 107
Synthetic cannabinoid/ SCDD Synthetic Cannabinoid/ 105 Management
designer drugs Designer Drugs
Tay-Sachs (HEXA gene) X MGL4 Molecular Genetics 248–
Syphilis X G Syphilis Serology 214 249
T3, free (triiodothyronine) ABTH Harmonized Thyroid 114 tCO2 AQ, AQ2, AQ3, Aqueous Blood Gas 92
X C1, C3, C3X, Chemistry and TDM 56–58 AQ4
CZ, CZX, AQQ, AQ2Q, Quality Cross Check, 44
CZ2X AQ3Q, AQ4Q Critical Care Aqueous
CZQ Quality Cross Check, 41 Blood Gas Series
Chemistry and TDM POC10, POC Competency Blood 53
X K/KK Ligand Assay, General 82 POC11 Gases
Temazepam DFC Drug-Facilitated Crime 108

ENR Code ENR Code
Temazepam (cont.) DMPM Drug Monitoring for Pain 107 Thyroid-stimulating LN5 Ligand Assay Cal Ver/Lin 121-
Management hormone (TSH) (cont.) 122
FTC Forensic Toxicology, 104 LN5S Ligand Assay, Siemens 121-
OFD
Criminalistics
Oral Fluid for Drugs of 100 Thyroxine (T4), free ABTH
Cal Ver/Lin
Harmonized Thyroid
122
114
22
Abuse X C1, C3, C3X, Chemistry and TDM 56–58
T Toxicology 96 CZ, CZX,
UDC Forensic Urine Drug 99 CZ2X
Testing, Confirmatory CZQ Quality Cross Check, 41
UT Urine Toxicology 96 Chemistry and TDM
Teriflunomide ZE Therapeutic Drug 60 X K/KK Ligand Assay, General 82
Monitoring, Extended Thyroxine (T4), total ABTH Harmonized Thyroid 114
Testosterone ABS Accuracy-Based 113 X C1, C3, C3X, Chemistry and TDM 56–58
Testosterone and CZ, CZX,
Estradiol CZ2X
LN8 Reproductive 123 CZQ Quality Cross Check, 41
Endocrinology Cal Ver/ Chemistry and TDM
Lin X K/KK Ligand Assay, General 82
X Y/YY Ligand Assay, Special 84 LN5 Ligand Assay Cal Ver/Lin 121-
Testosterone, DY Ligand Assay, Special 84 122
bioavailable, measured LN5S Ligand Assay, Siemens 121-
Testosterone, free, X DY Ligand Assay, Special 84 Cal Ver/Lin 122
measured Tick identification TMO Ticks, Mites, and Other 194
Tetrahydrozoline DFC Drug-Facilitated Crime 108 Arthropods
Thallium, urine TMU Trace Metals, Urine 103 Tissue parasite X BP Blood Parasite 193
Thallium, whole blood TMWB Trace Metals, Whole 103 identification
Blood X P Parasitology 192
Theophylline X CZ, CZX, Chemistry and TDM 56–58 PEX Expanded Parasitology 193
CZ2X, Z Tobramycin X CZ, CZX, Chemistry and TDM 56–58
CZQ Quality Cross Check, 41 CZ2X, Z
Chemistry and TDM CZQ Quality Cross Check, 41
LN3 TDM Cal Ver/Lin 121 Chemistry and TDM
Throat culture X D1 Throat 175 LN3 TDM Cal Ver/Lin 121
X MC4 Urine Colony Count 176 Topiramate DFC Drug-Facilitated Crime 108
Combination T Toxicology 96
X RMC Routine Microbiology 176 Total bile acids TBLA Total Bile Acid 78
Combination Total bilirubin X C1, C3, C3X, Chemistry and TDM 56–58
Thrombin time CGE/CGEX Coagulation, Extended 161 CZ, CZX, C4,
CGS4 Coag Special, Series 4 162 CZ2X
DBGN Dabigatran 163 CZQ Quality Cross Check, 41
Chemistry and TDM
Thrombophilia mutations X TPM Thrombophilia 252
Mutations FLD2 Body Fluid Chemistry 2 73
Thyroglobulin X TM/TMX Tumor Markers 89 IFS Interfering Substances 133
Thyroid-stimulating ABS Accuracy-Based 113 LN2 Chemistry, Lipid, 120
hormone (TSH) Testosterone and Enzyme Cal Ver/Lin
Estradiol LN2BV Chemistry, Lipid, 120
ABTH Harmonized Thyroid 114 Enzyme all Beckman
Ver/Lin
CZ, CZX,
CZ2X X NB, NB2 Neonatal Bilirubin 65
CZQ Quality Cross Check, 41 Total bilirubin, urine X CMP, CMP1 Clinical Microscopy 146
Chemistry and TDM DSC Dipstick Confirmatory 149
X K/KK Ligand Assay, General 82 X HCC2 Waived Combination 66
Total free fatty acids FCFS Fecal Fat 75
800-323-4040 | 847-832-7000 Option 1 | cap.org 339


ENR Code ENR Code
Total hCG X FP1T First Trimester Maternal 87 Toxicology, urine, X T Toxicology 96

Screening, Total hCG qualitative (cont.)
Total hemolytic CH50 Total Hemolytic 214 X UDS, UDS6 Urine Drug Screen 98
22 complement
Total iron binding X C3, C3X, CZ
Complement
Chemistry and TDM 56–58 Toxicology, urine,
X
X
UT
DMPM
Urine Toxicology 96
Drug Monitoring for Pain 107
capacity, measured CZX, CZ2X qualitative/quantitative Management
CZQ Quality Cross Check, 41 Toxicology, urine, X UDC Forensic Urine Drug 99
Chemistry and TDM
qualitative/quantitative Testing, Confirmatory

Total nitrogen, urine U Urine Chemistry, 68 Toxoplasma gondii X VR3 Antibody Detection- 205
General Infectious Disease
Total nucleated cells CBT Cord Blood Testing 227 Serology
SCP Stem Cell Processing 227 TPMT PGX3 Pharmacogenetics 251
Total nucleated cells HFC/HFCI Hemocytometer Fluid 150– Tramadol DFC Drug-Facilitated Crime 108
manual differential count Count 151 DMPM Drug Monitoring for Pain 107
(body fluid) Management
VBF Virtual Body Fluid 148 FTC Forensic Toxicology, 104
Total nucleated red cells CBT Cord Blood Testing 227 Criminalistics
SCP Stem Cell Processing 227 T Toxicology 96
Total protein X C1, C3, C3X, Chemistry and TDM 56–58 UDS, UDS6 Urine Drug Screen 98
CZ, CZX, UT Urine Toxicology 96
CZ2X
Transferrin X C3, C3X, CZ, Chemistry and TDM 56–58
CZQ Quality Cross Check, 41 CZX, CZ2X
Chemistry and TDM
FLD Body Fluid 72 Chemistry and TDM
FLDQ Quality Cross Check, 42 LN7 Immunology Cal Ver/Lin 123
X S2, S4 Immunology, Special 209
Transfusion medicine ETME1 Expanded Transfusion 229
LN2 Chemistry, Lipid, 120 Medicine Exercises
Enzyme Cal Ver/Lin
EXM, EXM2 Electronic Crossmatch 221–
LN2BV Chemistry, Lipid, 120 222
Enzyme all Beckman
X J, J1 Transfusion Medicine 220
Ver/Lin X JAT Transfusion Medicine, 221
Automated
SPE Protein Electrophoresis 76
Total protein, CSF X M, OLI CSF Chemistry and 74
Automated
Oligoclonal Bands
JE1 Transfusion Medicine, 220
Total protein, urine X CMP, CMP1 Clinical Microscopy 146
Education
Urinalysis
Competency
X HCC2 Waived Combination 66 Assessment
LN6 Urine Chemistry Cal 122 TMCAD Transfusion Medicine, 225
Ver/Lin Competency
X U Urine Chemistry, 68 Assessment
General TMCAE Transfusion Medicine, 226
Total tricyclics X SDS Serum Drug Screen 101 Competency
X ZT TDM, Special 60 Assessment
Touch imprint/crush prep TICP, TICP1 Touch Imprint/Crush 288 TMCAF Transfusion Medicine, 226
Prep Competency
Assessment
Toxicology, serum, X SDS Serum Drug Screen 101
qualitative X TRC Transfusion-Related 224
Cell Count
X T Toxicology 96
Trazodone metabolite DFC Drug-Facilitated Crime 108
Toxicology, urine, X DMPM Drug Monitoring for Pain 107
(m-CPP)
qualitative Management

ENR Code ENR Code
Trazodone FTC Forensic Toxicology, 104 Troponin I, plasma X PCARI, Plasma Cardiac Markers 65
Criminalistics PCARM,
T Toxicology 96 PCARMX
UT Urine Toxicology 96 POC12 Competency Plasma
Cardiac Markers
53
22
Treponema pallidum X G Syphilis Serology 214
Troponin I, serum X CRT, CRTI Cardiac Markers 62
Trichomonas vaginalis MVP Molecular Vaginal Panel 185
CRTQ Quality Cross Check, 42
TVAG Trichomonas vaginalis, 186
Cardiac Markers
Molecular
LN25 Troponin I Cal Ver/Lin 127
X VS, VS1 Vaginitis Screen 185
LN27 Troponin T Cal Ver/Lin 127
Tricyclic group T Toxicology 96
TNT Troponin T 62
X TNT5 Troponin T, 5 Challenge 62
Tumor necrosis factor CTKN Cytokines 212
Tricyclics, total X SDS Serum Drug Screen 101
(TNF)-alpha
X ZT TDM, Special 60
UGT1A1 PGX3 Pharmacogenetics 251
Triglycerides ABL Accuracy-Based Lipid 112
Unsaturated iron binding X C3, C3X, CZ, Chemistry and TDM 56–58
X C1, C3, C3X, Chemistry and TDM 56–58 capacity, measured CZX, CZ2X
C4, CZ, CZX,
CZ2X
Chemistry and TDM
Urea nitrogen X AQ2, AQ4 Aqueous Blood Gas 92
Chemistry and TDM
AQ2Q, AQ4Q Quality Cross Check, 44
FCFS Fecal Fat 75
Critical Care Aqueous
FLD Body Fluid 72 Blood Gas Series
FLDQ Quality Cross Check, 42 X C1, C3, C3X, Chemistry and TDM 56–58
Body Fluid Chemistry C4, CZ, CZX,
X LCW Ltd Chem, Waived 64 CZ2X
LN2 Chemistry, Lipid, 120 CZQ Quality Cross Check, 41
Enzyme Cal Ver/Lin Chemistry and TDM
LN2BV Chemistry, Lipid, 120 FLD Body Fluid 72
Enzyme all Beckman FLDQ Quality Cross Check, 42
except AU, Vitros Cal Body Fluid Chemistry
Ver/Lin
Triiodothyronine (T3), ABTH Harmonized Thyroid 114
total
Enzyme Cal Ver/Lin
CZ, CZX,
Enzyme all Beckman
CZ2X
CZQ Quality Cross Check, 41 Ver/Lin
Chemistry and TDM
Urea nitrogen, urine LN6 Urine Chemistry Cal 122
X K/KK Ligand Assay, General 82 Ver/Lin
LN5 Ligand Assay Cal Ver/Lin 121- X U Urine Chemistry, 68
122 General
LN5S Ligand Assay, Siemens 121- Urea nitrogen, vitreous VF Vitreous Fluid, Post- 101
Cal Ver/Lin 122 fluid mortem
Triiodothyronine (T3), free ABTH Harmonized Thyroid 114 Urease X RUR Rapid Urease 183
X C1, C3, C3X, Chemistry and TDM 56–58 Uric acid X C1, C3, C3X, Chemistry and TDM 56–58
CZ, CZX, C4, CZ, CZX,
CZ2X CZ2X
CZQ Quality Cross Check, 41 CZQ Quality Cross Check, 41
Chemistry and TDM Chemistry and TDM
X K/KK Ligand Assay, General 82 FLD2 Body Fluid Chemistry 2 73
Trimipramine T Toxicology 96 IFS Interfering Substances 133
UT Urine Toxicology 96 LN2 Chemistry, Lipid, 120
Enzyme Cal Ver/Lin
800-323-4040 | 847-832-7000 Option 1 | cap.org 341


ENR Code ENR Code
Uric acid (cont.) LN2BV Chemistry, Lipid, 120 Urobilinogen (cont.) POC3 POC Urine Dipstick 52
Enzyme all Beckman Competency
except AU, Vitros Cal Uroporphyrin X N/NX Urine Chemistry, Special 69
22 Uric acid, urine LN6
Ver/Lin
Urine Chemistry Cal 122
Urothelial carcinoma by
FISH, hybridization and
X CYI Fluorescence In Situ
Hybridization and
242
Ver/Lin interpretation on site Interpretation on Site,

X U Urine Chemistry, 68 Urothelial Carcinoma
General Vaginal wet preparations X CMMP Clinical Microscopy, 147
Urine albumin LN20 Urine albumin Cal Ver/ 126 (clue cell, epithelial cell, Misc
Lin trichomonas, or yeast)
X U Urine Chemistry, 68 Vaginitis screen BV Bacterial Vaginosis 184
General MVP Molecular Vaginal Panel 185
X UMC Urine Albumin 153 X VS BD Affirm VP III Antigen 185
Creatinine Detection
Urine albumin: creatinine ABU Accuracy-Based Urine 113 X VS1 Genzyme OSOM 185
ratio Trichomonas
U Urine Chemistry, 68 VS2 Vaginitis Screen, Virtual 186
General Gram Stain
UMC Urine Albumin 153 Valproic acid X CZ, CZX, Chemistry and TDM 56–58
Creatinine CZ2X, Z
Urine colony count MC3 Urine Colony Count 176 CZQ Quality Cross Check, 41
MC4 Urine Colony Count 176 Chemistry and TDM
Combination DFC Drug-Facilitated Crime 108
Urine crystals URC Crystals 149 LN3 TDM Cal Ver/Lin 121
identification
T Toxicology 96
Urine crystals, UAA Automated Urinalysis 149
semiquantitative
Valproic acid, free X CZ, CZX, Chemistry and TDM 56–58
Urine culture X D2 Urine Culture 175
CZ2X, Z
MC3 Urine Colony Count 176
X MC4 Urine Colony Count 176 Chemistry and TDM
Combination
Vancomycin X CZ, CZX, Chemistry and TDM 56–58
X RMC Routine Microbiology 176 CZ2X, Z
Combination
Urine dipstick X CMP, CMP1 Clinical MIcroscopy 146 Chemistry and TDM
CMQ Quality Cross Check, 46 LN3 TDM Cal Ver/Lin 121
Urinalysis
Vancomycin-resistant IDN, IDO Nucleic Acid Amp, 201
X HCC2 Waived Combination 66 Enterococcus Organisms
POC3 POC/Waived Urine 52 VRE Vancomycin-resistant 187
Dipstick Competency Enterococcus
Urine drug screen X DMPM Drug Monitoring for Pain 107 Vanillylmandelic acid X N/NX Urine Chemistry, Special 69
Management
Variant interpretation VIP, VIP1 Variant Interpretation 252
X UDS, UDS6 Urine Drug Screen 98 only Only
Urine eosinophils, wright SCM1 Special Clinical 152 Varicella-zoster virus ID1 Nucleic Acid 197
stain Microscopy (VZV) Amplification
Urine hCG, qualitative X UHCG Urine hCG 152 X ID5 Varicella-Zoster Virus, 198
Urine hemosiderin, SCM1 Special Clinical 152 Molecular
prussian blue stain Microscopy IDME Meningitis/Encephalitis 202
Urine sediment, color X CMP, CMP1, Clinical Microscopy 146– Panel
photographs CMMP 147 X VR1 Virology Culture 196
Urobilinogen X CMP, CMP1 Clinical Microscopy 146 X VR2 Viral Antigen Detection 196
CMQ Quality Cross Check, 46 by DFA
Urinalysis X VR3 Antibody Detection- 205
X HCC2 Waived Combination 66 Infectious Disease
Serology

ENR Code ENR Code
Vascular endothelial CTKN Cytokines 212 von Willebrand factor CGE/CGEX Coagulation, Extended 161
growth factor (VEGF) CGS3 Coag Special, Series 3 162
Venlafaxine T Toxicology 96 LN37 von Willebrand Factor 129
UT Urine Toxicology 96 Ag Cal Ver/Lin 22
Verapamil T Toxicology 96 Voriconazole AFD Antifungal Drugs 106
UT Urine Toxicology 96 Monitoring
Viability CBT Cord Blood Testing 227 VZV ID1 Nucleic Acid 197
Amplification
SCP Stem Cell Processing 227
X ID5 Varicella-Zoster Virus, 198
Vibrio cholerae GIP Gastrointestinal Panel 204
Molecular
Viral antigen detection X HC2 HSV by DFA 197
POC8 POC Influenza A/B Ag 52 by DFA
X VR2 Viral Antigen Detection 196 X VR3 Antibody Detection, 205
by DFA Infectious Disease
X VR4 Viral Antigen Detection 196 Serology
by EIA and Latex Wavelength and I Instrumentation 132
Viral isolation/ X HC4 HSV Culture 197 photometric calibration
identification WBC automated count ABF1, ABF2, Automated Body Fluid 148
X ID3 Influenza A, Influenza B, 198 (fluid) ABF3
RSV by NAA WBC count ABF1, ABF2, Automated Body Fluid 148
X ID5 HSV, VZV—Molecular 198 ABF3
X IDR Infectious Disease, 202 CBT Cord Blood Testing 227
Respiratory Panel X FH15 Centrifugal Hematology 137
X VR1 Virology Culture 196 X FH1-FH4, Hematology Automated 136
Virtual biopsy program, VBP/VBP1 Online Virtual Biopsies 266 FH6, FH9, Differential
online Program FH10, FH13,
Virtual gram stain VGS1 Virtual Gram Stain Basic 177 FH1P-FH4P,
VGS2 Virtual Gram Stain 177 FH6P, FH9P,
Advanced FH10P,
FH13P
Virtual peripheral blood VPBS Virtual Peripheral Blood 143
smear Smear FH3Q, FH4Q, Quality Cross Check, 45
Viscoelastic studies VES Viscoelastic Studies 166
Series
Viscosity V Viscosity 214
FL4 Flow Cytometry CD34+ 215
Vitamin A BMV3 Bone Markers and 86
X HE, HEP Basic Hematology 136
Vitamins
Vitamin B12 X K, KK, K2 Ligand Assay, General 82
X RWBC Rapid Total White Blood 140
LN5 Ligand Assay Cal Ver/Lin 121-
122 Cell Count
LN5S Ligand Assay, Siemens 121- SCP Stem Cell Processing 227
Cal Ver/Lin 122 WBC count (leukocyte- TRC Transfusion-Related 224
Vitamin B12, active MMA MMA and Active B12 82 reduced platelets) Cell Count
Vitamin D, 1, 25 dihydroxy BMV1 Bone Markers and 86 WBC count (leukocyte- TRC Transfusion-Related 224
Vitamins reduced RBCs) Cell Count
Vitamin D, 25-OH X ABVD Accuracy-Based 85 WBC count (urine) UAA, UAA1 Automated Urinalysis 149
Vitamin D WBC differental (2-part) X FH15 Centrifugal Hematology 137
LN40 Vitamin D Cal Ver/Lin 130 WBC differential EHE1 Expanded Virtual 144
X VITD 25-OH Vitamin D 84 (manual) Peripheral Blood Smear
Vitamin E BMV4 Bone Markers and 86 VPBS Virtual Peripheral Blood 143
Vitamins Smear
VKORC1 PGX Pharmacogenetics 251
Volatiles X AL1 Whole Blood Alcohol/ 101
Volatiles
X AL2 Serum Alcohol/Volatiles 101
800-323-4040 | 847-832-7000 Option 1 | cap.org 343


ENR Code ENR Code
WBC differential, X FH1-FH4, Hematology Automated 136 Zaleplon DFC Drug-Facilitated Crime 108
automated FH6, FH9, Differential ZAP-70 ZAP70 ZAP-70 Analysis by Flow 218
FH10, FH13, Cytometry
22 FH1P-FH4P,
FH6P, FH9P,
Zika virus VBDM Vector-Borne Disease— 200
Molecular
FH10P,
FH13P Zinc X R Trace Metals 78
FH3Q, FH4Q, Quality Cross Check, 45 Zinc, urine TMU Trace Metals, Urine 103
FH6Q, FH9Q Automated Hematology Zinc, whole blood TMWB Trace Metals, Whole 103
Series Blood
WBC differential, body VBF Virtual Body Fluid 148 Ziprasidone DFC Drug-Facilitated Crime 108
fluid Zolpidem DFC Drug-Facilitated Crime 108
WBC manual count (fluid) X HFC, HFCI Hemocytometer Fluid 150– FTC Forensic Toxicology, 104
Count 151 Criminalistics
West Nile virus X NAT Nucleic Acid Testing 232 T Toxicology 96
Worm identification WID Worm Identification 194 UT Urine Toxicology 96
Yeast identification X F Mycology and Aerobic 189 Zonisamide ZE Therapeutic Drug 60
Actinomycetes Monitoring, Extended
X F1 Yeast 189 Zopiclone/Eszopiclone DFC Drug-Facilitated Crime 108
X F3 Candida Culture 190
Yersinia enterocolitica GIP Gastrointestinal Panel 204
23 Program Code Page Index
Benefit from the most comprehensive

range of scientifically developed
programs.
• More than 650 Surveys and anatomic pathology
education programs
• 25 new proficiency testing and quality improvement
programs in 2019
• 600 experts in laboratory medicine support
CAP offerings
23
Program Code Page Index

Program Code Pg Program Code Pg Program Code Pg Program Code Pg Program Code Pg
A2MG 210 APT 150 BSTS 178 CRTQ 42 DMPM 107

AABT 224 APXBN 163 BU 85 CRYP 190 DPATH 267
AABT1 224 AQ 92 BV 184 CS 59 DPATH1 267
AABT2 224 AQ2 92 C1 56-58 CT 164 DPIHC 278
AABT3 224 AQ2Q 44 C3 56-58 CT1 164 DSC 149
AAT 245 AQ3 92 C3X 56-58 CT1Q 48 DY 84
ABF1 148 AQ3Q 44 C4 56-58 CT2 164 E 188
ABF2 148 AQ4 92 C7 77 CT2Q 48 E1 188
ABF3 148 AQ4Q 44 CAMP 180 CT3 164 EGFR 260
ABGIC 115 AQQ 44 CBT 227 CT3Q 48 EHE1 144
ABL 112 ARP 211 CCP 212 CT5 164 ELU 224
ABOSG 222 ASA 156 CD 102 CT5Q 48 EMB 157
ABS 113 ASC 211 CD30 279 CTKN 212 EPO 88
ABT 223 ASO 208 CDF2 180 CTQ 48 ESR 140
ABT1 223 AUP 283 CDF5 181 CY 242 ESR1 140
ABT2 223 AUP1 283 CES 212 CYBK 242 ESR2 140
ABT3 223 B27 237 CESX 212 CYCGH 244 ESR3 140
ABTH 114 BALL 216 CFDNA 260 CYCMA 244 ETB 102
23 ABU 113 BCP 139 CGB 160 CYF 242 ETME1 229
ABVD 112 BCP2 139 CGDF 160 CYH 243 EV 60
ACA 210 BCR 149 CGE 161 CYHI 282 EXM 221
ACE 71 BCS 178 CGEX 161 CYI 242 EXM2 222
ACL 211 BCS1 179 CGL 160 CYJ 243 F 189

ADL 71 BDP 228 CGLQ 47 CYK 243 F1 189
AFD 106 BDP5 228 CGM 169 CYL 243 F3 190
AFL 148 BDPV 228 CGS1 162 CYS 74 FCAL 75
AG 71 BDPV5 228 CGS2 162 CZ 56-58 FCFS 75
AHIV 231 BFC 149 CGS3 162 CZ2X 56-58 FCN 210
AHIVW 231 BGL 245 CGS4 162 CZQ 41 FF 88
AHT 210 BGL1 245 CGS5 162 CZVM 67 FGAL 190
AL1 101 BGS 85 CGS7 162 CZX 56-58 FH1-FH10 136
AL2 101 BL 102 CH50 214 D 173 FH1P-FH10P 136
AMH 84 BMD 139 CHPVD 287 D1 175 FH3Q 45
ANA 208 BMV1 86 CHPVJ 287 D2 175 FH4Q 45
APAPCE 286 BMV2 86 CHPVK 287 D3 175 FH6Q 45
APAPCPT 285 BMV3 86 CHPVM 287 D5 176 FH9Q 45
APAPJE 286 BMV4 86 CMMP 147 D6 177 FH13 136
APAPJPT 285 BMV5 86 CMP 146 D8 178 FH13P 136
APAPKE 286 BMV6 86 CMP1 146 D9 177 FH15 137
APAPKPT 285 BNP 61 CMQ 46 DADR1 240 FL 215
APAPLE 286 BNP5 61 CMSP 246 DADR2 240 FL1 215
APAPLPT 285 BNPQ 41 CPIP 14 DAI 98 FL2 215
APAPME 286 BOR 180 CPIP1 14 DAT 224 FL3 215
APAPMPT 285 BP 193 CRO 180 DBGN 163 FL4 215
APC 210 BRAF 260 CRP 208 DEX 174 FL5 216
APOE 245 BRAFV 278 CRT 62 DFC 108 FL6 216
APS 211 BRCA 246 CRTI 62 DML 237 FLAC 181
FLD 72 HER2 281 ING 86 LN33 128 MX1E 236

FLD2 73 HFC 150 ISH 258 LN34 129 MX2B 236
FLDQ 42 HFCI 151 ISH2 258 LN35 129 MX2C 236
FNA 290 HG 140 J 220 LN36 129 MX2E 236
FNA1 290 HGM 247 J1 220 LN37 129 MXB 237
FNAG 291 HIVG 199 JAT 221 LN38 130 MXC 237
FNAG1 291 HMS 64 JATE1 221 LN39 130 MYBC 279
FNPX 163 HPATH 145 JATQ 49 LN40 130 MYG 69
FOL 88 HPATH1 145 JE1 220 LN41 130 N 69
FP 87 HPS 181 K 82 LN42 131 NAT 232
FP1B 87 HPV 197 K2 82 LN43 131 NB 65
FP1T 87 HQBX1 277 KET 64 LN44 131 NB2 65
FPX 87 HQBX2 277 KIT 260 LN45 130 NEO 259
FR 294 HQBX3 277 KK 82 LN46 131 NGC 289
FR1 294 HQBX4 277 KRAS 260 LPE 76 NGC1 289
FSER 190 HQIHC 274 KSA 69 LPX 183 NGS 254
FSM 191 HQIP 271 KVM 90 M 74 NGSB1 255
FT 75 HQIPBX 276 LBAS 178 MBT 174 NGSB2 255
FTC 104 HQISH 272 LBC 151 MC3 176 NGSBV 257
G 214 HQMEL 273 LCW 64 MC4 176 NGSE 256
G6PDS 75 HQMMR 275 LKM 213 ME 239 NGSHM 255
GH2 63 HQNEU 272 LN2 120 MGEN 185 NGSST 254 23
GH5 63 HQNSC 276 LN2BV 120 MGL1 248-249 NIPT 88
GH5I 63 HQWSI 274 LN3 121 MGL2 248-249 NOB 105
GHER2 281 HSCRP 64 LN5 121-122 MGL3 248-249 NP 284

GHQ 42 HUEP 89 LN5S 121-122 MGL4 248-249 NP1 284
GIP 204 HV2 199 LN6 122 MGL5 248-249 NTA 102
GIP5 204 I 132 LN7 123 MHO 262 NX 69
GLI 261 ICSP 247 LN8 123 MHO1 262 OCB 151
GNBC 179 ID1 197 LN9 123 MHO2 262 OCBQ 46
GOCB 150 ID1T 197 LN11 124 MHO3 262 OFD 100
GPBC 179 ID2 198 LN12 124 MHO5 259, 262 OLI 74
GSA 64 ID3 198 LN12E 124 MK 278 P 192
H 210 ID5 198 LN13 124-125 MMA 82 P3 192
HBF 225 IDME 202 LN13C 124-125 MMR 278 P4 192
HBVL 198 IDN 201 LN15 125 MPA 60 P5 192
HBVL5 198 IDO 201 LN16 125 MRD 262 P16 279
HC1 181 IDPN 203 LN17 125 MRD1 262 PAPCE 286
HC2 197 IDR 202 LN18 126 MRD2 262 PAPCPT 285
HC3 181 IFS 133 LN19 126 MRS 182 PAPJE 286
HC4 197 IG 208 LN20 126 MRS2M 182 PAPJPT 285
HC6 186 IGHV 258 LN21 126 MRS5 182 PAPKE 286
HC6X 186 IGX 208 LN22 126 MRS5M 182 PAPKPT 285
HC7 186 IL 208 LN23 127 MSI 258 PAPLE 286
HCC 66 IM 208 LN24 127 MTBR 188 PAPLPT 285
HCC2 66 IMD1 249 LN25 127 MTP 261 PAPME 286
HCG 208 IMD2 249 LN27 127 MVM 80 PAPMPT 285
HCV2 198 IMD3 249 LN30 128 MVP 185 PARF 233
HE 136 IMW 209 LN31 128 MX1B 236 PCARI 65
HEP 136 IND 191 LN32 128 MX1C 236 PCARM 65
800-323-4040 | 847-832-7000 Option 1 | cap.org 347

PCARMX 65 QF 213 SBAS 178 U 68 WP4 168

PCNEO 217 QP201 25 SC 156 UAA 149 WP6 168
PCP1 191 QP202 26 SC1 156 UAA1 149 WP9 168
PCP2 191 QP203 27 SCDD 105 UBJP 76 WP10 168
PCP4 191 QP204 28 SCM1 152 UDC 99 Y 84
PCT 77 QT1 31 SCM2 152 UDS 98 YVM 90
PDL1 279 QT2 31 SCO 134 UDS6 98 YY 84
PEX 193 QT3 32 SCP 227 UDSM 109 Z 56-58
PF 166 QT4 32 SCS 142 UHCG 152 ZAP70 218
PF1 166 QT5 37 SDS 101 UMC 153 ZE 60
PGX 251 QT7 33 SE 213 UPBG 70 ZT 60
PGX1 251 QT8 33 SEC 250 URC 149
PGX2 251 QT10 34 SEC1 250 UT 96
PGX3 251 QT15 35 SFLC 214 UTCO 134
PHG 76 QT16 36 SM 156 UVM 70
PIA 167 QT17 36 SM1CD 156 V 214
PIAX 167 QTC 22 SM2CD 156 VBDM 200
PIP 265 QTP 22 SMCD 156 VBF 148
PIP1 265 R 78 SO 94 VBP 266
PIPW 264 RAG 223 SOQ 44 VBP1 266
PIPW1 264 RAP 89 SP 184 VES 166
23 PLA 75 RBCAT 223 SP1 184 VF 101
PLTM 169 RDS 213 SPE 76 VGS1 177
PM1 279 RETT 251 SPN 184 VGS2 177
PM2 281 RF 208 ST 184 VIP 252
PM3 279 RFAV1 218 STFR 80 VIP1 252

PM5 280 RFAV2 218 SV 156 VITD 84
PM6 280 RFX 208 SW1 79 VLS 199
PNA1 179 RHCVW 231 SW2 79 VLS2 199
PNA2 179 RMAL 193 SW4 79 VM1 230
PNH 217 RMC 176 T 96 VM2 230
POC1 52 RNA 260 TBLA 78 VM3 230
POC2 52 ROM1 152 THCB 106 VM4 230
POC3 52 RT 141 TICP 288 VM5 231
POC4 52 RT2 141 TICP1 288 VM6 231
POC6 52 RT3 141 TM 89 VM6X 231
POC7 52 RT3Q 45 TMCA 225 VPBS 143
POC8 52 RT4 141 TMCAD 225 VR1 196
POC9 52 RT4Q 45 TMCAE 226 VR2 196
POC10 53 RTQ 45 TMCAF 226 VR3 205
POC11 53 RUB 208 TMO 194 VR3M 205
POC12 53 RUBX 208 TMU 103 VR4 196
POC14 54 RUR 183 TMWB 103 VRE 187
POC15 54 RVBN 163 TMX 89 VS 185
POC16 54 RWBC 140 TNT 62 VS1 185
PRO 22 S2 209 TNT5 62 VS2 186
PS 225 S4 209 TPM 252 WBCR 66
PTHQ 43 S5 209 TRC 224 WBGQ 41
PV 156 SALC 77 TTD 205 WID 194
PV1 156 SARC 259 TVAG 186 WP3 168
Notes
Notes
Notes
Notes
Together, we move forward to achieve better You can offer your staff more than 100
patient care. CE credits.
Laboratory medicine is forever changing—more rapidly than ever before. Our comprehensive
range of laboratory quality solutions constantly evolves to keep in step with these changes,
enabling you more time for what matters most—accuracy in the laboratory.
Year over year the CAP innovates, drawing on the collective knowledge of thousands of
experts in laboratory medicine to help laboratories navigate the changes they face. Much of
this innovation comes from integrated solutions that include accreditation and proficiency
testing (PT). Leveraging this knowledge helps you stay ahead of new technologies, changing
testing requirements, and emerging diseases that contribute to the rapid evolution of
clinical laboratory medicine.
CAP PT programs give you confidence in your results by allowing you to compare your
performance against the largest peer groups. And our accreditation peer inspection model
allows participants to develop meaningful connections and share best practices.
The CAP strives to improve every aspect of PT and accreditation, including:
• Expanding our broad range of PT with new testing programs—39 new Surveys in 2019
and 2020 for microbiology, anatomic pathology, molecular pathology, and many other
disciplines
• Annually updating our 21 discipline-specific accreditation checklists—simplifying the

compliance process and providing a roadmap for running a high-quality laboratory
And we are never done moving forward. The CAP continues to innovate and improve our
laboratory quality solutions, providing better ways to serve you. After all, achieving the
highest quality service and best patient care possible is the primary goal for all of us.
Enhance your learning with continuing education (CE) content that is tightly
• For many of our Surveys, each member of a participating laboratory has

complimentary enrollment to online CE activities.
• Meet certification and licensure requirements with CE across multiple disciplines.
• Advance skills with education activities developed by more than 600 experts in
pathology and laboratory medicine.
• Access CE activities for up to 12 months.
To learn more and see how to access CE, visit cap.org and search Surveys CE.
Laboratory medicine is changing at a rapid pace. Our comprehensive range of programs
is constantly evolving to keep you in step with these changes, so you will have more
time for what matters most—accuracy in the laboratory.
• Choose from more than 650

programs—see pages 4-6 for our
full listing of new programs.
• Offer your staff up to 100 CE credits 2020 Surveys and Anatomic Pathology
with CAP Surveys. Education Programs
• Educate staff on testing trends and
best practices with our Participant
Summary Reports’ extensive
discussions.
• Purchase your programs and manage
your account online—you can review,

modify, and submit your prepopulated
quote.
From routine to esoteric, our programs help you deliver performance you can measure and
accuracy you can trust.
325 Waukegan Road

Northfield, IL 60093-2750
800-323-4040
847-832-7000 (Country code: 001) PERFORMANCE YOU CAN MEASURE. ACCURACY YOU CAN TRUST.
© 2019 College of American Pathologists. All rights reserved. 27780.0719

cap.org

1 - 2020-CAP Surveys Catalog

Uploaded by

Copyright:

Available Formats

1 - 2020-CAP Surveys Catalog

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1 - 2020-CAP Surveys Catalog

Uploaded by

Copyright:

Available Formats

What are some of the continuing education opportunities offered through CAP surveys?

What are some of the continuing education opportunities offered through CAP surveys?

How does CAP help laboratories stay up to date with changes in the field of laboratory medicine?

How does CAP help laboratories stay up to date with changes in the field of laboratory medicine?

Laboratory medicine is changing at a rapid pace.

Our comprehensive range of programs

• Choose from more than 650

2020 Surveys and Anatomic Pathology Education Programs

325 Waukegan Road

© 2019 College of American Pathologists. All rights reserved. 27780.0719

The CAP strives to improve every aspect of PT and accreditation, including:

• Annually updating our 21 discipline-specific accreditation checklists—simplifying the

• For many of our Surveys, each member of a participating laboratory has

8 Blood Gas, Critical Care, 18 Histocompatibility ............................... 235–240

14 Coagulation .......................................... 159–170 23 Program Code Page Index .................... 345–348

In just seconds, the CAP’s Performance Analytics Dashboard provides valuable

To view a demo, search Performance Analytics Dashboard at cap.org.

Quality Management Tools

Quality Cross Check

General Chemistry and Therapeutic Drug Monitoring

Transfusion Medicine, Viral Markers, and Parentage Testing

800-323-4040 | 847-832-7000 Option 1 | cap.org 5

Name Program Code Page

Quality Cross Check

General Chemistry and Therapeutic Drug Monitoring

Instrumentation Validation Tools

Transfusion Medicine, Viral Markers, and Parentage Testing

Genetics and Molecular Pathology

Continuing Education Programs

CME (Continuing Medical Education for Physicians)

Note to CME participants of enduring* materials courses:

CE (Continuing Education for Nonphysicians)

Surveys Continuing Education Activities

Surveys Educational Activities

800-323-4040 | 847-832-7000 Option 1 | cap.org 9

Surveys Self-Reported Training Opportunities

Continuing Certification (CC)

800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Autopsy Pathology AUP/AUP1 12.5**** NA Online 283

Digital Slide Program in FNA* FNA/FNA1 10 10 Online (DigitalScope) 290

Third Page Filler

Simplify ordering with our online store.

27686_OnlineStoreThird_filler.indd 1 5/22/19 4:13 PM

Clinical Pathology Improvement Programs (CPIP/CPIP1)

Competency Assessment Program

Competency Assessment Program with Optional

800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Assessment Course Schedule

Pro Course Schedule

Safety & Compliance Courses

Half Page Filler

800-323-4040 | 847-832-7000 Option 1 | cap.org 17

QMEd™ Online Educational Courses

Quality Management Educational Resources (QMEd) courses will help you:

About the Courses

Quality Manual Development

QMS Implementation Roadmap

800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Quality Management Tools

• Choose from more than 650

• Annually updating our 21 discipline-specific accreditation checklists—simplifying the

• For many of our Surveys, each member of a participating laboratory has